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SYNOPSIS 
In nature, microbes are constantly exposed to variable and stressful environments. Bacteria 
from the genus Pseudomonas are known for their ability to colonise multiple habitats and to 
rapidly adapt to new environments. Indeed, some members have crossed ecological barriers 
and established themselves in clinical settings. Pseudomonas aeruginosa, a problematic 
pathogen, is such an example. It bears intrinsic resistance to many drug classes; has the ability 
to acquire resistance through mobile genetic elements; has high resistance rates worldwide; 
and is frequently implicated in severe infections.   
 
The ability of Pseudomonas to withstand antibiotic selective pressure in the clinical 
environment is primarily due to the presence of multidrug resistance integrons (MRIs). These 
genetic platforms carry genes encoding antibiotic resistance and can cross ecological and 
phylogenetic barriers through associations with transposons and conjugative plasmids. This 
interaction had resulted in an increased incidence of clinical class 1 integrons in Pseudomonas 
aeruginosa. This can ultimately result in the formation of complex mosaic elements and 
complex phenotypes.    
 
However, studying the interaction between different mobile genetic elements and making 
predictions about the rate and dissemination of resistance genes is challenging. In the majority 
of cases, the source of these resistance genes is unknown. Furthermore, the biological 
processes governing the rate of resistance gene flow are unable to be quantified in vivo. 
Lastly, it is difficult to predict the success of resistance gene maintenance within a bacterial 
population. Thus, studying resistance gene flow over ecological and phylogenetic separations 
is very challenging.    
 
Based on previous studies, it is known that gene flow occurs from bacteria in natural 
environments such as soil and water to clinical bacterial populations. Understanding the 
various intragenomic rearrangements and intergenomic transfers involved in this is especially 
relevant to the evolution of multidrug resistance. This study explores the IS1111-attC family 
of insertion sequences as a model for this process in Pseudomonads. IS elements, integrons, 
and gene cassettes were surveyed in Pseudomonas species from clinical, domestic and natural 
environments. The role of target site preferences and transposition mechanisms of the IS1111-
attC elements in distribution patterns was investigated in models based on purified 
 
 
vi 
 
transposase and synthetic nucleic acid molecules  (in vitro) and using IS elements or target 
sites carried on various plasmid vectors (in vivo).   
 
The IS1111-attC subgroup of insertion sequences was found to be overrepresented within 
non-clinical isolates of the genus Pseudomonas from either natural or domestic environments 
relative to other genera or to clinical Pseudomonas isolates. Within this group they were 
specifically found in strains that had chromosomal integrons. The pattern of distribution 
suggests that all instances of IS1111-attC elements in class 1 integrons represent recent 
invasion of attC sites that has occurred when a class 1 integron was present in the same cell as 
a chromosomal integron.   
 
The IS1111-attC elements were shown to specifically recognize the attC recombination sites 
of integrons in binding assays and to specifically target the attC in mobility assays. 
Conditions affecting the rate of IS1111-attC movement between environmental and clinical 
Pseudomonads were also examined.  The mechanism for IS1111-attC translocation was 
demonstrated to be site-specific recombination. Furthermore, the mode of IS1111-attC 
translocation was observed to echo the integron integrase in that the target site is a single-
stranded form of the attC site. Significantly, the IS1111-attC transposase was found to 
preferentially bind the single strand forms of the top strand of the attC site, rather than the 
bottom strand attC site which has been shown to be the target of the integron integrase.   
 
This is the first evidence for IS1111-attC mobility in Pseudomonas cells occurring via a 
similar mechanism to integron gene mobilization and illustrates the potential for these 
elements to both move between environmental (chromosomal) and clinical (plasmid borne) 
integrons as well as facilitate interactions between them.    
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 Introduction 
 
1.1 Co-evolutionary arms race and antibiotic resistance: Red Queen hypothesis 
Environments are dynamic systems which change physically, chemically and biologically. 
For organisms to survive in ever changing environments requires them to adapt or die! Over 
multigenerational periods, evolutionary change in genomes is a major factor for survival. The 
evolution of antibiotic resistance represents a major challenge for the 21st century and can be 
thought of as an arms race between bacteria and humans. Such arms races have been 
recognised in evolutionary biology in the Red Queen hypothesis. 
  
VanValen first formulated the Red Queen hypothesis, which proposed that continuing 
adaptation is necessary in order for a species to maintain its relative fitness within a co-
evolving system (VanValen, 1973). In microbial ecosystems such as soil, bacteria and fungi 
produce antibiotics and other metabolites, as a means of competing for space and nutrients 
(Kümmerer, 2004). Microbes in such ecosystems are in an arms race to survive by 
developing competing mechanisms, which confer baseline resistance to their own antibiotics, 
and those released by their co-inhabitants. The nature of bacterial exposure to antibiotics has 
been changed by human activity though the extensive use and discharge of antibiotics into 
varying environments. While antibiotic resistance in natural ecosystems is a part of bacterial 
biology, antibiotic use and release by humans has exacerbated the resistance problem 
(Andersson & Hughes, 2014).  
 
Since the discovery and industrialization of antibiotics, their exploitation and intensive use in 
clinics and agriculture has altered the nature of the arms race between antibiotic production 
and resistance. Antibiotics, with the aid of humans, are now moving between habitats and at 
higher concentrations than ever occurred naturally. This has dramatically changed the nature 
of the selective pressures for evolution of resistance; bacteria must adapt rapidly and co-
evolve resistance to a range of antibiotic classes, leading to the emergence of multi-drug 
resistance (MDR) strains. The movement of genes between habitats by virtue of a series of 
specialized elements is now recognised as an important contributor to the emergence of 
MDR. For many organisms, increased incidence of MDR strains can largely be attributed to 
horizontal gene transfer (HGT) of resistance genes and subsequent formation of complex 
mosaic elements. This is particularly true of organisms that contribute to opportunistic 
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infections. Thus, excess amounts of antibiotic use has altered the  bacterial response strategy 
by favouring HGT and the formation of MDR phenotypes (Andersson & Hughes, 2014). 
 
Thus, when considering MDR one cannot just focus on a single clinical pathogen in the 
clinical system alone, but instead needs to consider numerous factors such as i) the ecological 
barriers the pathogen must overcome in order to establish in a clinical setting; ii) the intrinsic 
resistance mechanisms of the pathogen; iii) the origin of resistance gene; iv) the rate and 
success of resistance transfer across phylogenetic barriers; v) the mode of resistance transfer; 
vi) the maintenance of resistance phenotype in a population, as well as; vii) MDR organism 
spread from clinical setting into world-wide ecosystem (González-Zorn & Escudero, 2012). 
These observations highlight that MDR is a multifactorial problem involving many different 
species, genetic elements and habitats. It cannot be understood, or managed, by focussing on 
a few problem pathogens in the clinical context. A deeper appreciation and understanding of 
some of the rules governing the biological process of antibiotic resistance assembly and 
formation is required. 
 
1.2  Phylogenetic and ecological separation: old gene, new context 
Biological distance can be thought of as having two broad dimensions, phylogenetic (genetic) 
and ecological, both of which play key roles in MDR formation and dissemination. 
Phylogenetic separation can be defined as the separation of organisms based on evolutionary 
distance. This distance encompasses biochemical and molecular features within a bacterial 
species that have evolved over time. More importantly, bacteria with similar/identical genetic 
makeup are more likely to occupy the same ecological niches (Whiteley et al., 2001), and are 
more likely to exchange genetic material (Andam & Gogarten, 2011). Ecologically disparate 
species are species inhabiting distinct niches that are spatially separated and have differing 
physiochemical conditions, such as pH, nutrients, oxygen availability etc. The ability of a 
bacterial family such as Pseudomonadaceae, to cross ecological barriers and establish in 
varying ecological niches can be related back to its pangenome complexity (Silby et al., 
2011).   
 
Many antibiotic resistance genes are believed to have evolved within communities in non-
human environments such as soil and freshwater. A diverse collection of genes encoding 
resistance to antibiotics such as β-lactams, tetracyclines and glycopeptides, predate the  
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industrialization of antibiotics (D’Costa et al., 2011). The basic enzymology for such 
resistance exists in organisms that produce antibiotics and in the pathways for synthesis of 
antibiotic targets. For example, peptidoglycan modifying DD-peptidases (a penicillin-binding 
protein) are believed to be the ancestor protein to serine β-lactamases (Fisher et al., 2005; 
Massova & Mobashery, 1998). Therefore, antibiotic selective pressures are inferred to have 
impacted on ancestral enzymes resulting in optimization of enzymatic functions such that 
they degrade antimicrobial agents. Additionally, antibiotic selective pressures have impacted 
on the transfer of these enzymes across biological distance and new context (Fisher et al., 
2005; Massova & Mobashery, 1998). In this model, natural selection has evolved a resistance 
function before the resistance gene was able to cross into the clinical setting.  
 
When examining resistance elements and plasmids in clinical pathogens, it appears that 
specific, highly advantageous genes have been selected that result in beneficial resistance 
phenotypes. Given the specialized nature of resistance genes in pathogens, and the short 
evolutionary time scale since the introduction of antimicrobials for therapeutic use, it is 
widely postulated that antibiotic producing bacteria might be reservoirs of efficient resistance 
genes (Davies & Davies, 2010). Irrespective of the model for origins of resistance genes there 
are a series of key points to note. Modern resistance genes are almost certainly derived from 
multiple phylogenetically disparate organisms (Fournier et al., 2006). These organisms did 
not, and do not, typically occupy the animal-human context, or cause clinical disease. 
Therefore, for a resistance gene to establish in a clinical context, it has to overcome issues of 
ecological and phylogenetic separations. 
 
1.3 Genes and genome evolution 
Bacterial reproduction, typically performed by binary fission, is a process wherein the cell 
grows to twice its size, and then splits in two. Whilst binary fission appears as a simple 
process, it must occur at the correct location in the cell in order to ensure that each progeny 
daughter cell receives a complete complement of genes with high fidelity (Angert, 2005). 
Given that bacterial reproduction is asexual, the relationship between the species concept and 
genome structure is often difficult to define. Genome evolution, via mutation, rearrangement 
or acquisition of new genetic material (Hacker & Carniel, 2001), is thus key to bacterial 
survival in an ever changing habitat. Similarities and/or differences between genomes are a 
reflection of the organisms’ life history. Genome evolution can thus be used for species 
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classification, where members of the same bacterial species show genome relatedness. This 
relationship between genome composition of bacterial species and ecology provides the 
conceptual framework for understanding the evolution of multiple antibiotic resistance.   
 
Mass genome sequencing has altered the way we classify and compare bacterial species and 
has highlighted the fact that bacterial genomes do not evolve, or change, at a constant rate 
over the whole chromosome (Mira et al., 2010).  Comparative genomics has repeatedly 
shown that where a bacterial species is defined by a set of phenotypic and ecological (habitat 
restrictions and preferences) features, then members of that species also share a significant 
proportion of their genomes. The concept of pangenomes can arbitrarily be defined as the 
total gene repertoire of a bacterial species (Medini et al., 2005). Genome comparisons of 
different species has shown that genome similarity of members of the same “pheno-species” 
is higher than if members of different species are compared (Figure 1.1).  
 
Figure 1.1: An adapted schematic representation of comparisons of strains from A) different genera 
and B) the same species.   
Venn diagrams reveal a core set of genetic information that is shared by all members between and 
within a species. P represents pangenome overlap between two species. 
 
Genes can form stable, long-term associations with chromosomes. This association is an 
ongoing process whereby organisms have assimilated stable gene sets with adaptive 
advantages for their given environments. The following key concepts arise from comparative 
genome analysis (Figure 1.1): 
1) The extended (ancient) core: Some genes are always present. Chromosomal regions 
shared amongst all bacterial genera are defined as the extended core genome. When 
comparing more distantly related organisms, a smaller set of genetic information 
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“core genes” is still shared. It is estimated that the extended core genome contains in 
the order of 250 gene families, present in all bacterial genomes (Lapierre & Gogarten, 
2009).  
 
2) The core genome: Some genes define the unifying features of a species (core 
genome), others represent the total potential that may occur within a species 
(pangenome). The core genome is vertically inherited, and contains all the necessary 
genomic information for metabolic activity, housekeeping genes, cell envelope 
formation, binding proteins and phenotypic traits (Mira et al., 2010; Wolfgang et al., 
2003). The pangenome includes all genes, both vertically and horizontally acquired. 
Both aspects of genome complexity provides insight into how tightly defined the 
ecological niche of a bacterial genus/species is and of how “old” the species is. 
Accurate description of the core and pangenome within a species is influenced by the 
number of strains examined. Comparative genome analysis of 26 Streptococcal strains 
has revealed the core genome plateaus at ca 600 genes (Lefebure & Stanhope, 2007). 
This is interesting given that each strain contains between 1697-2376 coding genes 
and that the Streptococcus pangenome was postulated to contain over 6000 genes 
(Lefebure & Stanhope, 2007). Analysis of these 26 strains revealed that the 
Streptococcal pangenome is open, that is, genome complexity increases with 
additional strains being considered and an asymptote is not reached (Figure 1.2). 
Comparative genome analysis revealed that open pangenomes are characteristic of 
environmentally sourced species, capable of inhabiting multiple ecological niches 
(Medini et al., 2005). In comparison, the genome complexity within closed 
pangenomes does not alter, irrespective of the number of clinical isolates considered. 
In general terms clinically important organisms are clonal populations of organisms 
with tightly described species definitions and have closed pangenomes. (Figure 1.2).  
 
3) The character “recent” genes: Some genes define the differences between two 
species (or between two populations of the same species such as genomovars or 
pathovars).  These are present in a species core but not in an extended core and clonal 
variations in the character genomes are observed. When comparing sets of closely 
related species, the character genes are effectively the difference between these cores. 
8000 functional gene families are estimated to make up the character genome 
(Lapierre & Gogarten, 2009). These gene families contain niche-specific genes which 
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are essential for survival and adaptation in particular ecological system. An example 
is the production and release of varying siderophores by different Pseudomonad 
species (Sullivant & Gara, 1992).  
 
4) The “other” genes: These genes have arisen within a population through the presence 
of strong mutator alleles and/or floating genomes in order to increase mutation rates 
and persist in challenging environments, such as clinics. Broadly, the floating genome 
consists of mobile genetic elements, such as plasmids, transposons, insertion 
sequences, resistance gene cassettes etc., all of which can act co-operatively and 
become readily dispersed across ecological and phylogenetic contexts (Liebert et al., 
1999).  Generally, these other genes have resulted from rapid specialization in a single 
environment (Mena et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Size of shared extended genome and total genome is dependent on the number of isolates 
examined during comparative genome analysis. 
 
The relationship between genome composition and species concept is thus a product of the 
bacteria and its ecological niche. Organisms that live in the same environment and do the 
same things share a high proportion of the same genes. The emergence of antibiotic 
resistance has involved the recruitment of phylogenetically disparate genes from both the 
core and acquired (floating) pools. Comparative genome analysis of pathogenic clones 
revealed niche specific characteristics (Hilker et al., 2014). Acquisition of the genes allows 
clinical clones to encode adaptive capabilities in order to persist in an ever changing, hostile 
Asymptote 
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environment. The recruitment of these floating genes is however poorly understood. How do 
we then recognise when a gene has come in and established itself as part of a species 
genome? Comparisons between genomes and identification of acquired genes can be used to 
make predictions about the organism’s ability to cross ecological barriers, adapt and persist in 
a specific environment (Read & Ussery, 2006). Conceptually, this is influenced by the origin 
of this gene as well as its movement between genetic contexts, i.e. core to chromosomal 
framework. When comparing all genes within the core genome, it is difficult to determine 
gene origin or to predict gene flow. However, when comparing core genomes in a 
contextually ordered way (chromosomal framework), all genes are placed within an evolution 
context that allows us to compare and contrast gene flow and novelty. We can then define 
common ancestry, mode of gene acquisition, and make informative predictions of the 
adaptive response to “selective pressure” of these genes within/between species. 
 
Acquisition of foreign DNA can be distinguished by virtue of its distinctive phylogeny and 
inconsistent presence within a bacterial species.  Genetic differences between bacterial 
species are often observed in acquired genes and variation in genomes size between the 
species can often be explained by the presence of these foreign genes (Lukjancenko et al., 
2010).  The cooperative nature of genetic elements comprising the acquired genome leads to 
the production of novel biochemical pathways, multi-antibiotic resistance phenotypes, and 
increased virulence (Kung et al., 2010; Ozer et al., 2014).  More importantly, these elements 
are dispersed by horizontal gene transfer events; as such they are able to cross both ecological 
and molecular-genetic barriers, and establish in a range of prokaryotes (Gillings, 2013).   
 
The integron-gene cassette system is distinctive in that it straddles the divide between core 
and floating genome. Briefly, chromosomal integrons (CIs) fit the conceptual definition of 
core genes (albeit recently acquired) (Gillings et al., 2005; Holmes et al., 2003; Mazel et al., 
1998; Vaisvila et al., 2001). In contrast, gene cassettes associated with CIs almost never fit 
the concept of core genes and are part of the floating genome (Michael et al., 2004). A 
plasmid borne multi-resistance integron (MRI) is floating and varies from strain to strain – i.e 
it is not core. However where the MRI has become embedded in chromosome and that 
becomes a feature of the strain (e.g. Acinetobacter global clone) then it fits the core concept 
(Diancourt et al., 2010; Nemec et al., 2004). MRI platforms can be thought of as shuttles 
transferring genetic content between the floating and core genome. The primary interest is 
then in using the integron-gene cassette system in order to understand the forces involved in 
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the integration and spread of DNA across these genome components and bacterial species. 
Interactions between varying genome features need to be considered and their overall impact 
on speciation is vital to our understanding of adaptability, survival and resistance 
mechanisms in a selective environment. 
  
1.4 Resistance mechanisms 
Bacteria have evolved numerous mechanisms such as porins, efflux pumps, and cell 
permeability as a means of regulating cellular homeostasis. For instance, the AcrAB 
multidrug efflux pump in Escherichia coli, plays a physiological role in transporting acidic 
substrates out of the cell, thereby preventing toxicity (Du et al., 2014). In comparison, as a 
means of bypassing low outer membrane permeability, Pseudomonas aeruginosa relies on 
porins to facilitate nutrient uptake under nutrient-limited conditions (Tamber et al., 2006). 
The normal physiological roles of these mechanisms have adapted in such a way as to confer 
antibiotic resistance phenotypes. Efflux pumps, porins, and cell wall permeability are able to 
transport/channel/act on multiple substrates, including antibiotics (Hancock & Speert, 2000; 
Strateva & Yordanov, 2009). Thus bacteria have coping and resistance mechanisms against 
these bioactive molecules as a consequence of their natural physiology. Bacterial core 
genomes naturally encode resistance mechanisms to limit antibiotic susceptibility through an 
active process. These active resistance mechanisms includes antibiotic degradation or 
modification, and efflux (Figure 1.3) and are referred to as intrinsic resistance. Intrinsic 
resistance can be loosely defined as the natural ability of the microbe to resist the antibiotic 
by; i) lack of a drug target, ii) prevent antibiotic entry into the cell or iii) actively disable the 
antibiotic (D’Costa et al., 2006; Lister et al., 2009).  
 
Whilst bacteria are able to utilise their native cellular machinery as defence mechanisms 
against antibiotics, in some instance these mechanisms are acquired from genetically distant 
sources. In contrast to intrinsic resistance, acquired resistance is typically more specialized 
and targeted to a specific role in protection against a given antibiotic rather than conferring 
generalized stress protection or by having a different primary function. Acquired resistance is 
also typically a result of strong selective pressures and consequently associated with the 
accessory genome (Breidenstein et al., 2011). An example of this is the widespread 
occurrence of metallo-beta-lactamase resistance in Ps. aeruginosa, driven by plasmid-
mediated transfer (Lagatolla et al., 2004).   
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Figure 1.3: Intrinsic and acquired resistance mechanisms in Pseudomonas aeruginosa. 
Intrinsic Panel: Resistance by non-specific means such as low outer membrane permeability, porin 
activity and chromosomally encoded genes against aminoglycosides, quinolones and beta-lactams. 
Acquired Panel: Resistance is drug specific and mediated by mobile genetic elements such as 
plasmids. Acquired resistance includes resistance to β-lactams; the presence of antibiotic-modifying 
enzymes; target site mutations; ribosomal mutations or modifications; and metabolic bypass 
mechanisms. 
 
Plasmid mediated transfer of antibiotic resistance genes has been a major driving force in the 
successful dissemination of resistance in pathogenic clinical strains (Nikokar et al., 2013) and 
has greatly driven the adaptation and genomic fitness of opportunistic pathogens. However, 
what determines which resistance genes become plasmid mediated? What are some of the 
biological forces that drive this selection, and add to the complexity of acquired resistance?  
 
1.5  Overcoming ecological and phylogenetic separation: Horizontal gene transfer  
Horizontal gene transfer (HGT) is a key driver of genomic innovation by promoting the 
formation of co-adapted combinations of genes in bacterial communities. However, both 
spatial separation as well as differences in the molecular-genetic makeup of bacteria will 
have an effect on HGT success. Two fundamental constraints for HGT are the susceptibility 
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of the DNA to attack/degradation and the acceptability of the DNA to the recipient cell. The 
three major mechanisms involved in HGT, transduction, conjugation and transformation, 
display different strategies to address the two constraints. 
 
i) Susceptibility of DNA to attack and degradation: Strong habitat effect, some 
phylogenetic  
DNA is susceptible to chemical and enzymatic degradation. Consequently ‘naked’, cell-free 
DNA degrades over time. Therefore the proximity of the recipient cell is an important factor 
in how readily DNA is translocated within genomes and/or between species (populations).  
During conjugation, depolymerisation of pilin subunits precedes DNA transfer through a 
conjugative channel (Firth et al., 1996), thereby restricting the distance of separation between 
donor and recipient cells. The trade-off here is the requirement for physical proximity (µm 
distance), where close proximity drives the success of conjugative transfer (Coscollá et al., 
2011) (Figure 1.4). Conjugative transfer of DNA between a donor and recipient must occur 
within a defined ecological niche, and is also strongly dependent on a compatible transfer 
machinery between the two.  
 
During transformation, extracellular DNA is taken up from the surrounding environment. 
Natural transformation occurs commonly in highly populated niches such as soil and biofilms 
(Demaneche et al., 2001). In such environments, the DNA is not protected by a phage capsid 
or the host cell. Thus, DNA uptake has to occur before DNA “quality” is compromised. The 
success of natural transformation is however dependent on cell competency (Thomas & 
Nielsen, 2005), DNA uptake efficiency and cellular recombination machinery (Chen & 
Dubnau, 2004). For successful DNA transfer into a recipient cell to occur, the recipient must 
have the necessary outer membrane machinery for DNA uptake into the cytoplasm. Thus the 
molecular-genetic factors of the recipient play a vital role in natural transformation.  
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Figure 1.4: Modes of horizontal gene transfer and their relationships to spatial proximity. 
 
Finally, during transduction, DNA is packaged in a phage particle that serves as protection in 
the extracellular environment (Brüssow et al., 2004; Frost et al., 2005). Transduction is thus 
not restricted to short distances as the phage capsid allows transmission across habitat 
separations, hence ecological separation is less of a constraint in this case. However, the 
trade-off is the constraint on DNA acceptability as the phage particle is dependent on specific 
molecular recognition machinery (Frost et al., 2005). When the appropriate recognition 
machinery is present, phage mediated transfer of antibiotic resistance genes and pathogenicity 
islands has been noted to occur between distantly related bacterial species (Chen & Novick, 
2009; Koskella & Meaden, 2013; Mazaheri Nezhad Fard et al., 2011).  
 
ii) Acceptability of DNA: Genetic and biochemical factors greatly influence stable 
maintenance of newly acquired DNA 
A gene’s fitness is constrained by its context. For a newly acquired gene to persist, it must 
confer an advantage to its host related to the host’s environmental context. Integration of the 
gene into the chromosome must result in gene expression in order to continue this advantage. 
Gene maintenance is also related to integration with respect to cell division and replication 
machinery and finally, gene insertion is also impacted by surrounding genetic content 
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(adjacent genes within the chromosomal framework). Long-term maintenance and replication 
may occur through self-replication in the case of episomes, or through insertion into existing 
elements or chromosomal contexts (Eisen, 2000). Sharing common transcriptional and 
translational features, promoters and regulatory sequences, enhance the success of a HGT 
event by driving successful integration and expression of the newly acquired genes into the 
recipient cell (Andam & Gogarten, 2011; Iyer et al., 2004; Olendzenski et al., 2002). 
Therefore, the likelihood of a successful HGT event and DNA maintenance within a bacterial 
species is strongly correlated to the phylogenetic proximity of the partners (Coscollá et al., 
2011).  
 
In some instances, the foreign DNA cannot be maintained within the new recipient. Host 
factors, restriction-modification systems as well as genomic sequence divergence all limit the 
success of incorporation of the newly acquired DNA into the genomic, chromosomal context 
(Matic et al., 1996). Mismatch repair systems in some species have been noted to prevent 
homologous recombination based on insertions of distantly related genes. In the case of 
Escherichia coli and Salmonella typhimurium, the frequency of conjugational and 
transformational genetic exchange was found to be increased a thousand fold when the 
MutHLSU mismatch repair system was inactivated (Matic et al., 1995; Rayssiguieret  et al., 
1989).  
 
Phylogenetic relationships can thus be used to predict both genetic and ecological 
relationships between donor and recipient. Both ecological and genetic conditions must be 
met, and newly acquired DNA must be stably maintained, before a selective 
advantage/phenotype such as antibiotic resistance emerges. The dispersal of resistance genes 
in the modern era indicates that rather striking barriers of ecological and genetic distance 
have been repeatedly overcome to result in a major problem for humanity. Yet there is very 
little understanding about how antibiotic resistance genes overcome these ecological and 
genetic barriers.  
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1.6 Exploring the diversity of MGEs and complexity of the floating genome 
Mobile genetic elements (MGEs) facilitate HGT by overcoming some of the habitat and 
genetic barriers (Frost et al., 2005). Despite the variability in MGEs (Figure 1.5), some 
recurrent structural and enzymatic features are frequently seen. Based on these features, 
MGEs can be broadly classified as replicons; transferrers; translocators and accumulators.  
 
MGEs classified as replicons lower the molecular-genetic constraints related to stable 
maintenance. Replicons carry replication/partition genes that may be actively expressed in 
distantly related organisms (Tamminen et al., 2012). Their presence allows for self-
replication in a wide range of host cells and thus facilitate dissemination within and across 
habitats. Transferrers carry translocation genes with them and thereby possess autonomous 
mobility. Transferrers are also able to reduce the constraint of molecular-genetic distance 
through “sampling” available cell hosts. Similarly, translocators have the capacity to replicate 
in multiple and divergent hosts, found in varying ecological niches. Accumulators generate 
novelty through gene rearrangements, acquisition and altered expression and have the 
potential to increase microbial fitness (Nagy & Chandler, 2004, Schneider & Lenski, 2004).  
 
 
Figure 1.5: Mobile genetic elements are diverse yet share similar features that may include 
transposase genes, inverted repeats (IR), resistance genes and recombination sites (attC). 
These are all examples of MGEs that have genetic “handles” and thus possess the ability to 
translocate and recognise other MGEs that have abilities such as transfer and/or replication. 
 
1.6.1 Replicons-Plasmids 
Categorisation of plasmids is based on their autonomous replication mechanisms. Plasmids 
are extrachromosomal DNA elements, which are capable of replicating independently of the 
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genome. Plasmids categorized into the incompatibility groups IncP, IncQ and IncW, promote 
horizontal gene transfer of resistance genes among unrelated bacteria (Carattoli, 2013). The 
role of plasmids in the widespread dissemination of  resistance to the major classes of 
antimicrobials, such as β-lactams and aminoglycosides, is well understood and documented 
(Carattoli, 2009). Broad-host-range plasmids in the IncP-1 family have been linked to the 
spread of resistance to a broad spectrum of antibiotics, heavy metals, and quaternary 
ammonium compounds used as disinfectants (Popowska & Krawczyk-Balska, 2013). 
Furthermore, the IncP-1 family (of plasmids) is able to replicate in numerous species of 
Alpha, Beta- and Gamma-proteobacteria and are thus able to persist in a diverse range of 
ecological and genetic niches. Whilst these plasmids can replicate in a diverse range of 
bacteria, their overall stability is varied and eventual loss of the plasmid can be observed (De 
Gelder et al., 2007). Note also that not all broad-host range plasmids have the capacity to 
become as widespread as the IncP-1 family. Host range thus highlights constraints on overall 
distribution across ecological and genetic barriers.  
 
Host factors and plasmid-related interactions such as conjugative transfer, plasmid 
partitioning as well as accumulations of mutations are linked to plasmid loss and acquisition 
(Koraimann, 2004; Williams & Thomas, 1992). Success of conjugative plasmid transfer is 
dependent on close cell-to-cell proximity, presence of pilus and molecular recognition of 
pilus by recipient cell. Plasmid maintenance is a trade-off between the cost of plasmid 
mobility and the advantage they provide the host (Svara & Rankin, 2011). Acquisition of 
MGEs such as transposons, integrons and insertion sequences can provide a means of 
ensuring that these plasmids are maintained within a population by conferring a selective and 
adaptive advantage to its host. Therefore the replicon “cargo DNA”, highlights constraints on 
the selective advantage it may provide to its host bacterium.  
 
What remains largely unknown is how these MGE are acquired and assembled into replicons 
in the first place. If a plasmid does not provide an advantage, is likely to become a cell 
burden and may ultimately be lost from a population.  
 
1.6.2 Transferrers-ICE 
Integrative and Conjugative Elements (ICEs) are a group of self-transmissible genetic 
elements that must integrate into an existing replicon in order to achieve replication (Burrus 
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et al., 2002). ICEs are less dependent on Inc mechanisms for stable maintenance, thus are 
better able to co-exit with other replicons. ICEs act as vectors for gene transfer, ultimately 
resulting in the spread of antibiotic resistance genes (Larbig et al., 2002), metabolic genes 
(Klockgether et al., 2004), virulence and pathogenicity genes (Battle et al., 2008), and genes 
for toxic compound transportation (Larbig et al., 2002). ICEs with low target site specificity 
are termed conjugative transposons and are tens of kb in size. In comparison, ICEs with 
higher target sequence specificity and which are larger in size are termed genomic islands 
(GIs) (Wozniak & Waldor, 2010). 
 
Their complex genetic makeup arises by assembly of a  diverse range of MGEs, such as ISs,  
transposons (Tns) and antibiotic resistance genes (Juhas et al., 2009; Pembroke et al., 2002; 
Harada et al., 2010). By means of autonomous mobility, transferrers remove  constraints via 
their ability to alter their genetic context (chromosome ↔ plasmid)  (Douard et al., 2010).  
However, autonomous mobility does not guarantee long term maintenance of ICEs in a 
bacterial population. Additionally, surface exclusion may prevent ICE entry into a bacterial 
cell and thereby reducing the likelihood of long-term establishment of the ICE within the 
species (Frost et al., 1994). ICE mobility can result in the formation of novel genetic 
structures and the spread of virulence and resistance genes, but it still leaves us wondering 
how different MGE assemble into their ICE platform in the first place. 
 
1.6.3  Translocators and accumulators-transposons, compound transposons, 
bacteriophages, insertion sequences, integrons 
Translocators, such as Tns, compound transposons (CTns), and Insertion sequences (ISs), 
have the innate ability to translocate from one genetic context (e.g. chromosomal) into a new 
location (e.g. plasmid). Often their translocation process results in the mobilization of 
additional genetic cargo. This acquisition requires a degree of stable maintenance of the 
translocators as well as its DNA “cargo”. Once presented with a new genetic context, 
recombination of the translocators and its cargo must however ensure that recipient integrity 
is maintained in order for the translocator to persist within a population.  A classic example is 
the mobilization of resistance genes in the  class1 integron array by transposon Tn402 
(Gillings et al., 2009; Labbate et al., 2008; Sajjad et al., 2011). Translocation of such an 
integron array into a plasmid, impacts on dissemination of resistance within a bacterial 
population. Translocators alter both the genetic context of the resistance gene and its 
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ecological distribution to overcome both ecological and phylogenetic constraints of HGT. 
How exactly does the cargo DNA get into the translocator? What determines where and how 
fast the cargo is delivered? 
 
i) Transposons and Compound Transposons  
Transposons have undoubtedly been a source of genetic diversity, and Tn mobility is often a 
balance between positive and negative outcomes on the host. Tns can alter their fitness 
through association with other MGE such as plasmids. Tns mediate their own transfer within 
a genome, and integrate into unrelated DNA. Transposons can vary greatly in size and 
genetic makeup as they can harbour various accessory genes, such as metal resistance, 
antibiotic resistance and metabolic processing genes. Translocation of the Tn3 family is 
dependent on three key structural features; a tnpA gene for transposition, a tnpR gene for 
resolution, and short (15 to 40-bp) terminal inverted repeats (IR) (Bennett, 1999, 2004; 
Kleckner, 1981) (Figure 1.5). Translocation of antibiotic resistance genes in hospital, 
environment and commensal associated bacteria is mostly due to large broad-host-range 
plasmids and the transposons they carry (Minakhina et al., 1999).  
 
CTns consist of a central region flanked by two identical or near identical insertion sequences 
(ISs) (Figure 1.5).  This central region contains accessory genes for antibiotic resistance and 
metabolic pathways (Chalmers & Kleckner, 1996; Meer & Zehnder, 1991). The presence of 
the catabolic and antibiotic resistance genes on CTns, suggest a mechanism by which gene 
clusters can be generated to form novel catabolic and resistance pathways and become 
widespread. 
 
ii) Bacteriophages 
Bacteriophages can also be thought of as translocators. Many GIs are thought to have arisen 
by bacteriophage phi (ɸ) integrase machinery (Boyd et al., 2009). Recent evidence has 
emerged suggesting that bacteriophages in wastewater treatment plants are vehicles for the 
transfer of resistance genes that encode beta-lactamases (blaTEM, blaCTX-M) among Gram-
negative pathogens, and penicillin-binding protein 2a (PBP2a), associated with methicillin 
resistance (mecA gene) in staphylococci (Colomer-Lluch et al., 2011). This demonstrates that 
bacteriophage mediated HGT has the capacity to overcome both ecological and phylogenetic 
barriers. A constraint however is the bacteriophage capsid size, which limits the amount of 
cargo DNA that can be efficiently packaged and translocated. 
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iii)  Insertion Sequences (ISs): simplest, self-mobilisable transposable elements 
IS translocation can impact on bacterial genomes in numerous ways (Bartlett & Silverman, 
1989; Mahillon & Chandler, 1998; Mills et al., 1992; Sokol et al., 1994).  The primary 
function of ISs is to maintain themselves through random or site-specific translocation. IS are 
able to aggregate genes into mosaics, mobilize them, and thereby provide a positive net-effect 
to the host (Hacker & Carniel, 2001b; Klockgether et al., 2004a; Venkatesan et al., 2001). 
Despite being so widespread, IS translocation can be limited by phylogenetic separation 
(Mahillion & Chandler, 1998). Appropriate host factors may be necessary to drive the initial 
IS translocation into a higher-order translocation (Tn/CTn) or replicator.  
 
iv) Integrons and gene cassettes: accumulators of resistance genes 
In 1989, Stokes and Hall defined integrons as a genetic platform which served to accumulate 
genes. Most importantly, integrons harness the power of DNA translocation to overcome both 
ecological and phylogenetic boundaries. The minimal requirement for an active integron 
platform were identified as a core integron structure, intI and attI sites. Integrons are 
categorized by the amino acid sequence of the encoded DNA integrase. Site-specific 
recombination mediated by the integron integrase achieves directed insertion of gene 
cassettes into the integron platform, through the recognition of  two distinct recombination 
sites, attI and attC (Collis et al., 1993) (Figure 1.6).  
 
 
Figure 1.6: General structure of the integron-gene cassette system.  
The intI gene encodes a tyrosine recombinase (integrase) that catalyses site-specific recombination 
between the attI and attC sites, resulting in integration or excision of gene cassettes.  
 
Gene cassettes themselves are non-replicating, transcriptionally silent, circularised units 
containing a recombination site, attC, and one or more open reading frames (orfs) (Recchia & 
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Hall, 1995). The independence of gene cassettes is what makes integron accumulators. 
Conceptually a translocator goes to multiple different fixed points in the chromosome, but an 
accumulator brings multiple separate sites to one location. Thus in order to be expressed, 
gene cassettes must be integrated into the integron platform via site-specific recombination 
between attI-attC or attC-attC sites. Upon capture by the integron, gene cassettes are 
transformed from free circular molecules into linear integrated molecules. They are then 
replicated with the chromosome or plasmid hosting the integron (Collis & Hall, 1992). Once 
integrated, gene cassettes are expressed by the integron Pc promoter. The location and 
strength of this promoter varies between the different integron classes (Collis & Hall, 1995; 
Levesque et al., 1994). The incorporation of many different gene cassettes, by multiple 
recombination events, results in an array of gene cassettes.  Such arrays may range from 0 to 
200 cassettes in size (Boucher et al., 2007; Mazel et al., 1998). The accumulative nature of 
integrons, when coupled with antibiotic selection in clinical systems, can facilitate selection 
for integron-mediated multidrug resistant pathogens (Krauland et al., 2009; Leverstein-van 
Hall et al., 2002; Livermore & Woodford, 2006). While an integron is able to recruit gene 
cassettes, it requires a transferrer and a replicator to disseminate within/between bacterial 
populations (Frost et al., 2005).  An example of accumulators, translocators and replicators 
working co-operatively is found in plasmid pAX22. This plasmid contains integron In70 
carrying resistance genes to metallo-β-lactamases. Translocation of this integron is believed 
to be mediated by Tn7017. Mobilization of this integron-transposon  into the plasmid is 
believed to have occurred by an additional translocator, ISPa17 (Di Pilato et al., 2014).  
 
The environmental and genetic factors that regulate successful conjugative transfer of 
antibiotic resistance genes and MGEs in bacterial populations are highly complex (Beaber et 
al., 2004) and is often challenged with varying constraints. These constraints are largely 
dependent on interactions between multiple types of MGEs and differences in their 
mechanistic capacity (Table 1.1). 
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Table 1.1: A summary of the mechanistic capacities of MGEs 
MGE Genes/Enzymes Function 
Replicons 
rep/par genes 
Replication and partitioning of 
plasmid in cell 
Toxin/ antitoxin genes 
Ensure plasmid selection and 
maintenance in population 
Transferrers Transfer/ conjugation genes Vector for genetic information 
Translocators Transposase 
Self-mediated translocation 
without replication 
Accumulators 
Integrase, attI, attC, gene 
cassettes 
Recombination of genetic 
information into a meaningful 
context 
 
1.7 Site-specific recombination: a key process in multidrug resistance assembly and 
spread 
Despite structural, enzymatic and differences in target site preference, site-specific 
recombination is a recurrent theme for many MGE elements mentioned. Note that site-
specific recombination is especially important in multi-drug resistance generation and spread 
(Hall & Collis, 1995; Sundstrom et al., 1988).  Site-specific recombination enables efficient 
interactions between different MGEs and determines which MGEs interact. Site-specific 
recombination is a conservative process during which DNA strand exchange occurs between 
two DNA sequences with a limited degree of sequence homology (Grindley et al., 2006).  
Well known site-specific recombinases fall into one of two families: tyrosine recombinases (λ 
integrase family), and serine recombinases (resolvase family). Serine recombinases will not 
be examined in depth in this thesis. Instead it should simply be noted that serine 
recombinases require a serine within their active site to produce double strand breaks at the 
cross over sites before any exchange of DNA can be initiated (Grindley et al., 2006).  
 
Tyrosine recombinases use an active tyrosine amino acid to cleave one strand of the duplex 
chain at a time (Star et al., 1992). Members of this family include XerC and XerD, Cre of 
bacteriophage P1, FLP of yeasts, bacteriophage λ Int recombinases (Lee & Sadowski, 2005) 
as well as the integron integrase IntI. Tyrosine-recombinases exhibit strand selectivity during 
recombination reactions.  One strand on each participating DNA is cleaved by a reactive 
tyrosine residue to form a 3′-phosphotyrosyl intermediate and a free 5′-hydroxyl group.  
Strand exchange between the two sites follows, generating a Holliday junction (HJ) 
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intermediate (Figure 1.7). The opposite strands then exchange to form recombinant products 
(Blakely, 2000; Grindley et al., 2006).  
 
MGEs have evolved independently of one another (Table 1.2). Their fate and  impact on 
HGT is strongly linked to their ability to target their insertion sites with some MGEs 
displaying striking site-specific targeting within conserved genes (Peters & Craig., 2001; 
Petrovski & Stanisich, 2010; Stanisich et al., 1989) or site-structures (Tetu & Holmes, 2008).  
 
Table 1.2: MGE and their independent evolution-enzymes and mechanisms 
Recombinase 
Family 
Examples of 
elements 
Outcome Reference 
Serine 
Tn3 (TnA or 
type II 
transposons) 
and γδ 
One copy of the TE remains at the 
original site while the other copy is 
inserted at the new recombination res 
site 
Grinsted et al. 
(1979) 
Tyrosine 
XerC/XerD  
Crossover at the speciﬁc dif site 
present in the E. coli K-12 DNA 
replication terminus region  
Blakely, (2000) 
Cre-loxP 
Site-speciﬁc recombination between 
34-bp loxP sites 
Sternberg et al. 
(1981) 
Tn4555 
conjugal transposition is hypothesized 
to occur via a circular intermediate 
Tribble et al. 
(1997) 
Phage lambda 
integrase 
Integration and excision of DNA at 
attL and attR attachment sites  
Landy & Ross, 
(1977) 
Integron 
Integrase (IntI) 
Integration and excision of gene 
cassettes into the integron array by 
attIxattC and attCxattC recombination 
Demarre et al. 
(2007) 
DDE  
Tn7,Tn10, Tn5 
IS3 family 
Tn is excised from the original site 
and inserted at the new target site. 
Preference for the sequence 5′-
GCTNAGC-3′ as the target site 
Bender & 
Kleckner, (1986), 
1992; Kleckner et 
al. (1996)  
DEDD  
IS1111-attC 
family 
Predicted to target attC structure via a 
Piv/MooV transposase homologue 
Tetu & Holmes, 
(2008) 
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Figure 1.7: a) XerC/D, b) Cre-loxP, and c) IntI1 mediated recombination all require a precise cross-over of target DNA sites.  
XerC/D and Cre-loxP require two double stranded DNA strands for site-specific recombination, whereas IntI1 requires one double stranded attI and one 
single stranded attC hairpin. XerC/D is essential for chromosome segregation in E. coli and Cre-loxP is essential for bacteriophage P1 integration into the 
chromosome. i) Synapsis and attack involves the attachment of 4 enzymatic units and attack by the active tyrosine to form a 3′-P and 5′-OH radical. ii) 
Reactive Radical/Attack involves strand exchange driven by the reactive 5′-OH radical. iii) A Holliday junction forms iv) and v) is resolved by recombination 
and resolution. 
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1.7.1 IntI Integrase, an unorthodox site-specific recombinase 
IntI recombination can be thought of as non-classical site-specific recombination. In contrast 
to XerC/XerD (Figure 1.7A) and Cre-loxP (Figure 1.7B) recombinases which require two 
double stranded DNAs, IntI1 mediated site-specific recombination requires one double 
stranded  attI1 site and one single stranded, attC hairpin (Figure 1.7C). Francia et al., (1999) 
demonstrated that IntI1 binds double stranded attI molecules, but only single stranded attC 
substrates, specifically the bottom strand, were bound by IntI1. This single stranded attCbs 
adopts a double stranded DNA-like structure by the annealing the complementary IR, 
forming a structure similar to the canonical recombination site: two IR separated by a short 
spacer (Johansson et al., 2004, Stokes et al., 1997, Francia et al., 1997). Resolution of the 
Vibrio cholera IntI (VchIntIA)-attC crystal structure further supported the hypothesis that 
insertion of gene cassettes requires a single stranded, folded back attC (MacDonald et al., 
2006). 
 
The diverse range of attC sites in multidrug resistance integrons (MRIs) arrays highlights the 
ability of IntI1 to overcome phylogenetic boundaries. MRIs are functional integron platforms 
physically associated with mobile DNA elements (Tns), which can be transferred by 
conjugative plasmids. The lack of conservation between MRI attC sites, suggests that they 
originate from biologically distinct sources. In comparison, the ability of class 2 integrase 
(Int2) to overcome phylogenetic separations is believed to be limited given the high 
conservation, and relative simplicity of In2 arrays (Ramírez et al., 2010).  
 
Whilst IntI1 is able to recognize diverse attC sites, its action on attI sites is more specific (it 
only acts on attI1). attI sites are highly conserved within an integron class (e.g. attI1 occurs 
in class 1 integrons) (Partridge et al., 2000), and highly divergent between classes (Elsaied et 
al., 2011). Note that attI and attC sites are canonical DNA targets, and that IntI-attC binding 
is dependent on the topological conformation of the attC, whereas IntI1-attI1 binding is 
dependent on attI sequence recognition. Four IntI1 binding sites, (weak, strong and two 
regions within the simple site) are involved in IntI1-attI1 recombination activity (Partridge et 
al., 2000; Stokes et al., 1997) (Figure 1.8).  Binding sites 1 and 2 contain the core 
recombination site (GTTRRRY). Site 3 is the strong binding site while site 4 is the weak 
binding site and are direct repeats (DRs), which are adjacent to one another and are not 
conserved across all other attI sites (Stokes et al., 2001).  
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Figure 1.8: Schematic illustration of the structure of A) attI and B) attCaadB sites.   
A) Experimentally determined strong and weak IntI1-binding sites (Collis et al., 1998) and a pair of 
direct repeats, DR1 and DR2, are indicated by blue dashed boxes and arrows.  
B) The location of simple sites and their inverted repeats are shown by dashed red boxes and arrows. 
R′′ contains the recombination crossover point GTTRRRY (marked with vertical orange arrows). R′ 
contains the inverse core site with the consensus sequence RYYYAAC. The qacE part of the sequences 
is represented by smaller font size (Bouvier et al., 2009; Partridge et al., 2000). 
 
 
IntI specifically recognises cognate attI, which contrasts with its ability to recognise and bind 
variable, unrelated attC sites. The ability of IntI to overcome sequence and conformation 
constrains, as well as the formation of single stranded structures, are evolutionary driving 
forces and must be considered when studying the formation and dissemination of multi-drug 
resistance.  In summary, the roles of site-specific recombination are in either precisely joining 
or precisely separating DNA targets. Their specificity for one or both target sites is therefore 
an indicator of their biological roles. 
 
1.8 A model system for the study of gene flow across ecological and phylogenetic 
barriers 
Studying the interaction between different mobile genetic elements and making predictions 
about the rate of dissemination of resistance genes is challenging. In the majority of cases the 
source of these resistance genes is unknown. In vitro quantification of antibiotic resistance 
and sensitivity are routinely performed on pure cultures in clinical laboratories (Ahmed et al., 
2013; Chaudhary et al., 1998; Drago et al., 2005).  However, this a crude and often 
insensitive measure of resistance and thus cannot be regarded as a complete representation of 
resistance. In vivo quantification, whilst difficult to achieve and establish as a routine 
diagnostic approach, provides more information on resistance than does in vitro analysis 
(Nilsson et al., 2003; Riou et al., 2010). Understanding resistance at an in vivo level would 
result in more accurate drug administration, a localized form of treatment, and overall lower 
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resistance levels. Lastly, it is difficult to predict the success of resistance gene maintenance 
within a bacterial population. Understanding these factors is clearly important if we wish to 
make informative decisions about antibiotic administration and long-term efficacy in clinics. 
Given the multi-factorial nature of antibiotic resistance, studying resistance gene flow over 
ecological and phylogenetic separations requires the implementation of a few different model 
systems.  
 
1.8.1 Integron, the model system for gene flow between mobile and chromosomal 
contexts 
Based on the sequence of the encoded integrase (40%–58% identity), five different classes of 
mobile integrons (MIs) have been defined (Cambray et al., 2010). MIs can broadly be 
defined as integron platforms located on mobile elements such as plasmids or Tns. Class 1, 2 
and 3 integrons, exhibit a number of features not typical of the more diverse chromosomal 
integron classes.  Class 2 integrons are typically associated with Tn7-like transposons 
(Ramírez et al., 2010), while class 3 integrons are typically associated with Tn5053-like 
transposons (Collis et al., 2002). Hall et al. (1999) first suggested that different classes of 
integrons reflect different origins from different evolutionary groups. However, despite 
representing different evolutionary origins, integron classes can share resistance gene 
cassettes. For instance, the aadB antibiotic resistance gene can often be found in a variety of 
mobile integrons. This highlights the relative importance of HGT and interactions between 
different integrons in driving the spread of antibiotic resistance (Partridge et al., 2009). The 
majority of integrons encountered in the clinical context are class 1 integrons.  This is due to 
their ability to capture and express a diverse range of resistance genes. They are also 
widespread in pathogenic and commensal populations (Goldstein et al., 2001).  
 
Class 1 integrons are observed in various ecological habitats (Stalder et al., 2012), 
predominantly the clinical setting (Essen-Zandbergen, 2007), as well as different 
phylogenetic contexts, replicons, transferrers and translocators. The widespread 
dissemination of class 1 integrons (Int1) coincides with the widespread use of antibiotics and 
the selective pressure which they exert. As a response to these selective pressures and natural 
selection (Gillings et al., 2008), class 1 integron arrays are constantly evolving at a 
phenomenal rate.   
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Class 1 integrons most commonly contain between 0 to 9 cassettes, almost all of which 
encode antibiotic resistance determinants. This diversity often reflects the selective pressures 
that the bacteria needed to overcome, as the arrays often match the prevailing antibiotics used 
in the environment from which the strain was recovered (White et al., 2001; Xu et al., 2013). 
Despite variations in gene cassette arrays and the different genetic contexts that class 1 
integrons are found in, the 5ꞌ and 3ꞌ region of class 1 integrons are typically well conserved 
(Figure 1.9). They are associated with functional and non-functional transposons derived 
from Tn402, which can be further embedded in larger transposons such as Tn21.  
 
Stokes et al. (2006) and Gillings et al. (2008) performed PCR-based surveys for class 1 
integron integrase genes using non-clinical environmental isolates. These non-clinical class 1 
integrons, differed from their clinical “relatives” in two ways. Firstly the gene cassette 
content differs between these integrons and secondly, they did not contain the 3′ CS and 
Tn402-related flanking sequences. This work illustrated the importance of the Tn flanking 
gene in the mobilisation of the integron platform to the clinical environment where these 
resistance gene cassettes are selected.  
 
 
Figure 1.9: Resistance markers vary between integrons and in most cases are flanked by the 5'- and 
3'- conserved region (CS).  
Examples of class 1 integrons depicted here contain different resistance markers (aadB, aadA1a, 
dfrB2, oxa2, aac1, aadA2, cmlA1) and their respective cross-over attC sites (rectangles and small 
triangles). These integrons are localized on different transposons and plasmid backbones. The 5′CS 
region contains the intI1 and attI1 region.  3′CS region generally encompasses the sul1 resistance 
gene (sulphonamide), qacE resistance gene (quaternary ammonium), and orf5 (unknown function). 
 
Two fundamental questions have arisen from this research. Firstly, what was the genetic 
context/origin of the class 1 integron ancestor? Chromosomal class 1 integrons have 
commonly been observed in a wide range of nonpathogenic β-Proteobacteria, including 
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members of the genera Hydrogenophaga, Aquabacterium, Acidovorax, Imtechium, Azoarcus, 
and Thauera (Gillings, 2014). There is mounting evidence that suggests that a chromosomal 
class 1 integron within β-Proteobacteria was captured by a Tn402 transposon by site-specific 
recombination. This hybrid also contained the qacE cassette, which is able to confer 
resistance to disinfectants. Note that the use of disinfectants predates the use of antibiotics. 
Subsequent acquisition of the sulI gene encoding resistance to sulfonamides, and orf5, with 
an unknown function, resulted in a partial deletion of the qacE cassette, thereby generating 
the 3′-conserved region. Further steps involved deletions, insertions of tni, and acquisitions of 
additional antibiotic resistance cassettes.  Subsequent step involved the mobilization of the 
Tn402-integron hybrid into a replicon and/or other transposons such as Tn21 family. These 
events lead to the mobilization and widespread dissemination of the class 1 integron across 
ecological and phylogenetic contexts (Gillings et al., 2008). 
 
Secondly, what is the origin of resistance genes observed in clinical class 1 integrons? The 
answer to this question may also lie in the chromosomal framework of non-pathogenic 
bacteria! IntI homologs are present in 17% of available bacterial genomes and are prevalent 
in members of the γ-Proteobacteria (Cambray et al., 2010) (Figure 1.10). These clade specific 
integron homologs show some features of acquired genes (gene cassette arrays), yet unlike 
their mobilized counterparts, these show signs of incorporation into chromosomal framework 
of its host (Heidelberg et al., 2000). As such they are broadly referred to a Chromosomal 
integrons (CIs).  
 
CIs generally exhibit patterns of stable vertical inheritance in bacterial lineages (Boucher et 
al., 2007; Gillings et al., 2005; Holmes et al., 2003; Mazel et al., 1998; Mazel, 2006). Their 
“patchy” distribution across different bacterial genera, suggests that collectively CIs have 
experienced multiple losses and undergone multiple gene transfer events. Yet their 
chromosomal context and evolutionary trajectory also shows their co-evolution within a 
species. CIs within a species are often observed in the same locus. For instance,  the PA3672 
locus is one of the insertion points for Pseudomonas chromosomal integron (PCI) in Ps. 
stutzeri strain Q, Ps. stutzeri BAM17 and other Pseudomonads (Holmes et al., 2003). The co-
evolutionary trajectories of 16S rRNA DNA, housekeeping gene rpoA and intI, further 
emphasise that chromosomal integrons are an ancient feature of bacterial genomes (Nemergut 
et al., 2008). Their “fixed” genomic nature  increases their long-term stability to selective 
pressures, and in turn provides increased opportunity for the evolution of multi-gene 
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phenotypes (Koenig et al., 2009; Rosewarne et. al., 2010; Wright et al., 2008). CIs are very 
closely tied to the habitats within the ecological niche of their “host” organisms. In contrast, 
mobilized MRIs are widely distributed between species and are maintained as a consequence 
of the selective advantage they provide in an antibiotic rich environment (Boucher et al., 
2007). Consequently MRIs are found in a diversity of habitats. Given that MRIs carry 
antibiotic resistance genes, and CIs contain cassettes of no known resistance function, what is 
the origin of resistance cassettes? 
 
1.8.2 CI-to-MRI flow: Analysis of the gene cassette metagenome 
The functions encoded by gene cassettes in the clinical context and found in MRIs is well 
understood. Comparatively, the importance of gene cassettes recovered from environmental 
samples and genetic contexts, remains poorly understood. Environmental gene cassettes are 
numerous, diverse and generally do not confer resistance phenotypes. The vast pool of 
environmental gene cassettes is thought to represent a reservoir where: 
i) All gene cassettes are potentially able to be captured by a MRI integron integrase. 
This is supported by the diversity of gene cassettes/attC demonstrated to be 
recombination substrates to IntI (Holmes et al., 2003; Rowe-Magnus et al., 2002; 
Stokes et al., 2001). 
ii) Any gene can be captured within a cassette and become mobilized. The evidence 
to support this can be found in the sequence and structural diversity of ORFs: 
bioinformatic analysis suggests no limits to what is contained (Koenig et al., 
2008).  
iii) Under the right circumstance may provide its host with an evolutionary advantage. 
For example, by the expression of novel enzymes (Neild et al., 2004; Robinson et 
al., 2005). 
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Figure 1.10: Phylogenetic tree of known integron integrases (IntI).  
The highlighted group are progenitors of the class 1 integron scaffold. All other integrons are 
potential reservoirs of the gene cassettes that have been accumulated within this. 
A single integron integrase is included for each bacterial species. The number of gene cassettes 
associated with the organism is next to the accession number. Red vertical lines represent clades 
where the integrase is strongly linked to a chromosomal location within that genus. Blue vertical lines 
represent class 1,2 and 3 integron branches.  Adapted from Boucher et al., 2007. 
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Studies on the cassette metagenome have demonstrated that the high levels of gene cassette 
diversity within a habitat may exceed the total number of genes present in the chromosome/s 
of any one member of that community. In a study conducted by Michael et al. (2004), all 
gene cassettes were found to be distinct from chromosomal genes and only 17% of these 
matched to protein families with known functions. The  mechanistic evidence of the 
horizontal gene transfer event/s that led to the flow of resistance genes between 
environmental and clinical strains often remains unknown (Forsberg et al., 2012). More 
studies are necessary to establish a strong environment-clinic connection (Davies & Davies, 
2010). However, rather than mass screening the cassette metagenome, an alternative and 
more narrow screening approach may prove to be more informative. For active gene transfer 
to occur, MRIs and CIs have to co-exist in the same cell. Yet evidence for the co-occurrence 
of MRIs and CIs, and a gene exchange between them in a single cell is rare.  
 
1.8.3 attC sites: handles and markers for gene flow 
MRIs contain cassette arrays with highly divergent attC sites (Partridge et al., 2009). 
Structural recognition of attC simple sites by MRI is an important feature of integron 
mediated site-specific recombination. attC sites vary between 57-bp to 141-bp and display 
sequence variability primarily in the region between the highly conserved LH and RH simple 
sites (Recchia & Hall, 1995). These two sites are part of two potential antiparallel 
recombination core sites, R′-L′ and L′′-R′′, previously termed 1L-2L (LH simple site) and 2R-
1R (RH simple site) respectively (Bouvier et al., 2009; Recchia & Sherratt, 2002; Stokes et 
al., 1997). Despite attC sequence variability, the structural conservation of these simple sites 
leads to strong conservation of attC secondary structure (Figure 1.11). Also, this structural 
conservation ensures that extrahelical bases (G and T) necessary for IntI1 binding are always 
placed into the correct plane for covalent binding between IntI1-attC (Bouvier et al., 2009; 
MacDonald et al., 2006).  
 
Integrons, being able to recognise a wide diversity of attC sites, are therefore accumulators of 
the diverse range of genes associated with attC sites. Critical to their success is preservation 
of contextual information of the gene after capture. This includes the integrity of the ORF (so 
that nothing is deleted or frame-shifted) and its correct orientation so as to allow read-through  
from Pc. Thus structural recognition and strand polarity of attC sites is an important feature 
of this site-specific recombination system.  
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The diversity of attC sequences within MRIs suggests that each integrated gene cassette and 
its respective attC site may be traced back to a unique, environmental origin (Figure 1.12). 
CIs are hypothesized to be the reservoir for resistance genes. There is high homology of attC 
sites within the cassette arrays of clade specific CI. This homology means that attC sites can 
be used as lineage specific markers. For instance Pseudomonas stutzeri sites range from 73-
bp to 89-bp (Holmes et al., 2003; Vaisvila et al., 2001), while Vibrio attC sites, also known 
as Vibrio cholerae repeats (VCRs), are characteristically just over 100-bp long (Rowe-
Magnus et al., 2002).  
 
Despite the size and diversity of the cassette metagenome, there are only a few cases where a 
clinically relevant resistance gene has been traced back to its original environment source 
(Mazel, 2004) (Table 1.3). These resistance genes were part of the core genome in the source 
organism and are now seen in a new context in a sink organism. However even then, the 
resistance gene sequence identity and chromosomal context is not 100% identical. Note that 
integrons typically accumulate gene cassettes by IntI mediated site-specific recombination, 
however other processes can also lead to them acquiring genes (Verdet et al., 2000). Instead 
of utilizing resistance genes as a marker to study gene flow, attC sites and their structural 
conservation are hypothesized to be a more reliable marker to study gene flow between the 
different integron classes.  
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Figure 1.11: Schematic representation of secondary structures of single stranded attC sites.  
In all cases, the bottom strand is depicted. Despite the sequence variations and variable lengths 
between Pseudomonas-type attC, Pseudomonas PAR, classical and VCR sites, the RH and LH boxes 
are conserved throughout. Inverted repeats R′ and R′′ are indicated by blue boxes. Inverted repeats L′ 
and L′′ are indicated by pink boxes. Extrahelical bases recognized by IntI are pointed out by red 
arrows. Adapted from Bouvier et al., 2009. 
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Figure 1.12: Chromosomal integrons- reservoirs for resistance cassettes.  
Diverse attC sites are represented as triangles of different colour. Cassettes commonly observed in MRIs have attC sites that can be traced to homologous 
attCs within CI arrays. Adapted from Mazel, 2004.  
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1.8.4 Pseudomonas:  Model organism for gene flow 
Integrons are a paradigm for the movement of resistance genes between habitats and species. 
To model integron movement, exchange of gene cassettes across ecological and phylogenetic 
separation, and use attC sites as a marker for gene flow, there is a need for a bacterial genus 
that meets the following criteria: i) it must inhabit both environment and clinical 
environments, ii) it must contain both integron types, ie. MRIs and CI, iii) it must have both 
the capacity and opportunity to undergo HGT with opportunistic pathogens and iv) it must be 
found in habitats that intersect different environments with different levels of antibiotic 
selective pressures. 
 
A feature of the bacterial genus Pseudomonas is the ecological flexibility seen across its 
member species. This flexibility is demonstrated by wide distribution in varying habitats 
(Spiers et al., 2000), diverse carbon source range (Conrad et al., 1979; Wang & Nomura, 
2010), use of alternative electron acceptors (Lalucat et al., 2006), intrinsic resistance 
mechanisms (Lister et al., 2009) and a large and flexible genome and accessory genome 
ranging  between 5.1 to 7-Mb (Mikkelsen et al., 2011; Wiehlmann et al., 2007). Members of 
the genus Pseudomonas, in particular Ps. stutzeri, contain multiple chromosomal integron 
arrays. Pseudomonas chromosomal integrons (PCIs) display a limited co-evolution within the 
Pseudomonas host lineage arrays (Holmes et al., 2003; Vaisvila et al., 2001) (Figure 1.13).   
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Table 1.3: Source and sink relationships of resistance genes. Adapted from Partridge, 2011.    
bla= β-lactamase resistance, qnr= quinolone resistance, ? = origin or mechanism of plasmid mobilization unknown. 
Gene Source Sink Mobilization by Reference 
blaSHV Klebsiella pneumoniae Enterobacteriaceae IS26 Ford & Avison (2004) 
blaOXA-48 Shewanella spp. Enterobacteriaceae IS1999  Aubert et al. (2006) 
blaDHA-1 Morganella morganii 
Salmonella enterica serovar 
enteritidis 
In6 and In7 Verdet et al. (2000) 
blaCMY-2-like Citrobacter freundii Enterobacteriaceae ? Barlow & Hall (2002) 
blaACC-1 Hafnia alvei 
Klebsiella pneumoniae/ 
Enterobacteriaceae  
ISEcp1 Nadjar et al. (2000); Partridge (2007) 
blaACT-1 Enterobacter asburiae Enterobacter spp. ? Rottman et al. (2002) 
blaFox Aeromonas caviae 
Aeromonas spp., 
Pseudomonas spp. & 
Enterobacteriaceae 
? 
Fosse et al. (2003); Maravić et al. (2013); 
Voolaid et al. (2013) 
blaCTX-M-2 Kluyvera ascorbata Enterobacteriaceae ISEcp1B  Lartigue et al. (2006) 
blaCTX-M-3 Kluyvera ascorbata Enterobacteriaceae Possibly ISEcp1  Rodríguez et al. (2004) 
blaCTX-M-5 Kluyvera ascorbata Enterobacteriaceae ISEcp1  Humeniuk et al. (2002) 
blaCTX-M-8 Group Kluyvera georgiana Enterobacteriaceae ISEcp1-like & IS10-like Poirel et al. (2002) 
blaCTX-M-9 Group Kluyvera georgiana Kluyvera spp. 
IS3000, ISEcp1, IS903D, 
In60 
Olson et al. (2005) 
blaCTX-M-25 Kluyvera georgiana Enterobacteriaceae ISEcp1 & ISEcp1B Rodríguez et al. (2010) 
blaOXA-119 Shewanella xiamenensis Enterobacteriaceae ISShe2 Zong (2012) 
blaTEM ? Enterobacteriaceae Tn3, IS26  Bailey et al. (2011); Partridge & Hall (2005) 
qnrA Shewanella algae Enterobacteriaceae ? Poirel et al. (2005) 
qnr5 Vibrio spendidus Enterobacteriaceae ? Cattoir et al. (2007) 
qnrB19 Vibrio spendidus? 
Enterobacteriaceae & 
Aeromonas spp. 
ISEcp1 Cattoir et al. (2008) 
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However it should be noted that within the Pseudomonas bacterial lineage PCI distribution 
does not strictly follow the pattern of vertical inheritance. PCIs are overrepresented within the 
Ps. stutzeri species complex but less so in other Pseudomonads (Wilson, 2007). This bacterial 
clade contains a broad family of CIs where, closely related PCIs are observed within the same 
locus (Ps. stutzeri species complex). In comparison, unrelated PCIs are located within a 
different loci. This patchy PCI distribution among the various Pseudomonas species suggests 
that CIs are the result of multiple instances of acquisition by HGT from other bacterial 
genera, following the pattern of chromosomal drift. 
 
Ps. aeruginosa and Ps. putida lack PCIs but frequently contain mobile class 1 integrons (Lee 
et al., 2002; Davies & Davies, 2010). Chromosomal insertions of class 1 integron/transposon 
structures have also been noted in four distinct chromosomal loci including genomic islands 
in clinical Ps. aeruginosa isolates (Martinez et al., 2012). Chromosomal acquisition of these 
MGE only adds to the complexity of the accessory genome of Ps. aeruginosa and contributes 
to the range of antibiotic resistance phenotypes and the overall spread of resistance between 
Ps. aeruginosa strains (Kung et al., 2010).  
 
Given that Ps. aeruginosa shares a common habitat, such as soil, with other non-pathogenic 
Pseudomonads, we can predict that HGT events between these would occur (Figure 1.14). To 
understand how genetic material crosses ecological and phylogenetic boundaries, the 
widespread and clinically relevant bacterial genus Pseudomonas is used as a model system 
for gene flow. Furthermore, it is important to understand HGT between clinical Ps. 
aeruginosa and the prevalent Enterobacteriaceae co-inhabitant. 
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Figure 1.13: Distribution of chromosomal integrons across the Pseudomonas lineage.  
The tree was constructed from an alignment of 16S rDNA sequences spanning approximately 1300-
bp, using maximum-likelihood and neighbour-joining analysis. All Pseudomonas spp. in which 
integrons are known to be either present or absent are indicated (see key). Ps. aeruginosa contains 
mobile integrons and lacks a PCI. Note – not all of the strains indicated above have been screened for 
the presence of integrons and are included here as representatives only. Adapted from Wilson, 2007. 
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Figure 1.14: Sharing ecological niches is postulated to influence HGT between Pseudomonads and 
enteric organisms. 
  
To illustrate this concept, consider a clinical environment where gene flow occurs between 
the primary inhabitants, two distinct Pseudomonas populations and an enteric population 
(Figure 1.15). Genetic exchange is more likely to occur between the Pseudomonads than 
between a Pseudomonad and an Enterobacteriaceae. This is because the Pseudomonads are 
more likely to occupy a common ecological habitat, such as a biofilm, and have 
commonalities at the molecular level in terms of codon usage and control elements for gene 
expression, as a result promoting gene flow between the Pseudomonad populations. 
Comparatively, while Enterobacteriaceae can inhabit the same ecosystem, they are 
phylogenetically distinct. These various features promote gene flow and are predicted to 
occur at a lower rate due to "incompatible" biological machineries, and may involve a subset 
of Pseudomonas species and a mode of horizontal gene transfer.  
 
1.8.5 IS1111-attC elements target integron associated recombination sites  
In characterizing CIs associated with Pseudomonads, Tetu & Holmes (2008) discovered a 
subfamily of insertion sequences, IS1111-attC, which appeared to be preferentially inserted 
within Pseudomonas-type attC sites. This site-specific targeting of attC sites is expected to 
significantly impact integrons, but more importantly provides additional support to the idea 
of using attC sites as markers for gene flow.  
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Figure 1.15: Gene flow between related organisms in comparison to that between non-related 
organisms.  
Ecological and phylogenetic separation between Pseudomonad populations is minimal, thus gene 
flow between these two populations is predicted to readily occur. The enteric population shares the 
same ecological, antibiotic rich habitat as the clinical Pseudomonas population. Gene flow between 
these two populations is predicted to occur but at a low rate.  
 
IS1111-attC elements were categorized as members of the IS110/IS492 family. This family 
of insertion sequences displays some key differences to other IS families. All members of the 
IS110/IS492 family either lack or have very small (<7-bp) terminal inverted repeats (IRs). 
Translocation of these ISs is site specific and does not generate a target site duplication, with 
the exception of IS492 which has been shown to generate 5-bp repeats (Mahillon & 
Chandler, 1998). Furthermore, IS110/IS492 recombinases (transposases) are not related to 
the site-specific recombinases of the λ integrase or resolvase/invertase families. Instead the 
transposase resembles a phosphoryltransferase similar to the DDE Transposase (Tpase), a 
site-specific invertase/transposase (Mahillon & Chandler, 1998; Tetu & Holmes, 2008). 
ISPst6, a member of the IS1111-attC subgroup (Tetu & Holmes, 2008), was first discovered 
in a PCI in Ps. stutzeri ATCC14405. This 1371-bp insertion sequence has a simple 
organization: a single open reading frame, encoding a putative transposase (347 amino acids), 
flanked by relatively long noncoding sequences and bounded by conserved sub-terminal 
inverted repeats. The noncoding regions are 53 and 240-bp at the right and left ends, 
respectively (Figure 1.16).   
 
Importantly, ISPst6 has apparent high target site specificity towards PCI attC sites. This 
target specificity allows these ISs to come into close contact with cassette encoded genes. 
Tetu and Holmes found ISPst6 elements to be greatly over-represented in Ps. stutzeri 
genomovar 2 strains, but absent in Ps. stutzeri genomovar 8 strains. 
 
Predicted direction of gene flow 
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Figure 1.16: Schematic representation of ISPst6, a member of the IS1111-attC subgroup.  
The inverted repeat boundaries are indicated by red lettering. 
 
An ISPst6 footprint was observed in Ps. stutzeri genomovar 1 and 7 strains at the terminus of 
the array. Based on the distribution of IS1111-attC elements and the evolutionary radiation of 
the Ps. stutzeri species complex, Tetu and Holmes proposed that IS1111-attC elements 
undergo an infection-expansion-extinction cycle within the Ps. stutzeri complex. 
 
At the time of the Tetu and Holmes study, IS1111-attC elements had been observed in nine 
instances of MRI (class 1 integrons). Of these, all but one, found in Klebsiella pneumoniae, 
were present within a Pseudomonad. In all Ps. aeruginosa-MRI cases, the IS1111-attC 
elements were embedded in resistance gene associated attC-sites found on class 1 integrons 
(Poirel et al., 2005; Post & Hall, 2009). Thus, I postulate attC-targeted translocation of 
IS1111-attC elements can be exploited as a means of observing gene flow between different 
integron classes (attC sites) and Pseudomonads in different ecological habitats (Figure 1.17A 
& B). 
 
 
 
             
Figure 1.17: Proposed models for IS1111-attC flow from an environmental to a clinical 
Pseudomonad.  
 
A) An MRI located on broad host range plasmid is acquired by an environmental Pseudomonas 
containing a PCI+IS1111-attC. The MRI acquires a) gene cassette and/or b) an IS1111-attC 
element. This c) newly acquired, IS1111-attC may be passed onto d) a clinical Pseudomonas 
aeruginosa or another Pseudomonad through conjugation. The plasmid + IS1111-attC may 
be e) stably maintained under antibiotic selective pressure or f) inserted into the 
chromosomal context.  
B) Under certain conditions, a chromosomally embedded IS1111-attC might excise as a) a 
minicircle and b) become transported out of the environmental Pseudomonas. c) Natural 
transformation favours the uptake of the IS minicircle into a new host such as Pseudomonas 
aeruginosa. If this new host already contains an d) MRI, the IS1111-attC element may insert 
into an available e) MI attC site. Alternatively, the IS element may insert into an f) unknown 
chromosomal loci. 
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1.9 Two convergent enzymes, one recombination site 
The ability both of IntI and the IS1111-attC transposase to recognize attC target sites and 
integron platforms is an interesting example of convergent evolution. IS1111-attC site-
specific insertion into CI and MRI attC sites, suggests that attC specificity is an ancestral 
feature of both the IS1111-attC transposase and IntI, heterologous proteins with different 
catalytic mechanisms.  Based on amino acid sequence homology, IS110/IS482 transposases 
are related to the Piv/MooV family of DNA recombinases (Mahillon & Chandler, 1998). 
Briefly, Piv mediates site-specific inversion of a 2.1-kb chromosomal segment that encodes 
type 4 pilin in Moraxella lacunata and Moraxella bovis by targeting two identical 32-bp 
inverted repeats, invL and invR. Buchner et al. (2005) demonstrated the importance of the 
highly conserved amino acids D9-E59-D101-D104 for Piv catalytic activity. Notably, IS1111-
attC transposase contains the conserved D-E-D-D motif (D7-E51-D88-D91), which is predicted 
to be essential for binding of IS1111-attC transposase to attC sites.  
 
Recognition of the attC extrahelical bases G and T was linked to IntI recombination 
efficiency (MacDonald et al., 2006). Thus, I hypothesise that like IntI integrase, IS1111-attC 
transposase also recognises the structure produced by single-stranded fold backs with extra-
helical bases. It is possible that IS1111-attC transposase, like IntI, recognises and 
preferentially performs top-strand binding, having an equivalent site of attack. Alternatively, 
it could have a different site of attack and perform bottom-strand binding. Therefore studying 
transposase binding to an attC site may provide a paradigm for how single-stranded genetic 
material is recognized by convergent enzymes.   
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1.10 Aims 
Understanding intragenomic rearrangements mediated by insertion sequences in bacterial 
genomes is especially relevant to the evolution of multidrug resistance. The complexity arises 
as mobile genetic elements do not ‘belong’ to a particular cell or lineage and have 
independent evolutionary trajectories when compared to phylogenetic trees. As a means of 
studying HGT between environmental and clinical pathogens, Pseudomonas is used in this 
study as a model organism. This study also explores the IS1111-attC subgroup as a model for 
this process in clinical, and environmental, non-host associated Pseudomonads. 
 
Integrons and IS1111-attC elements together are postulated to comprise a model system for 
interaction between genetic elements. IS1111-attC elements have similar characteristics to 
gene cassettes; that is, they are predicted to form minicircle structures, and, upon insertion 
into an integron array, take up a linear form. IS1111-attC elements “obey” the same rules as 
gene cassettes by inserting site-specifically into the integron platform. This study explores the 
IS1111- attC family of insertion sequences as a model gene cassette for HGT processes. The 
broad aims of the study were: 
 
1) To survey the distribution of mobile integrons, Pseudomonas chromosomal integrons 
and IS1111-attC elements across three distinct populations (clinical 
Pseudomonadaceae, non-pathogenic environmental Pseudomonadaceae, clinical 
enteric outgroup) and test for an association between IS presence/absence and 
bacterial genera. 
 
2) To determine the mechanistic properties of IS1111-attC elements in vivo with altering 
genetic contexts. 
 
3) To test IS1111-attC transposase in vivo binding to different target substrates and attC 
conformations (single vs double stranded DNA: Pseudomonas-type attC, attCaadB and 
IS1111-attC minicircle junction). 
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 Materials and Methods 
 
2.1 General Material 
2.1.1 Media 
All media (Table 2.1) were sterilised by autoclaving at 121 kPa for 15 min.  Chemicals were 
purchased from Sigma-Aldrich or Ajax, and were of analytical grade. Plates were made by 
adding 1.5% agar. All media were made in RO water.   
 
 
Table 2.1: Media composition 
Media Ingredients Properties Use 
Luria- Bertani (LB) 
Broth 
1% (w/v) casein peptone (tryptone) 
(Amyl Media, Australia), 0.5% (w/v) 
yeast extract (Amyl Media, Australia), 
0.5% (w/v) NaCl.  Adjust to 1 L with 
distilled water 
pH 7. 4 
General 
purpose 
medium used 
to culture most 
strains in this 
study 
Luria-Bertani Agar 
(LBa) 
1% (w/v) casein peptone (tryptone) 
(Amyl Media, Australia), 0.5% (w/v) 
yeast extract (Amyl Media, Australia), 
0.5% (w/v) NaCl.  Adjust to 1 L with 
distilled water. Aliquot into 400 mL 
volumes and add 1.5% agar.  
pH 7.4 
General 
purpose 
medium used 
to culture most 
strains in this 
study. 
LBa/Amp100/IPTG/Xgal160 
Add 400 µL of Amp100 stock, 400 µL of 
1 M IPTG stock, 200 µL of 80 mg/mL 
X-gal stock to molten, cooled 400 mL 
LBa. 
pH 7.4 
Chemical 
transformation 
Blue-white 
selection 
Pseudomonas Isolation 
Agar (PIA) 
Bacteriological peptone 20.0 g (Amyl 
Media, Australia), MgCl2 1.4 g, KSO4 
10.0 g, glycerol 10.0 g, Agar 15.0 g 
(Langdon & Co., Australia). Adjust to 1 
L with distilled water 
pH 7.0 ± 
0.2 
Selective 
medium used 
for isolation of 
environmental 
and clinical 
Pseudomonads 
Lysogeny Broth /0.2% 
Glucose (LB/Glu) 
1% (w/v) casein peptone (tryptone, 
0.5% (w/v) yeast extract, 0.5% (w/v) 
NaCl, 0.2% Glucose. Adjust to 1 L with 
distilled water  
pH 7.4 
sterilised 
using short 
glucose 
cycle, 
115oC, 10 
min, 101.5 
kPa 
Used to grow 
E. coli 
Rosetta2 cells 
transformed 
with pMAL 
vector  
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2.1.3 Solutions 
All solutions were sterilised by autoclaving at 121oC, 101.5 kPa for 15 min unless specified 
otherwise.  In cases where the solution could not be autoclaved, filtration was used for 
sterilisation, using a 0.20 μm filter (Millex, Germany).  All chemicals were purchased from 
Sigma-Aldrich or Ajax, and were of analytical grade.  All solutions were made in reverse 
osmosis (RO) water unless indicated otherwise.  For recipes see Table 2.2.  
 
 
2.1.4 Antibiotics 
The antibiotics used in this work were purchased from Sigma-Aldrich.  All antibiotics were 
filter sterilized using 0.22 µm filter (Millex, Germany) and stored at -20oC, except chemicals 
in non-aqueous solvents, these were not sterilised.  Antibiotics were added to media after 
autoclaving from stock solutions. 
 
Table 2.3: Antibiotics  
Antibiotic Abbreviation 
Stock 
Concentration 
Dissolvent 
Ampicillin Amp100 100 mg/mL  In MQ water 
Carbenicillin Carb100 100 mg/mL In MQ water 
Chloramphenicol Cm25 25 mg/mL In 100% Ethanol 
Kanamycin Km50 50 mg/mL In MQ water 
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Table 2.2: Solutions  
Name Ingredients Sterilization 
1M Isopropyl-β-D-
thiogalactopyranoside (IPTG) stock 
Dissolve 2.38 g of IPTG in 8 mL of MQ water. Bring volumes to 10 mL. Aliquot into 1 mL 
volumes by filtration and store at -20oC. 
Filtration 
 80 mg/mL 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside 
(X-GAL) stock 
Dissolve 80 mg of X-GAL in 1 mL DMSO. Filter sterilize and aliquot into 1 mL volume. 
Store at -20oC. 
Filtration 
10 M Ammonium acetate Dissolve 385 g of ammonium acetate in 400 mL of RO. Adjust the volume to 500 mL with 
RO. 
Filtration 
1 M Tris- HCl pH 7.5 stock Dissolve 121.14 g of Tris[hydroxymethyl]aminomethane hydrochloride in 700 ml of 
RO.  Adjust pH to 7.5 with concentrated HCl.  Bring volume to 1 L with RO.   
Autoclave 
1 M Tris-HCl pH 9.5 
Dissolve 121.14 g of Tris[hydroxymethyl]aminomethane hydrochloride in 700 mL of 
RO.  Adjust pH to 9.5 with concentrated 10 N NaOH.  Bring volume to 1 L with RO.  
Autoclave 
1 M Tris-OH pH 11 
Dissolve 121.14 g of tris[hydroxymethyl]aminomethane in 700 mL of RO. Check that pH is 
at 11. Bring volume to 1 L with RO. 
Autoclave 
100 mM Magnesium chloride stock 
(MgCl2) 
Dissolve 2.03 g of magnesium chloride in 80 mL of H2O. Once dissolved, makeup up to 
100 mL with H2O. 
Autoclave 
0.5 M EDTA stock pH 8.0 Dissolve 186.12 g EDTA.Na2.2H2O in 800 mL RO. Adjust pH to 8.0 with 10 N NaOH. 
Adjust final volume to 1000 mL with RO. 
Autoclave 
1 M Boric acid 
Dissolve 6.183 g boric acid in 80 mL RO. Adjust volume to 100 mL with RO.  
 
Elution buffer (EB) 
5 mM Tris-HCl made from 1 M Tris-HCl stock. pH adjusted to pH 8.0 using 1 M Tris-base 
stock with pH 11. 
Autoclave 
TE buffer 
10 mM Tris-HCl from 1 M Tris-HCl pH 7.5 stock, 1 mM EDTA from 0.5 M EDTA stock. 
Adjust to pH 8.0.    
 
10xTBE buffer 
0.89 M Tris-HCl from 1 M Tris-HCl, 0.89 M Boric acid, 7 mM EDTA from 100 mM 
EDTA stock. Adjust to pH 8.0.   
Autoclave 
6X loading dye 
0.25% (w/v) Bromophenol blue, 30% (w/v) Glycerol in MQ H2O dissolved at 37oC with 
shaking at 200rpm until bromophenol blue is dissolved. 
 
Phosphate buffered saline (PBS) (pH 
7.2-7.4) 
Dissolve 8.0 g NaCl, 200 mg KCl, 1.44 g Na2HPO4O, 200 mg KH2PO4O in 900 mL RO. 
Adjust pH to 7.2-7.4 with concentrate HCl. Bring volume up to 1L with RO. 
Autoclave 
Ethidium bromide staining solution 
(0.5 µg/mL) 
Add 50 µL of 10 mg/mL Ethidium bromide solution (Amresco, USA) to 1-L of RO water. 
Mix gently. 
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SOUTHERN HYBRIDIZATION REAGENTS 
Maleic acid buffer pH 7.5 
Dissolve 10.73 g Maleic acid, 7.01 g NaCl in 600 mL MQ H2O. Adjust pH to 7.5 with 
NaOH pellets. Finally, adjust the volume to 800 mL with MQ water. 
Autoclave 
Blocking solution Dilute powdered (100x) Blocking Reagent (Roche) to 1x using Maleic acid buffer 
Not sterilised, make 
fresh prior use 
Saline sodium citrate (SSC) 20x pH 
7.0 stock 
Dissolve 175.3 g of NaCl and 88.2 g of tri-sodium citrate in 800 mL of MQ water. Adjust 
pH to 7.0 with 10 N solution of NaOH. Bring final volume to 1 L with MQ water. 
 
0.5x SSC (HIGH) 
0.5x SSC from 20x SSC stock, 0.10% (w/v) SDS. Adjust the volume to 800 mL with 
sterilized MQ water. 
 
1x SSC (MEDIUM) 
1x SSC from 20x SSC stock, 0.10% (w/v) SDS. Adjust the volume to 800 mL with 
sterilized MQ water. 
 
2x SSC (LOW) 
2x SSC from 20x SSC stock, 0.10% SDS. Adjust the volume to 800 mL with sterilized MQ 
water. 
 
Washing buffer pH 7.5 
Dissolve 10.73 g Maleic Acid, 7.01 g NaCl, Tween20 0.30% (w/v) in 600 mL MQ water. 
Adjust to pH 7.5 with NaOH pellets. Finally adjust the volume to 800 mL with sterilized 
MQ water. 
Autoclave 
Antibody solution Anti-DIG-AP 1:1000 in blocking solution.  
Not sterilized, make 
fresh prior use 
Stripping solution Dissolve 6.39 g NaOH and 0.8 g SDS in 800 mL MQ water.  
Detection buffer 
Dissolve 2.34 g NaCl in 40 mL of 1 M Tris-HCl pH 9.5 stock. Bring volume to 400 mL in 
MQ water. 
 
PLASMID/ DNA PURIFICATION 
CTAB lysis buffer 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1 M NaCl, 1% CTAB  
Cell lysis solution (plasmid 
preparation) 
0.2 M NaOH, 1% SDS (prepared fresh from autoclaved 2 M NaOH and filter sterilised 10% 
SDS). 
Not sterilised,  
Precipitation solution  3 M potassium, 5 M acetate, (pH 4.8).  
1xPBS 
Dissolve 8 g NaCl, 0.2 g KCl, 1.44 g Na2PO4, 0.24 g KH2PO4. Adjusted to 1 L distilled 
water. Adjust to pH 7.0.  
Autoclave   
Sodium acetate 3 M NaOAc, adjust to pH 4.8 with concentrated glacial acetic acid  
24:1 Chloroform/Isoamyl-alcohol 
Mix 24 vol Chloroform to 1 vol Isopropanol and leave to stand overnight at room 
temperature. 
Do not autoclave 
Phenol/chloroform/isoamyl-alcohol  Solution comes pre-equilibrated with TE buffer at pH 8.0 (Ratio 25:24:1). Ready-to-use 
ROSETTA COMPETANCY 
KCM buffer 100 mM KCl, 30 mM CaCl2, 50 mM MgCl2. Store at -20oC. Filter sterilized 
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Rosetta resuspension buffer LB broth at pH 6.1 (autoclaved) supplemented with 10% PEG (3350 or 8000), 5% DMSO, 
10 mM MgCl2 from 100 mM MgCl2 stock, 10 mM MgSO4 from 100 mm MgSO4 stock, 
10% (w/v) glycerol. Store at 4oC. 
Filter sterilized 
AFFINITY CHROMATOGRAPHY (MBP COLUMN) 
100 mM Phenylmethylsulfonyl 
fluoride (PMSF) 
Dissolve 17.42 mg of PMSF in DMSO to get a 100 mM solution. Filter sterilise and use 
immediately. 
Filter sterilise 
MBP column buffer Combine 20 mM Tris-HCl from 1 M stock at pH 7.5, 200 mM NaCl from 5 M stock, 100 
µL PMSF from 100 mM stock, and 1 mM DTT in 500 mL of sterile MQ water and add 100 
µL of complete protease inhibitor cocktail (Sigma-Aldrich). Adjust pH to 7.4 and bring 
solution to 1 L. 
Not sterilised. 
20% Maltose solution Dissolve 20 g of maltose in 100 mL RO. Sterilise and store at -20oC. Filter sterilised. 
MBP elution buffer MBP column buffer supplemented with Maltose solution to get a final concentration of 50 
mM maltose. Make up fresh just prior use. 
Not sterilised. 
SDS-PAGE 
SDS-PAGE 1x Tris glycine 
electrophoresis buffer 
0.25 M Tris/HCl, 0.192 M glycine, 0.1% (w/v) SDS, adjust pH to 8.3. Store at 4oC. Not sterilised 
4x Resolving buffer (1.5 M) 
Dissolve 181.7 g of Tris in 800 mL of RO, adjust pH to 8.8 with concentrated HCl acid. 
Bring solution to 1 L with RO. 
Not sterilised 
4x Stacking buffer (0.5 M) 
Dissolve 60.6 g of Tris in 800 mL of RP, adjust pH to 6.8 with concentrated HCl. Bring 
solution to 1 L with RO. 
Not sterilised. 
10% SDS solution 
Dissolve 10 g of SDS in 80 mL RO. Adjust pH to 7.2 with concentrated HCl and bring 
solution to 100 mL with RO. Store solution at RT.  
Filter sterilise. 
20% Ammonium persulfate (APS) 
Dissolve 2 g ammonium persulfate in 10 mL of MQ water. Filter sterilise and aliquot into 1 
mL volumes. Store at 4°C. 
Filter sterilise. 
SDS-PAGE 12% acrylamide gel 
(makes 2 resolving gel) 
Combine 4 mL RO water, 3.3 mL 30% acrylamide/ bisacrylamide (19:1) (Sigma-Aldrich), 
2.5 mL 4x Resolving buffer, 100 µL 10% SDS, 60 µL 20% APS, 4 µL TEMED.  
Not sterilised, used 
fresh 
SDS-PAGE 5% acrylamide gel 
(makes 2 stacking gel) 
Combine 2.03 mL RO water, 0.44 mL 30% acrylamide/ bisacrylamide (19:1) (Sigma-
Aldrich), 0.83 mL 4x stacking buffer, 33 µL 10% SDS, 20 µL 20% APS, 4 µL TEMED. 
Not sterilised, used 
fresh 
Colloidal coomassie blue staining 
solution 
Combine 40% (v/v) methanol, 7% (v/v) glacial acetic acid, with 0.025% (w/v) Coomassie 
R250 Brilliant Blue in RO. 
Not sterilised. 
Coomassie high destain solution Combine 40% (v/v) methanol, 7% (v/v) glacial acetic acid, in RO. Not sterilised. 
Coomassie low destain solution Combine 10% (v/v) methanol, 7% (v/v) glacial acetic acid, in RO. Not sterilised. 
5x SDS gel loading buffer 0.125 mM Tris-Cl (pH 6.8), 100 mM DTT, 4% (w/v) SDS, 0.02% (w/v) Bromophenol blue, Not sterilised. 
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20% (v/v) glycerol. Aliquot in 1 mL volumes and store at -20oC. 
GEL SHIFT ASSAYS 
10x TBE (pH 8.3) 
Dissolve 60.6 g Tris, 55.6 g Boric acid, 9.3 g EDTA in 800 mL RO. Adjust pH to 8.3 with 
concentrated HCl. Bring volume to 1 L. 
Autoclave. 
1xTBE (pH 8.3) Make 1 L volume from 10x TBE pH 8.3 stock. Autoclave. 
10% Ammonium persulfate (APS) 
Dissolve 1 g of ammonium persulfate in 10 mL MQ water. Filter sterilise, aliquot into 1 mL 
volumes and store at -20oC. 
 
EMSA gel (non-denaturing 
polyacrylamide gel, makes 1 gel) 
Combine 9 mL of 40% (w/v) acrylamide/ bisacrylamide (19:1) (Sigma-Aldrich), 50.6 mL 
1x TBE (pH 8.3), 400 µL 10% APS, 40 µL TEMED. 
Not sterilised. 
EMSA loading dye 6x 30% Ficoll, 0.1% Bromophenol blue, 0.25% Xylene cyanole in 50 mL MQ water.  Not sterilised. 
EMSA running buffer (0.5x TBE, pH 
8.3) 
Make 1 L volume from 10x TBE pH 8.3 stock. 
Not sterilised. 
1 M Dithiothreitol (DTT) 
Dissolve 1.55 g of DTT powder in 10 mL of deionized water. Filter sterilise and aliquot into 
0.5 mL volumes. Store at -20oC.  
Filter sterilised. 
10x Reaction buffer (need 50 mL) 100 mM Hepes (pH 7.9), 100 mM NaCl and 50 mM MgCl2 in RO.  Autoclave. 
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2.1.5 Equipment 
Details of equipment used in this study are shown in Table 2.4. 
 
Table 2.4: Equipment list and respective supplier 
Equipment Name Manufacturer 
Eppendorf BioPhotometer Eppendorf (Germany) 
Eppendorf Centrifuge 5424 Eppendorf (Germany) 
Eppendorf Centrifuge 5810R Eppendorf (Germany) 
Gradient S Thermocycler Eppendorf (Germany) 
GS-800 Calibrated Densitometer Bio-Rad (USA) 
Junior Orbital Shaker Lab-Line (USA) 
Nanodrop 1000 Spectrophotometer Thermo Scientific (USA) 
Orbital Mixer Shaker Ratek (Australia) 
PowerPac HC Bio-Rad (USA) 
FLA 9000 (phosphoimager) 
Typhoon 
GE Healthcare Life Sciences (USA) 
Stratalinker® UV Crosslinker 1800 Stratagene (USA) 
Voyager-DE™ STR Workstation Applied Biosystems (USA) 
 
2.2 Bacterial strains 
All strains were grown in Luria- Bertani broth (LBb) or on LB agar. Clinical Pseudomonads 
and enteric isolates were grown at 37oC, and all other Pseudomonads including controls were 
grown at 30oC. A collection of 125 clinical Ps. aeruginosa strains (representing multiple 
patients, across three hospitals in Sydney) were isolated, identified and provided by 
collaborators around Sydney, Australia (Appendix Table A1). Also a group of 52 enteric 
isolates (outgroup) were provided by collaborators (Appendix Table A3). All control strains 
used in this study are outlined in Table 2.5. In summary, Ps. stutzeri strains (representing 
genomovars 6, 2, & 8) were used as control isolates for the presence of PCI and IS elements. 
Ps. aeruginosa isolates PAO1, MB 225158 Adelaide, and 216.2B were controls for IS1111-
attC-like elements and mobile class 1 integrons. A conjugative plasmid carrying a class 1 
integron (pR388) and a Ps. fluorescens (negative for class 1 integron, IS1111-attC and PCI) 
were also included in most analyses. Genomic DNA from Thaura species, containing a class 
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2 integron on transposon Tn7 was used as a class 2 control in preliminary Southern 
hybridization analysis.  All strains were grown in LB broth or on LB agar, and were stored at 
–80oC in LB medium containing 15% (v/v) glycerol for long-term strain storage. The 
clinically relevant Ps. aeruginosa and gram negative unknowns were grown at 37oC, and all 
other Pseudomonads including controls were grown at 30oC 
 
2.2.1 Clinical Isolates 
All clinical Ps. aeruginosa strains were isolated by collaborators from the following 
hospitals: Sydney Adventist Hospital (sample set TS-) and Sydney Westmead Hospital 
(sample sets JIP- and SSP-). See Table A2 environmental (non-host associated) 
Pseudomonads were kindly provided by Mitch Brown from Westmead, Sydney (Table A2).  
 
2.2.2 Isolation of Pseudomonads from domestic environments 
An additional 68 environmental Pseudomonads (Table A2) were isolated from mop and 
sponge samples from 6 geographically distant domestic environments around Sydney, 
Australia (Figure 2.1). 1 g of mop thread or 1g of sponge was weighed out and resuspended 
by vigorous vortexing in 9 mL of 1x PBS. This suspension was serially diluted to range 
between 10-1-10-9 and 100 μL was spread plated per dilution onto PIA. Plates were first 
incubated overnight at 30oC, and then at room temperature for another 48 hrs. Colonies with 
different morphologies were selected, streaked onto fresh PIA plates and grown overnight at 
30oC. Final purification was done on LB agar at 30oC, overnight.   
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Table 2.5 Strains as reference controls for integron and insertion sequence assays  
Control strain 
Shorthand 
nomenclature 
Element 
Reference 
MI 
IS1111-
attC 
PCI 
Ps. stutzeri ATCC 
14405 
Pst405 
- + + 
Zobell & Upham, 
(1944) 
Ps. stutzeri ATCC 
17587 
Pst587 
- + + 
Stanier et al. (1966) 
Ps. stutzeri ATCC 
17595 
Pst595 
- + + 
Stanier et al. (1966) 
Ps. stutzeri ATCC 
17641 
Pst641 
- - + 
Stanier et al. (1966) 
Ps. mendocina NW1 PsNW1 - + + Wilson (2007) 
Ps. stutzeri RNAIII PstRNAIII - + + 
Sikorski, pers. comm. 
Ps. straminea KM91 PsKM91 - + + McNicol (2002) 
Ps. stutzeri DNSP21 PstDNSP21 - - + 
Rius et al. (2001) 
(array and attI only, 
no intIX) 
Ps. stutzeri strain Q PstQ - - + 
Holmes et al. (2003) 
Ps. fluorescens 
NCTC 7244 
Pfluro 
- - - 
University of Sydney 
strain collection 
Ps. aeruginosa NCTC 
3756 
Paeru 
- - - 
University of Sydney 
strain collection 
Ps. aeruginosa PAO1 PAO1 - 
Putative 
tpase 
- 
Stover et al. (2000); 
Winsor et al. (2011) 
Ps. aeruginosa 216.2B 216.2B + - - 
Westmead Hospital 
strain collection 
E. coli strain UB1637 
pR388 
R388 + - - 
Datta & Hedges 
(1972) 
Thaura sp. Tn7 ColE Tn7 intI2 - - 
L. Woolfended as 
per. comms. 
Note: MIs, IS1111-attC elements and PCI in these strains were previously identified by Southern hybridisation 
screening, PCR screening and genome sequencing (Tetu, 2007; Wilson 2007; references as listed table). 
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Figure 2.1: Workflow for the isolation of Pseudomonads from environmental samples.  
Weigh out 1 g of sample (mop thread or sponge) and suspend bacterial cell by vortexing vigorously in 
1 mL of 1x PBS. Dilute the resuspended cell (10-1-10-9) and spread plate 100 µL of each dilution onto 
fresh PIA. For the first round of plating, incubate overnight at 30oC and then two days at room 
temperature (RT). For the second round, pick distinct colony morphologies and streak individually 
onto fresh PIA. To ensure purity for the last round streak plate onto LB agar and incubate at 30oC 
overnight. These plates were also used as master plates for subsequent experiments. 
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2.3 High molecular weight genomic DNA extraction 
High molecular weight DNA was extracted from all isolates and control strains using a 
CTAB/phenol/chloroform method, modified from Sambrook and Russell (2001). Cells from 
5 mL overnight LB cultures were pelleted using centrifugation, washed in several volumes of 
TE, and resuspended in 2 mL CTAB lysis buffer (50 mM Tris-HCL pH 8.0, 10 mM EDTA, 1 
M NaCl, 1% CTAB). Lysozyme (1 mg/mL) and Proteinase K (ProK) (100 mg/mL) were 
added to the cell suspension, followed by an incubation at 37oC for 1-2 hrs, and extraction 
with one volume of chloroform:iso-amyl alcohol (25:1). After recovery of the aqueous phase, 
high molecular weight DNA was purified by a standard phenol/chloroform extraction and 
ethanol precipitation protocol as described previously (Sambrook & Russell, 2001). 
Recovered DNA was dissolved in 100 μL TE and stored at –20oC. DNA quantity and quality 
were determined using a Nanodrop spectrophotometer.  
 
2.3.1 Ammonium acetate purification of low molecular weight PCR amplicons 
PCR reactions were pooled to give a total of 400 µL ~1 µg of DNA. Equal volumes of 
phenol: chloroform: isoamyl alcohol (25:24:1) were added, inverted and then centrifuged for 
3 min at 14200 rpm at room temperature. The top phase was extracted with an equal volume 
of chloroform. The centrifugation step was repeated and 0.2 volume of 10 M ammonium 
acetate and 2.5 volume of pure chilled ethanol were added to the top phase. This solution was 
inverted and chilled at 40C for 30 min. The precipitate was recovered at 14200 rpm for 5 min 
at 4oC, and the pellet was washed with 70% ethanol. The centrifugation step was repeated 
again and the pellet was dried at 500C for 5 min, before being dissolved in 1x TE (pH 8.0). 
The Protocol was amended from Sambrook and Russell, 2001. 
 
2.3.2 Crude DNA extraction via cell boil-lysing 
A sterile pipette tip was used to pick an individual colony, which was then resuspended in 
100 µL of 100x DMSO stock. The resuspension was boiled at 99oC for 15 min to lyse 
bacterial cells and centrifuged at 14200 rpm for 5 min. The supernatant was removed and 
1xTE was added.  The DNA was stored at -200C till subsequent use. 
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2.4 Polymerase Chain Reaction 
All PCR amplification mixtures contained the reagents listed in Table 2.6, unless otherwise 
indicated. PCR reactions were performed in a total volume of 25 µL unless otherwise 
indicated. 
The PCR cycling conditions used varied depending on the primers (Table 2.7) used and are 
indicated for each assay (Table 2.8). The thermocycler used was a Gradient S Thermocycler 
(Eppendorf). Amplification products were separated using agarose gel electrophoresis. 
 
Table 2.6: PCR reagents and concentration 
Reagent Concentration Manufacturer 
Primer  50 pmol per primer IDT, USA 
dNTP mix 200 nM per dNTP New England Biolabs 
MgCl2 2 mM New England Biolabs 
1x Thermopol® 
Buffer 
20 mM Tris-HCl, 10 mM (NH4)2SO4, 
10 mM KCl, 2 mM MgSO4, 0.1% 
Triton® X-100, pH 8.8 
New England Biolabs 
Taq DNA 
polymerase 
1 U New England Biolabs 
DNA 10-100 ng/µl N/A 
  
2.5 Agarose gel electrophoresis  
Agarose gel electrophoresis was used to determine the size and concentration of all DNA 
recovered by direct extraction or amplification by PCR. Molecular grade, DNase and RNase 
free agarose (Bioline, USA) was used at concentrations between 1%-2% in 0.5xTBE buffer. 
All samples were run in a horizontal electrophoresis unit at 1-5 V/cm. 0.5 μl of GelRed™ 
(10000x, Biotium, Ca) was used per 50 mL 0.5x TBE gel volume. Alternatively gels were 
post stained for 15 min in ethidium bromide staining solution. Fractioned DNA was then 
visualised under UV-light and an image captured using the Gel Doc™ XR+ Bio-Rad system 
(Bio-Rad, USA). 
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Table 2.7: Primers  
Primer Target Sequence (5′-3′) Reference 
CHAPTER 3 
BOX1AR BOX repeats CTACGGCAAGGCGACGCTGACG Louws et al. (1994) 
f27 16S rRNA DNA AGAGTTTGATCMTGGCTCAG Weisburg et al. (1991) 
r1492 16S rRNA DNA TACGGYTACCTTGTTACGACTT Weisburg et al. (1991) 
LW18 intIQ PstQ (AY129392) TATCGATCCAAAGGACTCAGC L. Woolfended as per com. 
LW19 intIQ PstQ (AY129392) CATGTTGCCTCGCAGTCTGG L. Woolfended as per com. 
LW14 intI1 E. coli pR388 In3 (U12441.2) CTTTGTTTTAGGGCGACTGC L. Woolfended as per com. 
LW15 intI1 E. coli pR388 In3 (U12441.2) ATGCCCGTTCCATACAGAAGC L. Woolfended as per com. 
ST87 Pst405/Pst587 ISPst6 ATATGGACTCTCCCCACAAG Tetu & Holmes (2008) 
ST117 Pst405/Pst587 ISPst6 TAATGGACTCTCCCCGCACC Tetu & Holmes (2008) 
ST8 PstDNSP21 attC TGGCAGAAAACTGTGATCTC Tetu (2007) 
ST9 PstDNSP21 attC GAGTTATCTGCGTAAATATC Tetu (2007) 
ST10 PsNW1 attC (EF648216) AAATGCACTCTAACAAGTCG Tetu (2007) 
ST11 PsNW1 attC(EF648216) AGGGTCATGAGCATTACCTC Tetu (2007) 
ST12 PstKM91 attC TTCAGGTTGAGTCGCTTACC Tetu (2007) 
ST13 PstKM91 attC GATATTTTTCATAAAGGTTCCTA Tetu (2007) 
HS915 intI1 gene  CGTGCCGTGATCGAAATCCAG Martinez et al. (2013) 
HS916 intI1 gene TTCGTGCCTTCATCCGTTTCC Martinez et al. (2013) 
CHAPTER 4 
ST96 BGC093 flanking DNA in Pst587 TTTCACGAGTATTCCCGAGG Tetu & Holmes (2008) 
ST139 BGC093 flanking DNA in Pst587 AATATGACACCAAGCACTCC Tetu & Holmes (2008) 
MZ09 attCaadB flanking DNA in pUS21 GCTTTCAGGTCGCGATATGC This study 
MZ10 attCaadB flanking DNA in pUS21 TTCTGCAGAAGCTTGGCG This study 
AJH17 PstQ attC sites and array  CCCAGYGARCGARGYGAGCG Holmes et al. (2003) 
AJH27 PstQ attC sites and array  GGCTGAAGCCVGCCCCTTARC Holmes et al. (2003) 
NVC15 pBBR1MCS2vector backbone GCTTCCGGCTCGTATGTTGTGTGG N. Coleman as per com. 
NVC16 pBBR1MCS2vector backbone GCAAGGCGATTAAGTTGGGTAACG N. Coleman as per com. 
ST89 ISPst6 minicircle junction  GAACGCTTGGCCCCYGCTGC Tetu & Holmes (2008) 
ST123 ISPst6 minicircle junction  CGGCAACCTGGTAAACGGAC Tetu & Holmes (2008) 
CHAPTER 5 
MZ03 start of tpase in Pst405  GCGGGATCCATGAAACGCATAGCGATTG (BamHI site) This study 
MZ04 end of tpase Pst405 CCGCTGCAGTCAGGCGGGCTTTGTGC (PstI site) This study 
ELF21 pMAL-c2X backbone GTCAGACTGTCGATGAAGCCC E. Liew as per com. 
ELF22 pMAL-c2X backbone GCAACTGTTGGGAAGGGCGAT E. Liew as per com. 
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Table 2.8: Details of PCR thermocycling protocols  
Primer 
combinations 
Target 
(expected size) 
Thermocycling protocol 
CHAPTER 3 
BOXA1R rep regions (Variable) 94oC x 5 min, [94oC x 30 sec, 53oC x 30 sec, 72oC x 8 min] x 35 cycles, 72oC x 5 min x 1 cycle.   
Southern hybridization: probe generation 
LW18/LW19  PstQ intIPstQ (500-bp) 94oC for 5 min, [94oC 30 sec, 56oC 30 sec, 72oC 1 min] x 30 cycles, 72oC for 5 min x 1 cycle 
LW14/LW15  E. coli pR388 In3 intI1-attI1 (551-bp) 94oC for 5 min, [94oC 30 sec, 58oC 30 sec, 72oC 1 min] x 30 cycles, 72oC for 5 min x 1 cycle 
ST87/ST117  Intact ISPst6 (1340-bp)  94oC for 5 min, [94oC 30 sec, 57oC 30 sec, 72oC 2.5 min] x 30 cycles, 72oC for 5 min x 1 cycle 
ST8/9 probe PstDNSP21 (100-bp) 94oC for 5 min, [94oC 30 sec, 52oC 30 sec, 72oC 20 sec] x 30 cycles, 72oC for 5 min x 1 cycle 
ST10/ST11  PsNW1 attC (100-bp) 94oC for 5 min, [94oC 30 sec, 60oC 30 sec, 72oC 20 sec] x 30 cycles, 72oC for 5 min x 1 cycle 
ST12/ST13  PstKM91 attC (100-bp) 94oC for 5 min, [94oC 30 sec, 55oC 30 sec, 72oC 20 sec] x 30 cycles, 72oC for 5 min x 1 cycle 
PCR screening for MGE 
LW14/LW15  intI1-attI1 (551-bp) 94oC for 5 min, [94oC for 30 sec, 57oC for 30 sec, 72oC for 45 sec] x 30 cycles, 72oC for 5 min x 1 
cycle 
HS915/HS916  intI1 (371-bp)  94oC for 5 min, [94oC for 30 sec, 62oC for 30 sec, 72oC for 30 sec] x 30 cycles, 72oC for 5 min x 1 
cycle 
ST87/ST117  ISPst6 (1346-bp) 94oC for 5 min, [94oC for 30 sec, 60oC for 30 sec, 72oC for 2.5 min] x 30 cycles, 72oC for 5 min x 1 
cycle  
ST96/ST139 BGC093 attC with flank (219-bp) 94oC 5 min, [94oC 30 sec, 60oC 30 sec, 72oC 20 sec] x 30 cycles, 72oC for 5 min x 1 cycle 
CHAPTER 4 
MZ09/MZ10 attCaadB with flanking DNA in pUS21  94oC 5 min, [94oC 30 sec, 57oC 30 sec, 72oC 10 sec] x 30 cycles, 72oC for 5 min x 1 cycle  
NVC15/NVC16 Transformation screen 94oC for 5min, [94oC 30 sec, 60oC 30 sec, 72oC 2 min] x 30 cycles, 72oC for 5 min x 1 cycle 
AJH17/AJH27 PstQ attC sites and array  (variable) 94oC for 5 min, [94oC 30 sec, 65oC 30 sec, 72oC 2 min] x 30 cycles, 72oC for 5 min x 1 cycle 
NVC15/NVC16 pBBR1MCS2 vector backbone (variable) 94oC for 5 min, [94oC 30 sec, 55oC 30 sec, 72oC 2 min] x 30 cycles, 72oC for 5 min x 1 cycle 
ST89/ST123 ISPst6 minicircle junction (258-bp) 94oC for 5 min, [94oC 30 sec, 55oC 30 sec, 72oC 2 min] x 30 cycles, 72oC for 5 min x 1 cycle 
CHAPTER 5 
MZ03/MZ04* Ps. stutzeri ATCC 14405 tpase 98oC 2 min, [98oC 10 sec, 65oC 30 sec, 72oC for 30 sec] x 35 cycles, final 72oC for 5 min x 1 cycle 
MZ03/ELF22 pMAL-tpase junction  94oC for 5 min, [94oC 30 sec, 55oC 30 sec, 72oC 2 min] x 30 cycles, 72oC for 5 min x 1 cycle 
MZ04/ELF21 pMAL-tpase junction  94oC for 5 min, [94oC 30 sec, 55oC 30 sec, 72oC 2 min] x 30 cycles, 72oC for 5 min x 1 cycle 
 *Phusion™ High fidelity polymerase was used. 
Chapter 2 Materials and Methods 
57 
 
2.6 Chemical transformation of bacterial cells 
 
See Table 2.9 below for information about the E.coli expression systems used in this study. 
 
Table 2.9:  E. coli expression systems  
Strain Shorthand  Use Description Reference 
E. coli 
JM109  
JM109 
Used as a cloning 
expression system for 
pGEM-T Easy vector 
system 
recA1 supE44 endA1 
hsdR17 gyrA96 relA1 thi 
∆(lac-proAB)F9[traD36 
proAB+ lacIq lacZ 
∆M15];GmS, GFP-, Lac+ 
Yanisch-Perron et 
al. (1985) 
E. coli 
Rosetta2 
(DE3) 
Rosetta 
Used for MBP-fusion 
protein expression  
F- ompT hsdSB(rB- mB-) gal 
dcm (DE3) pLysSRARE2 
(CamR) 
Novagen, Madison, 
WI 
E. coli 
Epi300TM 
Epi300 
Used for fosmid 
library construction 
F- mcrA Δ(mrr-hsdRMS-
mcrBC) Φ80dlacZΔM15 
ΔlacX74 recA1 endA1 
araD139 Δ(ara, leu)7697 
galU galK λ- rpsL (StrR) 
nupG trfA dhfr 
Epicentre, Madison, 
WI 
 
2.6.1 E. coli JM109 cells 
Fresh LB/Amp100/IPTG/X-Gal plates were prepared and equilibrated to 37oC. 2 μL of 
ligation reaction was added to 50 µL of thawed E. coli JM109 cells on ice. The tube was 
gently flicked to mix and placed on ice for 20 min. The cells were heat-shocked for 45 sec in 
a water bath at 42°C. Tubes were immediately returned to ice for 2 min. 200 μL room-
temperature LB medium was added to cells and incubated for 1.5 hrs at 37°C with shaking 
(~200 rpm). The transformation mix was then plated onto duplicate LB/Amp100/IPTG/X-Gal 
plates and incubated overnight (16–24 hrs) at 37°C. Ligation and transformation efficiencies 
were assessed with reference to uncut vector, cut/re-ligated vector as appropriate. Individual 
colonies were picked based on blue-white selection and screened by boil-lysing DNA and 
using universal primer pair M13F (5′-GTAAAACGACGGCCAGT-3′) and M13R (5′ 
AACAGCTATGACCATG- 3′). Screening PCR conditions were as following; 1 cycle at 
94oC 5 min, then 30 cycles of [94oC for 1 min, 55oC for 30 sec, 72oC for x seconds], and one 
final round of extension at 72oC for 5 min. Note x sec is determined by expected product size, 
i.e. 1 min/ 1-kb. 
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2.6.2 Making E. coli Rosetta2 culture stocks for transformation experiments 
E. coli Rosetta2 cells were grown overnight in 10mL LB at 37oC with shaking at 200 rpm. 
Overnight culture was diluted 1 in 100 into fresh LB and grown to ~OD600nm = 0.4 at 37
oC, 
200 rpm. Cells were pelleted at 4000 rpm at 4oC and resuspended on ice in 1/20 volume with 
pre-chilled Rosetta resuspension buffer. Resuspended cells were aliquoted into 50 or 100µL 
volumes, snap frozen in liquid N2 and stored at -80
oC.  
 
2.6.3 Transformation of E. coli Rosetta2 with the pMAL and/or pMBPTpase plasmid 
50 µL aliquots of chemically competent E. coli Rosetta2 cells were thawed on ice and 50µL 
KCM solution was added. 2 µL of plasmid (pMAL or/and pMBPTpase) was added and mixed 
by flicking tube. The transformation reaction was incubated on ice for 20 min and heat 
shocked at 42oC for 90 sec. 200 µL room temperature LB broth was added immediately 
thereafter and cells were recovered at 37oC for 2 hrs prior to plating onto LB agar containing 
carbenicillin (100 µg/mL) and 2% glucose. 
 
2.7 Electrical transformation of bacterial cells 
2.7.1 Making Ps. stutzeri st. Q (PstQ) and Ps. stutzeri ATCC17641 (Pst641) culture stocks 
for electroporation experiments 
PstQ and Pst641 were streaked onto LB agar (no antibiotic) and grown at 30oC for 2 days. 50 
mL LB broth was inoculated with single colonies of PstQ/Pst641 and grown overnight at 
30oC, 200 rpm. 1 L LB broth was inoculated with 1:100 overnight culture and cells were 
grown at 30oC, 200 rpm to an OD ~1.0. The culture was pelleted in pre-cooled centrifuge 
bottles by spinning at 7500 rpm, 4oC, for 15 min and kept cool from this point onwards. The 
supernatant was discarded and the cell pellet washed in pre-chilled 10% Sucrose/1 mM 
MgSO4, 1 mM HEPES solution. The centrifuge cycle and wash step were repeated two more 
times. Finally the cells were suspended in 2-3 mL of the solution above and aliquoted into 
110 µL stocks prior to storage at -80oC. 
 
2.7.2 Electro-transformation of PstQ and Pst641 
Electrocompetent PstQ and Pst641 cells (50 µl) were thawed on ice and 1 µg of plasmid was 
added to the cells. The cells were mixed before transfer to pre-chilled electroporation 
cuvettes. The cells were electroporated at 200 Ohms, 2.5 Volts and a capacity of 25 µFD. 
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Immediately after, 750 µL LB broth was added to the cuvette, cells were mixed gently by 
pipetting and the mixture was transferred to a 1.5 mL microcentrifuge tube. The cells were 
incubated for 2 hrs at 300C, 200 rpm. Cells were then plated onto LB agar supplemented with 
kanamycin at 50 μg/ml (LB/Km50) and incubated at 30oC for 4 days.  
 
2.8 Plasmid miniprep-Alkaline lysis 
E. coli JM109 cells containing appropriate plasmid constructs (Table 2.10) were grown in 50 
mL LB/Km50 overnight at 37oC. Cells were pelleted and washed in 2 mL TE and lysed in 2 
mL of cell lysis solution at room temperature for 5 min. 3 mL of ice-cold precipitation 
solution was thoroughly mixed in and the total incubated on ice for 15 min. The supernatant 
was recovered after 15 min centrifugation at 4000 rpm and an equal volume of isopropanol 
was added and incubated on ice for 15 min. The sample was spun at 4000 rpm for 15 min.  
5mL of 70% cold ethanol was added to the recovered pellet, and left to stand for 5 min at 
room temperature to ensure a maximum plasmid yield recovery.  
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Table 2.10 Plasmids used/generated  
Plasmid  Backbone Use Size Properties Reference 
pGEM-T 
Easy 
pUC 
General purpose 
cloning 
3.0-kb 
pBR322 ori, AmpR; contains multiple cloning site 
within lacZ fragment allowing for blue/white 
selection 
Promega 
Corporation 
pUS21 pUC19 aadB-attC  template  2.8-kb 
pBR322 ori, AmpR; amplified aadB 59-be (105-
bp) at XbaI/PstI site in pUC19 
Coleman & Holmes 
(2005) 
pMAL-c2 pUC MBPTpase expression 6.6-kb 
pBR322 ori, AmpR, malE gene with multiple 
cloning site, Factor Xa cleavage site 
New England 
Biolabs 
pPsattC1/ 
pPsattC2 
pBBR1MCS2 
Kovach et al.  (1995) 
Pseudomonas-type attC 
trap 
5.35-kb 
mod, rep, KmR, Ps.- like attC site (219-bp) cloned 
into SmaI site. In pPsattC1 the attC site is found in 
the opposite orientation to the ori/rep gene. In 
pPsattC2, the attC site is in the same orientation as 
the ori/rep 
This study 
pPsattC1-IS ISPst6 containing trap 6.64-kb 
mod, rep, KmR, Ps.- like attC site (219-bp) cloned 
into SmaI site with a translocated ISPst6 element 
This study 
paadB-
attC1/ 
paadB-attC2 
Classical attCaadB trap 5.24-kb 
mod, rep, KmR,  classical attC site (100-bp) cloned 
into SmaI site. In paadB-attC1, the attC site is 
found in the appositive orientation to the ori/rep 
gene. In paadB-attC2, the attC site is in the same 
orientation as the ori/rep 
This study 
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2.9 Isolation of genomic DNA for Fosmid library construction 
The ISOLATE Genomic DNA Mini Kit from Bioline was used to extract high quality 
genomic DNA with amendments to the manufacturers protocol. Changes were as per figure 
2.2 and the following; the culture was grown overnight at 30oC for environmental and 37oC 
for clinical isolates in 4 x 10 mL volumes (40 mL total). Cells were pelleted at 4000 rpm for 
20 min at room temperature. Cell pellets were washed in 0.9% NaCl and the spin cycle was 
repeated. 800 µL Lysis Buffer D (kit supplied) and 300 µL 20% SDS was added per cell 
pellet. The tube was inverted several times and 50 µL ProK (kit supplied) was added, before 
vortexing and incubated for 1 hr at 37oC. ProK was inactivated at 50oC for 30 min. 400 µL 
Binding buffer (kit supplied) was added and mixed by inversion for 2 min. The content was 
transferred to the spin column provided which was then spun at 14000 rpm for 3 min. Eluate 
was discarded and 700 µL Wash buffer (kit supplied) was added and spun again as above. 
Wash was repeated once more. 100 µL of Elution buffer (kit supplied) was added per column 
and the column was incubated at 50oC for 10 min. Final elution step involved centrifugation 
at 14 000rpm for 3 min. The 4 x 100 µL elutions were pooled into one 400 µL total volume 
and purified further by Phenol: Chloroform: Isoamyl extraction (see 2.9.1). 
 
2.9.1 Phenol: chloroform: isoamyl extraction of genomic DNA 
To ensure that pure DNA was obtained, and the high levels of polysaccharide produced by 
Pseudomonad strains was removed prior to fosmid library construction, an additional 
cleaning step was carried out. 400 µL of phenol: chloroform: isoamyl alcohol (25:24:1) was 
added to the purified DNA from section 2.9, and mixed by gently inverting 10 times. The 
sample was centrifuged at 13000 rpm for 10 min at room temperature and 370 µL of the 
upper aqueous phase was collected gently. Equal volume of chloroform: isoamyl alcohol 
(24:1) was added, inverted and then centrifuged for 10 min at 13000 rpm. 350 µL of upper 
phase was collected again and equal volumes of chloroform: isoamyl alcohol (24:1) was 
added. The tube was inverted and spun at 13000 rpm for 10 min again. 320 µL of the upper 
aqueous phase was collected and 1/10th volume of 3 M Sodium acetate (pH 5.2) was added. 
The tube was mixed by gentle inversion. 2.5 volumes of -20oC 100% ethanol was added and 
mixed again by gently inverting. The tube was chilled at -20oC for 30 min and DNA was 
pelleted by centrifugation at 14000 rpm for 10 min at 4oC. The pellet was washed with 70% 
ethanol kept at -20oC, then the pellet was dried at 50oC for 5-10 min and finally resuspended 
in 25-30 µL of MQ water before storage at -20oC.   
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High molecular weight DNA extracted from individual isolates was analysed by gel 
electrophoresis. 0.8% Agarose in 0.5X TBE gels were prepared. 2 µL of gDNA was loaded 
per isolate. An initial run at 100V for 5 min was done so as to allow all of the DNA to exit 
the well and enter the agarose medium. The gel volume was 50 mL set as a 5 cm x 10 cm gel 
and was then run at 18 V overnight. Once the run was complete, the gel was stained in 
ethidium bromide staining solution for 30 min and was visualized by UV-light using the Gel 
Doc® XR+ system (Bio-Rad, USA). Total DNA yields were estimated by comparison to 
DNA standards and control DNA. 
 
Figure 2.2: Flowchart of gDNA extraction protocol from isolates used in Fosmid construction.  
40 mL of culture was grown per isolate overnight. Four separate Bioline columns were used to purify 
the gDNA. Elutions were pooled and an additional phenol: chloroform: Isoamyl alcohol step was 
added to ensure that the gDNA was pure. DNA quality and quantity was confirmed by gel 
electrophoresis prior to fosmid construction. 
 
 
2.9.2 Fosmid library construction 
To recover IS1111-attC, the genes flanking them, as well as potential integrons, Fosmid 
libraries were constructed using the CopyControl™ Fosmid Library Production Kit 
(Epicentre) according to the instructions supplied with the kit. For each Fosmid library 
constructed, 384 clones were selected for further analysis. All libraries were stored at -80oC 
in 96-well plates in 200 µL of LB broth supplemented with 12.5 µg/mL chloramphenicol, 
10% L-arabinose and 15% glycerol. E. coli Epi300 (Epicentre) cells were transformed with 
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phage packaged fosmids and were grown overnight at 37oC as per manufacturer’s 
instructions. Cells were diluted from 100-10-3 and plated onto LB agar supplemented with 
12.5 µg/mL chloramphenicol (Cm) and grown overnight at 37oC. Individual colonies were 
picked and resuspended into 200 µL LB/12.5 µg Cm/10% L-arabinose wells of 96-well 
plates. 
 
2.9.3 Fosmid screening via Southern hybridization 
Screening for IS1111-attC elements in Fosmid clones was accomplished using a pooled 96-
well plate method (Figure 2.3). Each Fosmid library (ie. per isolate) had 4x 96 well plates. 
Clones were grown overnight at 37oC, 200 rpm. For ease of screening, wells in individual 
columns were pooled. 5 µL per well was added to a microcentrifuge tube. In total 12 tubes 
were obtained per 96-well plate. All tubes were heated at 99oC for 10 min, and cellular debris 
was spun down at 14000 rpm for 3 min. The supernatant was reheated at 99oC for 10 min and 
chilled on ice for 1 min prior to spotting 3 µL onto a nylon membrane (Hybond N+, 
Amersham). The membrane was hybridized against a 1347-bp IS1111-attC probe as per 
section 3.2. A positive southern hybridization signal corresponds to a positive 96-well plate 
column. The 96-well plates were revisited and 10 µL was removed from the individual wells 
in the corresponding positive column, to give 8 tubes per positive column. The cells in the 
individual tubes were boil-lysed and hybridized as mentioned above. Fosmid was extracted as 
per manufacturer’s instructions. 
 
2.9.4 Fosmid purification 
When purified fosmid was required for analysis such as restriction digestion and PCR, 
induction of the fosmid to high copy number was performed according to the Epicentre 
instructions. The fosmid was then extracted using an alkaline lysis plasmid purification 
protocol (see section 2.8). Purified fosmid DNA was stored in TE buffer at -20oC.  
 
2.10 Fosmid sequencing 
Glycerol stocks were sent to the commercial sequencing service Macrogen Inc. (Korea). This 
sequencing service extracted the fosmids from glycerol stocks, generated a shot gun library 
and used a 6X sequencing platform prior to assembling contigs.  
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2.11 Bioinformatics analysis 
All sequences were analysed for the presence IS1111-attC elements and intI homologs to determine 
the nature of genes flanking the arrays using the various search options available on the NCBI website 
(Altschul et al., 1997). Geneious 6.1.5 ORF predict function was used to locate all open reading 
frames greater than 100 codons within the sequence data with an atg, gtg and ttg start codons.  
SnapGene® Viewer 2.3 DNA Sequence (GSL Biotech LLC, USA) was used to draw and annotate 
fosmids maps.  
 
 
 
Figure 2.3: Screening fosmids libraries for IS1111-attC elements.  
Putative clones, in 96-well plates, were pooled into 12 individual tubes, boil-lysed and spotted onto a 
N+-membrane for southern hybridization. Once a positive clone was identified, individual wells in a 
“positive” column are screened to identify the E. coli Epi300 clone that contained the IS1111-attC 
element.
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 Distributions of IS1111-attC, mobile and chromosomal 
integrons within the bacterial genus Pseudomonas 
3.1 Introduction 
Acquired antibiotic resistance in many Proteobacteria is strongly associated with resistance 
genes on plasmid borne MRIs (Livermore, 2002; Odumosu et al., 2013). It is evident these 
genes have been acquired from foreign sources across wide biological distances. However, 
understanding how resistance determinants are able to cross ecological barriers and come 
together in a given bacterial cell is poorly understood. Host related molecular and genetic 
factors are postulated to influence multiresistant phenotypes, yet these are also poorly 
understood.  
 
Despite environmental organisms constituting a reservoir of resistance genes (Allen et al., 
2010; Cantón, 2009; Mazel, 2004), there are limited examples of resistance genes that are 
shared between non-pathogenic environmental and human pathogens (see Table 1.3). In the 
few cases that are characterized we can see two features: i) the source-sink organisms are 
genetically related, emphasizing that HGT is more prevalent in related organisms sharing 
ecological and molecular-genetic traits; and ii) additional “specialized” mobile elements have 
also been involved. For example, the blaCTX-M resistance gene was translocated by ISEcp1 
from the source Kluyvera ascorbata to an Enterobacteriaceae sink. I postulate that the lack 
of observations of source-sink relationships for more phylogenetically and ecologically 
separated organisms is simply harder to observe. Transfer of a chromosomal framework 
(core) gene is easy to detect because that gene is always present in the source population. The 
integron-gene cassette system is both the major source for multi-drug resistance in 
Proteobacteria and a special challenge in the exploration of source-sink relationships. The 
gene cassettes in source populations (CIs) are not core genes. Thus they are not present in all 
cells and their movement from source to sink is much harder to observe.  
 
Gene cassettes were hypothesized to have a discrete source population in environmental 
Pseudomonads (Pseudomonas 1) (Figure 3.1). For gene cassettes to cross into a related sink 
population (clinical Pseudomonas 2), they would conceivably need to overcome medium 
ecological distance where these two populations have overlapping, but distinct habitat 
preferences. Available data suggests a key ecological difference is the extent to which they 
are animal associated (Figure 1.13). Both groups are readily isolated from planktonic and 
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biofilm habitats in freshwater systems, but Ps. aeruginosa is by far more frequently 
encountered as an opportunistic pathogen, a low abundance member of the normal microbiota 
(Markou & Apidianakis, 2014) in the gut and impaired mucociliary clearance [notably in 
cystic fibrosis patients (Folkesson et al., 2012) and ventilators (Planquette et al., 2013)]. In 
the context of this study, a key genetic distinction between Pseudomonas populations is the 
presence of chromosomal integrons. These are typically, but variably, present in the Ps. 
stutzeri group but absent in the Ps. aeruginosa group. IS1111-attC are exploited as the “core” 
gene cassette. They are so frequently observed in PCIs that their movement is postulated to 
be readily observable. I used three groups of γ-Proteobacteria that represent three distinct 
categories of pair-wise biological separations. To study the flow of genetic material between 
ecological and molecular-genetic barriers, chromosomal integrons, MRIs and IS1111-attC 
elements were used as a model system for HGT and resistance acquisition.  
 
 
Figure 3.1 Conceptual framework for the study using IS1111-attC elements as a model for gene flow 
across biological distances. 
IS flow between Pseudomonas populations is postulated to have to overcome medium ecological 
separations, but low genetic distances. IS flow between a clinical Pseudomonas population and 
enteric population is predicted to be limited by the high genetic differences despite reduced ecological 
distance. Ecological and phylogenetic distances between Enterobacteriaceae and population 1 is thus 
predicted to have a vast impact on IS1111-attC translocation. Blue arrows represent IS1111-attC 
flow between groups, orange arrows represent IS1111-attC flow between different strains/species 
within a group. 
 
IS1111-attC and gene-cassettes are both genetic entities that are dependent on integrons for 
residence in a cell. The availability of IS residence sites (attC) is predicted to be limited in 
Pseudomonads with no PCIs and/or there is potential molecular incompatibility. As such, 
IS1111-attC spread between Pseudomonas populations 1 and 2 may need to overcome low 
levels of molecular-genetic separations. Furthermore, IS spread within a clinical system to a 
genetically unrelated group (Enterobacteriaceae) is predicted to be governed by low 
Environmental
(Pseudomonas 1)
• Medium ecological 
separation
• Low phylogenetic 
distance 
Clinical
(Pseudomonas 2)
• Low ecological separation
• High phylogenetic distance Clinical
Enterobactereciae
• High ecological separation
• High phylogenetic separation  
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ecological distance but high molecular-genetic distance (Figure 3.1).  Thus by tracking its 
distribution across the three populations in Figure 3.1, we can assess the relative importance 
of ecological barriers in MDR formation. Secondly, by exploring the details of the genetic 
insertion points we can examine what molecular-genetic interactions were part of the IS1111-
attC translocation process. 
 
3.1.1 Aims 
IS1111-attC was used as a model gene cassette to test the relative contributions of genetic 
and ecological aspects to gene flow and MDR formation in integrons. Characteristically, 
IS1111-attC members mimic gene cassettes as they site-specifically target integron associate 
recombination sites within PCIs and MRIs (Tetu & Holmes, 2008). The primary aim in this 
chapter was to identify potential source and sink elements (MRIs, PCIs and IS1111-attC) in 
three biologically distinct Proteobacteria populations.  The fundamental question is: Is gene 
flow of IS1111-attC elements greater between phylogenetically related organisms 
(Pseudomonad to Pseudomonad) or between non-related organisms (Pseudomonad to non-
Pseudomonad)?  
 
 The overall study design was based on the following predictions: 
1) IS1111-attC elements are dependent on the presence of MRIs in clinically relevant 
Pseudomonads 
2) IS1111-attC elements are dependent on the presence of PCIs in environmental  
Pseudomonads isolated from low selective pressure environments (domestic) 
3) IS1111-attC elements are overrepresented in the genus Pseudomonas relative to their 
distribution in an enteric outgroup 
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3.2 Methods 
For general media and solution recipes, as well as PCR conditions, refer back to Chapter 2. 
3.2.1 Strain Collection 
The strain collection primarily consisted of clinical isolates obtained from various patients 
and environmental isolates from inert objects such as sponge and mop samples (Table 3.1). 
All 125 clinical human isolates and 9 non-host associated clinical environmental isolates 
were kindly donated by collaborators. Sixty-three Pseudomonads were isolated as per section 
2.2 from domestic sponge and mop samples. An additional six non-host associated isolates 
were recovered from hospital mop and swab samples. For more information on all isolates 
refer to the Appendix, Tables A1-A3. 
 
Table 3.1 Strain collection  
 
 
Clinical+ 
Non-clinical  
Hospital 
 
Environmental Ps. 
(water, soil) 
Domestic  
 
Pseudomonad 125 6 9 63 
Enteric 
outgroup 
52 0 0 0 
+ From clinical specimens (blood, sputum, wounds etc.) 
 
3.2.2 Genotyping domestic environmental Pseudomonas strains 
Fingerprinting Pseudomonad isolates obtained from sponge and mop samples was done using 
a repetitive sequence based PCR using the BOXA1R sequence (BOX-PCR) (Versalovic et 
al., 1994). This approach generates fingerprints that can discriminate bacteria at very fine 
resolution and can therefore distinguish different strains of the same species (Louws et al, 
1994; Gillings & Holley, 1997).  The technique uses just one oligonucleotide BOXA1R, 
which acts as both a forward and reverse primer. Band-classification was done by manual 
correction of automated analysis with Quantity-One software. Cluster analysis of BOX-PCR 
banding patterns was done manually using Quantity-One software at a 1.5% tolerance level. 
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3.2.3 Southern Hybridisation 
High molecular weight genomic DNA was extracted for all isolates as per section 2.3. DNA 
was quantified and its purity was checked by NanoDrop® spectrophometry analysis and gel 
electrophoresis. Approximately 200-400 ng of high molecular weight genomic DNA of each 
isolate was denatured at 99oC for 15 min in MQ water and kept on ice during spotting onto a 
nylon membrane (Hybond N+, Amersham). The membrane was air-dried and the DNA was 
UV autocross linked to the membrane using the Stratalinker® UV Crosslinked (Stratagene, 
USA). The DNA was cross-linked with 1200 microjoules (x100) for a period of 45 sec using 
a 254-nm light source. 
 
Southern Hybridisation was performed as described by Southern (1975) with modifications 
by Sambrook and Russel (2001). Probes for southern hybridisation were labelled with 
digoxygenin-6-dUTP (Roche) directly by PCR (Figure 3.2). The efficiency and yield of the 
labelling reaction was assessed using standard gel electrophoresis of amplified probes. Band 
intensity after staining with ethidium bromide was used to gauge the yield of the labelling 
reaction, and as the addition of DIG-dUTP to a PCR product affects electrophoresis, 
retardation of the labelled PCR product relative to an unlabelled control was used to assess 
labelling efficiency.  
 
All hybridisations were performed in pre-dissolved and pre-heated DIG Easy-Hyb Granules 
(Roche) as per manufacturer’s instructions. 25 ng/mL denatured DIG-labelled probe was 
added to dissolve DIG Easy-Hyb Granules in a total volume of 20 mL/100 cm2 membrane 
size. This was incubated overnight at the hybridisation temperature of ~55oC. Hybridization, 
immunological detection and visualisation steps were performed using the DIG Nucleic Acid 
Detection Kit (Roche Applied Science) according to the manufacturer’s instructions.  
Stringency washes, to remove unbound probe, were carried out as follows (20 mL/100 cm2): 
once for 5 min with 2x SSC, 0.1% SDS at 20°C, followed by two 15 min washes with 0.5x 
SSC, 0.1% SDS at 60°C.  To visualise bound probe, the membrane was evenly soaked in 
CDP-Star solution (Roche Applied Science) and allowed to incubate for 10 min prior to 
exposure to X-ray film (Kodak X-OMAT, Henry Schein Regional). Multiple exposures, 
employing different incubation times, were performed following each hybridization, to 
optimise the signal strength. 
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Figure 3.2 Probes and their respective target sites used in southern hybridization experiments. 
 % indicates the expected sequence variation in these targets for each probe. 
A) PCI probe: based on a 456-bp region corresponding to the chromosomal integron integrase  
B) attC cocktail probe (~100-bp per probe): three different Ps.-type attC sites from Ps. mendocina NW1, Ps. straminea KM91 and Ps. stutzeri DNSP21.  
C) IS1111-attC probe (1.3-kb): detect different levels of divergences of IS1111-attC elements. An IS1111-attC may reside as i) non-integrated minicircle or 
embedded in chromosomal attC; ii) intact IS; iii) IS1111-attC footprint iv) located on MRI 
d) MRI class 1 integron probe (550-bp): pR388 integron integrase region and attI recombination site.  
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3.2.4 Southern hybridization thresholds of detection 
Southern hybridization signals will be influenced by the copy number, sequence divergence 
and sequence extent of the targeted genes. An extensive array of controls were used to 
interpret the hybridization screens (Table 3.2). A positive signal was determined to be true if 
the isolate had a signal stronger than the control strains, and was consistent with predicted 
sequence divergence. Ps. stutzeri ATCC 14405 (Pst405) and Ps. stutzeri ATCC 17587 
(Pst587) contain at least three full intact copies of IS1111-attC elements. Ps. stutzeri ATCC 
17595 (Pst595) and Ps. stutzeri RNAIII (PstRNAIII) contain an IS1111-attC footprint.  These 
strains serve as positive controls for sequences that have greater than 50% identity over 
regions of 200 nucleotides and an IS1111-attC copy number of 1-3. In comparison Ps. 
stutzeri strain Q (PstQ) contains no IS1111-attC elements and Ps. aeruginosa PAO1 contains 
six transposases that are distantly related to IS1111-attC transposase. These two strains serve 
as negative controls for non-specific hybridization to sequences with less than 30% sequence 
homology. Similar detection thresholds are applied for the MRI, PCI and Ps. attC probes.  
 
 
Table 3.2 Control strains  
Control strain ID 
Element 
MRI 
IS1111-
attC 
PCI 
Ps. stutzeri ATCC 14405 Pst405 - + + 
Ps. stutzeri ATCC 17587 Pst587 - + + 
Ps. stutzeri ATCC 17595 Pst595 - + + 
Ps. mendocina NW1 PsNW1 - + + 
Ps. stutzeri RNAIII PstRNAIII - + + 
Ps. straminea KM91 PsKM91 - + + 
Ps. stutzeri strain Q PstQ - - + 
Ps. fluorescens 
NCTC 7244 
Pfluro 
- - - 
Ps. aeruginosa PAO1 PAO1 - -/+* - 
Ps. aeruginosa 216.2B 216.2B + - - 
Ps. aeruginosa MB PstMB + + - 
E. coli R388 R388 + - - 
*Ps. aeruginosa PAO1 has 6 putative transposases which display approximately 60% sequence similarity and 
38% identity to IS1111-attC transposase.  
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3.2.5  Polymerase chain reaction of gene fragments for sequencing and sequence 
analysis 
Amplification of IS1111-attC and integron sequences was achieved by PCR using 10-100 ng 
of template DNA. Purification of the PCR product was carried out with Qiaquick PCR 
purification kit (Qiagen) prior to cloning into a pGEM-T® Easy vector system (Promega) (as 
per manufacturer’s instructions). For difficult to sequence PCR products, or where multiple 
PCR products were obtained, the PCR product was cloned into pGEM-T Easy vector also. 
Automated sequencing was carried out by the Australian Genome Research Facility (Sydney, 
Australia) on an ABI 3730xl 95 capillary automated DNA sequencer. Geneious 6.1.5 
software was used for all alignments and annotations of sequence reads, and the National 
Centre for Biotechnology Information (NCBI) BLAST website 
(www.ncbi.nlm.nih.gov:80/BLAST) utilizing both BLASTN and BLASTX programs were 
used to search the recovered nucleotide sequences for homologs. 
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3.3 Results 
3.3.1 The non-clinical, environmental isolate set is composed of diverse members of the 
genus Pseudomonas 
The primary aim was to compare and contrast the distribution of MRIs, PCIs and IS1111-
attC elements between Pseudomonads occupying distinctly different habitats. All 125 clinical 
and 9 non-clinical isolates provided by collaborators had previously been identified as 
belonging to the genus Pseudomonas. An additional sample set of 63 non-clinical (domestic) 
isolates were recovered from mop and sponge samples from six suburban homes in Sydney, 
Australia. An additional 6 hospital environmental Pseudomonads were isolated in this study 
from a hospital panroom swab and bench swab sample. For more comprehensive information 
about these environmental isolates see Appendix Table A2. See Table 3.3 for a brief 
overview of the environmental isolate series isolated in this study using the selective medium, 
Pseudomonas Isolation agar (PIA).  
 
Table 3.3 Environmental isolates recovered on PIA from mop, sponge and swab samples. 
Isolate 
Series* 
Habitat Number of strains 
AP Hospital Panroom Swab 3 
AS Hospital Bench swab 3 
ES Domestic Sponge 5 
FM Domestic Mop 11 
JM Domestic Mop 11 
JS Domestic Sponge 7 
LS Domestic Sponge 15 
MS Domestic Sponge 6 
NS Domestic Sponge 8 
TOTAL 69 
*Abbreviation for person supplying the sample and sample type, e.g. Mia Sponge= MS 
 
To exclude sibling isolates and confirm independence of the 69 non-clinical isolates, all were 
typed by BOX fingerprinting. Grouping of the PCR banding patterns was done manually 
using Quantity-One software and bands were analysed in comparison to each other and the 
100-bp molecular weight markers.  The results of the BOXA1R PCR indicated that the vast 
majority of environmental Pseudomonads are genetically distinct and independent isolates 
(53/69 different BOX patterns). See appendix Figure A1 for all BOXA1R profiles.  
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In summary, eight out of sixty-nine isolates (8/69), FM3, FM8, JM3, JM4, LS11, LS14, MS5 
and PO6, consistently failed to give a BOX-PCR product despite producing a strong 16S 
rRNA DNA PCR amplicon. It is likely that these isolates do not contain repetitive regions to 
which the BOXA1R primer could anneal. Also, no observable difference in BOX-PCR 
banding patterns was seen for isolates AP1 and AP3. 16S rRNA DNA sequencing identified 
both isolates as Ps. putida W619 (iso. AP1) and Ps. putida ND6 (iso. AP3). Also both 
isolates hybridized positively only to the MI probe and no other probe. Similarly, AS1 and 
AS3 had identical BOX repetitive patterns and 16S rRNA DNA sequencing identified both 
isolates as Pseudomonas sp. AS1 and Pseudomonas sp. AS3. However, the southern 
hybridization “profiles” varied in that AS1 hybridized positively to both the MI and IS1111-
attC probe and AS3 was negative for all probes tested.   
 
Finally, LS5, LS12, LS15, NS1, NS2 and NS5 had identical patterns. Further differentiation 
of these isolates was made possible using southern hybridization (See section 3.3.2). For 
instance LS5 was identified as positive for IS1111-attC and Pseudomonas-type attC site. In 
comparison isolates LS12 and LS15 are negative for all mobile elements of interest. Isolate 
NS2, despite having an identical BOX rep pattern, was isolated from a different domestic 
source. Similarly, NS1 and NS5 display the same BOX rep pattern. However these two 
strains were of very little interest as they were found to lack PCI, MI, Pseudomonas-type attC 
and IS1111-attC. Finally, JS3 and JS6 had identical BOX patterns but JS3 hybridized 
positive for PCI and Pseudomonas-type attCs. JS6 was negative for all elements.   
 
Use of PIA proved successful in recovering independent isolates. Note, where an isolate was 
of interest based on the southern hybridization data, the 16S rRNA DNA was sequenced to 
further validate that it indeed was a Pseudomonad. In conclusion, the environmental sample 
set is comprised of different members of the Pseudomonadaceae family.  
 
3.3.2 Distribution of IS1111-attC elements, MRIs and PCIs across three phylogenetic 
groups  
All isolates were examined by Southern hybridization and PCR for the presence of MRIs, 
IS1111-attC elements, PCIs and Pseudomonas-type attC sites (Table 3.4). An array of 
controls was used for every southern hybridization and that a positive signal was called such 
when the hybridization intensity was 50-100% of that of the controls (Figure 3.3).   
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Table 3.4 Distribution of MRIs, PCI, and IS1111-attC across Pseudomonads based on Southern 
hybridization and PCR findings. 
Geographic group 
No. 
isolates 
Distribution (%)a 
No. of 
recovered 
sequencesb  
IS1111-
attC 
MI PCI 
Ps. 
attC 
MI+  
IS1111-
attC 
PCI+ 
IS1111-
attC 
IS1111-
attC 
MI 
P
se
u
d
o
m
o
n
a
d
a
ce
a
e 
Clinicalc 125 
34 
(27%) 
24 
(19%) 
4 
(3%) 
2 
(2%) 
19 
(15%) 
2 (2%) 14 9 
N
o
n
-C
li
n
ic
a
ld
 
Total 78 
17 
(22%) 
11 
(14%) 
13 
(17%) 
9 
(12%) 
6 (8%) 9 (12%) 9 8 
Hospital 6  1 (17%) 
6 
(100%) 
0 (0%) 0 (0%) 1 (17%) 0 (0 %) 1 4 
Environment 9 3 (33%) 1 (11%) 
2 
(22%) 
2 
(22%) 
0 (0%) 2 (22%) 3 0 
Domestic 63 
18 
(29%) 
4 (6%) 
11 
(18%) 
7 
(11%) 
4 (6%) 8 (13%) 5 3 
E
n
te
ro
b
a
ct
er
ia
ce
a
e 
Outgroup 52 0 (0%) 
11 
(21%) 
0 
(0%) 
0 
(0%) 
0 (0%) 0 (0%) 0 2 
a) Data are presented as a total percentage from southern hybridization and PCR screens, where bold denotes 
the data for each population. 
b) Number of recovered sequences by PCR and sequencing. 
c) All clinical isolates were derived from independent sample sets, annotated as TS, JIP, SSI and P (Table A1). 
d) Non-clinical Pseudomonads are further subdivided into the following categories: hospital (swabs, panroom 
swab, sponge, mop); environmental (soil, water); and domestic (swab and sponge.) 
 
24 clinical strains (19%, 24/125) gave a signal of comparable intensity to the positive MRI 
control and significantly different from all negative controls (Figure A2 Part A). In 
comparison, three percent of the clinical isolates (3%, 4/125) hybridized with a PCI probe 
and 2% (2/125) also probed positive for Pseudomonas-type attC sites (Figure A2 Parts C & 
D). Two Pseudomonas aeruginosa isolates SSI2.84 and JIP117 gave a weak signal with the 
PCI but not the Pseudomonas attC probe. These two isolates were found to carry an MI, 
hence the PCI signal is believed to be a cross-reaction with an MRI probe due to the low 
stringency conditions used during hybridization washes rather than the presence of a true 
PCI. MIs are often carried on high copy number plasmids, hence the weak signal detected 
under low stringency conditions. Isolate P15 (Ps. stutzeri ATCC 17588) and isolate P17 
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(Pseudomonas stutzeri), hybridized for PCI and Pseudomonas-type attC, but not MRI.  27% 
(34/125) of the clinical Pseudomonads emitted a positive hybridization signal for IS1111-
attC elements (Figure A2 Part B).  
 
In comparison, 14% (11/78) of non-clinical Pseudomonads positively hybridized to the class1 
integron probe (Figure A3 Part A). 17% (13/78) produced a hybridization signal to PCI probe 
(Figure A3 Part C) and 12% (9/78) hybridized to the Pseudomonas-type attC cocktail probe 
(Figure A3 Part D). Finally, 22% (17/78) of the non-clinical isolates were positive for 
IS1111-attC elements (Figure A3 Part B).  
 
The clinical enteric outgroup used in this study is a collection of 52 isolates obtained as  part 
of an antibiotic cycling study at Westmead Hospital, Sydney (Ginn et al., 2012). 21% (11/52) 
of this group was MI positive but were all negative for IS1111-attC, PCIs and Pseudomonas-
type attC sites (Figure A4). Two isolates within this sample set gave a rather strong signal for 
an MI. 16S rRNA DNA sequencing identified these two isolates as Enterobacter sp. JUNL-1 
and Enterobacter cloacae subspecies cloacae ATCC 13047.  
 
Given these observations I conclude that chromosomal integrons, IS1111-attC and 
Pseudomonas-type attCs are all more prevalent within Pseudomonads than the 
Enterobacteriaceae outgroup. 
 
3.3.3 IS1111-attCs are overrepresented in MRIs in clinical, and in PCIs in non-clinical 
Pseudomonads respectively 
To determine if an IS1111-attC element can co-exist in cells with multiple types of integrons, 
mobile class1 vs. chromosomal integrons, southern hybridization data was examined for any 
isolates that hybridized to two or more probe combinations (Table 3.4).   
 
15% (19/125) of clinical Pseudomonads hybridized to both an MI and IS1111-attC probe. 2% 
(2/125) of the clinical isolates were observed to hybridize to both a PCI and IS1111-attC 
element.  Given the small percentage containing a PCI and IS, suggests that these are 
acquired at lower rates within the clinical Pseudomonads. The inverse was observed for the 
non-clinical Pseudomonads. 12% (9/78) of these isolates produced a hybridization signal for 
both the PCI and IS1111-attC element, whilst only 8% (6/78) produced positive signals for 
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both MI and IS1111-attC elements. In the case of the enteric outgroup, no such association 
was observed as no IS1111-attC elements were recovered from these 52 isolates.  
 
These data support previous findings of Tetu and Holmes (2008), where IS1111-attC were 
found to have a strong association with PCIs. This current study demonstrates that IS1111-
attC are associated with MIs within clinical Pseudomonads and that generally IS1111-attC 
are over-represented within the Pseudomonadaceae.     
 
3.3.4 PCR detection and sequence analysis of IS1111-attC elements 
Screening and sequencing efforts targeting IS1111-attC hybridising fragments across all 
hybridisation positive clinical and environmental strains recovered a total of 23 strains. 
However two sequences from domestic Pseudomonas sp. JM7 and Pseudomonas aeruginosa 
SSI 2.37, were disregarded from further analysis as these were found to be non-specific 
products. Thus 21 IS elements spanning different levels of divergence, are considered to be a 
representation of IS1111-attC related sequences as observed by hybridisation intensity, and 
sequence divergence within this strain collection.   
 
PCR recovery using primers targeting intact IS1111-attC from the non-clinical set generally 
resulted in multiple banding patterns (Figure 3.4, Lanes 1-6 & Figure A2). Tetu and Holmes 
(2008) found that multiple banding patterns are readily obtained when more than one IS1111-
attC element is located within a PCI array. In comparison, recovery of IS1111-attC elements 
from host associated Pseudomonas isolates, resulted in a single band of the expected size 
(Figure 3.3, Lanes 12-30).  
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Lane Isolate ID 
Number of bands & 
corresponding size (bp) 
Additional information where 
1300-bp product was sequenced 
1 JM1 
2 bands (400-bp & 1300-
bp) 
 
2 JM2 
6 bands (200bp, 600-bp, 
1000-bp, 1100-bp, 1300-
bp, 1500+bp) 
 
3 JM6 
6 bands (200bp, 600-bp, 
1000-bp, 1100-bp, 1300-
bp, 1500+bp) 
 
4 JM7 1 band (1300-bp) Sequenced- non-specific product 
5 JM10 
7 bands (100-bp, 200bp, 
600-bp, 1000-bp, 1100-
bp, 1300-bp, 1500+bp) 
 
6 AS1 
2 bands (1000-bp & 
1300-bp) 
Sequenced- ISUnc1-like element  
7 LS5 1 band (1300-bp) 
 
8 LS6 1 band (1300-bp) 
 
9 LS8 1 band (1300-bp) 
Sequenced-confirmed ISUnc1-like 
element 
10 LS13 1 band (1300-bp)  
11 NS6 1 band (1300-bp) Sequenced- non-specific product 
12 TS464 1 band (1300-bp) 
 
13 TS491 1 band (1300-bp) Sequenced- confirmed ISPa21-like 
14 TS504 1 band (1300-bp)  
15 TS558 1 band (1300-bp) Sequenced-confirmed ISUnc1-like  
16 TS684 1 band (1300-bp)  
17 TS589 1 band (1300-bp)   
18 TS597 1 band (1300-bp)  
19 TS598 1 band (1300-bp)   
20 TS599 1 band (1300-bp)  
21 TS600 1 band (1300-bp)  
22 TS616 1 band (1300-bp)  
23 TS620 1 band (1300-bp)  
24 TS629 1 band (1300-bp)  
25 TS630 1 band (1300-bp)  
26 TS631 1 band (1300-bp)  
27 TS634 1 band (1300-bp)  
28 TS653 1 band (1300-bp)  
29 TS654 1 band (1300-bp)  
30 TS664 1 band (1300-bp)  
31 Pst587 1 band (1300-bp)  Positive control 1.3-kb IS1111-attC 
32 -ve 0 Negative control MQ water only 
Figure 3.3: IS1111-attC PCR screen across a subset of environmental and clinical Pseudomonas 
isolates.  
All isolates were previously identified via southern hybridization to contain IS1111-attC elements.   
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Previously, Tetu and Holmes (2008) recovered a total of 9 IS elements and two IS-like 
fragments from three Pseudomonas stutzeri genomovar 2 strains. Using a criterion of 98% 
sequence identity, 21 independent IS1111-attC occurrences (14 host associated and 9 non-
host associated) were identified in this study. All 21 were attributed to one of the previously 
described isoforms, ISUnc1-like, ISPa21-like and ISPst6-like.  Sequences corresponding to 
the right hand non-coding region (Figure A7) were used to generate Figure 3.4 as this region 
is typically retained in degenerate IS1111-attC elements, so it is suitable for global analysis 
of IS sequences (Tetu & Holmes, 2008).   
 
Eight clinical isolates (JIP004, JIP009, JIP041, JIP044, JIP045, JIP047, JIP073, TS558), one 
hospital environmental Pseudomonas sp. AS1, one environmental Ch. meningosepticum iso. 
PO6, and two domestic environmental isolates (Delftia sp. LS8 and Pseudomonas sp. FM4) 
were found to have ISUnc1-like elements. These recovered sequences represent divergent 
ISUnc1-like elements where sequences from Ps. aeruginosa isolate JIP004 and JIP041 are 
97-98% identical to the reference ISUnc1-like sequences (ISUnc1 Pa and ISUnc1 Psp7).  
ISUnc1-like sequence from six remaining host associated isolates (JIP009, JIP044, JIP045, 
JIP047, JIP073, TS558) are 99% identical to the ISUnc1-like sequence recovered from 
domestic isolate, Pseudomonas sp. FM4. This isolate also hybridized to the PCI probe but not 
an MRI probe. Note that 16S rRNA DNA sequence analysis for isolate FM4 revealed 98% 
(1387/1409) identity to Ps. putida ATCC12633 type strain 16S rRNA DNA. A PCI 
association with a lineage within Ps. putida is thus the likely source for ISUnc1-like 
elements. 
 
Two clinical Ps. aeruginosa isolates, JIP052 and TS491, have ISPa21-like elements. These 
IS elements have previously been observed in clinical Ps. aeruginosa isolates and in each 
case were in the attC site of a resistance cassette in a class 1 integron (attCaacA7, attCblaGES-9, 
attCaadA7) (Poirel et al., 2005; Tetu & Holmes, 2008).  
 
Finally, two domestic isolates (Unknown Pseudomonas sp. FM1 and FM3), two 
environmental isolates (Chryseomonas luteola iso. PO5, Ps. mendocina ATCC25411 iso. 
P13), and three clinical isolates (Ps. stutzeri ATCC17588 iso. P15, Ps. aeruginosa JIP117 
and SSI2.84) have IS1111-attC elements with more than a 96% identity to ISPst6. 
Acquisition of an ISPst6-like element by a clinical strain reflects recent acquisition of the IS 
from an environmental Ps. stutzeri strain. Note however that the ISPst6-like sequence from 
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Ps. aeruginosa iso. SSI2.84 was not included in Figure 3.5 because the non-coding side was 
not recovered (see Appendix Figure A8). Nevertheless, the recovered IS sequence displayed 
98% (825/834) sequence identity to Pst587 ISPst6.  
 
Attempts to sequence the 16S rRNA DNA from isolates FM1 and FM3 were unsuccessful. 
Culture based work and microscopy of the culture stocks showed that they were 
contaminated by Bacillus species. This media is based on the production of pyocyanin, as 
such contamination by Bacillus sp. is believed to have occurred when FM1 and FM3 were 
incubated overnight in LB broth, before long-term storage in glycerol solution. The initial 
southern hybridization and sequencing efforts for FM1 and FM3 were not reproducible when 
genomic DNA was prepared freshly from the Bacillus contaminated glycerol stocks.  
 
3.3.5 Recovery of class 1 intI1-attI1 junctions from all three sample sets 
To determine if the various ISUnc1-like and ISPa21-like elements are in independent MRIs, I 
looked at fine scale patterns of relations to integrons. MRIs are the most comprehensively 
studied integron due to their high impact on the spread of antibiotic resistance (Stalder et al., 
2012). PCRs for the intI1-attI1 junction were conducted as a means to validating the southern 
hybridization findings across all sample sets. However, the correlation between the 
hybridization data and PCR was inconsistent due to the intI1 gene being prone to 
degeneration, deletion and insertional disruption. An additional intI1 screening approach was 
thus conducted using intI1 internal primers (HS915 and HS916) (Chowdhury et al., 2009).  
 
In figure 3.5A, 12 clinical isolates were screened using the LW primer pair (intI1-attI1). Six 
out of twelve gave an expected product size of ~550-bp. Using the HS primer pair (Figure 
3.5B) additional samples (lanes 6, 7 and 9) gave a PCR product. Note that sample in lane 7 
failed to give a product using the LW primer pair, however a weakly amplified ~370-bp 
HS915-HS916 product was observed.  
 
Similar results were obtained in that when the clinical TS sample set was screened using the 
HS primer pair only two isolates (TS464 and TS491) produced a weakly amplified product of 
~370-bp. However, when screened with the LW primers, 21% (4/19) of clinical TS isolates 
(TS464, TS491, TS589 and TS654) produced a PCR product of the correct size (Figure A6a).  
 
Chapter 3 Distributions of IS1111-attC, mobile and chromosomal integrons 
81 
 
 
Figure 3.4: Dendogram showing the relationship of the IS1111-attC group of elements to other 
members of the IS1111 family.   
Phylogeny based on the alignment of 325 nucleotide positions. A gap alignment penalty of 10 was 
first applied but alignment was manually annotated. Tree was rooted using ISMol1.Most clinical IS-
elements comprise a clade with ISUnc1-like elements (red). Two clinical isolates branch with ISPa21-
like sequences. Domestic (green) and environmental (blue) Ps. isolates cluster with the known 
associated ISPst6-like. Figure A4 shows alignment used to generate above tree.  Blue numbers 
represent different IS1111-attC subgroups. All recovered sequences fall into subgroups 6, 10 and 15.  
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Lane 
Isolate ID intI1-attI1 
(LW14/LW15) 
~551bp 
Internal intI1 
(HS915/HS916) 
~350bp 
Additional information 
1 JIP031 - -  
2 JIP038 - -  
3 JIP041 + + Sequenced-confirmed intI1-attI1 
4 JIP073 + + Sequenced- confirmed intI1-attI1 
5 JIP080 + + Sequenced- confirmed intI1-attI1 
6 JIP106 - + Array of products possibly due to 
insertions or deletions in the intI1  
7 JIP117 - + Weakly amplified intI1 using HS 
primers 
8 SSI2.37 + + Sequenced- confirmed intI1-attI1 
9 SSI2.84 - + Array of products possibly due to 
insertions or deletions in the intI1 
10 SSI3.44 - -  
11 SSI3.34 + + Sequenced- confirmed intI1-attI1 
12 SSI5.34 + + Sequenced- confirmed intI1-attI1 
13 R388 intI1 + + Positive control 
14 No template 
control 
- - No template control, no DNA only 
MQ water 
Total positive 6 9  
Figure 3.5: A) intI1-attI1 and B) intI1 internal screen in a subset of 12 clinical Pseudomonads.  
Table outlines the PCR findings and sequencing results. 
 
 
 
A) 
B) 
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Note that using HS915/916 primer pair was found to be successful when screening clinical 
isolates for MRIs. However, these primers produced a range of non-specific PCR products 
ranging between 500-1500-bp, when used to screen the environmental population (Figure 
A6b). Similarly, screening environmental Pseudomonads with LW (intI1-attI1) primers 
resulted in variably sized PCR products. In Figure 3.6, two isolates produced a product size 
of 1-kb and 1.5-kb in size (lanes 1 and 6 respectively). Three domestic environmental 
Pseudomonads (JM2, JM6 and LS13) failed to give a PCR product (lanes 2, 3 and 10). Three 
isolates (lanes 4, 8 and 9) gave a PCR product of the expected size and two (lanes 5 and 7) 
resulted in PCR product approximately 100-bp smaller than expected.  
 
 
 
 
 
 
 
Lane Isolate ID intI1-attI1 
(LW14/LW15) 
~551bp 
Additional information 
1 JM1 + Product is 2x expected size 
2 JM2 -  
3 JM6 -  
4 JM10 + Sequenced- confirmed intI1-attI1 
5 AP1 + Size is ~400-bp 
6 AP2 + Product is 1.5x in size- sequenced, contains a 
IS insertion in intI1 gene 
7 AP3 + Sequenced- confirmed intI1-attI1 with 105-bp 
deletion 
8 AS1 + Sequenced- confirmed intI1-attI1 
9 AS2 + Sequenced- confirmed intI1-attI1 
10 LS13 - DNA was diluted 10 fold and intI1-attI1 was 
amplified and confirmed by sequencing at a 
later stage 
11 R388 intI1 + Positive control ~551-bp 
12 NTC - No template control, no DNA only MQ water 
Figure 3.6: intI1-attI1 PCR screen of domestic and hospital environmental Pseudomonas isolates.  
Lanes 1-10: 10 environmental Pseudomonads. Lane 11 is positive control pR388 and lane 12 is NTC. 
Table Note gel is a Gel-red gel. The top of each band corresponds to the correct product size. 
 
Different PCRs targeting different regions of the intI1 gene were observed to give separate 
results and highlighted possible deletions and insertions. These deletions and insertions in 
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intI1 may also explain the observed inconsistencies with southern hybridization screening for 
MRIs. 
 
3.3.6 Phylogenetic analysis of the recovered intI1-attI1 sequences reveals different MRI 
populations  
Nineteen intI1-attI1 sequences were recovered across all sample sets (Table 3.5), and were 
analysed for single nucleotide polymorphisms (SNPs) in reference to the E. coli pR388 (In3) 
intI1-attI sequence. In this study the pR388 intI1-attI1 sequence (Accession U12441) is also 
referred to as the wild-type integron (WT).  SNP positions are in reference to the starting 
point of alignment, nucleotide A of the wild-type integron (Figure A9 & A10). Given that the 
amplicon sequences were generated using Sanger sequencing, the SNPs called were also 
confirmed against the chromatogram files. Broadly, the intI1-attI1 sequences can be divided 
into two groups based on a SNP at position 263. 
 
Table 3.5: Observable SNPs in recovered intI1 sequences based on pR388 class 1 integron In3 as the 
type sequence 
Group 
SNPs between intI1 
sequences 
Clinical 
Non-Clinical 
Clinical 
Enteric 
Total 
(n=19) Hospital 
 
Domestic 
1  SNP263t 5 0 2 2 9 
1a SNP263t 4 - 1 1 6 
1b SNP263t + SNP268c - - - 1 1 
1c SNP263t+ SNP288a 1 - 1 - 3 
2 SNP263c 4 6 0 0 10 
2a  SNP263c 4 3 - - 7 
2b SNP263c+ Deletion - 1 - - 1 
2c SNP263c+Insertion (IS4) - 1 - - 1 
2d SNP263c+SNP113a - 1 - - 1 
 
 
Group 1 is defined by thymine (T) at position 263 (SNP263t). Five out of nine intI1-attI 
sequences from clinical Pseudomonads, one domestic environmental Pseudomonad, and one 
enteric intI1-attI1 were observed to have SNP263t. Two subtypes (1b and 1c) of SNP263t were 
also observed. Subtype 1b) has an additional SNP at position 268 where the wild-type 
nucleotide guanine is replaced by a cytosine. This 1b SNP subtype was only observed in the 
intI1-attI1 sequence of the second outgroup isolate, Enterobacter sp.  11045. Subtype 1c) has 
an additional SNP at position 288 where an adenine is located. One clinical (Ps. aeruginosa 
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JIP080) and one domestic (Brevundimonas sp. LS13) isolate belong to the SNP263t+ SNP288a 
subtype.  
 
Group 2 has a different SNP at position 263, where the thymine of the type sequence is 
replaced by cytosine (SNP263c). Four clinical, four hospital environmental, and two 
environmental intI1-attI1 sequences can be categorized into the 2a) SNP263c group. However, 
further diversification can be seen across the six non-clinical sequences. One sequence was 
placed into subtype 2b). Pseudomonas sp. AP3 was found to have a 105 base pair deletion in 
the intI1 gene between positions 329-434. Subtype 2c) was observed in the clinical 
environmental Stenotrophomonas. sp. AP2 and involves an insertion of 956 base pairs 
between positions 329-434. This insertion has an 86% identity to IS4 transposase gene found 
on a plasmid pSWIT02 in Sphingomonas wittichii RW1.  The final subtype is 2d) was 
observed only once in Chryseobacterium meningosepticum isolate P06. To date this may be 
the only example of an intI1-attI1 sequence recovered from a Chryseobacterium 
meningosepticum.  
 
Whilst sequencing based errors may introduce SNPs, the probability of this occurring across 
all 19 recovered intI1-attI1 sequences is small. In all cases, PCR products were directly 
sequenced throughout different periods within this study. Thus, the observed SNPs are 
believed to be genuine.  
 
3.3.7  Distinct IS1111-attC groups are associated with different intI1 subgroups  
For 7/21 of the recovered IS1111-attC elements, MRI sequence data was available. Their 
association was analysed and mapped against a simplified version of the IS1111-attC tree in 
Figure 3.4 to generate Figure 3.7. This observation of IS-IntI co-association in independent 
strains means multiple acquisitions of the IS followed by spread of the IS-Int mosaic. Note 
that during the course of this study, collaborators at the University of Technology Sydney 
published the intI1 sequence of the clinical isolate Ps. aeruginosa iso. TS491 (Martinez et al., 
2013).  
 
There is an emerging pattern where the same IS phylotype is always seen in the same Int SNP 
type. Group 2 intI1 sequences with SNP263c were present in 5 of the 7 strains harbouring an 
IS of the ISUnc1-like clade. The ISUnCu1 group is found in at least three distinct integrons. 
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Two of these are the MRI subgroups (SNPc and SNPt) and one is a PCI in Pseudomonas sp. 
FM4. Isolate FM4 did not hybridize to an MRI probe, and PCR based recovery of the MRI 
was not successful. It did however hybridise to a PCI probe, thus the ISUnc1-like element in 
isolate FM4 is believed to be located on a PCI. Note that ISUnc1 (Psp7) (AY139602) and 
ISUnc1 (Pa) (DQ302723) are both located on a class 1 integron for which the integron 
integrase and attI sequence are not available; as such, the subgroup preference for these two 
reference sequences remains unknown. However based on their clustering with the recovered 
ISUnc1-like sequences in this study, they may show preference for integron group 1 (SNPt) 
(Figure 3.7). 
 
Group 1 intI1 sequences with SNP263t were present in clinical Ps. aeruginosa isolates TS491 
and JIP052. These isolates were confirmed to have ISPa21-like elements. Ps. aeruginosa 
isolate JIP041 possessed an ISUnc1-like element, and also was classified into the IntI group 
2. This ISUnc1-like element branched separately from all other recovered ISUnc1-like 
sequences that target group 2 integrons. In comparison the ISPa21 group occur in at least two 
distinct integrons. The reference ISPa21 (AY920928) sequences embedded in blaGES-9 and 
aacA7 sites are located on an MRI integron In109. When compared to the pR388 MRI 
sequence, In109 has the following SNP profile: SNP263c+ SNP268g + SNP288a (Figure A10). 
The integron integrase In163 sequence for reference ISPa21 (aadA7; AY660529) is not 
available. Thus its SNP subgroup could not be determined. ISPa21-like elements are 
associated with Int SNPt and SNPc subgroups (Figure 3.7). 
 
Finally, ISPst6 group is overrepresented in PCI within the Ps. stutzeri complex. The 
recovered ISPst6-like sequences were from the domestic and hospital environmental isolates 
FM3, FM1, P05, and P13. ISPst6-like elements in clinical Ps. aeruginosa isolates JIP117 and 
SSI2.84 are predicted to reside in IntIs distinct from the two SNP sets seen in this study. Ps. 
stutzeri is thus believed to be a source for ISPst6-like elements (Figure 3.7). 
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Figure 3.7: Sub-tree of IS1111-attC tree from figure 3.6 with intI1-attI1 groups overlaid.  
Distinctly branching IS1111-attC elements appear to have become associated with distinct intI1 
groups. These differ from the well characterized ISPst6-like elements which are known to reside in 
PCIs. Any IS1111-attC element that clusters within the ISPst6-like clade is predicted to reside in a CI.  
 
3.3.8 Fine mapping of IS1111-attC genetic contexts 
To define the insertion point and genomic context of IS1111-attC elements in the set of 
selected examples, fosmid-based cloning was applied using high molecular weight genomic 
DNA extracted using a Bioline kit (Figure A11). Criteria for isolate selection was as follows: 
1) Do IS1111-attC elements occur outside an integron context? 
Isolate LS5 was identified as a Stenotrophomonas maltophilia by 16S rRNA DNA 
sequencing. This isolate produced a convincing IS1111-attC signal but failed to produce 
either both PCI, Ps. attC or MRI signals by means of southern hybridization. Bioinformatic 
analysis of Stenotrophomonas maltophilia K279a (Accession NC_010943.1) indicates the 
presence of a putative ISXac3 like transposase. But an IS1111-attC element has not been 
recovered from a Stenotrophomonas maltophilia to date. Hence recovery of the IS element 
and it genetic context was considered. 
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2) Where both MRI and PCI exist in the same cell, do IS1111-attC elements jump 
between these different integrons? 
Two domestic environmental Pseudomonads, namely Ps. alcaligenes str. S3 (iso. JM2) and 
Ps. alcaligenes str. Y34 (iso. JM6), were chosen for fosmid construction. Southern 
hybridization data indicated that these two strains contain both MRI and PCIs, however PCR 
and sequencing efforts failed to recover these sequences. Attempts to PCR amplify IS1111-
attC resulted in a banding pattern of various sized products suggesting that there may be 
more than one IS1111-attC element present. IS1111-attC PCR banding patterns differed in 
these isolates, suggesting that these two isolates have differences in their arrays and were 
hence chosen as candidates for fosmid construction. 
 
3) Was a single class 1 integron borne on a mobile genetic element responsible for the 
spread of ISPst6-like elements into human clinical isolates JIP117 and SSI2.84? 
Two epidemiologically unrelated, clinical Ps. aeruginosa isolates, SSI 2.84 and JIP117, were 
of particular interest. Partial IS1111-attC sequences were recovered from both clinical 
isolates suggesting a recent acquisition of the IS into the clinical system. NCBI BLAST 
analysis showed that the IS1111-attC sequences from isolate SSI 2.84 (Figure A8) and 
JIP117 were 99% (841/845 bases) and 99% identical (849/851 bases) identical to Ps. stutzeri 
strain ATCC 14405 ISPst6 respectively. However, the MGEs (integron and plasmid) 
responsible in this acquisition is unknown.  
 
3.3.9 Identifying individual fosmid clones that are positive for IS1111-attC elements 
Each column of eight distinct fosmid clones over a number of 96-well plates per library was 
pooled for southern hybridization screening. This pooled column screening approach, with 
two rounds of hybridization, was used to efficiently identify individual fosmid clones positive 
for IS1111-attC elements (Figure A12 & Figure 3.8).    
 
JM2 fosmid library, column 44 (C44) gave a positive signal with the IS1111-attC probe. All 
8 clones comprising this pooled column were spotted out individually and clone G was 
identified as the only clone that produced an IS1111-attC hybridization signal. This fosmid 
clone was annotated as JM2C44G. Similarly for the JM6 library, column 39 (C39) was 
positive for an IS1111-attC element. When clones in C39 were screened individually, clone 
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D (JM6C39D) and H (JM2C39H) were positive for an IS element. In particular, clone 
JM6C39D hybridized strongly, matching the relative intensity of the positive controls Pst587, 
JM6 gDNA, Ps. aeruginosa MB216.2B as well as Ps. aeruginosa PAO1. 
 
LS5 library, column 2 (C2) clones were screened individually, and clones E and F produced a 
faint hybridization signal when probed against an IS1111-attC probe. These were annotated 
as LS5C2E and LS5C2F. Note that hybridization negative controls, E. coli pR388 and Ps. 
strameia KM91 did not produce a hybridization signal as expected. 
 
For clinical libraries SSI2.84 and JIP117, individual fosmid clones containing IS1111-attC 
elements were also identified by southern hybridization screening. SSI2.84C9 clones G and 
in particular H were IS1111-attC positive. Interestingly, for the JIP117 clone library a pooled 
column screen approach resulted in 38 out of 46 columns testing positive for an IS1111-attC 
element. Four columns, C9, C22, C34 and C47 were selected at random and all clones were 
spotted out individually and re-screened for the presence of IS1111-attC elements. C9 
contained two positive clones C9F and C9H, C22 has three positive clones, C22A, C22C and 
C22E. C34 had five clones C34A, C34C, C34D, C34E, C34F (Figure 3.8B). Column 47 was 
interesting because initially the pooled clones gave an IS signal, but screened individually, no 
clone gave an IS1111-attC signal when hybridized with this IS probe. Therefore, the primary 
C47 result is believed to be due to non-specific binding of the probe to the DNA template. 
 
Based on the hybridization data, five fosmid clones JM2C44G, JM6C39D, LS5C2E, 
JIP117C34A and SSI2.84C9H were selected for subsequent analysis involving restriction 
digestion (Figure A14) and screening for MRIs (Figure A13) and IS1111-attC elements 
(Figure A15). The five clones were also sequenced by Macrogen (Korea). See Table 3.6 for 
summary information regarding IS1111-attC screening results, genome fold coverage, contig 
number and total kb of sequence obtained, for these fosmids. 
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Figure 3.8: Identifying individual fosmid clones containing an IS1111-attC across five fosmid 
libraries. 
 A) JM2 C44, JM6 C39, LS5 C2 and SSI2.84 C9 
B) JIP117 C9, C34, C47. The probe used was an intact ~1.3-kb ISPst6 generated from Pst587 gDNA. 
Red boxes denote fosmid clones of interest. 
 
 
A) 
 
 
 
 
 
 
 
B) 
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Table 3.6: Summary of fosmid libraries 
 
Strain 
ID 
Total 
fosmid 
clones 
Fold-
genome 
coverage 
Clone of 
interest 
IS1111-attC 
presence 
# of raw 
sequence 
reads 
# of 
sequences 
reads used 
in 
assembly 
Contigs 
in 
assembly  
Fold 
coverage 
of fosmid 
Total kb  
assembled 
Hybe  PCR  
C
li
n
ic
a
l 
JIP117 384 1.92a JIP117C34A + + 384 273 6 6.1 32.769 
SSI2.84 480 2.40a SSI284C9H  + + 384 255 2 7.4 35.134 
N
o
n
-
C
li
n
ic
a
l 
JM2 384 2.40b JM2C44G + + 384 325 3 6.1 50.569 
JM6 480 3.00b JM6C39D + + 384 322 3 6.6 39.755 
LS5 192 1.20c LS5C2E + + 384 293 4 7.2 32.483 
The fold-genome coverage was calculated based on an average insert size of 30-kb (see Appendix A6.2) and assuming a genome size of a) 6 Mb for Ps. aeruginosa (PAO1 
reference), b) 4.8 Mb Pseudomonas alcaligenes (NBRC 14159 reference) c) 4.8 Mb Stenotrophomonas maltophilia (K279a reference).  Fold coverage of fosmids = number 
of reads used in assembly x average length of reads = number of bases of sequence. Fold coverage between 6-8x means confidence in sequence coverage for fosmid. 
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3.3.10 Annotations of assembled contigs 
A total of ~190-kb of sequence information was obtained from the five clone libraries. The 
provided assemblies did not contain the anticipated IS1111-attC sequences (Figure A16). To 
validate the contig assemblies, all were de novo re-assembled from raw reads. See appendix 
figure A17 for schematic figures of assembled de novo contigs. The assembly parameters 
were set to maximum sensitivity as per Appendix Table A5. For all of the five fosmids de 
novo assembly produced more than one contig (Table 3.7). 
 
Table 3.7: de novo assembly summary 
Pseudomonad 
group 
Isolate 
IS 
Fosmid clone 
ID 
# of de novo 
contigs 
de novo contig size 
(kb) 
Clinical 
JIP117 C34A 2 17.8 & 11.6 
SSI2.84 C9H 0* 0* 
Environmental 
JM2 C44G 0* 0* 
JM6 C39D 1 38.602 
LS5 C2E 2 10.8 & 21.66 
*JM2C44G and SSI2.84C9H contigs could not be de novo assembled to produce a continuous read. Failure to 
assembly into contigs occurs mostly due to the lack of sequence homology between the individual contig ends 
(Baker, 2012). 
 
For all individual contigs as well as continuous contigs, open reading frames (orfs) were 
identified using Glimmer plug-in in Geneious with default setting of bacterial “atg” start 
codon. A total of 178 orfs were analysed and identified using BLASTn NCBI search (Table 
A6). The assemblies were mapped to completed reference genomes (Section 3.3.11) to see if 
they were ‘missing” IS1111-attC reads and to validate that isolates SSI2.84, JIP117, JM2 and 
JM6 were Pseudomonads and LS5 was Stentrophomonas sp. 
 
3.3.11 Genome mapping of contigs confirms the absence of IS elements in fosmid clones  
All contigs were mapped against completed reference genomes from Ps. aeruginosa PAO1 
(NC_002516), Ps. mendocina ymp (NC_009439), Ps. resinovorans (NC_021499) and 
Stenotrophomonas maltophilia K279a (NC_010943). This mapping was undertaken to 1) 
validate the construction of the contigs and predicted orfs, 2) look for areas of sequence 
variation between contigs and genomes and 3) place the contigs in respect to the genome, i.e. 
GI vs chromosomal framework. Contigs had extensive synteny to published genomes (Figure 
A18) and no hot spots for integron or IS1111-attC insertions were identified. In all cases no 
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IS1111-attC and intI1 sequence homologs were identified (Table 3.8). Three possibilities 
would account for the lack of IS1111-attC sequences in these fosmids: 
1) Sent the wrong data set: All contigs were validated to be of Pseudomonad and 
Stenotrophomonas origin. This is consistent with these isolates being identified as 
such by 16S rRNA DNA sequencing. Thus this does not explain the lack of IS1111-
attC sequence data in the sequenced fosmids. 
2) Fosmid sequence is systematically biased against IS regions: The precedent for IS 
regions being difficult to assemble and sequence is based on the doctorate works by 
Tetu (2007) and Wilson (2007). In this current study, all raw reads were mapped 
against re-assembled scaffolds and the relative contigs sizes were accounted for.  
3) Wrong fosmid clones were sequenced: whilst the contigs had no regions with integron 
signatures they did have foreign DNA signatures.  
 
To recover fosmids containing IS1111-attC elements and intI1, perhaps more than 384 
fosmids would also need to be screened per fosmid library, thereby increasing the overall fold 
coverage for large genomes such as those of the Pseudomonadaceae family.   
 
Table 3.8: Synteny of fosmid contigs to best reference genomes 
 Fosmid ID 
Size 
recovery 
Mean % 
identity*  
Extent of synteny to best 
reference genome 
Relevant 
features 
C
li
n
ic
a
l JIP117C34A ~30-kb 95-99% 
2 loci separated by 3 Mb in 
PAO1 reference 
No IS1111-
attC or intI 
homologue 
SSI284C9H ~35-kb 95-99% 
1 locus with 4-kb deletion in 
PAO1 reference 
No IS1111-
attC or intI 
homologue 
E
n
v
ir
o
n
m
en
ta
l 
LS5C2E ~35-kb 95-99% 
1 locus with 1.5-kb deletion 
in K279a reference 
No IS1111-
attC or intI 
homologue 
JM2C44G ~49-kb ~60-65% 
1 locus in 
NBRC106553/ymp 
extensive region of synteny 
identified 
No IS1111-
attC or intI 
homologue 
JM6C39D ~39-kb ~60% 
1 locus in NBRC 
106553/ymp: no extensive 
regions of synteny identified 
No IS1111-
attC or intI 
homologue 
*Mean % identity to best reference genome. Synteny was based on genome mapping of all contigs against 
reference genomes. JIP and SSI contigs were mapped against 6 Mb for Ps. aeruginosa (PAO1) reference 
genome. LS5 contigs were mapped against 4.8 Mb Stenotrophomonas maltophilia (K279a) reference. JM2 and 
JM6 contigs were mapped to both 5 Mb Ps. mendocina ymp (NC_009439) and 6.3Mb Ps. resinovaroans NBRC 
106553 (NC_021499) genomes.  
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3.4 Discussion 
3.4.1  IS1111-attC elements are over-represented in Pseudomonadaceae 
Insertion sequences are commonly used as epidemiological and phylogenetic markers for the 
study of internal genome dynamics (da Silva Rabello et al., 2010; Cerveau et al., 2011; Kenna 
et al., 2006; Vandelannoote et al., 2014; Vorská et al., 2001). In this study, IS1111-attC 
elements were used as an epidemiological and phylogenetic marker for between-population 
dynamics in opportunistically pathogenic γ-Proteobacteria, of the families 
Pseudomonadaceae and Enterobacteriaceae. I examined three strain collections that were 
defined by distinct aspects of their evolutionary ecology. Two Pseudomonad strains 
collections, from distinct ecological and phylogenetic backgrounds (clinical & environmental) 
and a clinical Enterobacteriaceae collection were screened for IS1111-attC elements. I 
examined two aspects of IS1111-attC distribution across these strain collections: i) Frequency 
- the number of IS1111-attC observations per independent bacterial strains, and; ii) Diversity 
- the number of independent IS1111-attC elements per strain collection. Collectively this 
approach provided insight into the nature of IS reservoirs in different bacterial communities; 
the extent and manner of movement between communities; and the extent to which they 
spread within communities. 
 
IS1111-attC frequency shows that strains of the family Pseudomonadaceae are more likely to 
harbour the IS than Enterobacteriaceae (Table 3.4). To determine the statistical significance 
of this finding, a larger strain collection is required, however a trend is apparent. Comparable 
IS1111-attC frequencies were seen in both environmental and clinical Pseudomonad groups. 
Data were primarily based on hydridisation analyses, with a subset confirmed by sequence 
recovery. Both sequencing and hybridization data indicated that IS1111-attC elements were 
found in different contexts in the two Pseudomonad collections. The environmental group 
IS1111-attCs were observed in a chromosomal framework, whereas in the clinical 
Pseudomonad group they were in an accessory (mobile) context.  
 
IS1111-attC diversity shows that there are differences in the distribution of different IS1111-
attC elements within and between the three strain collections. Within the Pseudomonadaceae 
that reflect both ecological and phylogenetic dissimilarities. The clinical Pseudomonas set 
(Ps. aeruginosa lineage) was shown to have low IS1111-attC diversity, whereas the 
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environmental Pseudomonas set (Ps. stutzeri lineage) had high IS1111-attC diversity (Figure 
3.3 & 3.4). The low diversity, combined with high frequency, implies a small number of 
independent IS elements circulating within the clinical population. This interpretation is 
consistent with the observation that IS1111-attC elements are MRI-borne within the clinical 
Pseudomonas group. In comparison, high diversity of IS1111-attC implies a large number of 
independent IS1111-attC elements in the environmental pool and implies environmental 
Pseudomonads are IS1111-attC reservoirs. Given that no repeat IS1111-attC observations 
were made in the environmental Pseudomonas group, this suggests very low level of IS 
spread within this group (Tetu & Holmes, 2008; Figure 3.4). 
 
One interesting aspect of IS1111-attC diversity in the environmental Pseudomonadaceae is 
that it shows a punctuated distribution. ISs from the same genomovar are more closely related 
than those of distinct genomovars. For instance, the ISPst6 subgroup is overrepresented in 
PCIs in Ps. stutzeri species complex genomovar 2 (Tetu & Holmes, 2008). The PCIs also 
show a similar punctuated distribution within the environmental population based on integron 
integrase sequence relationships (Wilson, 2007). Using the terminology of comparative 
species genomics, the distribution of IS1111-attC diversity in PCI/genomovars is consistent 
with their being nascent character genes (Figure 1.13). Although, there are no examples of 
two strains with the same IS/gene cassette association as would be predicted for ‘true’ 
character genes, the pattern is indicative of lineage-specific associations arising through 
repeated independent formation of IS1111-attC/ gene cassette associations within PCIs, rather 
than movement of the hybrid associations between the PCI of strains in a genomovar. Taken 
together, this indicates that in broad terms the environmental Pseudomonads are the reservoir 
for IS1111-attC elements, but at genomovar level we can also predict the specific 
Pseudomonas lineage that is the source for each clade of IS1111-attC elements. This capacity 
may provide insights to gene cassette flow between integrons. 
 
In Pseudomonas aeruginosa the presence of IS1111-attC elements is predicted to be 
dependent on MRIs, since they lack PCIs. I observed that MRIs were similarly 
overrepresented in the clinical Pseudomonads and Enterobacteriaceae strain collections 
relative to the environmental Pseudomonads. However, IS1111-attCs were not seen at the 
same frequency in these two clinical collections.  Two types of IS1111-attC elements, ISPa21 
and ISUnc1 were seen in association with MRIs in my clinical Ps. aeruginosa strains and 
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none in the clinical Enterobacteriaceae collection. I postulate that the ability of an IS1111-
attC to specifically move between gene cassettes within a cell means they essentially act as 
gene cassette tags and allow study of gene cassette flow between integrons and across 
bacterial populations in different habitats. In the clinical context, IS1111-attC elements can 
thus be used as evolutionary and epidemiological tools for the study of integron-mediated 
gene transfer in pathogenic Bacteria. Where an IS is observed in an MRI, its original source is 
predicted to be a Pseudomonad population with PCI.  This source population for the IS can be 
inferred from its sequence relationship to IS1111-attC groups with known associations to 
PCIs, thus indicating historical movement of that integron. 
 
3.4.2 Identifying IS1111-attC source-sink relationships 
In addition to the two examples described above, in silico database searches indicate further 
examples of IS1111-attC elements in MRIs (Table 3.9). Importantly these include strains 
from outside the genus Pseudomonas and in most such cases the IS-gene cassette combination 
observed in a non-Pseudomonad has also been observed in an integron in a Pseudomonad. For 
example the aadA1-ISUnc1 association has been seen in E. coli, A. baumannii and Ps. 
aeruginosa. The higher frequency of IS1111-attC in Pseudomonads, combined with the co-
occurrence of identical IS/gene cassette associations in the clinical isolates and various 
Pseudomonas strains suggests that IS1111-attC elements on MRIs have spread from 
Pseudomonas in clinical environments (primarily Ps. aeruginosa). My data show that an 
environmental strain identified by 16S sequence as Ps. putida has an IS1111-attC in a PCI 
(Figure 3.4 & Table A2) with high sequence relationship to the ISUnc1 element that has 
spread through one group of Ps. aeruginosa on class 1 integrons and onto enterics.  
 
MRI carrying pathogenic Pseudomonas putida isolates have been documented (Lee et al., 
2002; Lombardi et al., 2002; Ramos-gonzález et al., 2006). Database analysis revealed that a 
clinical Ps. putida, HB3267 (CP003739.1), contains an MRI annotated as having an 
IS116/IS110/IS902 element. Closer examination revealed that this IS is embedded in a 
quaternary ammounium resistance gene (qacE) attC and is identical (1376/1376 bp) to 
ISKnp4 (Post & Hall, 2009). Furthermore, the insertion point in attCqacE is identical to that of 
ISKnp4. This IS should be annotated as an IS1111-attC member.  
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Table 3.9: Examples of IS1111-attC elements in enteric bacteria found from in silico search  
Groupa) Database ID Organism IS attC context Genetic context Size (bp) 
%  identity 
to reference  
Reference 
)I
S
U
n
c1
-l
ik
e
 
AY139602 UnCul plasmid Psp7  ISUnc1 aadA1 InXX intI1 1381 100% Tennstedt et al. (2003) 
DQ302723 Ps. aeruginosa ISUnc1 aadA1 InXX intI1 1382 98.9% Unpublished 
FJ267652.1  Ps. aeruginosa  ISPa21 aac(6’) intI 1382 98.8% Unpublished 
AM932676.1 E. coli ISUnc1 aadA1 MRI intI1 1379 99.7% Kadlec & Schwarz (2008) 
KF921554.1 E. coli ISUnc1-partial aadA1 MRI intI1 1322 99.8% Unpublished 
EU089665.1 E. coli ISUnc1-partial aadA1 MRI intI1 1071 99.6% Moura et al. (2007) 
JN253504.1 Ac. baumannii ISAba3 aadA1 MRI intI 1375 99.9% Karah et al. (2011) 
KC675185.1d) En. cloacae ISPa21 aadA1 MRI inti1 1381 99% Unpublished 
KC675185.1c) En. cloacae ISPa21 blaOXA10 MRI intI1 1381 99% Unpublished 
IS
P
a
2
1
-
li
k
e
 AY920928 Ps. aeruginosa DEJ  ISPa21 blaGES-9 In109 intI1 1374 100% Poirel et al. (2005) 
AY920928 Ps. aeruginosa DEJ  ISPa21 aacA7 In109 intI1 1374 100% Poirel et al. (2005) 
AY660529 Ps. aeruginosa  ISPa21 aadA7 In162 intI1 1375 99% Unpublished 
ISPaX1-
like 
AM296017 P. aeruginosa  ISPaX1 aac(6)-II  InXX intI1 1376 100% Unpublished 
IS
P
a
X
2
-
li
k
e
 DQ522236 Ps. aeruginosa  ISPaX2 aadB InXX intI1 1377 100% Unpublished 
AM749812.1 Ac. baumannii ISPa21 aadB MRI intI 1377 100% Toleman & Walsh (2007) 
IS
K
p
n
4
-
li
k
e
b
)  
EF408254 K. pneumoniae ISKnp4 qacH MRI intI1 1376 100% Post & Hall (2009) 
JX275775.1 En. cloacae ISPa21f) ∆qac1 MRI intI1 1364 93.7% Sonnevend et al. (2012) 
AJ704863.3e) K. pneumoniae ISPa21f) smr MRI intI1 1340 93.7% Colinon et al. (2007) 
KF894700.1e) K. pneumoniae ISPa21-partialf) smr MRI intI1 763 95.0% Unpublished 
Grey boxes highlight the reference sequence/s in each subgroup. 
a) IS1111-attC subgroups are defined when the IS DNA >95% identical and protein >98% identical to the isoform founder 
b) ISKnp4 is 97.7% identical to ISPaX2.  
c) Match IS in aac(6’) in FJ267652.1 Ps. aeruginosa 
d) Match IS in aadA1 in FJ267652.1 Ps. aeruginosa 
e) Matches 100% to JX275775.1 in En. cloacae 
f) Requires reclassification as ISKnp4-like elements. 
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To validate the hypothesis that Ps. putida is a source of ISUnc1, and to determine its PCI 
context, there is need for a comprehensive Ps. putida collection as seen with the Ps. stutzeri 
set (Tetu & Holmes, 2008).  
 
The acquisition of IS1111-attC elements by MRIs does not appear to be restricted to any 
phylogroup and the intact is stably maintained. For instance, ISUnc1-like elements were 
recovered from Chryseobacterium meningosepticum PO6 and Delftia sp. LS8 (Figure 3.4). IS 
acquisition by Ch. meningosepticum is postulated to have occurred by a mobile class 1 
integron (Figure A4) via a previous interaction with a Ps. putida reservoir. This is particularly 
interesting given that Ch. meningosepticum has been proposed as the primary source for 
metallo-beta-lactamase resistance genes in clinical Ps. aeruginosa (Bellais et al., 2000; Poirel 
et al., 2000). Here I provide additional support to the idea of active HGT between Ch. 
meningosepticum and Pseudomonads. Given that no MRI class 1 was detected in Delftia sp. 
LS8, ISUnc1-like acquisition here is postulated to have occurred via a different route. Delftia 
spp. are known to carry class 3 integrons (Xu et al., 2007), thus the ISUnc1-like element may 
be residing in a class 3 mobile integron array. However, the distribution of class 3 integrons 
was not examined in this study as they are not commonly found in Pseudomonads. The low 
level of diversity in IS-gene cassette fusions suggests a low rate of loss or gain of IS1111-
attC by MRI and suggests long-term stability of the IS-gene cassette within a clinical 
population.  
 
3.4.3 Class 1 integron subgroups have different exposure to PCI gene cassette reservoirs 
Data presented in this study suggests that IS1111-attC subgroup elements are associated 
specifically with integrons (Figure 3.9). I conclude that different Class 1 integron subgroups 
appear to be circulating differently, sampling from different ecological niches and thus have 
differing probabilities for IS1111-attC acquisition. IS1111-attC spread thus appears to be a 
dependent on the plasmid, transposon and the MRI in which it is located. Given that MRIs 
are seen on diverse replicons, we can expect some constraints on their movement, due to 
plasmid incompatibility mechanisms and host range.  This is expected to impose some 
constraints on the exchange and distributions of IS1111-attC and of gene cassettes. Also 
selective pressure may result in the re-arrangement of gene cassettes on the plasmid and may 
produce different IS-gene cassette fusions.  
 
Chapter 3 Distributions of IS1111-attC, Mobile and Chromosomal Integrons 
99 
 
 
Figure 3.9: SNP tree of class1 integrons. 
Each tip represents a distinct variant of intI1, defined by accumulated mutations. IS elements have  a 
dichotomous distribution that suggests the class 1 integrons have diverged into two clonal pools that 
are circulating differently. 
 
3.4.4 A proposed model for IS1111-attC spread across barriers 
Divergent IS1111-attC copies have been detected in varying integron arrays and suggests a 
very recent, and possibly ongoing, expansion. IS1111-attC distribution indicates that 
horizontal transfer occurs frequently and possibly simultaneously in different genomes. The 
success of IS1111-attC spread between different genera is postulated to be dependent on the 
fitness of the MRI carrier (Figure 3.10). Maintenance of the tight association between IS 
lineages and PCIs in Pseudomonas genomovars is believed to reflect vertical inheritance 
(Figure 3.10A) and PCIs coinciding with 16S rRNA DNA evolution (Figure 1.13). If the 
environmental Pseudomonas acquires an MRI containing replicon (Figure 3.10B), then the 
MRI can potentially acquire an IS1111-attC (Figure 3.10C). HGT of the newly formed 
IS/MRI association is then able to drive the dissemination of the newly embedded IS1111-
attC into new populations (clinical Pseudomonas) (Figure 3.10D). Due to antibiotic selective 
pressures, the replicon is then shared between different clinical populations (Figure 3.10E), 
such as Ps. aeruginosa and Enterobacteriaceae. Thus, clinical pathogens become a sink for 
MRI mediated spread of IS1111-attC elements. This is process could equally apply to gene 
cassette movement across ecological and phylogenetic contexts. 
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 Figure 3.10: Postulated flow of IS1111-attC elements between environmental and clinical stains.  
A) IS1111-attC spread within the Pseudomonas stutzeri complex is postulated to occur by 
vertical inheritance.  
B) B-E) IS1111-attC spread across ecological and molecular-genetic barriers is postulated to 
occur by MRIs.  
 
  
E) 
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3.4.5 Further work 
Why are multiple imperfect IS1111-attC replicates seen in the PCI-containing strains and 
only single perfect IS1111-attC replicates seen across the MRI-containing strains? The 
varying distribution and copy number of IS1111-attC between PCIs and MRIs, suggests that 
IS1111-attC translocation activity is not constant over time. This reflects the situation with 
gene cassettes generally where chromosomal integrons contain multiple copies of imperfectly 
replicated attC sites (with very diverse ORFs) but MRIs tend to contain single copies of near-
perfect replicated attC sites with the same (or near perfect) gene. To explore this further, we 
need to consider the mode of IS translocation and host factors associated with translocation 
success. Based on the detection of ISPst6 minicircles (Tetu & Holmes, 2008) and work 
conducted on other members of the IS110 family (Partridge & Hall, 2003; Prosseda et al., 
2006), I predict that the IS1111-attC transposase in PCIs has a baseline activity that drives 
translocation of IS1111-attC elements through the formation of an IS mini-circle intermediate  
(Chapter 4).  Insertion into various attC sites, suggests that the target mechanism does not 
depend on sequence conservation at or around the insertion point. Instead, I postulate that the 
recognition of a conserved attC structure drives the success of IS translocation, as seen with 
integron integrase preference for attC hairpins (Johansson et al., 2004) (Chapters 4 and 5). 
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 Examining the in vivo translocation activity of IS1111-attC 
elements and mechanisms of recombination. 
 
4.1 Introduction 
My data, and all published observations, show that IS1111-attC elements are exclusively 
observed in attC sites (Poirel et al., 2005; Post & Hall, 2009; Tetu & Holmes, 2008). Data 
presented in Chapter 3 demonstrated that IS1111-attCs are over-represented in environmental 
Pseudomonad chromosomal arrays, and also affirmed an interesting pattern that had 
previously been reported (Tetu & Holmes, 2008). Within the Pseudomonas 1 sample group 
the ISs are typically found in multiple near-identical copies whereas within either the 
Pseudomonas 2 sample group or the Enterobacteriaceae sample group the ISs are typically 
found in single copy. This pattern is postulated to reflect repeated insertion of the IS elements 
having occurred in some contexts and not in the others. This suggests that there are 
molecular-genetic constraints to IS activity that differ between these populations, potentially 
acting as further barriers to the net rate of gene movement between these populations. This 
prompted me to explore differences in the insertion context in each group and what clues this 
might give as to the mechanisms of translocation. 
 
Table 4.1: Summary of the correlations between patterns of IS1111-attC occurrence and aspects of 
target sites, context and cell host (data from Tetu & Holmes, 2008) 
Pattern 
of IS 
element 
Biological context of the IS element 
attC context Replicon context Cell context 
Ps.-
type 
Other 
attCa 
Chromosome Episome Pseudomonadaceae Enterobacteriaceae 
Multiple 
copies in 
cell 
√√√ 0b √√√ 0b √√√ 0 
Single 
copy in 
cell 
0c √√ 0c √√√ √√c √√  
√√√= 95-100% of instances of that pattern (e.g. multiple copies) are seen in the indicated context; √√=60% 
cases; √= 5-10% cases  
a: Non-Pseudomonas-type attC sites in which IS1111-attC have been observed  
b: Ps. aeruginosa DEJ (AY920928)contains two ISPa21 copies in other attC sites (blaGES-9 & aacA7)on a 
plasmid-borne int1  
c: Pseudomonas strains (gv.1 & 7) with remnant footprints are an exception. They have no intact IS1111-attC 
copies and a single pseudocopy in a chromosome.  
 
IS1111-attC elements have been seen in a total of 39 target sites contexts (Poirel et al., 2005; 
Post & Hall, 2009; Tetu & Holmes, 2008, Table 3.9). Over 70% of these are in 
Pseudomonas-type attC sites, the remainder are in at least three distinct structural subclasses 
of attC sites (Figure 4.1). However, it is only in PCIs and Pseudomonas-type attC sites where 
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they have been observed in multiple adjacent copies (Table 4.1). This suggests that IS activity 
is different in different contexts. This phenomenon is unlikely to reflect absolute specificity 
to the Pseudomonas-type attC since ISs are also observed in other attC sites, but it might 
reflect much greater levels of activity (higher affinity). However the Pseudomonas-type attC 
site distribution co-varies with other factors including the replicon (a chromosome) and the 
host cell (Pseudomonas 1 group). 
 
IS1111-attCs have also been seen on multiple replicons, including chromosomes and 
episomes. The majority are in the chromosome in Pseudomonas-type attC sites (Tetu & 
Holmes, 2008). The remainder are on class 1 integrons, in at least 19 different MRI arrays, 
carried on a range of translocators and replicons. Finally, IS1111-attCs are seen only in 
Proteobacteria to date. Within Pseudomonadaceae, IS1111-attCs are observed in MRIs in 
clinical Pseudomonas, whereas in environmental Pseudomonads, they are primarily observed 
in a PCI context. Outside of the Pseudomonadaceae, IS1111-attC are found to be associated 
with MRIs rather than chromosomal integrons/arrays. Here I aimed to explore which aspects 
of the molecular-genetic system, such as attC site preference, replicon preference and/or host 
cell preference, are able to influence IS1111-attC acquisition and insertion at specific sites.  
 
 
 
 
 
 
 
 
Figure 4.1: Diversity of attC sites in which IS1111-attC have been observed.  
Alignment of Pseudomonas-type (black bar) and “other attC” (red bar) housing IS1111-attC 
elements. At least three distinct attC structures are seen in the “other attC” group (red numbers). 
Insertion site of IS1111-attC occurs between positions h and i (yellow arrow). Adapted from Tetu and 
Holmes (2008). 
 
Tetu and Holmes (2008) observed a partial translocation event of an IS1111-attC element 
into a Pseudomonas-type attC, located on a fosmid, in an E. coli host. They defined partial 
translocation as being when; i) only ISPst6 IRR junction in a plasmid trap in E.coli is 
observed by means of PCR screening but not the IRL junction, and ii) no attC-trap plasmid, 
consistent with containing a single intact copy of ISPst6 in E.coli, is observed (Tetu & 
1 
2 
3 
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Holmes, 2008). Their study highlighted the likelihood that Pseudomonas host machinery and 
host factors, such as expression levels of the native IS1111-attC Tpase, constrain IS1111-attC 
movement. In order to address which Pseudomonas host factors might be important in 
IS1111-attC translocation, we need to consider how ISs translocate and what factors are 
known to influence this. The observed spread of IS1111-attCs across PCI arrays may be 
explained by an opportunistic event, wherein a host cell was infiltrated by one IS1111-attC 
element at a time until all, or almost all, available PCI attC sites were occupied. Given that 
translocation rates of ISs are estimated to be rather low (10-5-10-8 per element per generation) 
(Souse et al., 2013), the probability of acquiring an identical IS multiple times, and inserting 
it in the same location, diminishes as the number of insertion events increases. Hence a series 
of opportunistic events alone is an unlikely explanation for IS1111-attC distribution across 
PCI arrays. In a plasmid context, this may very well have occurred because only a single 
IS1111-attC is observed at a time. Instead I postulate that IS1111-attC distribution is more 
likely a feature of its translocation mechanism. 
 
The relative homogeneity of IS1111-attC elements across PCI arrays (Tetu & Holmes, 2008) 
suggests that they translocate by a copy-&-paste mechanisms. During copy-&-paste, a single 
IS1111-attC molecule can enter a cell and expand within the genome (Figure 4.2A). 
However, multiple IS1111-attCs could reflect multiple independent acquisitions of a single 
molecule, or a single acquisition on a multi-copy plasmid. In contrast, IS1111-attC 
heterogeneity across a range of varying MRI attCs can be explained by cut-&-paste 
translocation. Here multiple IS1111-attC molecules must enter the cell and/or be formed in it 
during cut-&-paste translocation (Figure 4.2B). Note, however, that insertion sequences, such 
as IS2, translocate by both copy-&-paste and cut-&-paste mechanisms (Biel & Berg, 1984; 
Mahillon & Chandler, 1998). Similarly, IS1111-attC translocation may occur by both means; 
however, this remains to be determined. 
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Figure 4.2: Conceptual models a) copy-&-paste and b) cut-&-paste for IS1111-attC translocation 
between attC sites. 
A) Topological flexibility of chromosomal DNA and host factors (Loot et al., 2012) are 
postulated to play a vital role in bringing two PCI attCs within proximity of one another. 
B) Reduced number of target sites in MRIs, as well as accessory factors necessary for plasmid 
replication (Biel & Berg, 1984) are predicted to affect IS1111-attC translocation efficiency 
during cut-&-paste. 
 
 
4.2 Aims 
There are a number of precedents for the genomic context of IS elements influencing their 
success. These include DNA secondary structure, target site context and target site orientation 
(Partridge & Hall, 2003), mode of DNA replication, and accessory factors that help resolve 
the synaptic complex formed between the IS and its target DNA (Mahillon & Chandler, 
1998). The relative importance of these influencing factors for any one IS is reflected by its 
translocation mechanisms.  
 
The work presented in this chapter tests the following hypotheses: 
1) IS1111-attC translocation requires accessory factors in Pseudomonads. 
2) IS1111-attC elements preferentially insert into Pseudomonas-type attC sites. 
3) The likelihood of repeat IS1111-attC translocation events is dependent on the 
copy number and context of the IS.  
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4.3 Methods 
For general media and solution recipes, as well as PCR conditions, refer back to Chapter 2. 
4.3.1 Construction of “attC-traps” 
A Pseudomonas attC-site was amplified from Ps. stutzeri strain ATCC 17587 (BGC093) 
using primers ST96 and ST139 (Tetu & Holmes, 2008). The 219-bp PCR product consists of 
a 76-bp Pseudomonas attC site flanked by upstream (22-bp) and downstream (121-bp) 
sequences. This PCR product was cleaned using Qiagen PCR Purification Kit (as per 
manufacturer’s instructions). Similarly, an attCaadB site was amplified from pUS21 using 
primers MZ09 and MZ10. Given the small product size of 100-bp, this PCR product was 
cleaned using ammonium acetate precipitation (see section 2.3.1).  
 
To generate the synthetic attC-traps, 1 µg of purified PCR product was end-repaired using 
NEB Quick Blunt Mix (as per NEB instructions) and ligated overnight at 4oC with SmaI-cut 
pBBR1MCS2 using an insert to vector ratio of 5:1. Prior to ligation, digested pBBR1MCS2 
vector was dephosphorylated using Antarctic phosphatase as per NEB instructions. 5 µL of 
the ligation reaction was transformed into chemically competent E. coli TOP10 cells by heat-
shock at 42oC for 30 sec. Cells were recovered at 37oC for 1 hr in 200 µL LB and plated onto 
LB/Km50 plates overnight at 37oC. PCR primers targeting the plasmid regions flanking the 
cloning site (NVC15 and NVC16) were used to screen for positive clones. Additionally, 
primer combinations using NVC15/NVC16 primers and attC primers ST96/ST139, 
MZ09/MZ10, were used to determine the orientation of the cloned Pseudomonas-type and 
classical attCaadB sites respectively. 
 
In total, two Pseudomonas-type attC and two classical attCaadB traps were generated. The 
same site was cloned into pBBR1MCS2 in one or other orientation relative to the plasmids 
ori (rep) region (Figure 4.3A & B). The resulting vectors were termed pPsattC1 and 
pPsattC2, paadB_attC1 and paadB_attC2. Purified plasmid preparations were extracted from 
50 mL LB overnight culture of E.coli JM109 cells (See section 2.7). 
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Figure 4.3A: Construction of Pseudomonas-attC traps.  
Pseudomonas stutzeri ATCC17587 genomic DNA was used as PCR template with BGC093 specific primer ST96 and ST139 to give a 219-bp product 
consisting of the Pseudomonas-type attC site (76-bp) and flanking DNA (Red boxed attC site). Post PCR purification reaction, the product was cloned in one 
or other orientation in pBBR1MCS2.  Each construct, pPsattC1 and pPsattC2 was used in subsequent natural transformation assays to detect IS1111-attC 
translocation. 
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Figure 4.3B: Construction of classical attCaadB traps.  
Purified pUS21 plasmid DNA was used as PCR template with primers MZ09 and MZ10 to give a 100-bp product consisting of the classical attCaadB site (60-
bp) and flanking DNA (Red boxed attC site). Post PCR purification reaction, the product was cloned in one or other orientation in pBBR1MCS2.  Each 
construct, paadB_attC1 and paadB_attC2 was used in subsequent natural transformation assays to detect IS1111-attC translocation.   
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4.3.2 Natural transformation of Pst587 
Each synthetic trap was naturally transformed into Pst587. This strain is known to have a 
PCI, carrying one confirmed intact ISPst6 element and a truncated ISPst6 footprint. Pst587 
also contains at least 2, empty attC sites, BGC092 and BGC093. A single colony of Pst587 
was patched into a standard size of 1 cm diameter onto a LB plate and grown at 30oC for 24 
hrs. pattC trap DNA (pPsattC or paadB_attC) was applied straight onto the colony as a 
solution of  1-µg in 5 µL of EB and allowed to absorb. The plates were incubated for 24 hrs 
(without inverting) at 30oC. The bacterial growth was harvested and resuspended in 300 µL 
PBS and incubated on LB/Km50 plate (100 µL/plate) (Figure 4.4). Plates were incubated at 
30oC for 2 days, then examined for the appearance of transformants.  
 
 
Figure 4.4: Natural transformation of Pst587 with pattC traps.  
 pattC traps are naturally transformed into Pst587 overnight at 30oC. The cell pellet is resuspended in 
PBS and equal volumes of resuspended cell mass are spread plated onto LB/Km50. pattC-trap encode 
KmR. After 2 days at 30oC, transformants are visible and are screened for a transposition event (see 
section 4.2.3).  One plate was used for whole plate screens where the total cell mass was removed and 
used in PCR with plasmid flanking primers. Individual transformants were screened from the other 
two plates.  In parallel, Pst587 cells are transformed with 1xTE as a negative control and/or 
pBBR1MCS2 vector only to test the transformation efficiency of Pst587. 
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4.3.3 Screening natural transformants for IS1111-attC translocation  
Crude DNA extractions were prepared for 50 colonies of transformant per experiment as 
outlined in section 2.3.2. 1 µL of crude DNA preparation was used as PCR template with 
plasmid flanking primers (NVC15 and NVC16) to screen for successful translocation of 
ISPst6 into pattC- traps (Figure 4.5). Positive PCR product sizes were expected to be 1.8-kb 
and 1.7-kb for pPsattC-IS and paadB_attC-IS respectively. Where a PCR positive 
transformant was observed, its plasmid was recovered as per section 2.8. To generate a pure 
template for sequencing, purified plasmid DNA was used firstly with plasmid flanking 
primers NVC15 and NVC16. A second PCR was done by a nested PCR approach using 
primers ST96 and ST139 and the final PCR product was ligated into pGEM-T Easy vector as 
per manufacturer’s instructions and cloned into E.coli JM109 as per section 2.6.1. Plasmid 
from a clone positive for the PCR product was purified and sequenced using M13F and 
M13R primers at AGRF Sydney Node, Australia. 
 
 
Figure 4.5: Theoretical experimental design and recovery of IS1111-attC element translocation a 
using synthetic trap.  
a) Natural transformation of pattC traps into Pst587 cell b) ISPst6 is predicted to exist as minicircles 
within the cell c) ISPst6 site-specifically inserts into the pattC trap. Plasmid backbone primers, 
NVC15 and NVC16 are used to screen transformants for a translocation event into the pattC traps. 
Primers ST96 and ST139 are used in a nested PCR approach to give product of 1.5-kb corresponding 
to the attC and embedded ISPst6 element. The final recovered construct is termed pPsattCIS (or 
pattCaadB IS). 
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4.3.4 PCI invasion by plasmid-borne ISPst6 in PstQ and Pst641 via electroporation. 
To test ISPst6 translocation potential and ability to invade a Pseudomonas species (Figure 
4.6), pPsattC1-IS was electroporated into PstQ and Pst641 as per section 2.7.2. Previous 
profiling of PstQ and Pst641 chromosomal integron arrays showed complete absence of 
IS1111-attC elements (Holmes et al., 2003; Tetu & Holmes, 2008). Electroporation was used 
as the transformation mode as PstQ and Pst641 do not show natural competency under the 
experimental conditions applied here. Electrocompetent cells of PstQ and Pst641 (50 µL), 
prepared as per section 2.6.1, were electroporated with 1 µg of vector pPsattC1-IS as per 
section 2.6.2. As done previously for Pst587 natural transformants, individual PstQ and 
Pst641 transformants were patch-plated and boil-lysed to extract crude DNA. 1 µL of crude 
DNA preparation was used as PCR template for the following PCR screens to test i) for 
ISPst6 disruption of the wild type PstQ/Pst641 array using AJH17/AJH27 primer pair, ii) if 
ISPst6 translocation from pPsattC1-IS trap has restored the original synthetic attC site using 
NVC15/NVC16 primer pair and iii) if plasmid ISPst6 had generated minicircles within PstQ 
and Pst641 using ST89/ST123 primer pair. 
 
 
Figure 4.6: Introduction of pPsattC1_IS into Pseudomonads via electroporation. 
a) Transformation of pPsattCIS into PstQ and Pst641 cells b) ISPst6 is hypothesised to translocate 
out of the plasmid c) ISPst6 is predicted to target the chromosomally located attC site. D) One or 
more attC sites of the array will be invaded by ISPst6. PCRs target IS minicircle, PCI array and 
pPsattC-IS.  
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4.4 Results 
4.4.1 Ps. stutzeri ATCC 17587 is naturally transformable with double stranded plasmid 
containing an attC site 
To test the translocation potential and target specificity of ISPst6 within its natural host 
Pseudomonas, purified plasmids, termed pattC traps, were added directly to naturally 
competent Pst587 cells. On average, 106 and 70 Pst587 transformant colonies were seen 
when transformed with 1 µg of pPsattC1 and pPsattC2 DNA respectively (Table 4.2). In 
contrast when Pst587 cells were transformed with paadB_attC traps, the colony counts were 
93 and 90 for paadB_attC1 and paadB_attC2 respectively. The difference in colony counts 
with the pPsattC traps may be significant but is more likely due to a slight variation in the trap 
concentration added to the cells or in the harvesting method. Transformation of Pst587 with 
synthetic attC-traps was comparable to the 101-106 cfu/µg DNA transformation efficiency 
observed for Pst587 with foreign gene cassettes (Gestal et al.,  2011). Where Pst587 cells 
were transformed with TE buffer only, no transformants were obtained on the LB/Km50 plates 
as wild-type Pst587 is not intrinsically resistant to kanamycin.  
 
Table 4.2: Transformation efficiency of Pst587 cells with synthetic attC-trap 
attC-type Synthetic trapa) 
Experiment 1 
colony count b) 
Experiment 2 
Colony count 
b) 
Transformation yield/µg 
DNA 
(Average colony count) 
Pseudomonas-
type 
pPsattC1 (→) 97 115 106  
pPsattC2 (←) 69 71 70  
attCaadB 
paadB_attC1 (→) 92 94 93  
paadB_attC2 (←) 81 99 90  
Negative control 1xTE buffer only  0 0 0 
a)(←/→) orientation of attC site in relation to rep site on pBBR1MCS2.  
b) In each experiment, the colony count is an average of two plate counts of Pst587 transformants.  
 
A preliminary screen of the whole transformation plate did not reveal translocation of IS into 
attC-traps. That is, using plasmid flanking primers NVC15/NVC16, only PCR products 
corresponding to “empty” Pseudomonas-type (~550-bp) and attCaadB (~420-bp) traps were 
observed (Figure A19). In order to increase the sensitivity of detection for an ISPst6 
translocation event, individual transformants (50 per experiment) were screened instead of the 
total plate mass (see 4.3.2). 
 
Translocation of ISPst6 was detected, at a rate of 4% (4/100) for Pst587 cells transformed 
with pPsattC1. In comparison, detection of translocation into all other attC-traps was <1%. 
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ISPst6 translocation into pPsattC1 produced PCR products of both 550-bp and ~1.8-kb 
(Figures A20 & A21). This 1.3-kb increase corresponds to the size of an IS1111-attC 
element. Screening individual transformants did not overcome the PCR bias towards the 
smaller PCR product. 
 
Primer combinations involving one flanking primer (NVC15/NVC16) and one primer 
targeting the IS transposase gene (ST123), was used to re-screen a subset of 50 Pst587 
transformants for IS translocation. This approach increased detection sensitivity so that 4% 
(2/50) of Pst587 cells transformed with paadB_attC1 were positive for translocation (Table 
4.3, Figure 4.7), where previously the detection rate was below 1% using flanking primers 
only. Similarly, sensitivity was improved for Pst587 transformed with pPsattC1. Detection 
levels for pPsattC2 and paadB_attC2 remained below 1% (Figure A22). 
 
Table 4.3: Recovery efficiency of IS1111-attC translocation into pattC traps in Pst587 
attC 
type 
Trap 
Experiment 1a) 
Flanking  
Experiment 2a) 
Flanking  
Totalb) 
Experiment 2c) 
Flanking/IS  
Ps.-
type 
(73bp) 
pPsattC1 (→) 6% (3/50)* 2% (1/50) 4% (4/100) 4% (2/50) 
pPsattC2 (←) <1%  (0/50) <1%  (0/50) 
<1% 
(0/100) 
<1%  (0/50) 
attCaadB  
(60bp) 
paadB_attC1 (→) <1%  (0/50) <1%  (0/50) 
<1% 
(0/100) 
4% (2/50) 
paadB_attC2 (←) <1%  (0/50) <1%  (0/50) 
<1% 
(0/100) 
<1%  (0/50) 
a) All positive transformants identified were from one plate in each experiment.  
b) Based on findings in experiment 1 and 2.  
c)Transformants from experiment 2 were rescreened using one primer in the plasmid backbone (NVC15/NCV16) 
and one primer in the ISPst6 (ST123).  
* See appendix A2.1.  
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Figure 4.7: Definitive assay screen for IS1111-attC translocation into attC-traps.   
A) Schematic representation of primer combination used to detect translocation. Primers NVC16 and 
ST123 were used on boil-lysed Pst587 cells. Red arrow in parts B and C corresponds to the correct 
product size.  
B) Pst587 transformant 10 (NT10) and transformant 20 (NT20) are positive for pPsattC1-IS 
translocation. Pst587 transformants 1-27 are shown here. C) Pst587 transformant 1 (NT1) and 
transformant 15 (NT15) are positive for paadB_attC1-IS translocation. Pst587 transformants 1-27 are 
shown here. Note that there was no available positive control for this PCR, however in silico analysis 
predicted products of 353-bp (for pPsattC1) and 298-bp (for paadB_attC1). Additional bands (400-
500-bp) are non-specific products, and were observed in the no template control DNA also. 
 
Recovered pPsattC1-IS plasmid traps from transformants NT10 and NT20 were further 
characterized by restriction digestion mapping (Figure 4.8). The Pst587 NT1-recovered 
plasmid preparation paadB_attC1-IS was further analyzed by PCR only (Figure A23) and was 
found to contained a mixed plasmid population consisting of IS invaded and non-invaded 
attCaadB  sites. The Pst587 NT15 plasmid population could not be recovered as the colony was 
not viable due to prolonged storage on agar plates. 
A) 
 
 
 
 
 
 
 
B) 
 
 
 
 
 
 
C) 
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4.4.2 Restriction mapping detects mixed plasmid populations 
Figure 4.8 shows that Pst587 transformants NT10 and NT20 both had a mixed plasmid 
population composed of pPsattC1 and the IS invaded, pPsattC1-IS. The banding patterns of 
PvuII digests of NT10 and NT20 plasmids (Figure 4.8D) matched in silico predictions for 
those of pPsattC1-IS (Figure 4.8A) and pPsattC (Figure 4.8B). In comparison, pPsattC1 only 
contained the predicted five bands ranging from 360-bp to 2071-bp.  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: PvuII predicted digests for plasmids a) pPsattC1-IS b) pPsattC c) pBBR1MCS2. D) PvuII- 
digested plasmid from NT10 and NT20.  
The profile confirms presence of a mixed plasmid population, consisting of pattC and pattC-IS. 
Arrows indicate additional bands in NT10 and NT20 plasmid prepapration that correspond to 
presence of pPsattC1-IS.  
 
The mixed plasmid populations from NT10 and NT20 were seperately transformed into E.coli 
JM109 to recover the pPsattC1-IS component. Characterization of only NT20 pPsattC1-IS 
will be discussed from this point onwards. The plasmid topology of pPsattC1-IS was analysed 
by gel electrophoresis (Figure 4.9).  
 
A) B) 
C) D) 
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To demonstrate that an intact IS had invaded the pPsattC-1 trap, and that a 1.3-kb increase in 
plasmid size was a result of trap invasion, purified plasmid preparations were run out on low 
percentage agarose gels (Figure 4.9). During agarose gel electrophoresis, purified pPsattC1-IS 
ran at a molecular weight of greater than 10-kb despite its predicted size being 6-7-kb, while 
the pPsattC1 and pBBR1MCS2 controls produced faint bands of the correct sizes (5.4-kb and 
5.1-kb respectively) (Figure 4.9A). pPsattC1-IS also ran at a far greater molecular weight than 
predicted under lower percentage agarose, while the pPsattC1 and pBBR1MCS2 controls 
produced bands of the expected size (Figure 4.9B). 
 
 In both gels, the purified, uncut pPsattC1-IS showed multiple electrophoretic forms than ran 
significantly slower than linear 10 kb DNA markers.  This is consistent with the insertion of 
the IS into the trap producing a double-stranded molecule with multiple topological forms. To 
confirm that a single IS had invaded the trap, restriction digestion using BamHI was 
performed on the pPsattC1-IS vector. Cut pPsattC1-IS vector produced a band of the expected 
size (6.7-bp). However, a higher molecular weight band (>10-kb) corresponding to uncut 
pPsattC1 was also seen (Figure 4.9C). This incomplete digestion could be due to the newly 
inserted IS interfering with digestion, as the attC is situated 9-bp downstream of the BamHI 
site, or excess pPsattC1 in the digest.  BamHI-cut pBBR1MCS2 also produced a band of the 
expected size (5.1-kb).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: a) 1% agarose b) 0.75% agarose topological analysis of pPsattC1-IS, pPsattC1, 
pBBR1MCS2. 
pPsattC1-IS was predicted to travel at 6.7-kB, pPsattC1 5.3-kb and pBBR1MCS2 5.1-kb. c) 1% 
agarose gel of BamHI digest of pPsattC1-IS and pBBR1MCS2 plasmids.  
BamHI cut pattCIS (predicted size 6734-bp)  BamHI cut pBBR1MCS2 vector (size 5144-bp). 1.5-kb 
increase in pPsattC1-IS corrsponds to the cloned in 219-bp attC with flanking region and inserted 1.3-
kb ISPst6 element. E. coli gDNA was loaded as control.  
A)             B)                   C) 
 
 
 
 
 
Chapter 4 Examining the in vivo translocation activity of IS1111-attC elements 
117 
 
The increase in relative size of the pPsattC1-IS plasmid in comparison to the pPsattC1 
plasmid, as seen by BamHI profiling, confirmed that an IS1111-attC element had indeed 
invaded the synthetic Pseudomonas-type attC trap.  
 
4.4.3 Sequencing results confirm that ISPst6 inserted into Pseudomonas-type attC sites 
To determine the precise nature of insertion of ISPst6 into the synthetic pPsattC1 trap, 
plasmid flanking primers were used to amplify the 1.8-kb region containing the “trapped” 
ISPst6 element. However, these primers are prone to mispriming, hence a nested PCR 
approach was also used to generate a PCR product of 1.5-kb. This sequenced product 
corresponded to a complete ISPst6 insertion into the Pseudomonas-type attC site. All relevant 
features such as the flanking region, Pseudomonas-attC site, IS non-coding regions, inverted 
repeats and transposase gene (tpase) were identified. 
 
The recovered sequence from Pst587 transformant NT20 was analysed by BLASTn was 99% 
(1367/1371 bases) identical to a chromosomally embedded ISPst6 (BGC094) from Ps. 
stutzeri ATCC 17587 (EF648209.2) (Figure 4.10). Five ISs were previously known from 
Pst587 (Tetu & Holmes, 2008). This recovered sequence was not identical to the published IS 
from Pst587, thus suggesting the capture of a previously unsequenced IS1111-attC copy. One 
base difference was observed in the tpase ORF, where a thymine was replaced by an adenine 
at position 446. Six frame translation of the recovered tpase with the adenine substitution 
does not result in frame shift or stop codon formation, however, it does alter the amino acid 
from a negatively charged glutamic acid to a hydrophobic valine (Figure 4.11).  
 
Figure 4.11: Translated amino acid sequence of the predicted and recovered tpase gene. 
Note the single amino acid variation at position 98, where a valine was recovered instead of the 
predicted glutamic acid. 
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Figure 4.10: Sequencing pPsattC1-IS confirmed the presence of ISPst6 within the Pseudomonas-type 
attC site.  
A linear plasmid map of the predicted pPsttC1-IS is shown. The boxed region corresponds to the 1.5-
kb sequenced region. Sequence alignment of the recovered 1.5-kb product is shown relative to the 
predicted pPsattC1-IS sequence. Nucleotide differences between the two are annotated with an astrix. 
The alignment was generated using Geneious. 
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Two base differences are also observed in the non-coding region adjacent to IRL where 
guanine and cytosine replace an adenine at position 1414 and thymine at position 1427 
respectively. Also in IRL, an adenine is replaced by a guanine in the recovered sequence at 
position 1441. Interestingly, this identical three base difference is observed in ISPst6 elements 
in Ps. stutzeri ATCC 14405. The extent of variations observed here is comparable to that seen 
within other PCI assays.  Finally, three base differences were noted in the recovered 
Pseudomonas-type attC site at positions 35, 44 and 55.  Differences in the Pseudomonas-attC 
site may have occurred as a result of a replication error during translocation. Sequencing or 
PCR errors are also not uncommon when dealing with MGE. These results demonstrate that 
ISPst6 is able to insert into both Pseudomonas-type attC and classical attCaadB sites, however, 
there appears to be a high efficiency for the Pseudomonas-type attC. It is noteworthy that 
insertion appears to be dependent on the orientation of the target site in the plasmid.  
 
4.4.4 IS1111-attC invasion of chromosomal attC array  
To test the translocation potential of IS1111-attC elements and their ability to invade PCI 
arrays, the IS1111-attC element was delivered into three different Ps. stutzeri strains by 
electroporation of the plasmid pPsattC1-IS (Table 4.4).  
 
Table 4.4: PCI characteristics of Pst405, Pst641 and PstQ 
Straina) Gv. IntI 
IS1111-attC 
Presence b) 
IS1111-attC 
minicircles 
attC sites 
available c)  
Competencyd) 
Pst405 2 
Not 
active 
4 intact 
copies 
Present >2 Electrocompetent 
Pst641 8 Active None Absent >2 
Natural*  
Electrocompetent 
 PstQ 8 Active None Absent >2 Electrocompetent 
 a)Pseudomonas stutzeri ATCC14405, Pseudomonas stutzeri ATTC17641 (Tetu & Holmes, 2008), 
Pseudomonas stutzeri st. Q (Holmes et al., 2003). 
b)Represents the presence (and copy number) or absence of IS1111-attC elements within PCIs in these wild-type 
strains.  
c) Availability is simply the number of empty (thus available) PCI attC sites into which the introduced IS1111-
attC can insert.  
d) Pst641 is naturally competent for small linear DNA, but not circular DNA under the conditions used in this 
experiment 
 
4.4.4.1 IS1111-attC is stably maintained in the plasmid 
An initial experiment was conducted in which pPsattC1-IS was electroporated into Pst405. 
This is a strain in which the IS naturally exists and is presumed to be fully active with respect 
to IS mobility. Fifty Pst405 transformants were screened for a loss of IS from pPsattC1-IS. 
Chapter 4 Examining the in vivo translocation activity of IS1111-attC elements 
120 
 
All fifty transformants maintained intact pPsattC1-IS constructs (Figure A24), and no 
transformant containing an empty pattC trap was detected. Given that wild-type Pst405 
contains IS minicircles as well as multiple ISPst6 elements within its PCI array, it was not 
possible to test for other signs of activity such as the formation of minicircles by the plasmid-
introduced IS.  
 
4.4.5 Introduced IS elements are able to undergo initial stages of mobilization to form 
minicircles. 
To observe ISPst6 proliferation across PCIs, pPsattC1-IS was electroporated into PstQ and 
Pst641. Both of these strains have at least 2 available attC sites for insertion, and lack IS1111-
attC elements. As with Pst405, no loss of ISPst6 from pPsattC1-IS was observed after 
screening fifty PstQ transformants with plasmid-flanking primers (Figure A24). PstQ and 
Pst641 transformants were also screened for the presence of ISPst6 minicircles and variations 
within their PCI arrays. 8% (4/50) of PstQ and 25% (3/12) Pst641 transformants gave the 
predicted PCR product of ~258-bp when ISPst6 minicircle primers were used (ST89 and 
ST123) (Figure A25). The PstQ positive transformants were annotated as PstQET2, PstQET8, 
PstQET49 and PstQET50.  Pst641 positive transformants were annotated as Pst641ET5, 
Pst641ET9 and Pst641ET11. High molecular weight DNA was extracted from these six of the 
seven positive transformants and the minicircle screen was repeated (Figure 4.12). The 
Pst641ET5 plasmid population could not be recovered as the colony was not viable due to 
prolonged storage on agar. 
 
A PCR product corresponding to an ISPst6 minicircle junction region was present in the 
positive control strain Pst587 and absent in the wild type PstQ strain. pPsattC1-IS purified 
plasmid was added as control and gave two false positive products (~1500-bp and 900-bp). In 
silico analysis indicated that these products are the result of non-specific binding of the 
primers to the mob and rep genes on pBBR1MCS2. Transformants PstQET2, PstQET8, 
PstQET49, PstQET50 have composite banding patterns. That is, all four transformants display 
the 2 plasmid bands (1500-bp & 900-bp), as well as the 350+-bp and ~500+-bp band present in 
PstQ WT and finally the ~258-bp minicircle band. Pst641ET9 and Pst641ET11 all produce a 
band of 258-bp, corresponding to the minicircle. The minicircle PCR bands from PstQET2 
and Pst641ET9 were cloned and sequenced for identification 
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Figure 4.12: PstQ and Pst641 transformants contain ISPst6 minicircles.  
Expect product size is 258-bp (red arrow). Pst587 positive controls, PstQ wild-type was used as a 
negative control as well as pPstattC1-IS purified plasmid construct. NTC: no template control, red 
arrow points to cloned and sequenced bands. 
 
4.4.5.1 Sequencing confirms the presence of ISPst6 minicircles in transformants 
PstQET2 and Pst641ET9. 
The 258-bp PCR product from PstQET2 and Pst641ET9 (Figure 4.12) was cloned into 
pGEM-T Easy and sequenced. In both cases the product contained all the expected features of 
an ISPst6 minicircle - these are IRs, non-coding regions (NCRs) and tpase gene (Figure A26). 
Splitting the 258-bp sequence at the 10 base pair junction resulted in two fragments annotated 
as PstQET2 1-137-bp and PstQET2 138-258-bp, and Pst641ET9 1-137-bp and Pst641ET9 
138-258. The respective sequences completely aligned to the intact ISPst6 located on 
pPsattC1-IS (Figure 4.13). I conclude that the 258-bp minicircle present in the PstQ and 
Pst641 transformants originated from activity of the IS element introduced to the cells on the 
plasmid.  
 
 
Non-specific products 
1) Plasmid backbone source 
2) Strain PstQ source 
3) Strain PstQ source 
4) Plasmid backbone source 
1 
2 
3 
4 
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Figure 4.13: Minicircles from PstQ transformant 2 and Pst641 transformant 9 recovered minicircles 
align with attC embedded ISPst6 from pPsattC1-IS.  
 
4.4.6 Insertion into PCI attC sites was not detectable. 
A “global” assay for IS invasion was performed in which the PCIs were screened using 
previously published primers, AJH17 and AJH27, to target PstQ integron arrays. Four 
transformants, PstQET2, PstQET8, PstQET49 and PstQET50, and all twelve Pst641ET were 
examined for differences in their integron array by comparing their PCR banding pattern to 
that of the wild-type PstQ and Pst641. No differences in the PCR banding patterns were 
observed (Figure 4.14). Thus IS1111-attC proliferation across the PstQ and Pst641 PCIs was 
not detected. 
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Figure 4.14: ISPst6 does not appear to have invaded the PstQ chromosomal arrays.  
a) Schematic representation of InPstQ (Holmes et al., 2003). This array contains 10 gene cassettes. 
Primers AJH17 and AJH27 were used to amplify the array. These primers bind Ps.-type attC-sites. 
Resulting PCR product is a PCR array of varying sizes.  
b) InPstQ array PCR results show no variation between wild type PstQ strain and transformants 
PstQET2, PstQET8, PstQET49, PstQET50 arrays. Pst587 and PstQ positive controls for PCI arrays. 
pPsattC1-IS plasmid DNA negative control. NTC is the no template control. 
c) InPst641 array PCR results show no variation between wild-type Pst641strain and transformants. 
Pst641 was the positive control for PCI arrays. Note Pst641ET5 is not included as the culture was not 
viable. NTC is the no template control. 
 
A)    
 
B)    
 
C)    
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4.5 Discussion 
4.5.1 IS1111-attC elements translocate with regional-specificity into attC sites  
Translocation of insertion sequences plays a major role in the horizontal spread of antibiotic 
resistance genes amongst prokaryotes (Soki, 2013). In chapter 3, I established a correlation 
between PCI-IS1111-attC in environmental and MRI-IS1111-attC co-occurrence in clinical 
Pseudomonads. Previously, Tetu & Holmes (2008) demonstrated partial translocation of 
IS1111-attC when using an E. coli host and a single copy fosmid containing a PCI array. 
Their results implied that all conditions for complete translocation were not met.   
 
In my study, intact translocation of ISPst6 was detected in the Pseudomonas-type attC trap 
when a low copy plasmid pBBR1 (~20-30 copies per cell)  (Kovach et al., 1995; Lefebre & 
Valvano, 2002) was used as the trap backbone and introduced into a Pseudomonas host. More 
importantly, in my study, IS1111-attC translocation was confirmed as site-specific in the one 
instanced studied, emphasising the importance of site–specific recombination in the overall 
dissemination of these IS elements. Furthermore, no target site-duplications of the 
Pseudomonas-type attC site were identified upon ISPst6 insertion. This is in line with the 
general characteristic of  previously studied IS110/IS1111 insertion sequences  (Bruton & 
Chater, 1987; Henderson et al., 1989; Mahillon & Chandler, 1998;  Partridge & Hall, 2003). 
IS1111-attC was translocated to two distinct structural types of attC sites: Pseudomonas-type 
and classical attCaadB. Translocation into the Pseudomonas-type was confirmed by 
sequencing, and by PCR mapping for the classical site. IS1111-attC translocation activity into 
and out of the attC-trap was observed across four different Ps. stutzeri strains containing 
different PCI arrays. If IS1111-attC translocation is “dependant” on Pseudomonas host 
factors, it may explain why IS1111-attC translocation into non-Pseudomonads (enteric) is not 
as readily observed. Spread of IS1111-attC elements into non-Pseudomonads is thus believed 
to be the results of MRI driven movement, rather than IS1111-attC only. 
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4.5.2 Orientation-specific translocations is a feature of ISPst6 elements 
Four synthetic attC traps were transformed into a naturally competent Ps. stutzeri ATCC 
17587 containing PCI-embedded ISPst6 elements. These traps differed in their respective 
attC sites, Pseudomonas-type and classical attCaadB, and in the respective orientations in 
which these sites were cloned into the pBB1MCS2 plasmid backbone (Figure 4.15).  
 
 
Figure 4.15: Linear map of pBBR1MCS2 and orientations of cloned recombination sites (attCaadB and 
Pseudomonas-type attC).  
IS1111-attC translocation was observed in attC sites cloned in orientation 1 but not in orientation 2. 
 
ISPst6 translocation was observed in both types of attC sites when they were cloned in 
orientation 1, implying that translocation is not strictly dependent on the attC sequence 
(Figure 4.15). attC sequence variation may have an effect on the IS1111-attC Tpase ability in 
preferentially recognizing the Pseudomonas-type over attCaadB sites. It was harder to detect IS 
translocation into attCaadB by PCR assays using flanking primers, suggesting that there was a 
lower plasmid population with attCaadB-IS translocation. Translocation was not observed 
when the sites were cloned in orientation 2, implying that some other molecular features were 
necessary for successful translocation. This orientation-specific translocation suggests that 
IS1111-attC elements are able to recognise single stranded attC targets. I postulate that the 
formation and recognition of a single stranded attC structure and its accessibility to the IS 
transposases drives IS translocation into orientation 1. Given what is known about IntI strand 
preference towards single stranded attC sites (Francia et al., 1999), it may also be that 
IS1111-attC transposase preferentially binds single stranded attCs.  
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4.5.3 To jump or not to jump? Potential routes for single stranded attC site generation 
In order to account for the observed orientation-specificity by ISPst6 towards orientation 1 
attC sites, scenarios that may result in the production of single stranded attC sites, and thus 
lead to ISPst6 translocation, are discussed here: 
 
Case 1: Natural transformation and ssDNA uptake promote ISPst6 transposition 
Although, Ps. stutzeri is one of the better known models in population genetics (Lalucat et al., 
2006), the mechanisms of transformation have not been studied. Based on other model 
systems and the presence of genome homologs, predictions can be made as to the mechanisms 
involved in the active uptake of foreign DNA into the bacterial cell. Initially, double stranded 
DNA is bound to the cell surface, and is subsequently pulled through the secretin pore by 
retraction of a pilus, such as the type 4 pilus (T4P) (Chen & Dubnau, 2004). One strand of 
DNA is trafficked in a single stranded state into the cell, while the other strand is degraded. If 
natural transformation is the mechanism by which single stranded attC site is generated as the 
plasmid is taken up, then there is predicted to be a strand bias.  
 
There is precedent for this in Neisseria gonorrhoeae, which has been shown to take up DNA 
through the recognition of a non-palindromic 10 or 12 nucleotide DNA uptake sequence 
(DUS10 or DUS12). More interestingly, the ssDUS12 Crick strand was observed to enhance 
transformation efficiency  in comparison to the ssDUS12 Watson strand (Duffin & Seifert, 
2012). Assuming that plasmid uptake in Ps. stutzeri follows an analogous mechanism, then 
one would predict single stranded attC-traps enter the Pseudomonas cytoplasm and yield a 
transient attC hairpin. This hairpin is predicted to be necessary for transposase recognition 
and site-specific recombination of IS1111-attC into the attC sites. However, DNA uptake 
does not explain why Pst587 transformants with mixed plasmid populations, containing 
empty and invaded attC sites, were observed.  
 
Case 2: Plasmid replication exposes the attC site for ISPst6 attack 
To ensure that a fixed concentration of a low copy number plasmid is maintained in the 
bacterial population, it has to be replicated once per cycle and effectively partitioned to the  
daughter cells (Pinto et al., 2012). For instance, ColE1 plasmid replication in E. coli is 
initiated by antisense RNAII and a repertoire of proteins that monitor plasmid number and 
ensure that the plasmid population is maintained (Del Solar et al.,1998).  This is achieved by 
RNAII binding to the target strand and acting as an attachment point for DNA polymerase I 
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(Cesareni et al., 1991).  However, antisense RNAI binding to RNAII, alters the structural 
conformation of RNAII, which can no longer act as a binding partner for DNA polymerase I 
(Cesareni et al., 1991), thus resulting in inhibition of leading strand synthesis, and halting 
plasmid replication. This arrest results in the temporary formation of single stranded plasmid. 
However, this RNAI-RNAII complex formation is reversible (Xu et al., 1993).  
 
While the precise mechanism of pBBR1 plasmid replication is still unknown, there is some 
evidence to suggest that it does not occur via the rolling circle method (Antoine & Locht, 
1992a; Antoine & Locht, 1992b; Szpirer et al., 2001). I postulate that as the replication 
machinery attaches to pBBR1, the double stranded plasmid is disrupted to generate single 
strands. It may be maintained in a single stranded state due to the attC site acting as an 
antisense molecule. There is a precedent for replication leading to differential propensity for a 
single stranded attC to be exposed and able to form hair-pins (Bikard et al., 2010). If pBBR1 
replication results in single stranded attC formation and subsequent IS invasion, then this 
could explain why transformants containing mixed plasmid populations were recovered.  
 
Partridge and Hall (2003) observed that the transposition efficiency of IS4321, an IS1111 
subgroup member, increased when the 38-bp TIR target site was cloned into pACYC18:Tn21 
in an orientation facing away from the ori site. They too postulated that the overall orientation 
of the single stranded site impacts on promoter placement and plasmid replication. Similarly, 
I predict that as pBBR1 is disrupted, single stranded attC sites form bulged hairpin structures, 
which may, depending on their strand location, pose problems by destabilizing replication 
machinery or interfering with the  antisense RNA (Gerhart et al., 1994). Alternatively, if attC 
site orientation had no effect on plasmid replication, it may be that inverse translocation of 
ISPst6 had a negative effect on replication by acting as an inhibitor or replication terminator. 
An inhibitory effect on plasmid replication would result in a lower detection threshold of IS 
translocation due to a reduction in plasmid copy numbers, whereas termination of plasmid 
replication would result in eventual loss of the plasmid from the Pseudomonas population (del 
Solar et al., 1998), thus no detection of IS1111-attC translocation. 
 
Case 3: Formation of single stranded attC during transcription by RNA polymerase 
A transcription terminator is a section of nucleic acid sequence that initiates the release of 
newly synthesised mRNA from the transcription complex, freeing RNA polymerase and 
related transcriptional machinery (Henkin, 1996). Rho-dependent and Rho-independent 
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transcriptional terminators are widely distributed sequences across prokaryotic genomes 
(Henkin, 1996). This discussion will not go into the mechanistic differences between  Rho-
dependent and Rho-independent transcription terminators, but will merely highlight that in 
Rho-independent termination, there is a precedent for the formation of stem-loops on one 
strand during transcription (Henkin, 1996; Von Hippel, 1998). 
 
I propose that the secondary structure formed by single stranded attC sites has the capacity to 
resemble transcriptional terminators, thereby promoting dissociation of RNA polymerase 
through allosteric effects and thus affecting pBBR1 replication. This may explain why 
IS1111-attC elements were only observed in attC sites cloned in orientation 1. Hairpins of 
attC sites cloned in orientation 2 were perhaps more likely to result in replication fork 
stalling, and RNA polymerase destabilization, thereby reducing the overall stability of the 
mRNA-DNA-RNA polymerase complex. Hence no IS1111-attC translocation was observed 
in orientation 2. 
 
4.5.4 Does IS1111-attC undergo a non- replicative (cut-and-paste) or a replicative (copy-
and- paste) translocation mechanism?  
A postulated feature of IS1111 elements is the ability to move via circular intermediates, 
where the terminal inverted repeats of a single IS are brought together and are then separated 
by a characteristic number of base pairs of flanking sequence (Prosseda et al., 2006; Tetu & 
Holmes, 2008). In this study, IS1111-attC minicircles were detected in Ps. stutzeri st. Q and 
Ps. stutzeri ATCC 17641 transformants after the introduction of the IS via a pPsattC1-IS trap. 
In contrast, IS minicircles were absent in the wild-type strains.  
 
ISPst6 minicircles are predicted to be non-replicating, so integration of the IS into a 
chromosomal framework or plasmid is necessary for its replication and spread. However, in 
this study, integration of IS1111-attC into PCIs arrays was not observed. To overcome 
extinction within a cell/population, IS1111-attC integration into the PCI was predicted to be 
essential for maintenance and transposase expression (Thomas & Nielsen, 2005). What 
molecular-genetic factor controls IS1111-attC integration into a PCI? IS1111-attC may only 
invade single-stranded Pseudomonas-attC sites during genomic DNA replication, repair, or 
transcription. Realistically, there is only a small window of opportunity for successful 
invasion of IS1111-attC to occur!  
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SI hypothesised that if ISPst6 translocated through a cut-&-paste mechanism, then the 
original attC trap would be restored. However, restoration was not observed and only the 
intact plasmid-embedded IS-attC was detected. The presence of IS minicircles within the 
transformants implied that ISPst6 transposase was actively expressed in at least the early 
stages of movement. As the plasmid replicated, a newly synthesised IS copy would have been 
generated on both the leading and lagging strand. It is quite possible that one of these newly 
copied ISs was able to excise as a minicircle once the replication fork had passed. This would 
ensure that one IS copy was maintained within one strand, whilst allowing evacuation from 
the other strand. This echoes the cut-&-paste nature of transposon Tn10. Tn10 translocates 
only after the replication fork passes, leaving a hemi-methylated copy behind in each sister 
chromosome (Bender & Kleckner, 1986). The co-occurrence of intact copies of plasmid 
embedded ISPst6 and minicircles, may well be explained by a non-replicative mechanisms 
such as that of Tn10. However, at this stage, this hypothesis requires further validation.  
 
4.5.5 Further work 
I have detected ISPst6 translocation by demonstrating the in vivo capture of the IS by a 
plasmid trap in its native Pseudomonas host. Furthermore, I have also detected the formation 
of ISPst6 minicircles, in previously “un-infected” Ps. stutzeri strain Q and strain 
ATCC17641, following the introduction of a ptrap-IS plasmid. I have confirmed that the final 
outcome of ISPst6 transposition is site-specific recombination into attC, and I predict that IS 
minicircle are an intermediate step in transposition, and that they can form in multiple cell 
types. However, the sequential steps leading up to IS transposition into attC sites are still 
unknown and a few key questions remain unanswered: 
1) What precisely are the steps involved in ISPst6 translocation?  
2) Is IS1111-attC transposase target recognition purely sequence-specific or is it 
structural? 
3) Is IS1111-attC transposase recognition of different attC sites as flexible as the IntI1 
target range? 
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 Characterization of recombination site-preferences of Ps. 
stutzeri IS1111-attC transposase 
5.1 Introduction 
Thus far I have demonstrated activity of IS1111-attC towards both Pseudomonas-type and 
attCaadB sites in laboratory cultures. I have also shown that the frequency of IS1111-attC 
insertion is subject to attC orientation where translocation was observed in attC sites cloned 
in one orientation in the plasmid multiple cloning site (Figure 4.13), but not the other. DNA 
orientation (also referred to as polarity in this study) is biologically significant, thus the 
underlying causes were explored. This dependency on polarity could be a selective 
consequence of effects on surrounding genes/functions, such as IS insertion, potentially 
affecting plasmid replication (Collis et al., 2001). Alternatively, it could be a mechanistic 
feature of IS1111-attC recombination mechanism; for example, only one strand may be 
involved in the reaction, and its presentation is affected by orientation specific processes.  
 
There is precedence for a mechanistic origin of polarity with integron integrase mediated 
recombination between a double stranded (ds) attI and a single stranded (ss) attC (Cambray et 
al., 2010; Johansson et al., 2004). IntI-mediated recombination requires only three DNA 
strands, where one of these single strands contains a palindrome able to form an energetically 
stable duplex (hairpin), thereby producing a structure that is equivalent to a double stranded 
DNA molecule. The single-stranded DNA is the bottom strand of attC (Francia et al., 1999) 
and its preferential targeting results in a biologically important outcome where the orientation 
of the incoming cassette ORF is preserved with respect to Pc (Partridge et al., 2009).  
 
Unlike IntI, which is a tyrosine recombinase, IS1111-attC encodes a transposase with a 
conserved D-E-D-D motif that is essential for activity of the Piv/MooV family of DNA 
recombinases (Buchner et al., 2005; Tobiason et al., 2001). In this study, two mechanisms for 
the observed polarity were considered. Firstly, biased attC strand formation was considered 
where the hypothesis is that single-stranded attC sites are also an IS1111-attC target and the 
formation of this strand is subject to orientation effects. Based on the IntI model, I predict that 
the IS1111-attC transposase will only bind to one strand of the attC site as well as to a double 
stranded IS1111-attC minicircle (Figure 5.1). Secondly, specific recognition of and 
preference for some attC subclasses over others was hypothesised to play a role in the 
distribution patterns of IS1111-attC across PCI and MRIs. Work presented in chapter 4 
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revealed that IS1111-attC transposition was not attC sequence dependent; however, the 
findings alluded to the importance of attC structural recognition.  
 
 
Figure 5.1: a) IntI1-mediated recombination of dsattI and ssattCbs compared to proposed B) IS1111-
attC transposase mediated recombination of dsIS1111-attC minicircle junction and ssattCts or 
ssattCbs.  
In a) only one (black) attC strand participates. In b) both the attC top strand (ts) and bottom strand 
(bs) can participate. Arrows point to the nucleotide pair involved in recombination cross-over where 
nucleotides highlighted in green in panel c) and d) are key nucleotides. 
 
Given that both top and bottom strands of attC are possibilities for IS1111-attC Tpase 
recognition, I aimed to explore whether or not a single strand was a recombination partner, 
and, if so, which strand that is. IS1111-attC inserts into the precise attC palindromic position 
(positions h and i) despite variation in attC sequences (Tetu & Holmes, 2008). The presence 
of extrahelical bases is important for specificity and polarity in the IntI system (Francia et al., 
1999; MacDonald et al., 2006) and is predicted to be essential for IS1111-attC transposase 
binding also. If Tpase and IntI both target the same attC bottom strand, and recognize the 
same extrahelical bases (G and T) (Figure 5.2 A), this is predicted to result in a competitive 
environment between these two heterologous enzymes. If IS1111-attC Tpase preferentially 
recognises the attC top strand, it would have a spatially separated binding site as illustrated in 
Figure 5.1, thereby reducing any competitiveness with IntI. attC structure and strand 
availability is thus postulated to play a key role in Tpase binding and overcoming  molecular-
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genetic constraints. For instance, the role of the variable terminal structure (VTS) in 
influencing single-stranded template formation and affinity for IntI attachment has been 
demonstrated (Bouvier et al., 2009; Loot et al., 2010). Thus it is unlikely that the polarity 
comes from the IS1111-attC minicircle. Tpase is postulated to be able to recognise a tag 
between the two 12-base repeats, thereby reducing overall polarity. High tolerance to 
sequence variation, specificity of insertion point and orientation bias appear to be shared 
features of IntI and IS1111-attC Tpase.  
 
 
 
 
Figure 5.2: Comparison between attCaadB and Pseudomonas-type (BGC101) attC   
a) classical attCaadB and Pseudomonas-type attC aligned according to secondary structure position 
prediction (blue). Black shading notes sequence identity between the two attC sites. Arrows point to 
IS1111-attC and Gene cassette insertion points 
b) classical attCaadB. attCaadB has a 9-bp insertion between positions s and S.  
c) Pseudomonas-type attC has an 18-bp insertion at m-n and an 8-bp insertion at s-S.  
Structural similarities between these two attC sites and the flipped out extrahelical G and T 
nucleotides necessary for IntI docking (green). Bases in red depict protein-phosphate contacts of 
IntI1. Adapted from Bouvier et al., 2009. 
Chapter 5 Characterization of recombination site-preferences of Ps. stutzeri IS1111-attC transposase 
133 
 
5.2 Aims 
Given the biological importance of integrons in bacterial evolution and adaptation, 
understanding how IS1111-attC elements and in particular the transposase interact with 
integron systems will provide molecular insights into this complex system. Firstly, an in vitro 
system for IS1111-attC transposase expression would need to be developed based on IntI 
research (Gravel et al., 1998). The aims were: 
 
1) To determine IS1111-attC Tpase sequence specificity or preference to potential 
recombination substrates.  
2) To study the binding of IS1111-attC Tpase to double stranded recombination 
substrates.  
3) To study the binding of IS1111-attC Tpase to single stranded recombination 
substrates.  
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5.3 Methods 
For general media and solution recipes, as well as PCR conditions, refer back to Chapter 2. 
5.3.1 PCR, restriction digestion and cloning of IS1111-attC tpase into pMAL-c2X 
A 1044-bp DNA fragment encoding IS1111-attC transposase was amplified by PCR from 
Pst405 (BGC101) genomic DNA by using the primers MZ03 and MZ04. The PCR product 
was purified using Qiagen PCR Purification kit, and a double digest using BamHI and PstI 
(New England BioLabs, Canada) was performed using 500 ng of purified PCR product at 
37oC, overnight. Enzyme inactivation was performed at 65oC for 20 min prior to an additional 
round of purification. 500 ng of pMAL-c2X (NEB) was also digested overnight using 
BamHI/PstI at 37oC. Digested vector was subsequently dephosphorylated for 1 hr at 37oC 
using Antarctic phosphatase (New England BioLabs, Canada) as per manufacturer’s 
instructions.  
 
Ligation of insert and vector was done at a ratio of 3:1 at 4oC overnight using T4 DNA ligase, 
10x T4 DNA Ligation buffer, 10x ATP. The ligation mixture was transformed into 
chemically competent E. coli JM100 cells by heat shock at 42oC (Section 2.6.1). Plating was 
done on LB/Amp100 at 37oC overnight. Positive ligation clones were identified using a PCR 
screen where one primer targets the tpase gene and other is a plasmid backbone primer. 
Primer combinations were MZ03/ELF22, and MZ04/ELF21. Positive clone was grown 
overnight in 50 mL LB/Amp100 and the plasmid was purified as described in section 2.7. 
Purified constructs (Figure 5.3) were stored at -20oC and were used to transform E. coli 
Rosetta cells for protein expression. 
 
5.3.2 Overexpression of recombinant proteins 
5.3.2.1 Cell expression system- E. coli Rosetta 2 cells 
The E. coli Rosetta 2 strain was used as the cell expression system. This strain is a BL21 
derivative designed to enhance the expression of eukaryotic proteins that contain codons 
rarely used in E. coli. It supplies tRNAs for 7 rare codons (AGA, AGG, AUA, CUA, GGA, 
CCC, CGG), which were all strongly represented in the tpase gene. 50 µL of Rosetta cells 
were thawed on ice and 50 µL of KCM buffer was added to the cells with 1 µL pMAL-Tpase 
construct. As a control, pMAL-c2X was added to a separate tube of Rosetta cells. The cell 
suspension was mixed and incubated on ice for 20min. Cells were then heat shocked at 42oC 
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for 90 sec, 200 µL of LB was immediately added and cells incubated at 37oC for 1.5 hrs 
before being plated onto LB/Carb100/Cm12.5/Glu2%. Transformants were recovered overnight 
at 37oC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Expression construct used to produce a Maltose-binding transposase fusion protein.  
The BamHI and PstI sites were used to clone the tpase gene into the pMAL-c2X vector backbone. 
Blown out panel is the corresponding amino acid sequence of the ISPst6 Pst405 tpase. MBP-tag 
amino acid sequence is underlined in purple, Factor Xa site in green and Tpase in yellow. 
 
5.3.2.2 Expression of fusion protein 
Figure 5.4 outlines the expression and purification steps of MBPTpase from Rosetta cells. 
Single colonies of transformed E. coli Rosetta 2 were used to inoculate LB containing 
carbenicillin (100 µg/mL), chloramphenicol (12.5 mg/mL) and 2% glucose and shaken 
overnight at 180 rpm and 37oC. Six litres of LB media containing carbenicillin (100 µg/mL), 
chloramphenicol (12.5 mg/mL) and glucose (0.2%) was inoculated with the overnight culture 
to a starting OD600nm of 0.05. Cultures were shaken at 180 rpm at 37
oC until an OD600nm of 0.3 
was reached. The temperature was then lowered to 16oC and cells were grown to an OD600nm 
of 0.5 still shaking at 180 rpm for approximately 2 hrs. Overexpression of recombinant 
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protein was induced by addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to 0.3 mM, 
the culture was incubated overnight (~20 hrs). Cells were harvested by centrifugation (4000 g, 
20 min, 4oC), resuspended in 30 mL MBP column buffer and stored at -20oC. Overexpression 
was confirmed by SDS-Page analysis on 10% polyacrylamide gel run at 110 Volts 40 min, 
stained for 30 min in Coomassie blue and destained in low destain solution overnight.   
 
5.3.2.3 Cell lysis 
Cell pellets were thawed in ice water baths and DNase I (1 mg/mL) (Sigma-Aldrich, USA) 
was added to a final concentration of 10 µg/mL. Cells were incubated on ice for 10 min 
before sonication in 8x15 sec bursts with a 30 sec resting period in between the bursts. 
Soluble and insoluble fractions were separated by centrifugation at 4000 g, 20 min at 4oC. 
 
 
Figure 5.4: Flow diagram of the protein preparation strategy. At each purification step, 30 µL of 
liquid is reserved for subsequent SDS-PAGE analysis. 
Growth & 
expression
•Expression of MBP-Tpase in E. coli Rosetta cells
•Overnight growth in 50 mL LB/Amp100/Cm12.5/Glu2% at 37oC, 180 rpm
• Inoculate 6-L  LB/Amp100/Cm12.5/Glu0.2% with overnight culture
•Grow to OD600 ~0.3 at 37
oC, lower temperature to 16oC and grow to OD600 ~0.5
• Induce with 0.3 mM IPTG for  ~20 hrs at 16oC with 180 rpm shaking
Crude Collection
•Harvest cells by centrifugation at 4000 g for 20 min at 4oC.
•Discard supernatant and resuspended pellet in 30 mL MBP column buffer
•Reserve 30 µL for SDS-PAGE analysis-Total cell load
•Lyse cells by thawing and sonification in 8x15 sec bursts on ice
•Reserve 30 µL for SDS-PAGE analysis-Crude lysate
Soluble 
Collection
•Centrifugation of lysate at 4000 g for 20min at 4oC. 
•Reserve soluble fraction and 30 µL for SDS-PAGE analysis-Soluble
•Discard insoluble fraction
Elution
Chromatography
•Load soluble fraction onto prepared amylose column
•Collect all flow-through fractions and reserve 30  µL for SDS-PAGE analysis
•Wash column in 12 column volumes using MBP column buffer
•Collect all wash fractions and reserve 30 µL for SDS-PAGE analysis
•Elute fusion protein with MBP column buffer supplemented with 50 mM Maltose
•Collect all elution fractions and reserve 30 µL for SDS-PAGE analysis
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5.3.3 Purification and identification of MBPTpase fusion protein 
5.3.3.1 Purification using amylose affinity chromatography  
The amylose resin was poured into a 2.5 x 10 cm column. The column was prepared by 
washing with 5 column volumes of MBP column buffer, 3 volumes of reverse osmosis water, 
followed by 3 volumes of MBP column buffer. The soluble protein fraction was then loaded 
onto the column and all of the flow-through was collected. The column was then washed in 
12 column volumes of MBP column buffer. Finally, the fusion protein was eluted with MBP 
column buffer supplemented with 50 mM maltose. 10 fractions of 1 mL each were collected 
and purification was confirmed by SDS-PAGE analysis.  
 
5.3.3.2 In-gel trypsin digestion 
Protein bands of interest were excised from the gel with a sharp scalpel using a clean scalpel 
per protein band of interest. Protein strips were cut into 1-2 mm3 cubes and put into 1.5 mL 
microcentrifuge tubes. Gel cubes were destained using 500 µL of 60% (v/v) 50 mM 
ammonium bicarbonate (Sigma-Aldrich) and 100 µL 40% acetonitrile for 1 hr at room 
temperature. If needed, this step was repeated 2-4 times until all Coomassie blue was washed 
out of the gel cubes. Gel cubes were washed by adding 100 µL 100% (v/v) acetonitrile and 
vortexing to mix. The above washing step was repeated until the gel plugs were solid white in 
colour. Gel plugs were completely dried using vacuum centrifugation (30min, 40oC, 
Concentrator 5301, Eppendorf). Dehydrated cubes were rehydrated in 8 µL of 50 mM 
ammonium bicarbonate containing 12 ng/µl modified sequencing grade trypsin (New England 
BioLabs, Canada) for 60 min at 4oC. This will bring trypsin to its active pH 7-9. Excess 
trypsin solution was removed by centrifugation and the rehydrated gel cubes were incubated 
overnight at 37oC in 20 µL of 50 mM ammonium bicarbonate.   
 
5.3.3.3 Peptide Mass Fingerprinting  
For MALDI-TOF MS analysis, peptides were desalted and concentrated using C18 micro- 
columns (PerfectPure, Eppendorf) according to the manufacturer’s protocol. Peptides were 
eluted onto a MALDI plate with 2 µL of matrix solution (10 mg/mL α-cyano-4-
hydroxycinnamic acid in 0.1% TFA and 50% acetonitrile). Mass spectra were acquired in the 
mass: charge range of 800-3500 m/z on a Q-STAR XL Hybrid mass spectrometer equipped 
with a MALDI ion source (Applied Biosystems Inc., Foster City, USA). The instrument was 
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calibrated using [Glu1] Fibrinopeptide B peaks 175.1200 and 1570.6774 (Sigma-Aldrich, St. 
Louis, MO, USA). The resulting protein mass spectra were manually inspected and analysed 
with Analyst QS 1.1 software (Applied Biosystems, Bardon, Australia). The generated 
monoisotopic peak masses were compared to the predicted in silico digests of MBPTpase 
fusion protein. 
 
5.3.4 Electrophoretic Mobility Shift Assays (EMSA) 
5.3.4.1 Radiolabelling of oligonucleotides 
All oligonucleotides were manufactured by IDT (Coralville, Iowa) (Table 5.2). 
Oligonucleotides were resuspended in sterile MQ water to produce ~100 µM stocks. Double 
stranded (ds) DNA fragments for binding assays were generated by heating equimolar 
concentrations of top and bottom strands oligonucleotides in a total volume of 50 µL with 1 
µL of 100 mM NaCl added. The DNA mixture was heated for 20 min at 95oC, and cooled 
gradually in the heat block overnight to room temperature to generate dsDNA. Single 
stranded and double stranded  oligonucleotides were 5′-end labelled with a ~20 pmol [γ-32P] 
ATP (300 μCi/mmol) in T4 polynucleotide kinase (PNK) buffer (70mM Tris-HCl, 10mM 
MgCl2, 5mM DTT, pH6.7).  T4 PNK was added to 500 mU/µL and incubated at 37
oC for 1 
hr, then inactivated by heating at 65oC for 20 min. Unincorporated [γ-32P] ATP was removed 
by centrifugation in a mini Quick Spin oligo column (Perkin-Elmer) for 4 min at 1000 g. 
Radiolabelled oligonucleotides were stored at ~20oC. 
 
5.3.4.2 Protein-DNA sample preparations 
To test MBPTpase binding to labelled oligonucleotides, binding reactions were set up using a 
constant concentration of 32P-radiolabelled oligonucleotide (150 pmol) and increasing 
concentrations of protein (Table 5.1). Fusion protein and oligonucleotide were added to a 
reaction mixture (10 mM HEPES, 50 mM KCl, 2.5 mM MgCl2, 100 mM DTT, 67 µg/mL 
BSA, pH 7.7) in a final volume of 25 µL. Samples were briefly spun down and EMSA 6x 
loading dye was added just prior to loading onto a Native EMSA gel.  
 
 
 
 
Chapter 5 Characterization of recombination site-preferences of Ps. stutzeri IS1111-attC transposase 
139 
 
Table 5.1: Tested protein concentrations for corresponding oligonucleotide 
attC Strand Protein Concentrations tested 
P
se
u
d
o
m
o
n
a
s-
ty
p
e ds 
20 
nM 
50 
nM 
100 
nM 
200 
nM 
400 
nM 
600 
nM 
800 
nM 
1  
µM  
2 
µM 
3 
µM 
4 
µM 
5 
µM 
ssTop 
200 
nM 
400 
nM 
600 
nM 
800 
nM 
1  
µM  
2  
µM 
3  
µM 
4  
µM 
5 
µM 
7.5 
µM  
10 
µM 
20 
µM 
ssBottom 
200 
nM 
400 
nM 
600 
nM 
800 
nM 
1 
 µM  
2  
µM 
3  
µM 
4  
µM 
5 
µM 
7.5 
µM  
10 
µM 
20 
µM 
C
la
ss
ic
a
l 
a
tt
C
a
a
d
B
 
ds 
100 
nM 
200 
nM 
400 
nM 
600 
nM 
800 
nM 
1  
µM 
2  
µM 
4  
µM 
5 
µM 
10 
µM 
20 
µM 
40 
µM 
ssTop 
1  
µM 
2 
µM 
3 
µM 
4 
 µM 
5 
 µM 
7.5 
µM  
10 
µM 
20 
µM 
25 
µM 
30 
µM 
35 
µM 
40 
µM 
ssBottom 1 µM 
2 
µM 
3  
µM 
4 
 µM 
5  
µM 
7.5 
µM 
10 
µM 
20 
µM 
25 
µM 
30 
µM 
35 
µM 
40 
µM 
 
5.3.4.3 EMSA Native PAGE  
A 180 mm x 160 mm x 1.5 mm, 8% (w/v) non-denaturing polyacrylamide 
(acrylamide/bisacrylamide 19:1) gel made in 1x TBE buffer (5 mM Tris, 9 mM boric acid, 
0.25 EDTA pH7.8) was pre-run in 0.5x TBE at 110 volts for 30 min. Samples were subjected 
to electrophoresis at 24 mA for 2.5 hrs at room temperature.  The gel was transferred to 
Whatman filter paper and exposed on a phosphor-imaging screen for 16 hrs before imaging 
with a Typhoon Phosphorimager (GE Healthcare).  
 
5.3.4.4 EMSA Native PAGE - Competition assays 
To control for specificity of binding of transposase, EMSA competition assays were 
performed (Figure 5.5). An equal concentration (40 µM) of MBPTpase and MBP control was 
used across all binding reactions. All labelling and binding reactions were conducted as per 
section 5.3.4.1 and 5.3.4.2, however increasing concentrations (10x-50x) of unlabelled 
oligonucleotide (cold target) were also added. In the final reaction, 100x non-specific 
competitor, EGG-m2F or EGG-m2R or EGG-m2 (Table 5.3) was added. If the transposase 
bound specifically to the target site, this interaction will be unaffected by the presence of a 
non-specific competitor target. 
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Table 5.2: DNA structures tested in EMSA experiments  
 
Sites Strand Sequence (5′-3′) Additional comments 
P
s.
-t
yp
e 
a
tt
C
  
(7
6
-b
p
) 
BGC101T Top 5′ GCCTAACATTGCGTTCAAATCGTTCGCTTCGCTCACTGGGACGGGCTAAAGCCCGCCCCTTAACCAAACGTTAGGC 3′ ISPst6 already resides 
within this attC-site in 
Pst405. Transposase used 
in this study was cloned 
from this strain. 
BGC101B bottom 5′ GCCTAACGTTTGGTTAAGGGGCGGGCTTTAGCCCGACCCAGTGAGCGAAGCGAACGATTTGAACGCAATGTTAGGC 3′  
BGC101 dsDNA 
5′ GCCTAACATTGCGTTCAAATCGTTCGCTTCGCTCACTGGGACGGGCTAAAGCCCGCCCCTTAACCAAACGTTAGGC 3′ 
3′ CGGATTGTAACGCAAGTTTAGCAAGCGAAGCGAGTGACCCTGCCCGATTTCGGGCGGGGAATTGGTTTGCAATCCG 5′ 
C
la
ss
ic
a
l 
a
tt
C
a
a
d
B
  
(6
0
-b
p
) 
aadBT Top 5′ GCCTAACAATTCGTCCAAGCCGACCCGCTTCGCGGCGCGGCTTAACTCAGGTGTTGGGC 3′ This site naturally 
harbours an IS1111-attC 
(ISPaX2). ISPaX2 
transposase is 79% 
identical to ISPst6 
transposase purified in this 
study. 
aadBB bottom 5′ GCCCAACACCTGAGTTAAGCCGCGCCGCGAAGCGGCGTCGGCTTGGACGAATTGTTAGGC 3′  
aadB dsDNA 
5′ GCCTAACAATTCGTCCAAGCCGACCCGCTTCGCGGCGCGGCTTAACTCAGGTGTTGGGC 3′ 
3′ CGGATTGTTAAGCAGGTTCGGGCTGGGCGAAGCGCCGCGCCGAATTGAGTCCACAACCCG 5′ 
IS
J
u
n
c
ti
o
n
  
(5
0
-b
p
) 
ISJuncT Top 5′ TGCTTGTGGGGAGAGTCCATATAGGCTGTAATGGACTCTCCCTGCACCAC 3′ This site is formed in the 
minicircle of IS1111-attC 
elements and is strongly 
conserved. It is the 
cognate one for the cloned 
protein. 
ISJuncB bottom 5′ GTGGTGCAGGGAGAGTCCATTACAGCCTATATGGACTCTCCCCACAAGCA 3′ 
ISJunc dsDNA  
5′ TGCTTGTGGGGAGAGTCCATATAGGCTGTAATGGACTCTCCCTGCACCAC 3′ 
3′ ACGAACACCCCTCTCAGGTATATCCGACATTACCTGAGAGGGACGTGGTG 5′ 
The sequences are all derived from integrated attC sites within PCIs and MRI arrays. This is the form in which they are predicted to appear as substrates for the IS1111-attC 
Tpase. The underlined region is seen by IntI during integrative reactions between attC x attI.  Also note that T4 Polynucleotide kinase (PNK) efficiently catalyses the transfer 
of the gamma-phosphate from ATP to the 5′-OH group on both single and double stranded DNA (Berkner & Folk, 1977). 
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Figure 5.5: Schematic representation of an EMSA competition assay.    
If MBPTpase binds a hot target, the protein-DNA complex is detected on the native EMSA. This binding 
will disassociate with the addition of increasing concentrations (10x-50x) of cold target due to the 
specific binding of the cold target to the Tpase, hence binding will not be detected. If the MBPTpase-
attC interaction is unaffected by the presence of a 100x excess non-specific competitor, the protein-
DNA complex will be detected on the native EMSA.  
In the case of the MBP only control, the addition of all competing agents is expected to interfere with 
detection, thus no shift in mobility is expected to occur. 
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Table 5.3: Non-specific competitor EGG-m2F/R  
Name 
(45bp) 
Strand Nucleotide sequence M-Fold Structural Prediction Additional Comments 
EGG-m2F top 5′GGAGAGCTGACTTTCTGTTATCAGGGACGCAGGAGGAGGCGCCGA3′ 
 
The ‘sense’ strand in the 
original source* 
EGG-m2R bottom 5′TCGGCGCCTCCTCCTGCGTCCCTGATAACAGAAAGTCAGCTCTCC3′ 
 
The ‘anti-sense: strand in 
the original source* 
EGG-m2 dsDNA  
5′GGAGAGCTGACTTTCTGTTATCAGGGACGCAGGAGGAGGCGCCGA3′ 
3′CCTCTCGACTGAAAGACAATAGTCCCTGCGTCCTCCTCCGCGGCT3′ 
The dsDNA molecule 
was formed by annealing 
equimolar amounts of the 
two oligos under 
conditions described in 
5.2.4.4. 
*This nucleotide sequence includes a zinc finger binding motif. This zinc finger binding motif is unrelated to attC and does not have any palindromic properties. Also, the 
topology between the EGG-m2 competitor differs to that of the IS binding partners in Table 5.2. The secondary structure needed so as to present the two extra-helical 
residues to Tpase do not form in the EGGm2 sequence. 
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5.4 Results 
5.4.1 in silico analysis of IS1111-attC Transposase 
DNA recombinases have been frequently found to be challenging to purify due to their 
hydrophobic nature, large size and/or need for accessory protein binding partners (Table 5.4). 
Based on in silico analysis using http://web.expasy.org/protparam/, the ISPst6 transposase 
was predicted to be ~38 kDa in size and have a weak hydrophilic property (-.478 GRAVY). 
Similarly, IntI1 is also predicted to be ~39 kDa in size and have a weak hydrophilic property 
(-.313 GRAVY). Weak hydrophobicity in both recombinases is indicative of them having a 
hydrophobic core region (Messier & Roy, 2001). Furthermore, both proteins have similar 
isoelectric values greater than 10. Previous workers had found that inclusion of soluble 
domains such as FLAG or MBP improved IntI solubility and purification (Collis et al., 1998; 
Gravel et al., 1998). Given this, a Maltose Binding Protein (MBP) tag was selected as an 
appropriate protein tag to increase the overall solubility of IS Tpase, and a protease site, 
Factor Xa, was included to enable recovery if necessary. 
 
Table 5.4: in silico predictions of IS1111-attC transposase and IntI1 using ProtPram ExPASy  
 Tpase IntI1* 
Number of amino acids (aa) 347 337 
Molecular weight (Da) 39679.8 38381.1 
Theoretical pI 10.14 10.25 
Total number of negatively charged 
residues (Asp + Glu) 
36 32 
Total number of positively charged 
residues (Arg + Lys) 
61 48 
Ext. coefficient  
60430 M-1 cm-1, at 280 
nm 
57410 M-1 cm-1, at 280 
nm 
Instability index (II)  55.02 unstable 46.85 unstable 
Aliphatic index 90.26 90.00 
Grand average of hydropathicity 
(GRAVY) 
-0.478 Hydrophilic -0.313 Hydrophilic 
*IntI1, class 1 integron integrase from Ps. aeruginosa plasmid pVS1 (Accession number AAC44315.1) (Bissonnette & Roy, 
1992). 
 
17.5% (61/347 aa) and 14.2% (48/337 aa) of the predicted Tpase and IntI1 sequence 
respectively are positively charged amino acids. To avoid potential for non-specific 
interaction with DNA during protein purification, DNase I was included. Furthermore, given 
the G+C richness of tpase gene, E. coli Rosetta 2 cells were used as the expression host 
strain.  
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5.4.2 Expression and purification of MBPTpase and MBP control 
Initial attempts to express transposase at 37oC resulted in barely detectable levels of MBPTpase 
fusion protein in the crude cell lysate by SDS-PAGE analysis (Figure 5.6A). Altering the 
concentration of IPTG from 0.4 mM to 1 mM also failed to enhance expression. Induction at 
high temperature is believed to result in packaging of MBPTpase into inclusion bodies. 
Attempts to purify the MBPTpase from inclusion bodies using 8M Urea were successful (data 
not shown) however, the final yields of folded-soluble MBPTpase were low (≤ 1 µM). 
Additionally the use of urea may pose a problem as it can denature the transposase, thereby 
possibly making it inactive for DNA binding. To avoid the formation of inclusion bodies by 
“leaky expression”, glucose was added to the overnight culture medium, to suppress the lac-
promoter, and the induction temperature was lowered to 25oC. This resulted in higher 
MBPTpase yields (Figure 5.6B).  
 
 
 
 
 
 
 
Figure 5.6: SDS-PAGE analysis reveals poor overexpression of MBPTpase fusion protein in Rosetta 
cells induced with 0.4 mM and 1 mM at A) 37oC and B) 25oC.  
Samples were taken before (-IPTG) and after (+IPTG) induction. Arrow indicates expected product of 
~81 kDa. 30 µL of cell mass was boil-lysed in 30 µL SDS loading dye at 99oC for 15 min. 10 µL of 
crude extract was loaded onto the SDS-PAGE gel.  
 
Initial attempts to recover the fusion protein by affinity chromatography gave very poor 
yields. Most of the fusion protein was lost in the insoluble fraction.  To improve final 
MBPTpase yield, the culture conditions for induction and expression were lowered to 16
oC and 
the growth period extended to a maximum of 24 hours. Additionally the culture volume was 
increased from 50 mL to 6-L (1x 1-L culture flasks). This resulted in significantly improved 
yield of MBPTpase fusion protein in whole cell lysates (Figure 5.7).  
 
 
 
A) B) 
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Figure 5.7: SDS-PAGE of A) MBP control and B) MBPTpase fusion proteins, expressed at 16
oC for 24 
hours.  
Samples were taken before (-IPTG) and after (+0.2 mM IPTG) induction. Expressed bands of the 
expected size (A) ~42kDa and (B) ~81kDa are observed in post induction lanes. 30 µL of cell mass 
was boil-lysed in 30 µL SDS, 10 µL of crude extract was loaded onto the SDS-PAGE gel.  
 
An initial low speed centrifugation step was performed to remove insoluble protein from the 
cell lysate prior to affinity chromatography. Loading the protein onto the column and 
subsequently washing the column did result in some loss of the MBPTpase fusion (Figure 
5.8A, lane 4). However, a loss was to be expected given that not all of the fusion protein was 
predicted to be folded correctly. To elute the maximum concentration of the fusion protein 
from the amylose column, the concentration of maltose in the elution buffer used was 
increased from 10 mM to 50 mM (Figure 5.8A, lanes 5-9). Upon elution with 50 mM maltose 
buffer, the fusion protein ran at the expected ~81 kDa size, with the greatest concentration of 
protein found consistently in fractions 2 and 3 (lanes 6 and 7). However, additional bands 
with molecular weights of less than ~81 kDa were unexpectedly observed (Figure 5.8B). In 
parallel, the MBP control was eluted as a single band of ~42 kDa by the addition of 50 mM 
maltose buffer (Figure A27).   
 
5.4.3 Mass Peptide fingerprint of MBP-Fusion protein  
A single band of ~81 kDa corresponding to MBPTpase was expected, however as per SDS-
PAGE analysis multiple bands were observed. To verify that the ~81 kDa band was the 
expected MBPTpase fusion protein, MALDI-TOF analysis was conducted. Also the smaller 
bands corresponding to estimated weights of 60 kDa, 39 kDa, and 30 kDa (Figure 5.8B) were 
randomly chosen and also analysed. 
 
 
A) B) 
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Figure 5.8:  SDS-PAGE analysis of purified MBPTpase fusion protein.  
A) MBPTpase was expressed in E. coli Rosetta2. Fraction 1: Cell lysate (soluble and insoluble 
fraction). Fraction 2: soluble fraction only. Fraction 3: flow through amylose resin. Fraction 
4: Column wash. Fractions 5-9: MBPTpase was eluted with 50 mM maltose. Expected protein 
size is ~81 kDa.  
B) SDS-PAGE of MBPTpase elution fraction 7. Arrows point to bands that were used for MALDI-
TOF analysis. A= ~81 kDa; B= 60 kDa; C= 39 kDa; D= 30 kDa 
 
Comparing the MALDI-TOF spectra of the four analysed bands suggested that the three 
smaller protein products are derived from MBPTpase fusion protein (Figures 5.9 & 5.10). 
Major peaks observed in the 81 kDa spectra, such as 1644.848 (m/z) and 1302.534 (m/z), 
were absent in the other spectra. Matching the MALDI-TOF spectra to the predicted in silico 
digest of MBPTpase amino acid sequences suggests that the protein was being truncated from 
the C’-terminus (Figure 5.9). Despite the addition of protease inhibitor cocktails during 
affinity purification of the fusion protein, this “truncated” banding pattern was continuously 
observed. Although multiple bands were obtained, the intact MBP-Fusion protein was 
estimated to range between 50%-70% of total protein yield based on SDS-PAGE analysis. 
Only elution fractions containing this estimated range and the same total protein 
concentration, as determined by spectrophotometry, were used for subsequent DNA binding 
assays. To determine the protein concentration the following formula was used: [(reading at 
260:280)/predicted MBPTpase extinction co-efficient M
-1 cm-1] x 106 = [mg/mL]. 
 
Truncated proteins are often the result of in vivo endoproteolytic cleavage. Despite the 
addition of protease cocktail inhibitors, truncated MBPTpase forms were present. This implies 
that these smaller forms are products of protein cleavage, or products of incomplete 
translation since fusion to the N-terminus can reduce the efficiency of protein translation 
(Terpe, 2003). The formation of truncated versions of the MBPTpase may have been reduced if 
A 
B 
C 
D 
A)                               FRACTIONS B) 
7 
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the tag was fused to the C-terminus instead. The use of a vector which tags both the C and N-
terminal ends of the Tpase may protect the protein from degradation (Hamilton et al., 2002; 
Podmore & Reynolds, 2002). A Polyhistidine-tag (His-tag) was considered at this stage, 
however the associated purification procedure requires the use of denaturants, high levels of 
salt and imidazole, all of which may interfere with the DNA binding assay. Imidazole in 
particular can lead to protein aggregates (Hefti et al., 2001). Thus, EMSA were carried out 
using a MBP bound Tpase, despite the presence of multiple MBPTpase protein variations.  
 
 
 
Figure 5.9: Amino acid sequence of the MBPTpase fusion protein showing the major expected peptides 
and their relative mass: charge ratio.  
Peptide prediction from in silico digest of MBPTpase amino acid sequence using PeptideMass 
(SwissProt). Yellow denotes the transposase amino acid sequence. Grey peptides are present in all 
excised bands and correspond to the MBP tag. Red peptides are observed in the 60kDa and 81 kDa 
bands (see figure 5.10 for MALDI-TOP spectra).   
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Figure 5.10: MALDI-TOF spectra of excised bands a) 81kDa, B) 60kDa, C) 39kDa, D) 30kDa. Peaks 1645.5504 (m/z) and 1301.3433 (m/z) found in 81kDa 
band are missing absent in all other spectra. MBPTpase peptides denoted by arrows. 
B) 
A) C) 
D) 
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5.4.4 DNA Binding assays 
To test if MBPTpase displays an attC site and strand preference, DNA binding assays 
(EMSAs) were conducted. The fusion protein was purified either the day prior, or on the day 
of the EMSA to ensure a maximum yield of intact MBPTpase, as approximated by SDSPAGE 
and spectrophotometry. The first assays were performed using total protein titrated (20 nM – 
40 µM) against a constant concentration of dsDNA labelled 5′ with 32-Phosphorous. Titrated 
MBP was used as a control (200 nM – 40 µM). Double stranded DNA substrates of 
Pseudomonas-type attC and classical attCaadB sites were tested first. 
 
5.4.4.1 Interaction of MBPTpase with dsDNA attC sites 
Purified MBPTpase was titrated from 20 nM-5 µM to test its binding specificity to double 
stranded Pseudomonas-type attC sites (Figure 5.11A). All 32-P labelled dsDNA was found in 
a single band migrating far down the native PAGE gel and no additional bands were 
observed, thus both strands were labelled with equal efficiency and/or were not denatured. 
When the purified MBPTpase was added to the double stranded Pseudomonas-type attC 
fragment, no retardation was observed. The MBP control titrated at a range of concentrations 
between 0.02 to 2 µM displayed no other bands but the labelled dsDNA. 
 
Similarly, MBPTpase binding specificity to double stranded classical attC sites was also tested. 
MBPTpase was titrated at a higher concentration range, from 100 nM-40 µM but despite this, 
all 32-P labelled attCaadB dsDNA was found in a single band migrating far down the native 
page gel and no additional bands were observed (Figure 5.11B).  
 
The MBP control, however was found to bind the dsDNA. The MBP protein was titrated 
between 2 µM to 40 µM. The more protein added, the more obvious the apparent shift was, 
and the less unbound DNA target was visible on the native gel. For example, where 2 µM 
MBP was added, a shift is observed as well as residual unbound target. At 40 µM MBP, all of 
the dsattCaadB appears to be bound. The ability of MBP to bind dsattCaadB was reproducible 
(data not shown). Note these findings suggest that the presence of IS1111-attC transposase 
impairs the binding observed with the MBP control. 
 
Based on these EMSAs, no mobility shift was observed in the presence of the transposase for 
either the Pseudomonas-type or the classical attCaadB sites. A shift was observed when the 
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MBP control was added to dsattCaadB but this shift is inferred to be non-specific. MBPTpase 
protein does not interact with the two tested double stranded DNA molecules. The MBP 
protein does show interaction at high concentrations with the double stranded attCaadB site 
(Pseudomonas-type attC not tested at high concentrations greater than 5 µM). The presence 
of the Tpase in the fusion appears to block the MBP interaction. 
 
 
 
 
 
 
 
 
Figure 5.11: EMSA of MBPTpase titrated against MBP- only control.  
A) ds Pseudomonas-type attC site. Constant concentration of 100 µmol of labelled DNA was used 
across all lanes. B) ds classical attCaadB  site. Constant concentration of 100 µmol of labelled DNA 
was used across all lanes. MBP control binds ds attCaadB as indicated by the arrows. Control Oligo 
lanes have no added protein.  
 
To determine the effect of secondary attC-structures and DNA binding specificity of the 
purified transposase, single-stranded DNA molecules of Pseudomonas-type attC and classical 
attCaadB sites were tested next. These sequences contain imperfect inverted repeats with the 
capacity to form hairpin structures under the conditions of this assay. 
 
5.4.4.2 Interaction of MBPTpase with ssDNA attC sites 
In Figure 5.12A binding of MBPTpase to the Pseudomonas-type attC top strand occurs in 
concentration range 7.5 µM to 20 µM as evidenced by a shift in DNA mobility. In Figure 
5.12B, binding of MBPTpase to the Pseudomonas-type attC bottom strand occurs in the 10 µM 
and 20 µM test lanes. However, in both instances, there was a lot of unbound DNA migrating 
as a single band. Furthermore, in both experiments, the MBP control was observed to bind 
both top and bottom strands of Pseudomonas-type attC sites non-specifically between tested 
concentrations of 5 µM to 20 µM. Thus it is difficult to exclude the possibility that the 
observed binding of the MBPTpase to labelled DNA target may also be non-specific. 
 
B) 
A) 
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For EMSA’s using the classical attCaadB site, the MBPTpase concentrations ranged from 1 µM 
to 40 µM. Where concentrations of MBPTpase ranged between 20-40 µM, some protein and 
DNA target remained in the well.  In Figure 5.12C, a shift was observed when MBPTpase, 
ranging between 2 µM to 40 µM, was bound to the classical attC top strand. However, note 
that the MBP control was binding far greater amounts of the labelled single strand as 
indicated by the pronounced shifting of labelled target. Similarly, for the bottom single strand 
in Figure 5.12D, a shift is observed for MBPTpase from 2 µM to 40 µM. As seen previously, 
this shift also occurs for the MBP control. 
 
To summarise, the MBPTpase protein influences the mobility of single-stranded attC sites but 
not double-stranded. However, it is possible that this effect is due to the MBP moiety since 
the control MBP also influences mobility. To test for the specificity of transposase binding to 
single-stranded DNA, and exclude non-specific interaction with the MBP domain, 
competition experiments were carried out with an excess of cold (non-labelled) target DNA 
(i.e. Pseudomonas-type and classical attCaadB  site) and non-specific competitor, EGG-m2F/R.  
 
5.4.5 EMSA competition assays 
To test that the interactions in Figure 5.12 included attC-specific effects that were dependent 
on the transposase moiety of the fusion protein, cold competition assays were done. These 
competition assays compare the ability of cold (unlabelled) oligonucleotides that are specific 
or non-specific to interfere with the MBPTpase + attC interaction. If the interaction is specific, 
addition of unlabelled attC target (cold target) will displace the binding and no migrating 
band will be observed. If an unlabelled non-specific competitor is added, it will not displace 
the binding and thus the bound complex will be retained. In all competition assays the 
concentration of fusion protein MBPTpase and MBP-only control was standardized to 40 µM.   
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Figure 5.12: EMSA of MBPTpase titrated against MBP control using ssDNA as binding substrates.  
 A) ssDNA Ps. specific attC top strand, B) ssDNA Ps. specific attC bottom strand,. C) ssDNA attCaadB 
top strand, D) ssDNA attCaadB bottom strand. Red boxes note area of shift. 
 
5.4.5.1 MBPTpase binds reproducibly to the top strand of Pseudomonas-type attC sites. 
In Figure 5.13A, lane 1 shows that the labelled target (ss Ps. attC top strand) runs as a single 
band. Lane 2 shows a band shift when MBPTpase or MBP is added. Lanes 3, 4, 5, 6, 7 all show 
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loss of band shift, indicating competition between the cold target (unlabelled ss Ps. attC top 
strand) and the labelled target for protein-binding. Lane 8 includes an unlabelled 
oligonucleotide (EGG-m2F) that is unrelated to attC sites. Addition of non-specific 
competitor was reproducibly demonstrated to have minimal/no impact on MBPTpase + ss Ps. 
attC top strand binding whilst interfering with MBP + ss Ps. attC top strand (see insert). This 
represents the key experimental test and notably the non-specific competitor does not 
interfere with MBPTpase.  
 
These findings suggest that the MBP interaction is non-specific but the Tpase one is specific. 
Even at half the concentration of MBPTpase (20 µM), binding to the top strand was 
recoverable when challenged with 100-fold non-specific competitor (see insert). The 
interaction between MBPTpase and labelled target is blocked by cold target (10-fold excess) 
but not by non-target. In comparison, the interaction between MBP only is blocked equally 
by both cold competitors.  
 
5.4.5.2 MBPTpase does not bind to the bottom strand of Pseudomonas-type attC sites. 
In contrast, binding between MBPTpase and the bottom strand was outcompeted by non-
specific competitor EGG-m2R (Figure 5.13B). Lane 1 shows the labelled test target (ss Ps. 
attC bottom strand) runs as a single band. Lane 2 shows the presence of the fusion protein 
causes a band shift. As seen previously, MBPTpase shifts the labelled target with greater 
efficiency than in MBP-only control. Lanes 3, 4, 5, 6, 7 all show no band shift indicating 
competition between the cold target (unlabelled Ps. attC bottom strand) and the labelled 
target for protein-binding. This is comparable in both panels. Addition of 100-fold excess 
non-specific competitor, EGG-m2R, in lane 8 outcompetes the labelled target for binding for 
MBPTpase fusion and MBP. The interaction between MBPTpase and labelled target, and MBP 
and labelled target is blocked by cold target (10-fold excess) as well as non-specific 
competitor. I conclude that the MBPTpase fusion is interacting specifically with Pseudomonas-
type attC and this interaction is dependent on the Tpase domain. Furthermore, this interaction 
also displays a strand preference where binding of MBPTpase to single stranded top strand was 
recovered  
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 Hot Target 
   Cold Target 
Cold 
NSC 
Lanes 1 2 3 4 5 6 7 8 
NSC - - - - - - - 100 
OH + + + + + + + + 
P - + + + + + + + 
OC - - 10 20 30 40 50 - 
 
Figure 5.13: Cold competition assay of single stranded A) top and B) bottom Pseudomonas-type attC 
site. MBPTpase binding was demonstrated reproducibly to the top strand and not the bottom. This 
binding at half concentration of MBPTpase (20 µM). For binding efficiency in each gel compare test 
lanes MBPTpase to control MBP lanes.  
Key: NSC= Non-specific competitor, OH= Oligo Hot (labelled), P= Protein, OC=Oligo Cold target 
(10-50x). Note that binding data for 20 µM MBP is unavailable.    
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5.4.5.3 MBPTpase binding to single stranded classical attC site is inconclusive 
In Fig 5.14 a similar gel shift is seen for the attCaadB test with both MBPTpase and MBP only.  
However in this case I was unable to show a differential response between target and non-
specific competitors. This could reflect either reduced sensitivity of detection or lower 
affinity of the Tpase to the target site. 
 
In Figure 5.14A, lane 1, the single stranded labelled attCaadBts test target can be seen 
migrating as two weakly labelled bands, rather than one strongly labelled band as was seen 
for the Ps. attC test. This banding pattern implies that two distinct forms of the labelled target 
are present. These could be variations in length (degradation or poor synthesis) or differing 
conformations. If only one of these forms were a target for the Tpase, then this would 
effectively reduce the sensitivity of detection for binding. Lane 2, shows that the presence of 
the fusion protein causes a band shift and that the intensity of the shifted band is greater than 
in MBP-only panel. In both cold competition assays, 10-fold excess of cold target was 
enough to displace the binding to the labelled attCaadB top and bottom strands (lanes 3-7).  In 
Figure 5.14A at 20-fold excess cold competitor, MBP control binding to attCaadB the top 
strand was displaced (lane 4). In comparison 30-fold addition of the cold competitor 
displaced MBP binding to the bottom strand (Figure 5.14B). However, a 100-fold excess 
addition of the non-specific competitor was enough to displace the binding of MBPTpase or 
MBP to both either attCaadB strands (lane 8).  
 
The fusion protein MBPTpase caused a gel shift with both top and bottom strand. The 
interaction was stronger for the top strand, which is consistent with preferential binding, but I 
was unable to demonstrate specificity of the interaction. I cannot exclude the possibility that 
both types of attC site are targeted by the Tpase.  
 
 
 
   
             
Figure 5.14: Cold competition assay of single stranded A) top and B) bottom classical attCaadB site. 
MBPTpase binding to either strand was not detected upon the addition of non-specific competitor. 
Increasing concentrations (60 µM and 80µM) of MBPTpase was also outcompeted for strand binding 
by the non-specific competitor Key: NSC= Non-specific competitor, OH= Oligo Hot (labelled), P= 
Protein, OC=Oligo Cold target (10-50x). Across all cold competition assays 40 µM MBPTpase and 40 
µM MBP were tested.   
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 Hot Target 
   Cold Target 
Cold 
NSC 
Lanes 1 2 3 4 5 6 7 8 
NSC - - - - - - - 100 
OH + + + + + + + + 
P - + + + + + + + 
OC - - 10 20 30 40 50 - 
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5.4.6 Testing the IS1111-attC minicircle junction as a binding partner for Tpase  
For successful recombination of an IS1111-attC element and an attC site to occur, a second 
partner site in the IS element is obviously required (Figure 5.1). Various lines of evidence 
(Partridge & Hall, 2003; Tetu & Holmes, 2008) and work presented in chapter 4, implicate a 
circular intermediate as the reaction partner for recombination. Here I tested the sequence 
formed by IS excision as a target for the MBPTpase (Figure 5.15).  
 
 
Figure 5.15: Schematic representation of the IS1111-attC minicircle and oligonucleotides used for 
MBPTpase DNA binding assays. 
Sequences encompassing the junction region of the top and bottom strands are shown in the red box. 
The inverted repeat regions are underlined and the junction formed upon circularisation is italicized.  
 
Binding assays in which the MBPTpase was titrated across a range of concentrations were not 
conducted for the IS Junction DNA. Previous work mentioned above, demonstrated the non-
specific binding of the MBP tag towards the DNA substrates. Consequently, only cold 
competition assays were carried out to test for interactions between the IS junction and 
transposase.  
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5.4.6.1 MBPTpase binding to ds IS junction cannot be outcompeted using cold target or a 
non-specific competitor.  
dsIS cold target outcompeted  MBPTpase binding when tested at 40 µM and 100 µM MBPTpase 
(Figure 5.16). In Figure 5.16A, lane 1 shows the labelled ds IS junction running as a single 
band. Lane 2 shows a band shift and that the shift intensity appears greater than in the MBP-
only panel. Note the presence of a fast migrating (low retardation) band in lane 2. This low 
retardation band is not present in the MBP-only experiment. Both fast and slow migrating 
bands were eliminated upon the addition of cold targets (lanes 3-7). Similarly, a 100-fold 
excess of ds stranded non-specific competitor displaced binding of MBPTpase, but it did not 
eliminate the fast migrating (low retardation) band. This pattern is consistent with specific 
binding of MBPTpase, but the mobility is much faster than expected for a fusion protein of its 
size (~81 kDa). However a Tpase fragment that retains binding could potentially explain this 
(Figure 5.8). A labelled protein lane (with no oligo) was not able to be run here but would 
help resolve this. In comparison, MBP-only binding was consistently observed across all test 
lanes. The addition of cold competitors (specific and non-specific) made little difference to 
the ability of MBP to bind the hot DNA target, hence the observed smearing in lanes 2-8 in 
the MBP test set.  
 
In order to increase the sensitivity of EMSA detection and determine if the fast migrating 
band is reproducible, the same experiment was repeated using 100 µM MBPTpase (Figure 
5.16B). As seen previously, band retardation for the fusion protein was at a constant size, 
implying that a stoichiometric oligo-protein complex was formed. The fast migrating (low 
retardation) band was observed when binding was challenged with 100-fold non-specific 
competitor, suggesting that this binding represents a metastable association between the 
fusion and labelled double stranded IS junction DNA. MBP-only binding to target DNA was 
as seen previously. However, note that at 100 µM MBP, addition of  cold competitors did not 
displace non-specific binding (lanes 3-8, control panel). 
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 Hot Target 
   Cold Target 
Cold 
NSC 
Lanes 1 2 3 4 5 6 7 8 
NSC - - - - - - - 100 
OH + + + + + + + + 
P - + + + + + + + 
OC - - 10 20 30 40 50 - 
 
 
 
Figure 5.16: Cold competition assay of double stranded IS minicircle junction DNA using A) 40 µM 
and B) 100 µM MBPTpase and MBP control.  
Note the fast migrating band (red arrow) was only observed in lanes 2 and 8 of MBPTpase binding to 
dsIS junction DNA. Key: NSC= Non-specific competitor, OH= Oligo Hot (labelled), P= Protein, 
OC=Oligo Cold target (10-50x).  In B) increasing concentrations of cold target for MBP only, results in 
slower migration (lanes 2-8, hence the apparent increase in size. 
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5.4.6.2 MBPTpase does not bind IS Junction DNA when presented in a single stranded 
conformation 
The MBPTpase binding assay with single stranded IS junction template revealed no evidence 
for specific binding to either the top or bottom strand of the DNA region formed at the IS 
minicircle junction. In Figure 5.17A, lane 1 in both test sets shows labelled top single strand 
oligonucleotide running as a single band (Unbound 1), but also running slower in comparison 
to labelled oligo in all other test lanes (Unbound 2). This may be due to uneven 
polymerization at the bottom of the gel, hence also the visible horizontal line running across 
the bottom of the gel, and/or salt concentration differences between the binding reactions and 
the oligonucleotide stock. Lane 2 in MBPTpase set, shows that the presence of the fusion 
protein causes two band shifts (Bound 1 & Bound 2) and an unbound oligonucleotide band at 
a faster migration state. In lane 2 of the MBP test, all of the hot oligonucleotide has been 
bound (unbound bands absent) by MBP resulting in two bound complexes. The addition of 
cold target or single stranded non-specific competitor resulted in displacement of hot 
oligonucleotide from both bound complexes in the MBPTpase test set (lanes 3-8). However, 
10-40 fold excess of cold targets failed to displace bound 2 complex binding for MBP-only 
(lanes 3-6). 50-fold cold targets and 100-fold addition of single stranded non-specific 
competitor EGG-m2F/R displaced binding of MBP bound complex 2 (lane 8).  
 
In Figures 5.17B, lane 1 shows labelled bottom single strand oligonucleotide running as a 
single band (Unbound 1), but running marginally slower in comparison to labelled oligo in all 
other test lanes (Unbound 2). Lane 2 shows binding of MBPTpase protein to the bottom strand 
also causes a two band shift (Bound 1 & Bound 2) and an unbound oligonucleotide band at a 
faster migration state (Unbound 2). In lane 2 of MBP-only test, all of the hot oligonucleotide 
has been bound (unbound bands absent). Addition of cold target and non-specific competitor 
displaced bound 1 & 2 complexes for MBPTpase (lanes 3-8). In comparison, addition of cold 
target to MBP only displaced bound 1 complex (lanes 3-7) but not bound 2. Bound 2 
complex was only displaced at 100-fold addition of single stranded non-specific competitor 
EGG-m2F/R (lane 8).  
 
 
 
 
 
Chapter 5 Characterization of recombination site-preferences of Ps. stutzeri IS1111-attC transposase 
161 
 
 Hot Target 
   Cold Target 
Cold 
NSC 
Lanes 1 2 3 4 5 6 7 8 
NSC - - - - - - - 100 
OH + + + + + + + + 
P - + + + + + + + 
OC - - 10 20 30 40 50 - 
 
 
 
Figure 5.17: Cold competition assay of single stranded IS minicircle junction DNA using 40µM of 
MBPTpase and MBP-only control.  
Key: NSC= Non-specific competitor, OH= Oligo Hot (labelled), P= Protein, OC=Oligo Cold target 
(10-50x). Across all cold competition assays 40 µM MBPTpase and 40 µM MBP were tested.   
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5.5 Discussion 
In chapter 4, I demonstrated the potential of IS1111-attC elements to translocate from a 
native attC site in a Pseudomonas chromosomal array to an artificially introduced site on a 
plasmid. Transposases of the IS110/IS492 family possess the conserved D-E-D-D motif (D7-
E51-D88-D91) that has been demonstrated to be essential for activity of the Piv/MooV family 
of DNA recombinases (Buchner et al.,¸2005; Mahillon & Chandler, 1998; Tobiason et al., 
2001). The Piv/MooV recombinase does not share the conserved amino acid motifs of site-
specific tyrosine (Y) or serine (S) recombinase family. Tpases in general are predicted to be 
poorly expressed. The low-level expression of Tpase may be sufficient for translocation but 
not for ease of protein isolation.  Thus Tpase purification from the Pseudomonas wild-type 
strain is predicted to be an ineffective method. Instead an MBP-expression system was 
developed and used successfully to purify the Ps. stutzeri IS1111-attC transposase as a 
maltose binding fusion protein (MBPTpase).  
 
To determine the DNA binding specificity of purified IS1111-attC transposase, its behaviour 
was explored via electrophoretic mobility shift assays (EMSAs) with nine different DNA 
targets. Binding between MBPTpase and single stranded attC sites was observed to differ in 
regards to an MBP control. This is also the first study where transposase was shown to bind 
preferentially to the top strand over the bottom strand of Pseudomonas-type attC sites. Also, 
transposase binding to the double stranded IS minicircle junction was observed but not to the 
single stranded forms.  
 
5.5.1 IS1111-attC transposase does not bind double stranded attC sites at a detectable 
level.  
Francia et al. (1999) first demonstrated the binding of the integron integrase to attI and attC 
sites. They found that purified IntI1 was able to bind the double stranded DNA fragment 
containing an attI, but was unable to bind double stranded attCaadA1. In this present study, no 
retardation was observed when purified MBPTpase was added to double stranded 
Pseudomonas-type and attCaadB sites. Thus as seen with IntI1, double stranded attC sites are 
not a binding partner for IS1111-attC transposase.  
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5.5.2 IS1111-attC transposase binds strand specifically to the top strand Pseudomonas 
attC sites 
By means of competition assays, Francia et al. (1999) also demonstrated preferential binding 
of IntI1 to single stranded attC sites. In my study, competition assays were successfully used 
to demonstrate the specificity of transposase binding to single stranded top strand of 
Pseudomonas-type attC. Relative mobility, calculated as the ratio of the distances travelled 
on EMSAs by the bound and unbound oligonucleotides, was calculated for recovered binding 
and compared to that of the unchallenged MBPTpase. Thus the observed shift was a fixed shift, 
where the relative mobility was the same regardless of the dose of competing agent (Table 
5.5). Note in calculating relative mobility, the midpoint of the diffuse band was used. 
 
Binding was reproducibly observed and was also seen see at half the MBPTpase protein 
concentration. The recovered binding would always appear as a diffuse rather than a defined 
band.  I interpret this diffuse band to represent specific interactions between the Tpase moiety 
of the fusion protein and the oligonucleotide. In cases where the target template, such as 
RNA (Bendak et al., 2012) or attC sites (Bikard et al., 2010), form hair-pin structures, diffuse 
EMSA bands are likely to occur. Diffuse bands may also result where the protein 
conformation is not stable, or the stoichiometry is variable (Hellman & Fried, 2007b). In 
comparison, defined bands of consistent relative mobility are expected where a binding of 1:1 
stoichiometry with a stable conformation exists. Binding of the transposase to the bottom 
strand of Pseudomonas-type attC was not detected by competition assays. When the MBP-
Pseudomnas-type attC interaction was challenged with the cold competitors, the amount of 
alteration to mobility varied with the competitor dose. This interaction is thus believed to be 
dose-dependent (Table 5.5). 
 
In summary, the findings presented here are most interesting as the integron integrase 
preferentially binds to the bottom strand of attC sites (Francia et al., 1999) whereas in 
comparison, Tpase does not, it binds to the top strand.  
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Table 5.5: Summary of EMSA experiments 
Grey boxes highlight differences and observations between MBPTpase and MBP control. Orange box highlights key finding. 
Key definitions: 
Fixed shift = relative migration remains the same regardless of dose (Relative mobility (Rm) constant), where Relative mobility was calculated as the distance migrated by 
bound hot oligonucleotide band divided by the distance migrated by the unbound hot oligonucleotide. 
Dose dependent shift = amount of alteration to migration varies with dose (Relative mobility (Rm) varies), where Relative mobility was calculated as the distance migrated 
by bound hot oligonucleotide band divided by the distance migrated by the unbound hot oligonucleotide. 
Out-competed = a heterologous molecule blocks binding to hot target 
Partial-competition = a heterologous molecule partially blocks binding to hot target, weak interaction between protein and target 
Not-competed = a heterologous molecule does not compete and block binding to hot target 
DNA Target Pseudomonas-type attC Classical attCaadB IS minicircle junction 
Strand 
conformation 
ds ssTop ssBottom ds ssTop ssBottom ds ssTop ssBottom 
MBPTpase Nothing 
Fixed shift 
Dose 
dependent 
shift 
Nothing 
Fixed shift 
Dose-dependent 
shift 
Fixed shift + 
oligo shift 
Dose-
dependent 
shift 
Dose-
dependent 
shift 
Specific 
Out-
competed 
Specific 
Out-
competed 
Partial-
competition 
Out-competed 
Out-competed 
shift but no 
Oligo shift 
Out-
competed 
Out-
competed Non-
specific 
NOT 
competed 
Non-
specific 
Out-
competed 
 
MBP Nothing 
Dose 
dependent 
shift 
Dose 
dependent 
shift 
Dose dependent 
shift at high 
concentrations 
Dose 
dependent 
shift 
Weakly Dose 
dependent shift 
Dose dependent 
shift at high 
concentrations 
+ no oligo shift 
Dose 
dependent 
shift 
Dose 
dependent 
shift 
Out-
competed 
Out-
competed 
Out-
competed 
Out-competed 
Not-
outcompeted  
Out-
competed 
Out-
competed 
Figure 5.11A 5.13A 5.13B 5.11B 5.14A 5.14B 5.16 5.17A 5.17B 
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5.5.3 Experimental evidence for IS1111-attC transposase interactions with classical attC 
sites is inconclusive 
The occurrence of IS1111-attC elements is increasingly being noted in clinically relevant 
contexts (Martinez et al., 2012; Post & Hall, 2009; Santos et al., 2010; Tetu & Holmes, 2008; 
Chapter 3). Here I explored the ability of Tpase to bind to different attCaadB structural targets.  
 
Initial binding assays using double stranded attCaadB sites showed that, like the integron 
integrase, Tpase does not bind. However, the MBP control was found to bind non-
specifically, and such binding was dependent on dose at high concentrations of protein. MBP 
also bound single stranded attCaadB conformations rather strongly and also in a dose-
dependent manner. I hypothesised that this is primarily due to MBP containing ~11% 
positively charged amino acids, Arginine and Lysine (42/387) which have the capacity to 
bind rather strongly to negatively charged DNA.  When challenged with a cold, non-specific 
competitor, the binding was dissociated, adding more evidence to MBP binding acting non-
specifically towards the tested DNA targets. 
 
EMSAs were used to test the binding specificity of Tpase to single-stranded attCaadB sites. 
Cold targets displaced the observed binding of Tpase to attCaadB sites as expected, however 
the cold, non-specific competitor unexpectedly displaced binding too. This is surprising given 
that in nature attCaadB sites are found to be occupied by IS1111-attC members. In principal, 
binding of transposase to attCaadB  sites should occur if it interacts with the target nucleic acid 
with greater affinity than its competitor and secondary binding does not discriminate between 
the sequences (Alves & Cunha, 2012).  The absence of a gel shift in the presence of the non-
specific competitor may reflect the low detection sensitivity of EMSAs, combined with a 
lower affinity for attCaadB and/or the formation of a stable secondary structure by attCaadB. 
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5.5.4 Factors impacting on EMSA sensitivity  
attCaadB sites are known to be a target for IS1111-attCs (Tetu & Holmes, 2008), so why was 
no convincing binding observed in my study? 
 
a) Lower labelling efficiency and/or oligonucleotide concentration: EMSA analysis 
revealed two different conformations of single stranded attCaadB sites for both the top and 
bottom strands. Oligonucleotide labelling was found to be at half-intensity when compared to 
Ps-type attC labelling. Binding to single-stranded attCaadB was therefore expected to have 
reduced intensity, with less oligonucleotide being bound. Specific binding between IS1111-
attC transposase and attCaadB site may still be present but was below the detection limits of an 
EMSA when challenged with a cold competitor. 
 
b) Greater instability of Tpase-attCaadB bound complex results in a diffuse band 
and/or an absent band: DNA-protein samples which are not at chemical equilibrium during 
the electrophoresis step are more likely to dissociate (Hellman & Fried, 2007a). Complete 
dissociation would result in no detection whereas partial, or slow dissociation, can result in 
the underestimation of the binding density (Hellman & Fried, 2007b). In chapter 4, I 
presented circumstantial evidence for a lower level of interaction of IS1111-attC with 
attCaadB traps in my transformation experiments. Dissociation of DNA-protein complexes 
may also be playing a role in in vivo interactions. To prevent dissociation small neutral 
additives such as glycerol or sucrose can be added in vitro to stabilize labile proteins and 
thereby enhance protein-DNA stability (Garner & Rau, 1995; Vossen et al., 1997).  
 
c) Multiple single stranded attCaadB conformers with differing band positions and 
band intensities were observed: It is not uncommon for secondary structure misfolding to 
occur (Sinan et al., 2011). Such structures may exist in solution as a mixture of differentially 
base-paired states of equilibrium (Gell et al., 2008). Once misfolding of attCaadB occurs, the 
site may no longer be available for Tpase binding, compromising the formation and detection 
of a metastable Tpase- attCaadB complex. For misfolded attCaadB to become available to 
IS1111-attC Tpase, attCaadB may need to unfold so as to allow Tpase to attach. Heat and/or 
chemical application (Sinan et al., 2011), as well as DNA-binding proteins can be used to 
refold the single-stranded hairpin, thereby making it more favourable for transposase 
recognition and binding. 
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5.5.5 Secondary binding partner for IS1111-attC translocation: the IS1111-attC 
minicircle junction 
Recombination reactions performed by integron integrase, revealed that it mediates 
recombination between non-canonical substrates (Loot et al., 2012). These non-canonical 
substrates involve a palindromic single-stranded attC site and a double stranded attI site. I 
postulated that the IS1111-attC element itself is the second binding substrate for 
recombination with a single stranded top strand of the Pseudomonas-type attC. The 
circularization of an IS1111-attC generates a region of 10 bases flanked by inverted repeats. 
Such regional characteristics are typical of targets for tyrosine recombinase (Grindley et al., 
2006). I hypothesised that this region is essential for recombination. IS minicircles are 
universally believed to be an intermediate phase/structure of the IS prior to linearization and 
integration of the IS into its site-specific target (Partridge & Hall, 2003).  
 
Evidence suggests that ISs undergo a structural change from a double stranded conformation 
to a single stranded form (Lewis & Grindley, 1997; Lewis et al., 2004; Lewis et al., 2012).  I 
have demonstrated that IS1111-attC Tpase does not bind single stranded IS junction DNA 
when challenged with a cold competitor. This raised the possibility that a double stranded IS 
junction is required during recombination. Cold target competitors were unable to displace all 
slow migrating Tpase-double stranded IS junction binding. Whilst the non-specific 
competitor was successful in displacing slow migrating binding, it was unable to displace the 
fast migrating Tpase-double stranded IS junction complex. Given the preservation of the fast 
migrating band suggests that there is weak binding of the transposase protein to double 
stranded IS junction DNA, and that this DNA is a template for Tpase mediated recombination 
with single stranded attC sites. This band results from the formation of a synaptic complex 
between Tpase and the double stranded target, and possibly represents the formation of a 
covalently closed linear molecule as seen with IntI1 binding (Bouvier et al., 2009; Johansson 
et al., 2004).  
 
The translocation/activity assays and EMSA findings highlight similarities between Tpase-
attC and the IntI-attC system. ISPst6 transposase possess the four acidic residues D-E-D-D 
(Tetu & Holmes, 2008) that are essential for Piv catalysis of inversion and RuvC-like 
Holliday junction resolvases (Buchner et al., 2005). Based on what is known about Piv, RuvC 
and integron-mediated recombination models, I propose a model for IS1111-attC Tpase 
mediated recombination with attC sites (Figure 5.18), where I predict that IS1111-attC 
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recombination involves a Holliday junction intermediate, although this remains to be 
validated experimentally. During IntI mediated recombination, two IntI moieties bind, with 
two contact points at attI and two at attC, and initiate classical site-specific recombination 
steps as catalysed by other tyrosine recombinases (Collis et al., 2002; Loot et al., 2012; 
MacDonald et al., 2006). I predict that two Tpase moieties are also needed at each attC and 
IS junction site (Figure 5.18i). Initial cleavage and strand transfer would most likely require 
Tpase binding to both the double stranded IS-minicircle as well as single-strand attCts. 
Subsequent steps are predicted to involve single-strand cleavage of attCts and IS junction, 
thereby resulting in a 5′-OH radical group (Figure 5.18ii). This reactive hydroxyl group 
would be involved in strand transfer via nucleophilic attack of the 3′-Phosphate group (Figure 
5.18iii).  The proposed model involves the formation of a Holliday junction (Figure 5.18iv). 
A second round of strand cleavage and exchange is predicted to result in IS1111-attC 
excision out of the attC site. Holliday junctions mediated by IntI are resolved by a replicative 
step, thus ensuring complete integration of the gene cassette into the integron platform 
(Cambray et al., 2010; Loot et al., 2012; MacDonald et al., 2006; Mazel, 2006). Therefore, 
replicative resolution of the IS1111-attC Holliday junction is similarly predicted to occur. 
 
The extrahelical G20'' in VCRs was demonstrated to play a critical role in IntI binding to attC 
bottom strand (Bouvier et al., 2009). It ensures proper geometrical assembly of VChIntIA to 
Vibrio attC through insertion into the hydrophobic pocket of VChIntIA, thus resulting in an 
interaction with the integrase protein (MacDonald et al., 2006). Given that IS1111-attC 
elements insert site-specifically into the same location within attC sites (between positions h 
and i in the palindrome) (Tetu & Holmes, 2008; Chapter 4), I predict that this event is 
dependent on the extrahelical bases of the attCts. I postulate that the conserved extrahelical 
bases (C and A) in the top strand play a role in docking the attC site into the transposase. It is 
plausible that Tpase-attC binding to the Pseudomonas-type attC top strand variable region is 
mainly due to non-speciﬁc interactions. To determine the types of Tpase-attC interactions 
that occur, DNA target mutagenesis and transposase binding to these modified sites would 
have to be analysed. 
 
The mechanistic details and host factors involved in IS1111-attC translocation are at present 
unknown. Accessory proteins are postulated to play a vital role in IS1111-attC translocation 
success and replication fork resolution. In E. coli and Ps. stutzeri strain Q and ATCC 17641, 
partial IS translocation was observed. Partial translocation is a recombination that has not 
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proceeded to complete resolution of the partners.  It is seen by formation of at least one 
covalent join between strand partners, but not formation of a completely resolved co-
integrate. Partial translocation is experimentally observed when; i) a PCR recovery of only 
ISPst6 IRR junction in a plasmid trap is observed but not the IRL junction in E.coli (Tetu & 
Holmes, 2008), ii) no attC-trap plasmid, consistent with containing a single intact copy of 
ISPst6 in E.coli, is observed (Tetu & Holmes, 2008), or iii) ISPst6 minicircles are observed, 
but no subsequent translocation into PCI arrays in PstQ and Pst641 (Chapter 4). Partial 
translocation of ISPst6 in these strains suggests that they lack enzymes involved in 
replication fork resolution, thereby resulting in replication arrest and partial/no IS1111-attC 
translocation (Loot et al., 2012). Despite variations between the different mechanisms of site-
specific recombination, accessory proteins are known to assist in the assembly of the initial 
complex and to drive the overall recombination reaction in the desired direction (Grindley et 
al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
             
Figure 5.18: A proposed model for IS1111-attC transposase mediated recombination with ssattC sites 
and double stranded IS junctions. This model is based on the working model for IntI1-mediated site-
specific recombination by Loot et al., 2012. 
i) IS1111-attC transposase dimers (red ovals) bind top attC strand and the IS1111-attC minicircle 
molecule. Each Tpase has two contact points per DNA target (pink ovals).  
ii) Transposase mediated-DNA hydrolysis of one strand at both sites leads to the generation of 
reactive 5′-hydroxyl groups and strand transfer between attC top strand and IS1111-attC.  
iii) Formation of a Holliday junction structure.  
iv) Host DNA ligase activity repairs any nicks.  
v) Subsequent replication and recombination of IS into additional site may occur.  
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5.5.6 Further Work 
Here I have demonstrated that the requirements for IS1111-attC transposase mediated 
recombination echo those of IntI1. IS1111-attC Tpase recombination requires a single 
stranded, Pseudomonas-type attC site (top strand) hairpin and a double stranded IS1111-attC 
minicircle. The ability of IntI and Tpase to preferentially target opposite attC strands, is 
predicted to reduce competition between them and drives strand orientation preference. 
Whilst I was able to demonstrate that IS1111-attC transposase acts in a similar fashion to IntI 
protein and targets attC sites strand specifically, questions remain to be answered: 
1) Is attC site recognition by IS1111 transposase specific?  
Work presented here suggests that transposase binding is strand and structure specific. DNA 
fingerprinting assays would determine the exact binding region of Tpase to the top strand of 
attC sites. 
2) Are the extrahelical bases in the top Pseudomonas attC site responsible for transposase 
docking? 
Work conducted using purified integron integrase has highlighted the importance of the 
conserved nucleotides G and T (Mazel, 2006) for protein binding and docking to single 
stranded attC sites. The exact point of transposase protein-attC DNA interaction to date 
remains unknown. To study this interaction, site alterations can be made to the Pseudomonas-
type attC site and tested individually using EMSAs.  
3) What role do the conserved amino acids D-E-D-D play in transposase activity on attC 
sites? 
These four acidic residues were shown to be crucial for Piv mediated inversion, however 
their role in IS translocation remains unknown. A mutagenesis library of transposase protein 
would shed insight into the role of these amino acids in attC site interaction. 
4) How is the site-specific recombination of IS1111-attC and attC site resolved? 
The current model for integron mediated recombination of attI and attC sites, as well as Piv 
mediated catalysis of inversion of invL and invR sites, involve a Holliday junction as an 
intermediate state. To investigate if IS1111-attC elements pass through an intermediate 
Holliday junction state in vitro, perhaps it may be possible, although challenging, to 
crystallise the transpose-HJ intermediate and determine its X-ray structure. Comparable 
studies have achieved this for the Cre-loxP site specific recombination system (Gopaul et al., 
1998). 
Chapter 6 Conclusions 
172 
 
 Conclusions 
6.1 Overview 
In this study I aimed to explore the role of horizontal gene transfer in the evolution of multi-
drug resistance. Bacterial multi-drug resistance is a world-wide problem, often associated 
with severe and untreatable infections. Treatment is very challenging due to the limited 
susceptibility of bacteria to antimicrobial agents and the high frequency of antibiotic 
resistance during therapy (Aloush et al., 2006). Bacterial population response to administered 
drug therapy; likelihood of MDR selection and rate of occurrence as a consequence of 
treatment; and origin of resistance genes, are just a few of the confounding factors of MDR. 
Many aspects of MDR remain poorly understood. In particular, factors that may 
facilitate/hinder movement of resistance genes, such as biological distances between different 
organisms and the rate of gene recruitment, require further investigating.  
 
In this study, biological distance was defined as the sum of i) molecular and genetic 
compatibility and ii) evolutionary and ecological relatedness between microorganisms. 
Biological distance encompasses spatial separations wherein phylogenetically related 
organisms may share similar genes and transcriptional machinery because they occupy 
distinct ecological niches (Friedrich et al., 2001) but never meet in high numbers. Also 
considered were the evolutionary mechanics of organisms wherein ecologically similar 
organisms that are distantly related, such as Cyanobacteria and Pseudomonadaceae, may 
frequently co-exist (Gallucci & Paerl, 1983) but differences in basic metabolism and cell 
processes impact on their ability to exchange DNA. Both intracellular and ecological contexts 
were predicted to have been overcome with respect to assembly of multi-resistance elements. 
The general assumption was that the vast majority of clinically relevant MDR is encoded by 
genes that originated in the environment, yet there are very few examples of direct gene 
exchange between these two ecosystems (Perry & Wright, 2013). The few examples 
available, are linked to various replicons and integrons (Stalder et al., 2012). Thus the 
fundamental question examined in this study was how genetic elements have evolved special 
features to facilitate movement across greater biological distances. 
  
Movement of genes between biologically distinct groups of γ-Proteobacteria implicated in 
multi-drug resistance was explored. The main bacterial groups were environmental and 
clinical Pseudomonas populations as well as a phylogenetically distant Enterobacteriaceae 
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clinical group. Integron-associated resistance across these groups was used as a model system 
to explore MDR formation. I specifically focussed on integrons, gene cassettes and the 
IS1111-attC elements as markers for gene cassette movement between groups of differing 
biological distance. The first series of experiments was based on the premise that PCI, 
Pseudomonas-type attC sites and IS1111-attC elements had a distinct source in 
environmental Pseudomonads. I aimed to test the hypothesis that IS1111-attC elements 
would move from the environmental pool into Ps. aeruginosa with higher frequency when 
compared to Enterobacteriaceae. A secondary aspect investigated was whether such 
movement would be dependent on mobilized class 1 integrons. 
 
6.2 IS1111-attC: an epidemiological marker element for ecological barrier crossing in 
Pseudomonadaceae 
To model our understanding of MDR formation and dissemination, the rate and movement of 
resistance genes from one ecological context to another must be addressed. However, as the 
environmental source for clinically relevant antibiotic resistance genes remains largely 
unknown, we are unable to examine gene flow in “real time” across ecological boundaries. 
Initial observations of IS1111-attC distribution in the Ps. stutzeri complex (Tetu & Holmes, 
2008) and MRIs led to the hypothesis that these ISs could be used as marker elements for 
gene cassette flow between Pseudomonads. I hypothesised that IS1111-attC mobility would 
occur without the need for selection/selective pressures allowing for its use in this study to 
explore gene flow across ecological barriers.  
 
I have shown IS1111-attC distribution includes Pseudomonads outside of the stutzeri species 
complex and is strongly associated with PCIs. The Pseudomonads studied were isolated from 
a variety of sample sites, ranging from soil, domestic sponges, mops and various tissues 
samples. IS1111-attC distributions were observed to vary across distantly related 
Pseudomonads, thus demonstrating that IS1111-attC can cross genetic barriers. The data 
from my study indicated IS1111-attC associated with PCIs in environmentally sourced 
isolates, but for clinical Pseudomonas aeruginosa isolates association was reliant on the 
presence of MRI.  
 
My data showed that IS1111-attC exists across the three conceptual groups in our model, but 
at different frequencies and in different contexts (Figure 6.1). From this I conclude that 
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IS1111-attC elements are not constrained by ecological separations and are able to establish 
in a variety of Pseudomonad populations. Thus, the observed frequency and distribution of 
IS1111-attC highlights the importance of ecological niche and compatibility in genomic 
machinery in facilitating IS dissemination. A larger, more explicitly targeted sample 
collection would be needed to formally test the significance of the observed IS frequency and 
diversity differences across the sample populations. This would also allow us to use IS1111-
attC elements to measure rates of gene flow across biological differences. 
 
 
 
Figure 6.1: Ecological and phylogenetic barriers impact on IS1111-attC distribution across 
Proteobacteria populations.  
Common, rare, and very rare frequencies were arbitrarily defined by the observed occurance of 
IS1111-attCs, PCIs and MRIs in this study, published studies and NCBI database searches. 
 
In this study, non-identical IS1111-attC elements were detected, indicating multiple 
independent acquisitions. However, these elements clustered to previously identified IS1111-
attC subgroups. Their distribution was consistent with the model of a diverse group of 
organisms (clinical Pseudomonads) acquiring IS1111-attC elements via a specific route (class 
1 MRI) from a narrow source pool (environmental Pseudomonads group) multiple times. The 
observation that diverse IS1111-attC elements were located on specific mobile complexes 
(intI1 subtypes) indicated that mobile elements were required to facilitate their transfer across 
ecological boundaries. Environmental Ps. stutzeri were hence considered an IS1111-attC 
reservoir from which Ps. aeruginosa has preferential access relative to Enterobacteriaceae. 
In this study, recovery of an environmental source for ISPst6-like elements in MDR Ps. 
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aeruginosa clinical isolates supported the idea that clinical Pseudomonas has access to the 
vast MGE pool from environmental sources.  
 
A subpopulation of Enterobacteriaceae were also screened for IS1111-attC elements, 
however none were recovered. Recent database analysis performed in this study revealed two 
cases where clinical Acinetobacter baumannii strains had acquired an IS1111-attC. To date 
no IS1111-attC elements have been detected in Acinetobacter baumannii resistance islands 
(Hamidian & Hall, 2011; Krizova & Nemec, 2010; Nigro & Hall, 2012). The two mentioned 
ISs were embedded within attCaadA1 (ISAba3 Accession number: JN253504.1) and attCaadB 
(ISPa21 Accession number: AM74982.12) sites in different MRI arrays. Both intI1 arrays 
were previously seen in episomal contexts in other clinical γ-Proteobacteria, such as Ps. 
aeruginosa and E. coli.  As such, I conclude that while these ISs were not embedded in a new 
target site context and were highly unlikely to be in a new replicon context, they are 
definitely in a new cell context.  
 
Antibiotic and bactericide contamination of the environment is predicted to be a driver for the 
increased recruitment of antibiotic resistance phenotypes (Davies & Davies, 2010). Selective 
pressure from human activity may influence the composition of the environmental floating 
genome and thus the balance of the resulting gene transfer events (da Costa et al., 2013; Perry 
& Wright, 2013). Clinical settings are highly selective and hostile environments to organisms 
not already adapted to their pressures. An organism removed from a clinical habitat into an 
environment such as soil, may encounter different selective pressures such as metal, 
antibiotic contamination and competition from the native population (Hibbing et al., 2010; 
Krishna et al., 2012). The presence of MGEs in clinical isolates provides these organisms 
with an advantage in sequestering novel elements from the floating genome. We can thus 
expect clinical organisms to persist in the environment (da Costa et al., 2013) due to their 
molecular-genetic makeup. Subsequent transportation back into the clinical/animal system is 
expected to occur with the organism having acquired new “molecular armour" through HGT 
with the native population.  
 
In comparison, environmental organisms are only expected to encounter excessive levels of 
antibiotic pressure when they move from their ecological niche to a clinical setting. For them 
to persist in this new niche, they may need to undergo mutations and/or acquire the necessary 
genetic makeup in order to survive. As they do not have all of the necessary components of 
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the floating genome in a meaningful context, I postulate that the potential for the long-term 
establishment of these environmental organisms is greatly reduced. My results support the 
hypothesis that organisms travel from clinical into environmental habitats, where they may 
acquire new genetic material at a greater rate in comparison to environmental organisms 
crossing into the clinic/animal system.   
 
6.3 Are there molecular-genetic barriers to IS1111-attC translocation between PCI 
and MRI contexts?  
IS1111-attC subgroups have the capacity to recognise and become associated with different 
attCs. This highlights a parallel in MRI integrase recognition of different attC sites (Biskri et 
al., 2005). Yet IS1111-attC distribution between PCI and MRI attCs is highly variable (Tetu 
& Holmes, 2008). Also, there is no evidence for dynamic sequence changes involving the IS 
in MRI arrays, despite it appearing to be common in PCI arrays. This raises the question as to 
whether there are barriers to IS1111-attC activity in Ps. aeruginosa, enterics, or class 1 
integrons that restrict further movement. If IS1111-attC elements move independently of 
MRIs under rate limiting conditions, then they should be present in multiple sites in 
Pseudomonas MRIs. If however, the MRI capture of IS1111-attC from a PCI source is not 
rate-limiting, we should see IS1111-attC elements in Enterobacteriaceae at similar 
frequencies.   
 
Firstly, I examined whether or not molecular-genetic barriers are a rate-limiting factor to IS 
acquisition and post-acquisition activity. Acquisition of IS1111-attC elements by the 
synthetic trap was confirmed to occur with mild or no dependence on attC site structure. 
Translocation efficiency varied when same/similar IS1111-attC and attC-target site partners 
were tested in two different species, Ps. stutzeri and E. coli. The difference in IS1111-attC 
translocation activity is thus believed to be influenced by host cell factors (Figure 6.2).  
 
Secondly, I examined the ability of IS1111-attC to recognise target site context and/or 
secondary structure.  IS1111-attC translocation was found to be a result of both genetic 
context and topology of DNA. Interestingly, whilst translocation was observed from a 
chromosomal Pseudomonas-type attC into an episomal attC context, the reverse was not 
observed. Once integrated into an episomal context, IS1111-attC post-translocation activity 
appeared to be altered. The target sites were the same in both bacterial species tested, but PCI 
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invasion by IS1111-attC was not detected. Differences in translocation were seen when 
natural transformation and electroporation were used, which implies that the formation of a 
single-stranded attC template is critical in IS1111-attC translocation success. 
 
6.3.1 Uptake method impacts on IS1111-attC acquisition: natural transformation vs 
electroporation 
In the Tetu & Holmes (2008) study only partial translocation of the IS was observed. This 
implied that while the IS was potentially functional, not all conditions for complete 
translocation had been met. To test the hypothesis that host cell differences affect IS1111-
attC translocation success, a natural host species Ps. stutzeri ATCC 17587 was used. In my 
study, complete translocation of IS1111-attC elements was found to be stably maintained.  
Complete translocation is said to have occurred when a single intact ISPst6 element, 
including both IRL and IRR junctions, are detected in the attC plasmid trap.  Recovery of the 
intact IS element suggests that the molecular-genetic barrier is not a limiting factor when 
considering IS1111-attC translocation from a chromosomal to an episomal context in a native 
Pseudomonas host. Instead, I propose that host associated factors are a major driving force in 
IS1111-attC translocation success (Figure 6.2).  
 
Figure 6.2: Overcoming molecular-genetic barriers in a Pseudomonas stutzeri host leads to 
successful IS1111-attC translocation into attC sites.  
E. coli JM109 was used as a host strain for long-term storage of pattC-IS. IS1111-attC minicircles 
were only observed in a Pseudomonas host, suggesting that host associated factors drive Tpase 
expression. Note electroporation of pattC trap into E. coli Epi300 was performed by Tetu & Holmes 
(2008).  
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As a further test, I transformed the plasmid-borne IS-attC into Pseudomonas stutzeri species. 
Transformation was only possible via electroporation, which raised the question as to the 
importance of presentation context of the IS-attC, rather than host cell properties. A 
precedent for this exists in IntI mediated recombination (Collis et al., 2001). Whilst no IS 
invasion of PCI arrays was detected, when the trap was electroporated into a Pseudomonas 
host (Figure 6.2), IS1111-attC minicircles were detected. This implies that the PCI array is 
“protected” from IS invasion and/or another Pseudomonas factor is required. In the case of 
host factors, the availability and recognition of a single stranded PCI-attC hairpin by IS1111-
attC is postulated to affect IS translocation success. Additionally, if Pseudomonas integrase 
IntIPstX and IS transposase target the same attC strand, steric interference may occur. Thus 
competition between these two recombinases may affect IS1111-attC translocation.  
 
In summary, IS1111-attC translocation into synthetic, plasmid-borne attC sites was observed 
to occur in a site-specific fashion. These findings also support the notion that the occurrence 
of a single IS1111-attC within an MRI in a Pseudomonad reflects the acquisition of a single 
IS from a PCI, as demonstrated here, or the acquisition of a pre-existing IS-gene cassette 
fusion (Tetu & Holmes, 2008).  
 
6.3.2 The context of the attC site impacts on IS1111-attC translocation: topology 
specificity  
The orientation in which attC was presented to IS1111-attC was noted to affect translocation 
efficiency (Chapter 4). IS1111-attC translocation preferentially occurred when the synthetic 
attC sites were cloned into one orientation. Similar results have been noted for IS4321 
translocation (Partridge & Hall, 2003) and IntI1 mediated recombination at synthetic attC 
sites (Collis et al., 2001). If recombination by IS1111-attC occurs in a strand-specific 
manner, then strand topology of the attC hairpin will differ between the two cloned 
orientations. Orientation preference is thus believed to be a feature of plasmid topology, 
where one orientation exposes the attC cruciform in a way which “presents” the attC top 
strand for transposase binding and recombination. Another possible explanation is that 
IS1111-attC translocation into one attC orientation ensures that the IS1111-attC PIRL and 
putative POUT promoter do not interfere with the rep region of the pBBR1 vector and thereby 
negatively affect plasmid fitness (Collis et al., 2001).  
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Furthermore, these in vivo findings add support to bioinformatic analysis of IS1111-attC 
orientation specific translocation into MRI and CI attC sites (Post & Hall, 2009; Tetu & 
Holmes, 2008). Orientation bias may reflect consequences of the mechanism by which Tpase 
mediates site-specific recombination. There are two main consequences predicted to arise due 
to preferential targeting of single stranded attC sites. Firstly, the fitness of IS1111-attC is 
dependent on biological processes that produce a single stranded attC. Secondly, orientation 
of IS1111-attC may cause polar effects on cellular processes, through the disruption of 
expression of any adjacent genes (Aubert et al., 2003; Kallastu et al., 1998). IS1111-attC 
orientation is a product of which attC strand is joined, as well as to which IS1111-attC the 
strand is joined. I predict that the top (non-coding) IS strand is the target for attC 
recombination (Chapter 5, Figure 5.18). Also, IS1111-attC direct repeats may act as targets 
for RNA polymerase, thereby pausing RNA polymerase activity and consequently leaving the 
IS top strand free to act as the attC recombination partner strand. Orientation preference is 
therefore an important feature of IS1111-attC translocation.  
 
6.3.3 IS1111-attC and micro-variations: a consequence of polymerase activity? 
Resolution of attC-attI junctions in IntI-mediated recombination was demonstrated to occur 
by replication, involving potentially multiple enzymes (Loot et al., 2012). A feature of IntI 
recombination substrates is that they show micro-variation.  The attC sites and also the 
cassette ORFs each show levels of heterogeneity that are higher than other genetic features in 
the same replicons. In a chromosomal integron, ‘families’ of attC sites are typically observed 
(XCR, VCR, PCR, etc.) (Gillings et al., 2005; Rowe-Magnus et al, 2002; Vaisvila et al., 
2001). Within one genome, the sequence variation across the attC sites is greater than the 
sequence variation between the intI genes of different strains (Ps. stutzeri- all observed 
genomovars; Vibrio cholerae and Xanothomonas campestris -all observed pathovars).  In 
Class 1 integrons, for those gene cassettes that have been widely disseminated (such as aadB 
and blaOXA) multiple variants have been observed in the different integron occurrences 
(Figure 1.12), but the intI1 sequence and the attI1 sequence show higher conservation. 
 
The same pattern is seen for IS1111-attC, whereby micro-variation is seen between cases 
where translocation is inferred to have occurred (i.e. between independent locations). 
Significantly the ‘captured’ element observed in my study was also non-identical to known 
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instances in Ps. stutzeri ATCC 17587 (Figure 4.10). In vivo activity of error prone DNA 
polymerases during DNA replication in Ps. stutzeri may result in minor IS1111-attC and 
Pseudomonas-type attC sequence differences across PCI arrays. Whilst there is no direct 
evidence of error prone replication in Ps. stutzeri, it is plausible that such polymerase activity 
can be used to explain the cases of imperfectly copied gene cassettes and attC sites across 
PCIs. Adaptation of a Pseudomonas population under environmental and selective pressures 
may result in stress-induced activation of error-prone DNA polymerases (Foster, 2000; 
Rosenberg, 2001; Tegova et al., 2004; Tenaillon et al., 2001) and result in IS-gene cassette 
genetic difference in population members. Interestingly, near perfect IS copies are observed 
in MRIs. IS variation is only introduced during translocation so if there is no ongoing 
movement there is no change. I propose that high fidelity polymerases involved in plasmid 
replication (Allen et al., 2011) are less likely to introduce errors/sequence differences in 
IS1111-attC elements, in comparison to their chromosomal counterparts.  
 
I propose that the occurrence of IS1111-attC-gene cassette micro-variants can be explained if 
the mechanism of co-integrate resolution in both IntI-mediated and Transposase-mediated 
recombination is inherently error prone. If  the ability to resolve the co-integrate is limited to 
a specific subset of DNA polymerases then this could conceivably restrict the range of cells 
in which active recombination involving IntI or IS1111-attC can take place. 
 
6.3.4 IS1111-attC may preferentially recognise Pseudomonas-type attC over attCaadB sites 
One of the most biologically significant features of IntI is its ability to recognise a wide 
variety of attC sites (Jacquier et al., 2009; Larouche & Roy, 2011). In vivo assays in this 
study demonstrated IS1111-attC ability to translocate into Pseudomonas and classical attC 
sites with equal propensity. In vitro EMSAs were used to test the binding specificity of Tpase 
to double stranded and single-stranded Pseudomonas and classical attC site. Whilst the 
results for IS1111-attC transposase binding to Pseudomonas-type attC were consistent with 
my predictions, the results from Tpase binding to attCaadB were somewhat inconclusive. The 
latter was surprising, given that attCaadB sites were found to be occupied by IS1111-attC 
members (Tetu & Holmes, 2008).  In principal, binding of transposase to attCaadB  sites 
should be possible if transposase interacts with the attC target with greater affinity than the 
competitor, and when the secondary binding does not discriminate between the sequences 
(Alves & Cunha, 2012). It is possible that additional molecular-genetic factors are necessary 
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for Tpase-attCaadB binding. In summary, in vivo data demonstrated that IS1111-attC 
transposase has a flexible attC substrate range. In vitro data together with in vivo data 
indicate that a structural conformation in Pseudomonas attC top strands is essential for Tpase 
binding. The precise single stranded conformations required may be more difficult to form 
for attCaadB sites, thus creating a degree of site preference. However, further experimentation 
is required before any conclusions can be made.   
 
6.3.5 The importance of DNA structures and presentation context in the HGT landscape  
Although the concept of the gene is still evolving, one feature that has been true since the 
introduction of Mendelian genetics is that the gene is a unit. As such it must have defined 
sequence boundaries. Primary sequence boundaries do not change topologically (at least not 
on timescales relevant to an individual cell’s physiology), while secondary sequence 
boundaries (secondary structures) do. Secondary structures formed by intrastrand base 
pairing are now known to often be critical for biological processes such as replication, 
transcription, CTX-phage integration, IS608 transposition, as well as integron mediated 
recombination of attC sites (Bouvier et al., 2009; Guynet et al., 2008; Val et al., 2005; Bikard 
et al., 2010). The use of secondary structures, that are transiently present, creates a scenario 
whereby temporal processes become important to cell outcomes and have led to optimisation 
of transfer events with other cell processes. 
 
Various processes can result in the transient production of single stranded attC hairpins 
(Bikard et al., 2010; Loot et al., 2010). DNA supercoiling and lagging strand synthesis can 
also favour the extrusion of an attC cruciform (Loot et al., 2013). The ability of IntI to 
recognise and recombine attC and attI sites, is a function of DNA topologies of both target 
sites. Topological properties of attC sites can be influenced by a few factors: 
i) Stability of single-stranded structure: Formation of an unstable attC hairpin is more 
likely to yield an unfavourable substrate for integron integrase (Loot et al., 2010). 
Multiple single-stranded attCaadB conformations were observed in EMSAs, some of 
which are hypothesised to be unfavourable for Tpase binding potential.  
 
ii) Resistance of double stranded structure: Length of the variable terminal structure 
(VTS) affects IntI binding and attI-attC recombination. The larger the VTS, the less 
efficient the DNA melting and the lower the recombination frequency (Loot et al., 
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2010). Inadequate melting of double stranded attC can lead to formation of unstable 
attC structures, which is unfavourable for Tpase binding.  
 
iii) Unwinding or stabilizing factors that promote either i) or ii): Ability to “attract” 
DNA binding proteins that destabilize the hairpin structure, such as RecA and Single 
Stranded Binding proteins (SSBs) (Cambray et al., 2011; Dickey et al., 2013; 
Marceau, 2012; Loot et al., 2010; Loot et al., 2013; Nowak et al., 2014). SSBs 
prevent DNA hairpin formation by stabilizing the single stranded DNA, and directing 
RecA binding to the hairpin (Kowalczykowski & Krupp, 1987; Meyer & Laine, 
1990). SSBs bind attC sites by structural recognition, rather than through sequence 
specificity (Cambray et al., 2011). This highlights that spatial presentation of contact 
points for binding is more important than the neighbouring bases.  
 
iv) Ability of IntI to displace SSBs/ from attC: Purified IntI has the capacity to capture 
and stabilize the attC hairpin, thus counterbalancing the effect of SSBs (Loot et al., 
2013). I postulate that Pseudomonas SSBs have an impact on the success of IS1111-
attC binding to single stranded attC sites thereby inducing an equilibrium state shift 
of the hairpin and destabilizing it in an effort to make it a linear DNA molecule. This 
binding is antagonistic, given that transposase binding to single stranded attC is 
believed to be dependent on hairpin formation. Hence transposase was unable to 
mediate the site-specific recombination of IS1111-attC into PCI-attCs. However, if 
IntI and Tpase act co-operatively, the ability of IntI to displace SSBs from attC sites 
would promote the formation of hairpins, thus allowing Tpase to bind and drive 
IS1111-attC translocation into attC strands.  
 
In conclusion, evolutionary adaptation of IS1111-attC transposase has allowed the enzyme to 
recognise DNA structures (cruciform) as gene handles for successful translocation. IS1111-
attC fitness and translocation is structure dependent in a manner that mimics IntI activity. 
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6.5 Convergent evolution, selective advantages of a “gene handle”. 
The significance of secondary structure formation in single stranded attC sites, and their role 
in integron mediated recombination and excision of gene cassettes, is well understood 
(Bouvier et al., 2009; Johansson et al., 2004; Larouche & Roy, 2011; Loot et al., 2013). As 
attC structure was hypothesized to be key a factor in IS1111-attC transposase recognition and 
binding, secondary structure formation was found to be particularly interesting in this study 
also. The ability of IntI and Tpase to target attC sites is expected to promote formation of 
mosaic genetic elements that ultimately result in complex phenotypes such as MDR. In this 
study, I have demonstrated that attC sites are a shared ancestral feature recognized by both 
the IntI and Tpase recombinases. Preferential binding of IS1111-attC Tpase to the attCts 
strand was shown repeatedly in mobility shift assays. This is in contrast to IntI binding, 
where the preference was for the attC bottom strand (Francia et al., 1999; Johansson et al., 
2004).   
 
As in the IntI binding assay, double stranded attC sites were not recognised by Tpase under 
in vitro conditions. Furthermore, a fast migrating mobility-shifted complex was observed 
when the IS1111-attC minicircle junction was tested as a Tpase binding partner. This was 
evidence that electrophoretically distinct subpopulations of Tpase-IS junction interactions 
exist, as shown by shifting oligonucleotide equilibrium. As a result, Tpase mediated site-
specific recombination between the IS and attC site is believed to involve a double stranded 
IS minicircle and a folded-back attCts. In conclusion, this study presents the first evidence of 
the molecular requirements for IS1111-attC site-specific recombination with integron 
associated recombination sites. Tpase attC binding ability has shed significant insight into the 
nature of specific DNA-protein interactions.  
 
The results presented throughout this thesis highlight that there is a dynamic and ongoing 
process of horizontal transfer of genetic material amongst environmental and clinical 
Pseudomonads. Furthermore, this study also highlights the detection of movement with 
which MGEs move between genetic contexts. Understanding the driving forces behind 
IS1111-attC distribution, abundance, and the molecular details involved in transposase 
interaction with the integron platform has shed light on the mechanisms that govern gene 
cassette flow between ecologically and phylogenetically distant Pseudomonads. 
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APPENDICES 
All of the isolates used in this study were screened for class 1 integrons (intI1), Pseudomonas chromosomal integrons (PCIs), Pseudomonas attC 
sites (Ps. attC-attC), and IS1111-attC elements by southern hybridisation and PCR. Where a clinical isolate tested positive for given element by 
with Southern hybridization or PCR, it is annotated as +.  
 
Table A1: Clinical, host associated Pseudomonads used in this study 
Ref. Organism Date Clinical Site  Hospital intI1  PCI 
Ps. attC-
attC 
IS1111-
attC 
TS464 Ps. aeruginosa 29/01/2010 Catheter specimen urine San Adventist + - - + 
TS491 Ps. aeruginosa 17/03/2010 Swab wound San Adventist + - - + 
TS504 Ps. aeruginosa 7/02/2010 Swab left heel San Adventist + - - + 
TS558 Ps. aeruginosa 21/03/2010 Midstream urine San Adventist + - - + 
TS589 Ps. aeruginosa 23/04/2010 Midstream urine San Adventist + - - + 
TS597 Ps. aeruginosa 3/05/2010 Fluid pleural fluid San Adventist + - - + 
TS599 Ps. aeruginosa 3/05/2010 Swab left lateral San Adventist - - - + 
TS600 Ps. aeruginosa 3/05/2010 Midstream urine San Adventist - - - + 
TS616 Ps. aeruginosa 3/05/2010 Unknown source San Adventist - - - + 
TS620 Ps. aeruginosa 17/05/2010 Swab vaginal San Adventist - - - + 
TS629 Ps. aeruginosa 21/05/2010 Fluid left drain San Adventist + - - + 
TS630 Ps. aeruginosa 24/05/2010 Swab left antrum San Adventist + - - + 
TS631 Ps. aeruginosa 25/05/2010 Midstream urine San Adventist - - - + 
TS634 Ps. aeruginosa 25/05/2010 Swab small ulcer San Adventist + - - + 
TS653 Ps. aeruginosa 16/06/2010 Swab left leg ulcer San Adventist - - - + 
TS654 Ps. aeruginosa 15/06/2010 Urine unknown meth San Adventist - - - + 
TS664 Ps. aeruginosa 22/06/2010 Swab right ear San Adventist - - - + 
TS684 Ps. aeruginosa 4/07/2010 Midstream urine San Adventist - - - + 
TS741 Ps. aeruginosa 18/08/2010 Swab right foot San Adventist - - - + 
JIP004 Ps. aeruginosa 8/03/2005 Urine Westmead - - - - 
JIP006 Ps. aeruginosa 9/03/2005 Wound Westmead - - - + 
JIP009 Ps. aeruginosa 11/03/2005 NBAL Westmead - - - + 
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JIP012 Ps. aeruginosa 25/03/2005 Blood Westmead - - - - 
JIP013 Ps. aeruginosa 22/03/2005 Urine Westmead - - - - 
JIP014 Ps. aeruginosa 22/03/2005 Right heel tissue Westmead - - - - 
JIP016 Ps. aeruginosa 22/03/2005 Toe tissue Westmead - - - - 
JIP019 Ps. aeruginosa 6/04/2005 Foot tissue Westmead - - - - 
JIP027 Ps. aeruginosa 8/07/2005 Blood Westmead - - - - 
JIP028 Ps. aeruginosa 13/08/2005 SP Westmead - - - - 
JIP029 Ps. aeruginosa 11/08/2005 Mandible wound Westmead - - - - 
JIP031 Ps. aeruginosa 15/08/2005 SP Westmead + - - + 
JIP032 Ps. aeruginosa 12/07/2005 Wound Westmead - - - - 
JIP033 Ps. aeruginosa 20/08/2005 Urine Westmead - - - - 
JIP037 Ps. aeruginosa 20/08/2005 SP Westmead - - - - 
JIP038 Ps. aeruginosa 19/07/2005 Wound Westmead + - - - 
JIP040 Ps. aeruginosa 25/09/2005 Tip Westmead - - - - 
JIP041 Ps. aeruginosa 27/10/2005 Tissue Westmead + - - + 
JIP044 Ps. aeruginosa 22/01/2006 Fluid bag Westmead + - - + 
JIP045 Ps. aeruginosa 5/02/2006 Wound Westmead + + - + 
JIP047 Ps. aeruginosa 16/02/2006 Wound Westmead - - - + 
JIP051 Ps. aeruginosa 28/02/2006 Wound Westmead - - - - 
JIP052 Ps. aeruginosa 9/03/2006 Wound Westmead + + - + 
JIP055 Ps. aeruginosa 1/08/2006 Wound Westmead - - - - 
JIP056 Ps. aeruginosa 19/08/2006 SP Westmead - - - - 
JIP067 Ps. aeruginosa 3/11/2006 Urine Westmead - - - - 
JIP068 Ps. aeruginosa 9/11/2006 SP Westmead - - - - 
JIP070 Ps. aeruginosa 29/11/2006 Blood Westmead - - - - 
JIP071 Ps. aeruginosa 6/06/2006 
Systemic-pulmonary 
collateral flow 
Westmead - - - - 
JIP072 Ps. aeruginosa 18/12/2006 Urine Westmead - - - - 
JIP073 Ps. aeruginosa 8/01/2007 Foot tissue Westmead + - - + 
JIP079 Ps. aeruginosa 22/01/2007 SP Westmead - - - - 
JIP080 Ps. aeruginosa 23/01/2007 SP Westmead + - - + 
JIP104 Ps. aeruginosa 20/03/2007 Blood Westmead - - - - 
JIP106 Ps. aeruginosa 30/03/2007 Urine Westmead + - - - 
JIP108 Ps. aeruginosa 14/03/2007 Blood Westmead - - - - 
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JIP111 Ps. aeruginosa 3/04/2007 Sputum Westmead - - - - 
JIP112 Ps. aeruginosa 8/04/2007 Sputum Westmead - - - - 
JIP113 Ps. aeruginosa 16/04/2007 Sputum Westmead - - - - 
JIP116 Ps. aeruginosa 17/04/2007 Wound Westmead - - - - 
JIP117 Ps. aeruginosa 19/04/2007 Abdominal swab Westmead + - - + 
JIP118 Ps. aeruginosa 24/04/2007 Wound Westmead - - - - 
JIP119 Ps. aeruginosa 25/04/2007 Wound Westmead - - - - 
JIP120 Ps. aeruginosa 2/05/2007 Swab Westmead - - - - 
JIP122 Ps. aeruginosa 11/05/2007 Urine Westmead - - - - 
JIP124 Ps. aeruginosa 11/05/2007 Groin Westmead - - - - 
JIP132 Ps. aeruginosa 5/06/2007 NBAL Westmead - - - - 
JIP134 Ps. aeruginosa 26/06/2007 Sputum Westmead - - - - 
JIP136 Ps. aeruginosa 13/07/2007 Wound Westmead - - - - 
JIP137 Ps. aeruginosa 18/07/2007 Wound Westmead - - - - 
JIP138 Ps. aeruginosa 12/09/2007 Swab Westmead - - - - 
JIP139 Ps. aeruginosa 13/09/2007 Leg Westmead - - - - 
JIP141 Ps. aeruginosa 15/09/2007 Urine Westmead - - - - 
SSI 1.25 Ps. aeruginosa 25-Apr-04 Respiratory C Sp Westmead - - - - 
SSI 1.28 Ps. aeruginosa 27-Apr-04 Urine Westmead - - - - 
SSI 1.48 Ps. aeruginosa 24-May-04 Respiratory C Sp Westmead - - - - 
SSI 1.58 Ps. aeruginosa 08-Jun-04 Neck collection Westmead - - - - 
SSI 1.63 Ps. aeruginosa 13-Jun-04 Respiratory C Sp Westmead - - - - 
SSI 1.65 Ps. aeruginosa 18-Jun-04 Respiratory C Sp Westmead - - - - 
SSI 1.69 Ps. aeruginosa 20-Jun-04 Respiratory C Sp Westmead - - - - 
SSI 1.9 Ps. aeruginosa 03-Apr-04 Respiratory C Sp Westmead - - - - 
SSI 1.95 Ps. aeruginosa 05-Jul-04 Respiratory C Sp Westmead - - - - 
SSI 2.1 Ps. aeruginosa 10-Jul-04 Respiratory C NBAL Westmead - - - - 
SSI 2.100 Ps. aeruginosa 13-Oct-04 Respiratory C NBAL Westmead - - - - 
SSI 2.17 Ps. aeruginosa 29-Jul-04 Respiratory C NBAL Westmead - - - - 
SSI 2.32 Ps. aeruginosa 03-Aug-04 Respiratory C NBAL Westmead - - - - 
SSI 2.37 Ps. aeruginosa 06-Aug-04 Respiratory C NBAL Westmead + - - + 
SSI 2.51 Ps. aeruginosa 16-Aug-04 Respiratory C NBAL Westmead - - - - 
SSI 2.84 Ps. aeruginosa 16-Sep-04 Blood Westmead + + - + 
SSI 2.87 Ps. aeruginosa 10-Oct-04 Respiratory C Sp Westmead - - - - 
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SSI 2.96 Ps. aeruginosa 11-Oct-04 Other C WS leg Westmead - - - - 
SSI 3.14 Ps. aeruginosa 13-Nov-04 Other C WS knee  Westmead - - - - 
SSI 3.35 Ps. aeruginosa 08-Dec-04 Blood dialysis fluid Westmead + - - - 
SSI 3.37 Ps. aeruginosa 07-Dec-04 Respiratory C NBAL Westmead - - - - 
SSI 3.38 Ps. aeruginosa 07-Dec-04 Catheter Urine Westmead - - - - 
SSI 3.40 Ps. aeruginosa 13-Dec-04 Respiratory C NBAL Westmead - - - - 
SSI 3.44 Ps. aeruginosa 25-Dec-04 Respiratory C SP Westmead + - - - 
SSI 3.53 Ps. aeruginosa 07-Jan-05 Respiratory C NBAL Westmead - - - - 
SSI 3.62 Ps. aeruginosa 16-Jan-05 Other C Tip Westmead - - - - 
SSI 3.71 Ps. aeruginosa 22-Jan-05 Respiratory C Sp Westmead - - - - 
SSI 3.72 Ps. aeruginosa 21-Jan-05 Blood Westmead - - - - 
SSI 3.77 Ps. aeruginosa 14-Feb-05 Foot  wound Westmead - - - - 
SSI 3.86 Ps. aeruginosa 21-Feb-05 Other C WS wound Mid  Westmead - - - - 
SSI 3.9 Ps. aeruginosa 30-Oct-04 Other C WS wound  Westmead - - - - 
SSI 3.91 Ps. aeruginosa 28-Feb-05 Respiratory C SP Westmead - - - - 
SSI 4.100 Ps. aeruginosa 06-Jun-05 Other C WS wound Westmead - - - - 
SSI 4.32 Ps. aeruginosa 29-Mar-05 Respiratory C SP Westmead - - - - 
SSI 4.37 Ps. aeruginosa 06-Apr-05 Tissue left stump Westmead - - - - 
SSI 4.41 Ps. aeruginosa 11-Apr-05 Respiratory sputum Westmead - - - - 
SSI 4.46 Ps. aeruginosa 20-Apr-05 Trachey wounds Westmead - - - - 
SSI 4.58 Ps. aeruginosa 28-Apr-05 Plerural fluid Westmead - - - - 
SSI 4.62 Ps. aeruginosa 05-May-05 Other C WS wound Westmead - - - - 
SSI 4.63 Ps. aeruginosa 03-May-05 Unknown Westmead - - - - 
SSI 4.69 Ps. aeruginosa 10-May-05 Urine Westmead - + - - 
SSI 4.77 Ps. aeruginosa 17-May-05 Respiratory C Sp Westmead - - - - 
SSI 5.25 Ps. aeruginosa 08-Jul-05 Respiratory C NBAL Westmead - - - - 
SSI 5.32 Ps. aeruginosa 07-Jul-05 Respiratory C Sp Westmead - - - - 
SSI 5.34 Ps. aeruginosa 12-Jul-05 Sternal Wound Westmead + - - - 
SSI 5.39 Ps. aeruginosa 19-Jul-05 Respiratory C NBAL Westmead - + - - 
SSI 5.41 Ps. aeruginosa 24-Jul-05 Respiratory C Sp Westmead - - - - 
P1 
Chryseobacterium 
indologenes 
28/04/2004 Bronchial washing  Westmead - - - - 
P2 Ps. mendocina 28/03/2004 Blood culture Westmead - - - - 
P4 Ps. fluorescens 28/11/2003 Bronchoalveolar lavag Westmead - - - - 
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P15 Ps. stutzeri ATCC 17588 15/01/1999 Human spinal fluid Westmead - + + + 
P16 Ps. aeruginosa 16/02/2006 Clinical Sputum Westmead - - - - 
P17 Ps. stutzeri 21/02/2007 Eye swab Westmead - + + + 
Note: All of the clinical Pseudomonad isolates were kindly provided by our collaborators. These clinical isolates were previously assigned a reference (Ref.) 
identity. TS, JIP, SSI refer to different antibiotic cycling studies carried out the respective Hospitals, from which these Pseudomonads were isolated. P was 
abbreviated form of Pseudomonad. Date refers to the date the isolate was recovered from clinical site at the given hospital. Medical abbreviations: NBAL: 
Non-bronchoscopic bronchoalveolar lavage; C: catheter; Sp: Spontaneous pneumothorax; WS: WoundStat.  
 
Table A2: Non-clinical, environmental isolates used in this study 
Isolate 
BLAST HIT 
Organism 
Accession  
number 
BLASTn % 
identity 
Date 
Sample 
Source 
intI1  PCI 
Ps attC-
attC 
IS1111-
attC 
Pseudomonas  
sp. JM1 
Ps. alcaliphila  KM248339.1 
99 
(1066/1068bp) 
May-2011 Jake's Mop - + - - 
Pseudomonas  
sp. JM2 
Ps. alcaligenes str. S3  DQ115541.1 99 (826/837bp) May-2011 Jake's Mop + + + + 
Pseudomonas 
 sp. JM3 
Unknown N/A N/A May-2011 Jake's Mop - - - - 
Pseudomonas 
 sp. JM4 
Unknown  N/A N/A May-2011 Jake's Mop - - - - 
Pseudomonas  
sp. JM5 
Unknown N/A N/A May-2011 Jake's Mop - - - - 
Pseudomonas 
 sp. JM6 
Ps. alcaligenes str. 
Y34 
FJ830845.1 99 (899/901bp) May-2011 Jake's Mop + + + + 
Pseudomonas 
 sp. JM7 
Unknown N/A N/A May-2011 Jake's Mop - - - + 
Pseudomonas 
 sp. JM8 
Unknown  N/A N/A May-2011 Jake's Mop - - - - 
Pseudomonas 
 sp. JM9 
Unknown N/A N/A May-2011 Jake's Mop - - - - 
Pseudomonas 
 sp. JM10 
Ps. sp. N3(2012b) JN820155.1 99 (892/904bp) May-2011 Jake's Mop + - + + 
Pseudomonas sp. 
JM11 
Unknown  N/A N/A May-2011 Jake's Mop - - - - 
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Pseudomonas  
sp. JS1 
Unknown  N/A N/A May-2011 
Jake's 
Sponge 
- - - - 
Pseudomonas  
sp. JS2 
Unknown  N/A N/A May-2011 
Jake's 
Sponge 
- + + - 
Pseudomonas  
sp. JS3 
Unknown  N/A N/A May-2011 
Jake's 
Sponge 
- + + - 
Pseudomonas  
sp. JS4 
Unknown  N/A N/A May-2011 
Jake's 
Sponge 
- - - - 
Pseudomonas  
sp. JS5 
Unknown N/A N/A May-2011 
Jake's 
Sponge 
- - - - 
Pseudomonas  
sp. JS6 
Unknown  N/A N/A May-2011 
Jake's 
Sponge 
- - - - 
Pseudomonas  
sp. JS7 
Unknown  N/A N/A May-2011 
Jake's 
Sponge 
- - - - 
Pseudomonas  
sp. AP1 
Uncultured Ps. sp. 
clone AV_5N-G03  
EU341207.1 
100 
(1400/1400bp) 
May-2011 
RNSH 
Panroom 
+ - - - 
Stenotrophomonas 
sp. AP2 
Stenotrophomonas 
maltophilia JV3  
NC015947.1 
100 
(1400/1413bp) 
May-2011 
RNSH 
Panroom 
+ - - - 
Pseudomonas  
sp. AP3 
Ps. putida WZX_19 EF440613.1 
99 
(1391/1397bp) 
May-2011 
RNSH 
Panroom 
+ - - - 
Pseudomonas  
sp. AS1 
Ps. aeruginosa 
ACZ01 
KM434772.1 
100 
(612/612bp) 
May-2011 
RNSH Sink 
Panroom 
+ - - + 
Pseudomonas  
sp. AS2 
Ps. aeruginosa PA94 KM013815.1 
99 
(1389/1390bp) 
May-2011 
RNSH Sink 
Panroom 
+ - - - 
Pseudomonas  
sp. AS3 
Ps. aeruginosa HE21 LN624810.2 
100 
(1076/1076) 
May-2011 
RNSH Sink 
Panroom 
- - - - 
Pseudomonas  
sp.  ES1 
Uncultured bacterium 
gene for 16S rRNA, 
partial sequence, 
clone: HSM-SS-011 
AB238774.1 
99 
(1079/1081bp) 
May-2011 
Yi Vee's 
Sponge 
- - - - 
Pseudomonas  
sp. ES2 
Unknown  N/A N/A May-2011 
Yi Vee's 
Sponge 
- - - - 
Pseudomonas  
sp. ES3 
Unknown  N/A N/A May-2011 
Yi Vee's 
Sponge 
- - - - 
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Pseudomonas  
sp. ES4 
Unknown  N/A N/A May-2011 
Yi Vee's 
Sponge 
- - - - 
Pseudomonas  
sp. ES5 
Unknown  N/A N/A May-2011 
Yi Vee's 
Sponge 
- - - - 
Pseudomonas  
sp. FM1 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- + - + 
Pseudomonas  
sp. FM2 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- + - - 
Pseudomonas  
sp. FM3 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- + - + 
Pseudomonas  
sp. FM4 
Ps. putida ND6 CP003588.1 99 (1399/1403) Jan-2012 
Feyza's 
Mop 
- + - + 
Pseudomonas  
sp. FM5 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- - - - 
Pseudomonas  
sp. FM6 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- - - + 
Pseudomonas  
sp. FM7 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- - - - 
Pseudomonas  
sp. FM8 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- - - - 
Pseudomonas  
sp. FM9 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- - - - 
Pseudomonas  
sp. FM10 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- - - - 
Pseudomonas  
sp. FM11 
Unknown  N/A N/A Jan-2012 
Feyza's 
Mop 
- - - - 
Pseudomonas  
sp. MS1 
Unknown  N/A N/A Jan-2011 
Mia's 
Sponge 
- + - - 
Pseudomonas  
sp. MS2 
Unknown  N/A N/A Jan-2011 
Mia's 
Sponge 
- - - - 
Pseudomonas  
sp. MS3 
Uncultured gamma 
proteobacterium from 
sea squirt 
Microcosmus sp. 
clone MspS123 
AY770721.1 99 (899/905p) Jan-2011 
Mia's 
Sponge 
- - - - 
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Pseudomonas  
sp. MS4 
Unknown  N/A N/A Jan-2011 
Mia's 
Sponge 
- - - - 
Pseudomonas  
sp. MS5 
Unknown  N/A N/A Jan-2011 
Mia's 
Sponge 
- - - - 
Pseudomonas  
sp. MS6 
Unknown  N/A N/A Jan-2011 
Mia's 
Sponge 
- - - - 
Pseudomonas  
sp. NS1 
Unknown  N/A N/A May-2011 
Nick's 
Sponge 
- - - - 
Pseudomonas  
sp. NS2 
Unknown  N/A N/A May-2011 
Nick's 
Sponge 
- - - - 
Pseudomonas  
sp. NS3 
Unknown  N/A N/A May-2011 
Nick's 
Sponge 
- - - - 
Pseudomonas  
sp. NS4 
Unknown  N/A N/A May-2011 
Nick's 
Sponge 
- - - - 
Pseudomonas  
sp. NS5 
Unknown  N/A N/A May-2011 
Nick's 
Sponge 
- - - - 
Agrobacterium  
sp. NS6 
Agrobacterium sp. 
DB14  
JQ4375441.1 
99(1258/1260b
p) 
May-2011 
Nick's 
Sponge 
- + - + 
Pseudomonas  
sp. NS7 
Unknown  N/A N/A May-2011 
Nick's 
Sponge 
- - - - 
Pseudomonas  
sp. NS8 
Unknown  N/A N/A May-2011 
Nick's 
Sponge 
- - - - 
Pseudomonas  
sp. LS1 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Pseudomonas  
sp. LS2 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Pseudomonas  
sp. LS3 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Pseudomonas  
sp. LS4 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - + - 
Stenotrophomonas 
sp. LS5 
Stenotrophomonas 
maltophilia K279a 
NC010943.1 
99 
(1077/1081bp) 
June-2011 
Laura's 
Sponge 
- - + + 
Stenotrophomonas 
sp. LS6 
Stenotrophomonas 
sp. U1369-101122-
JQ082152.1 
99 
(1074/1081bp) 
June-2011 
Laura's 
Sponge 
- - - + 
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SW177 
Pseudomonas  
sp. LS7 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Delftia sp. LS8 
Delftia acidovorans 
SPH-1  
NR074691.1 
99 
(1387/1391bp) 
June-2011 
Laura's 
Sponge 
- - - + 
Pseudomonas  
sp. LS9 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Pseudomonas  
sp. LS10 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Pseudomonas  
sp. LS11 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Pseudomonas  
sp. LS12 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Brevundimonas  
sp. LS13 
Brevundimonas 
vesicularis G1-1-80 
KC494327.1 
99 
(1026/1030bp) 
June-2011 
Laura's 
Sponge 
+ - - + 
Pseudomonas  
sp. LS14 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
Pseudomonas  
sp. LS15 
Unknown  N/A N/A June-2011 
Laura's 
Sponge 
- - - - 
P05 
Chryseomonas 
luteola 
N/A N/A 5/04/2005 Enviro. - - - + 
P06 
Chryseobacterium 
meningosepticum 
N/A N/A 1/07/1993 Water + + + + 
P07 Ps. alcaligenes N/A N/A Unknown Enviro. + - - - 
P08 Ps. oryzihabitans N/A N/A Unknown Enviro. - - - - 
P09 Ps. putida N/A N/A 1/07/1993 Enviro. - - - - 
P10 
Brevundimonas 
diminuta 
N/A N/A Unknown Enviro. - - - - 
P11 
Ps. aureofacium 
ATCC13985 
N/A N/A 20/01/1999 
Sandstone 
rock 
- - - - 
P13 
Ps. mendocina ATCC 
25411 
N/A N/A 15/01/1999 
Soil 
enrichment 
- + + + 
P14 
Ps. putida ATCC 
12683 
N/A N/A 20/01/1999 
Activated 
sludge 
- - - - 
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N/A: not available; Enviro: Environmental; RNS: Royal North Shore Hospitals. All Pseudomonad isolated annotated as “P#” were kindly provided by the Brown Lab. 
 
Table A3: Enteric (outgroup) isolates used in this study 
Ref. Organisms Date  Source Lab intI1 PCI 
Ps. attC-
attC  
IS1111-attC 
2045 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
2064 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
4060 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
6066 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
9023 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
11045 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
11047 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
13047 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
13090 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
14025 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
14050i Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
14050ii Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
15025 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
15053 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
15065 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
15066 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
15084 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
16075 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
18063 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
18064 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
18084 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
19072 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
19073 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
20019 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
20023 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
20060 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
20061 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
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22041 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
22042 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
23069 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
24025 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
25077 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
25078 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
26073 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
27010 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
27023 Unknown Gram Negative 16/6/09 Unknown Iredell Lab Westmead Hospital - - - - 
27092 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
28076 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
31044 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
33023 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
33024 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
33094 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
33100 Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
35070w Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
35070y Unknown Gram Negative 16/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
38085 Unknown Gram Negative 17/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
38763 Unknown Gram Negative 18/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
39010 Unknown Gram Negative 19/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
52098 Unknown Gram Negative 20/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
53049 Unknown Gram Negative 21/6/09 Unknown  Iredell Lab Westmead Hospital + - - - 
54026 Unknown Gram Negative 22/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
54062 Unknown Gram Negative 23/6/09 Unknown  Iredell Lab Westmead Hospital - - - - 
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APPENDIX A1: Characterization of isolates used in this study 
APPENDIX A1.1 BOX-REP analysis of environmental Pseudomonads 
Genomic fingerprints were generated for all environmental Pseudomonas strains in the collection 
using PCR. Fingerprints were generated using BOX-PCR, and involved the single primer BOXA1R. 
The number and size of all bands generated using BOX-PCR were determined using the Quantity-1 
software package (BioRad). Individual bands were detected using the automatic detection function 
within Quantity-1 (green) and any undetected bands were manually flagged (yellow). Bands in each 
isolate were matched to all other bands within the individual gels.  
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Figure A1: BOXA1R fingerprinting of environmental Pseudomonads. The positive control for this 
experiment was purified PstQ gDNA and the negative control contained MQ water as the template 
(No template control NTC). Isolate names are given at the top of the gel. 
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APPENDIX A1.2 Southern hybridization detection and recovery of MIs, IS1111-attC, 
PCIs and Ps.-type attC sites 
 
Southern hybridization was used to screen both the clinical and non-clinical 
Pseudomonadaceae groups as well as the Enterobacteriaceae outgroup. All membranes were 
screen with the following probes: 
 MI probe based on pR388 551-bp  
 IS1111-attC probe based on either Pst587 or Pst405 gDNA 1340-bp in size  
 PCI probe based on PstQ gDNA 456-bp  
 Pseudomonas-type attC cocktail: composed of three different Pseudomonas attC sites from 
Ps. streamia, Ps. mendocina and Ps. stutzeri 100-bp each site. 
 
The following controls were used:  
 Pst405 
 Pst587 
 Pst595 
 PstRNAIII 
 Pst641 
 PstDNSP21 
 PsKM91 
 PsNW1 
 PA01 
 PsMB 
 Ps216.2B 
 PstQ 
 R388 (intI1) 
 Psfluro 
 Thaura (Tn7 intI2) 
 Probe: To test probe labelling efficiency 200 ng of denatured probe (IS1111-
attC/intI1/PCI/Ps.- attC) was spotted onto the membrane only where noted. 
 
Equal concentrations of 400 ng gDNA was spotted per isolate and membranes were hybridized 
against respective probes. 
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Clinical TS (n=19) and JIP (n=54) sample set: PCI and  Ps. -attC  screen 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A TS464 TS491 TS504 TS558 TS589 TS597 TS598 TS599 TS600 TS616 TS620 TS629 
B TS630 TS631 TS634 TS653 TS654 TS664 TS684 
JIP  
004 
JIP  
006 
JIP  
009 
JIP 
012 
JIP 
013 
C 
JIP  
014 
JIP 016 JIP 019 
JIP  
027 
JIP  
028 
JIP  
029 
JIP  
031 
JIP  
032 
JIP  
033 
JIP  
037 
JIP  
038 
JIP 
040 
D 
JIP  
041 
JIP  
044 
JIP 045 
JIP  
047 
JIP  
051 
JIP  
052 
JIP  
055 
JIP  
056 
JIP  
067 
JIP  
068 
JIP  
070 
JIP  
071 
E 
JIP  
072 
JIP  
073 
JIP  
079 
JIP  
080 
JIP  
104 
JIP  
106 
JIP  
108 
JIP  
111 
JIP  
112 
JIP  
113 
JIP  
116 
JIP  
117 
F JIP 118 
JIP  
119 
JIP  
120 
JIP  
122 
JIP  
124 
JIP  
132 
JIP 
134 
JIP 
136 
JIP 
137 
JIP 
 138 
JIP 
139 
JIP 
141 
Controls JIP 147 PstQ Pst595 
PstDN
SP21 
PsNW1 
PsKM
91 
PAO1 216.2B 
PstDNS
P21 
probe 
PsNW1 
probe 
PsKM
91 
probe  
 
PCI 
Ps. attC 
OUTGROUP 
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Clinical TS (n=19) sample set: MI screen (See Figure 3.4 for IS1111-attC PCR Screen) 
 
 
1 2 3 4 5 6 7 8 9 10 
A TS464 TS491 TS504 TS558 TS589 TS597 TS598 TS599 TS600 TS616 
B TS620 TS629 TS630 TS631 TS634 TS653 TS654 TS664 TS684  
Controls Pst405 Pst587 Pst595 Pst641 PsNW1 PAO1 Ps216.2B PsMB PstQ Pfluro 
Controls R388 Tn7         
Clinical (SSI n=42) sample set: MI and IS1111-attC screen 
  1 2 3 4 5 6 7 8 
A  
SSI 
1.25 
SSI  
1.48 
SSI 
1.55 
SSI 
1.58 
SSI  
1.69 
SSI  
1.90 
 
B 
SSI  
2.01 
SSI  
2.17 
SSI  
2.32 
SSI  
2.37 
SSI  
2.51 
SSI  
2.84A 
SSI  
2.87 
SSI  
2.96 
C 
SSI  
2.100 
SSI  
3.10 
SSI  
3.14 
SSI  
3.35 
SSI  
3.37 
SSI 
3.38 
SSI  
3.40 
SSI  
3.44 
D 
SSI  
3.53 
SSI  
3.62 
SSI  
3.71 
SSI  
3.72 
SSI  
3.77 
SSI 
3.86 
SSI 
3.91 
SSI  
4.32 
E 
SSI  
4.37 
SSI 
4.46 
SSI 
 4.58 
SSI 
4.62 
SSI 
4.63 
SSI  
4.69 
SSI  
4.77 
SSI  
1.95 
Controls 
SSI  
4.100 
SSI 
5.32 
SSI 
5.34 
SSI 
5.39 
Pst405 Pst587 Pst595 R388 
Controls    PsMB Pfluro    
IS1111-attC 
 MI 
Appendices 
225 
 
  
Clinical SSI (n=47) sample set: PCI and  Ps. attC screen 
  1 2 3 4 5 6 7 8 9 10 11 12 
A TS464 TS491 TS504 TS558 TS589 TS597 TS598 TS599 TS600 TS616 TS620 TS629 
B TS630 TS631 TS634 TS653 TS654 TS664 TS684 
JIP  
004 
JIP  
006 
JIP  
009 
JIP  
012 
JIP  
013 
C 
JIP  
014 
JIP  
016 
JIP 
019 
 JIP 
027 
JIP 
028 
JIP  
029 
JIP 
031 
JIP  
032 
JIP 
033 
JIP  
037 
 JIP 
038 
 JIP 
040 
D 
JIP  
041 
JIP  
044 
JIP  
045 
JIP  
047 
JIP 
051 
JIP0 
052 
JIP  
055 
JIP  
056 
JIP  
067 
JIP 
068 
JIP 
070 
 JIP 
071 
E 
JIP 
072 
JIP  
073 
JIP 
079 
JIP  
080 
JIP  
104 
JIP  
106 
JIP  
108 
JIP  
111 
JIP  
112 
 JIP  
113 
JIP  
116 
JIP  
117 
F 
JIP 
118 
JIP  
119 
JIP  
120 
JIP  
122 
JIP  
124 
SSP 
1.28 
JIP 
132 
JIP  
134 
JIP  
136 
JIP  
137 
JIP 
138 
JIP  
139 
Controls 
JIP  
141 
PstQ Pst405 
PstDN
SP21 
PsNW
1 
PsKM9
1 
PAO1 
Ps216.
2B 
PstDN
SP21 
Probe  
PsNW
1 
Probe  
PsKM
91 
Probe  
 
Ps. attC 
 PCI 
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Clinical JIP (n=53) sample set: MI and IS1111-attC screen 
  1 2 3 4 5 6 7 8 9 10 11 12 
A 
JIP  
004 
JIP  
006 
JIP 
009 
JIP 
012 
JIP 
013 
JIP 
014 
JIP  
016 
JIP  
019 
JIP  
027 
JIP  
028 
JIP  
029 
JIP  
031 
B 
JIP  
032 
JIP  
033 
JIP 
037 
JIP 
038 
JIP 
040 
JIP 
041 
JIP  
044 
JIP  
045 
JIP 
047 
JIP  
051 
JIP  
052 
JIP  
055 
C 
JIP  
056 
JIP 
067 
JIP 
068 
JIP 
070 
JIP 
071 
JIP 
072 
JIP  
073 
JIP  
079 
JIP  
080 
JIP 
104 
JIP  
106 
JIP  
108 
D 
JIP  
111 
JIP 
112 
JIP 
113 
JIP 
116 
JIP 
117 
JIP 
118 
JIP  
119 
JIP  
120 
JIP  
122 
JIP 
124 
SSI 
1.28 
JIP  
132 
E 
JIP 
134 
JIP 
136 
JIP 
137 
JIP 
138 
JIP 
139 
JIP 
141 
JIP  
147 
     
Controls Pst405 Pst587 Pst595 Pst641 PsNW1 PAO1 
Ps216.
2B 
PsMB PstQ Pfluro R388 Tn7 
MI 
IS1111-attC 
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Domestic (n=58) sample set: MI and IS1111-attC  screen 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A JM1 JM2 JM3 JM4 JM5 JM6  JM7  JM8 JM9 JM10 JM11 JS1 
B JS2 JS3 JS4 JS5 JS6 JS7 AP1 AP2 AP3 AS1 AS2 AS3 
C ES1 ES2 ES3 ES4 ES5 MS1 MS2 MS3 MS4 MS5 MS6 N1 
D NS2 NS3 NS4 NS5 NS6 NS7 NS8 LS1 LS2 LS3 LS4 LS5 
E LS6 LS7 LS8 LS9 LS10 LS11 LS12 LS13 LS14 LS15   
Controls Pst405 Pst587 Pst595 Pst641 PsNW1 PAO1 
Ps216.
2B 
PsMB PstQ Pfluro R388 Tn7 
MI 
IS1111-attC 
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Domestic (n=58) sample set: PCI screen 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A JM1 JM2 JM3 JM4 JM5 JM6  JM7  JM8 JM9 JM10 JM11 JS1 
B JS2 JS3 JS4 JS5 JS6 JS7 AP1 AP2 AP3 AS1 AS2 AS3 
C ES1 ES2 ES3 ES4 ES5 MS1 MS2 MS3 MS4 MS5 MS6 N1 
D NS2 NS3 NS4 NS5 NS6 NS7 NS8 LS1 LS2 LS3 LS4 LS5 
E LS6 LS7 LS8 LS9 LS10 LS11 LS12 LS13 LS14 LS15   
Controls Pst405 Pst587 Pst595 Pst641 PsNW1 PAO1 PsMB 
Ps21.
2B 
Psflur
o 
PstQ R388  
Domestic (n=58) same set:  Ps. attC screen 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A JM1 JM2 JM3 JM4 JM5 JM6  JM7  JM8 JM9 JM10 JM11 JS1 
B JS2 JS3 JS4 JS5 JS6 JS7 AP1 AP2 AP3 AS1 AS2 AS3 
C ES1 ES2 ES3 ES4 ES5 MS1 MS2 MS3 MS4 MS5 MS6 N1 
D NS2 NS3 NS4 NS5 NS6 NS7 NS8 LS1 LS2 LS3 LS4 LS5 
E LS6 LS7 LS8 LS9 LS10 LS11 LS12 LS13 LS14 LS15   
Controls Pst405 Pst587 Pst641 
PstDN
SP21 
PsKM9
1 
PsNW
1 
PAO1 PsMB 
Ps216
.2B 
PsNW
1 
PstQ R388 
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Domestic  FM (n=11) sample set: MI and IS1111-attC screen 
 
 
 
1 2 3 4 5 6 7 8 9 10 
A FM1 FM2 FM3 FM4 FM5 FM6 FM7 FM8 FM9 FM10 
B FM11          
Controls Pst405 Pst587 Pst595 Pst641 PsNW1 PAO1 
Ps216.
2B 
PsMB PstQ Pfluro 
Controls R388 Tn7         
Domestic FM (n=11) sample set: PCI and Ps. attC screen 
 
 
  
 1 2 3 4 5 6 7 8 9 10 11 
A FM1 FM2 FM3 FM4 FM5 FM6 FM7 FM8 FM9 FM10 FM11 
Controls PstQ Pst405 
PstDN
SP21 
PsNW1 
PsKM 
91 
R388 PAO1 PsMB 
Ps216.
2B 
 
 
Control 
Probes 
intPst
Q 
 
PstDN
SP21 
PsNW1 
PsKM 
91 
     
 
MI 
IS1111-attC 
PCI 
Ps. attC 
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Clinical P (n=6) & Clinical Environmental P (n=9) samples set: MI, IS1111-attC and Ps. attC screen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 10 
A P01 P02 P04 P05 P06 P07 P08 P09 P10 P11 
B P13 P14 P15 P17       
Controls 
Pst 
405 
Pst 
587 
Pst 
595 
Pst 
641 
PsNW1 PAO1 
Ps216.
2B 
PsMB PstQ Pfluro 
Controls R388          
MI 
 IS1111-attC 
Ps. attC 
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Note: W: white colony morphology, Y: yellow colony morphology 
  
Clinical P (n=6) & Clinical Environmental P (n=9) sample set: PCI screen 
 
 
 1 2 3 4 5 6 7 8 
A P01 P02 P04 P05 P06 P07 P08 P09 
B P10 P11 P13 P14 P15 P17   
Controls Pst405 Pst587 Pst595 Pst641 PsNW1 PAO1 
Ps216.
2B 
PsMB 
Controls PstQ Pfluro R388      
Outgroup Enterobacteriaceae  (n = 55) sample set: IS1111-attC screen 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 2045 2064 4060 6066 9023 11045 11047 13047 13090 14025 
14050 
i 
14050 
ii 
B 15025 15023 15065 15066 15084 16075 18063 18064 18084 19072 19073 20019 
C 20023 20060 20061 22041 22042 23069 24025 25077 25078 26073 27010 27023 
D 27092 28076 31044 33023 33024 33094 33100 
35070
W 
35070
Y 
38085 38763 39010 
E 52098 53049 54026 54062         
Controls Pst405 Pst587 Pst595 
RNAII
I 
PsNW1 
PsKM
91 
Ps216.
2B 
PsMB PAO1 PstQ 
Ps 
fluro 
R388 
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Outgroup Enterobacteriaceae (n = 55) sample set: MI, PCI and Ps.-attC screen 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 2045 2064 4060 6066 9023 11045 11047 13047 13090 14025 
14050 
i 
14050 
ii 
B 15025 15023 15065 15066 15084 16075 18063 18064 18084 19072 19073 20019 
C 20023 20060 20061 22041 22042 23069 24025 25077 25078 26073 27010 27023 
D 27092 28076 31044 33023 33024 33094 33100 
35070w
hite 
35070y
ellow 
38085 38763 39010 
E 52098 53049 54026 54062         
Controls Pst405 Pst595 Pst641 RNAIII PAO1 
Ps216.
2B 
PsMB 
PstDNS
P21 
PsNW
1 
PsKM 
91 
R388 PstQ 
MI 
PCI 
Ps.-attC 
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APPENDIX A1.3 PCR detection and recovery of MIs (intI1-attI1 boundaries) and IS1111-attC 
elements  
PCR was used to recover IS1111-attC as well as MI sequences from positively hybridized clinical and 
environmental Pseudomonads. 
 
Figure A5: IS1111-attC PCR screen of FM domestic sample set. Expected product size is 1340bp (red 
arrow). Primers ST87 and ST117  were used. Lanes 1-11: FM1-FM11 isolates. –ve is the PstQ 
negative control, +ve is the Pst587 gDNA positive coltrol, NTC is the no template control where MQ 
was used as template. 
 
 
 
 
 
 
 
 
 
 
 
Figure A6: MRI screen using intI1 primer pairs LW14/15 and HS914 /915. Positive control used was 
purified genomic DNA from E. coli pR388 (lane 22 in A, lane 13 in B). Expected product size is 
indicated by red arrows.  
A) Clinical Pseudomonas aeruginosa TS sample set screened with i) HS915/916 & ii) LW14/15 
primer pairs. 
B) Environmental sample FM sample set screened with HS915/916 primers. 
A) 
i) 
 
 
 
 
ii) 
 
 
 
 
B) 
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APPENDIX A1.4 Sequence alignments  
The nucleotide sequence of the putative IS and MIs were used to search the National Centre for 
Biotechnology Information (NCBI) BLAST website utilizing BLASTN program.  
https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome  
 
Multiple sequence alignment was performed using the default settings of the Geneious Alignment 
module of the Geneious 6.1.5 package, with a gap open penalty of 6 and a gap extension penalty of 3. 
The IS1111-attC alignment was generated using 65% sequence similarity setting. Alignments were 
manually optimized in the alignment editor.  Phylogenetic analyses were performed using Geneious 
Tree Builder and the Jukes-Cantor genetic distance mode. The tree building method is Neighbor-
Joining with an appropriate outgroup as the root. The tree can be seen in Chapter 3 results. 
Alignments are shown in Figures A7-A10. 
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Figure A7: Sequence alignment of IS1111-attC elements from clinical and environmental isolates. The alignment was generated using Geneious software. All 
sequences were mapped against Ps. stutzeri ATCC14405 ISPst6 sequence. Ps. aeruginosa isolates JIP, SSI, TS are all clinically relevant. Isolates AS, P05, 
P06, P13 and P15 are clinical environmental isolates. Finally isolates FM and LS are domestic environmental isolates.  
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Figure A8:  a) schematic and b) alignment of Pseudomonas stutzeri ATCC17587 ISPst6 sequence and recovered ISPst6-like from human clinical isolate 
Pseudomonas aeruginosa SSI2.84. Sequence alignment is based on 834 nucleotide bases and displays 98% (825/834) sequence identity.  
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Figure A9: Sequence alignment of intI1-attI1 recovered sequences from clinical and environmental isolates. Alignment was generated using Geneious 
software. All sequences were mapped against E. coli pR388 intI1-attI1 sequence. Ps. aeruginosa isolates JIP and SSI are clinically relevant. Isolates AP, AS, 
P06 and P07 are clinical environmental isolates. Isolates JM and LS are domestic environmental isolates and 11045 and 11047 are two enteric isolates from 
outgroup. To examine the divergence of the recovered sequences, class 3 integron sequences were also added from En. cloacae and K. pneumoniae (intI3-
attI3). Note IS4-like insertion in isolates St. maltophilia iso. AP2.  SNPs at positions 113, 263, 268 and 288 are marked by red asterisks.  
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Figure A10: SNP comparison between clinical isolates JIP052 and TS491, class 1 integron In109 and 
class 1 integron In3 type sequence.  
 
  
 SNP Positions: 263       268                            288 
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Appendix A1.5 Fosmid library construction and screening 
To determine the genetic context of IS1111-attC elements in two clinical (SSI2.84 and 
JIP117) and three environmental Pseudomonas (JM2, JM6 and LS5) isolates, large-insert 
clone/fosmid libraries were constructed. See below for library construction methodology. 
 
A1.5.1 Obtaining high molecular weight DNA for fosmid by ISOLATE genomic DNA 
kit by Bioline.  
The ISOLATE Genomic DNA Mini Kit from Bioline was used to extract high molecular 
DNA for the construction of fosmids. Adequate yields ranging from 100 ng/µL to 300 ng/µL 
of gDNA were obtained (as estimated by gel electrophoresis). More importantly, the 
extracted gDNA was found to be of the correct size range of 20-40-kb (Figure A11). As a 
result there was no need for additional DNA shearing or separation by PFGE. The obtained 
gDNA was subsequently used for fosmid construction. 
 
Figure A11: Gel electrophoresis analysis confirms presence of high molecular weight genomic DNA 
for clinical isolates Pseudomonas aeruginosa JIP117 and SSI2.84 as well as environmental isolates 
LS5, JM2 and JM6. Fosmid control DNA is 42-kb in size and supplied as 100 ng/µL (supplied by 
Epicenter). 
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A1.5.2 Whole plate screening using ISPst6 as a probe 
1920 fosmid clones across the five fosmid libraries were screened for IS1111-attC using a 
pooled column approach as represented in methods section 2.10 (Figure A12). Each positive 
spot on a southern hybridization corresponded to one column in the 96-well plate. Each 
column consisted of 8 different fosmid clones. Once a positive column is identified, the 
southern hybridization screen was repeated, wherein all of the individual fosmid clones were 
spotted to identify the clone carrying the IS. Southern hybridization using the Pseudomonas 
ISPst6 probe indicated the presence of ISs in all 5 fosmid libraries. 
 
Genomic DNA derived from Pseudomonas stutzeri ATCC17587 (Pst587), was used as the 
positive control for the IS1111-attC and hybridized intensely at all times. Pseudomonas 
aeruginosa PAO1 also produced a hybridization signal as it has six transposase genes as part 
of it genome, Pseudomonas stutzeri DNSP21 was also found to be positive. E. coli plasmid 
R388 DNA, Pseudomonas stutzeri st. Q (PstQ), and Pseudomonas mendocina KM91 are 
IS1111-attC element negative and did not produce a hybridization signal as expected. For the 
JIP117 fosmid screen, genomic DNA from the original Pseudomonas isolates was spotted as 
an additional control.  
 
For the JIP117 library, southern hybridization was performed under very stringent conditions 
(60oC hybridization, 65oC wash temperature in 1x SSC buffer). Consequently, only two of 
the positive controls (Pst587 and MB216.2B) gave a positive signal but the expected genomic 
DNA did not. Despite the stringent conditions, 36 of the 48 screened columns hybridized 
strongly to the IS1111-attC probe. 
 
Additionally, the pooled columns in all five fosmid libraries were hybridized against a mobile 
class 1 integron probe as per conditions applied in Chapter 3 (Figure A13). Individual 
columns across all fosmid libraries were identified as being positive for a class 1 integron 
probe but were not perused further, as the primary goal was to identify fosmid clones with 
IS1111-attC elements. 
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Figure A12: Screening pooled fosmid columns with an IS1111-attC probe across five fosmid libraries. 
The probe used was an intact ~1.3-kb ISPst6 generated from Pst587 gDNA. Top left: JM2 fosmid 
library, top right: JM6 fosmid library; bottom left: SSI2.84 and LS5 libraries and bottom right: 
JIP117 fosmid library screen.  
 
 
 
Figure A13: Pooled column screen for MRIs.  
Based on a 516-bp probe using LW14 and LW15 primers and E. coli pR388 intI1 as template DNA. 
All controls other than PstKM91 and PStQ should be hybridizing and producing a signal for the MI 
probe. JM2C44, JM6C14 and JM6C39 were of interest. LS5C2 and SSI2.84C9 were of interested. 
Individual clones were screened for presence of the MI. 
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A1.5.3 Estimation of genomic coverage based on fosmid insert size. 
For each library, five or more clones were selected at random in order to estimate the average 
insert size and genomic coverage of each library. This was achieved by purifying the selected 
fosmid constructs and performing a BamHI restriction digest (Figure A14). The size of each 
clone was estimated by adding the sizes of all bands observed after electrophoresis in a 1.2% 
agarose gel. The genomic coverage of each library was estimated by calculating the total 
amount of DNA (in megabases) present in each library and dividing this total by the 
estimated total genome size of the relevant strain.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure A14: BamHI digest of randomly selected as well as IS1111-attC identified fosmid clones for 
each strain for which fosmid libraries were constructed.  
A band of ~8.1-kb is present in every fosmid digest and represents the entire fosmid vector 
pCC1FOS™. The remaining bands in each lane represent the cloned DNA. The sum of these bands 
gives the size for each clone. An average insert size of 30-kb was assumed for all fosmids clones. 
Arrows point to fosmids chosen for further analysis. 
 
8.1-kb 
vector 
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A1.5.4 IS1111-attC and mobile integron screen in fosmid clones of interest 
Preliminary attempts to screen the 1920 fosmid clones via IS1111-attC and MI PCR resulted in non-
specific PCR products being generated. Hence southern hybridization was used as a primary means of 
identifying IS positive fosmid clones. Once identified, IS1111-attC primers (ST87 and ST117) were 
used to screen for the presence of an IS from purified fosmid DNA. Interestingly this PCR was 
successful for the fosmid clones screened, with no instances of misprimed products such as those seen 
when genomic DNA was used as the PCR template.  This observation is hypothesized to be due to the 
reduced amount of potential mispriming targets available in the small clones (~30-kb) compared to 
entire genomes (~4-Mb).   
 
 
Figure A15: IS1111-attC PCR screen in purified fosmid clones.  
Expected product size is 1.3-kb. Pst587 was used as IS1111-attC positive control. NTC is the no 
template control where MQ was used as template. Expected product size was 1.3-kb. Note JM2C44G 
has 10x more gDNA than JM2C44G (100ng). When less gDNA is used as PCR template, the bands at 
1.5 and 1.0-kb are not obsereved. 
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A1.5.5 Scale diagrams of individual fosmid contigs 
In each array diagram all features are shown to scale (arrays are not to scale relative to each 
other).  Presence of ORFs was predicted using Glimmer plug-in in Geneious. ORFs were 
NCBI BLAST searched. The names of original isolate, size of contig as well as contig 
number are shown below the annotated array.  
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Figure A16:   Individual contig reads as assembled  by Macrogen and validated by raw read de novo 
assembly.  
All orfs were predicted using Glimmer plug-in in Geneious. Contig maps were generated using 
SnapGene.  
Appendices 
264 
 
A1.5.6 Scale diagrams of de novo assembled contigs  
Each array shown below is the product of de novo assembly of the individual contigs shown 
earlier in section A1.5.5. All contigs were assembled using de novo assembly function in 
Geneious using stringent assembly conditions outlined in Table A5. In each array diagram all 
features are shown to scale however arrays are not to scale relative to each other.  Presence of 
ORFs were predicted using the Glimmer plug-in in Geneious. ORFs were NCBI BLAST 
searched. The names of original isolate, size of contig as well as contig number are shown 
below the annotated array. For fosmids JM2 and SSI2.84, a continuous contig could not be 
generated. For LS5 and JIP117, two continuous contigs were generated.  
 
Table A5: Stringent conditions for de novo assembly using Geneious 
Condition Setting 
Maximum gaps per read  20% 
Maximum overlap 100bp 
Word length 10 
Ignore words repeated more than x times 1000 
Maximum mismatch per read 50% 
Maximum gap size 5 
Minimum overlap identity 80% 
Index word length 10 
Reanalyse threshold 0 
Maximum ambiguity 16 
Use paired read distances to improve assembly Activated 
Do not merge contigs where here is a variant with coverage over x ~6 
Merge homopolymer variants Activated 
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Figure A17: de novo assembled contigs based on individual contigs sequenced by Macrogen, Korea.  
Orfs were predicted using Glimmer plug-in in Geneious. Maps were constructed using SnapGene. 
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A1.5.7 Assigning orfs for all contig reads: see table A6 
All orfs from the SSI284 and JIP117 libraries had high sequence identity to previously characterised 
orfs from various Ps. aeruginosa strains.  The majority of the orfs from these two fosmid clones 
showed homology to transporter and secretion proteins, heat shock proteins, chaperone, kinases as 
well as proteases to name a few.  SSI2.84C9H orfs contain nine hypothetical proteins whereas 
JIP117C34A had none. These hypothetical proteins are not homologous to an IS1111-attC 
transposase gene or protein. Note, JIP117C34A contig 1 orf7 has a 99% (1042/1043bp) homology to a 
recombinase from Ps. aeruginosa YL84.  
 
All thirty-six orfs from LS5C2E contigs showed sequence homology either to St. maltophilia K27a or 
St. maltophilia D457. None of the identified orfs matched an IS1111-attC transposase or any other 
recombinase enzyme. orfs showed high homology to  transmembrane signaling regulatory proteins, 
malonate decarboxylase subunits, coenzymeA synthases as well as five conserved hypothetical 
proteins to name a few. 
 
Fosmid clones JM2C44G and JM6C39D were generated using Ps. alcaligenes genomic DNA. 
Surprisingly, none of the 42 orfs from the JM2C44G or the 35 orfs from JM6C39D showed sequence 
homology to any Ps. alcaligenes sequence information in NCBI.  Instead, these orfs displayed high 
homology to various Ps. resinovorans genes. This is perhaps to be expected given that Ps. 
resinovorans and Ps. alcaligenes cluster together based on their 16S rRNA DNA (Spilker et al., 
2004). Orfs were also identified as matching other Pseudomonas species. JM2C44G contig 19 orf8 
had a 74% (574/779) identity to a Mo regulatory and gene from Azotobacter vinlandii CA. Contig 20 
orf8 was 75% (50/67) identical to a hypothetical protein from Thermobispora bispora DSM43833 and 
orf10 was 82% (406/496) identical to Azotobacter vinelandii phosphogluconate dehydratase. Finally, 
orf15 had a 73% (180/246) sequence homology to a transcriptional regulator from the AraC family in 
Burkholderia sp.383.  
 
Similarly, JM6C39D contained orf24 that had a 77% (141/182) identity to a putative histidinol-
phosphate phosphatase from Sphingomonas wittichii RW1. Orf25 was 74% (895/1215) identical to a 
membrane protein in Serratia marcescens. Orf28 was 74% (145/195) identical to a hypothetical 
protein in Kitasatospora setae KM-6054, orfs 29 and 30 had an 80% (498/625) and 78% (679/874) 
homology to an Achromobacter xylosoxidans A8 nitroreductase protein and a regulatory helix-turn-
helix protein respectively. As with the previous three fosmid clones, none of the orfs in either 
JM2C44G or JM6C39H fosmid clones showed sequence homology to any IS elements.   
Appendices 
269 
 
Table A6: BLASTn Hits for predicted orfs across the five libraries 
ID BLASTN hit Organism 
Accession 
number 
% identity E-value 
Pseudomonas aeruginosa isolate SSI2.84 fosmid SSI2.84C9H contig 7 (size 7150-bp) 
orf1 
tRNA 2-selenouridine synthase/ glutathione-
dependent formaldehyde-activating protein 
Ps. aeruginosa PA3818 HG530068.1 582/585(99%) 0 
orf2 Hypothetical protein Ps. aeruginosa M18 CP002496.1 609/609(100%) 0 
orf3 Hypothetical Protein Ps. aeruginosa LES431  CP006937.1 426/426(100%) 0 
orf4 putative sulfate transporter/ chemotaxis transducer Ps. aeruginosa DK2 
CP003149.1 
 
1952/1959(99%) 0 
orf5 
Sulfate permease/ Methyl-accepting chemotaxis 
protein I (serine chemoreceptor) 
Ps. aeruginosa SCV20265 CP006931.1 1536/1542(99%) 0 
orf6 NADP-dependent oxidoreductase Ps. aeruginosa YL84 CP007147.1 1001/1005(99%) 0 
Pseudomonas aeruginosa isolate SSI2.84 fosmid SSI2.84C9H contig 8 (size 27984-bp) 
orf1 
N5-glutamine-S-adenosyl-L-methionine-
dependent methyltransferase  
Ps. aeruginosa RP73 CP006245.1 936/936(100%) 0 
orf2 Isochorismatase Ps. aeruginosa SCV20265  CP006931.1 596/597(99%) 0 
orf3 hypothetical protein Ps. aeruginosa YL84 CP007147.1 321/321(100%) 3E-162 
orf4 DNA mismatch repair protein MutS Ps. aeruginosa YL84 CP007147.1 558/558(100%) 0 
orf5 GTP cyclohydrolase I Ps. aeruginosa PA38182  HG530068.1   546/546(100%) 0 
orf6 hypothetical protein Ps. eruginosa LES431 CP006937.1 462/462(100%)  0 
orf7 hypothetical protein Ps. aeruginosa RP73  CP006245.1 381/381(100%) 0 
orf8 serine/threonine protein kinase Ps. aeruginosa YL84 CP007147.1 989/990(99%) 0 
orf9 
IcmF-related protein Serine/threonine protein 
phosphatase 
Ps. aeruginosa PA1R CP004055.1 724/729(99%) 0 
orf10 serine/threonine phosphoprotein phosphatase Stp1 Ps. aeruginosa M18 CP002496.1 3506/3528(99%) 0 
orf11 putative outer membrane  protein Ps. aeruginosa PA38182  HG530068.1 869/870(99%) 0 
orf12 protein ImpJ Ps. aeruginosa PA38182 HG530068.1 1330/1332(99%) 0 
orf13 type VI secretion protein Ps. aeruginosa LES431  CP006937.1 468/468(100%) 0 
orf14 FHA domain protein Ps. aeruginosa PAO1-VE13  CP006832.1 1191/1194(99%) 0 
orf15 hypothetical protein Ps. aeruginosa PA38182  HG530068.1 117/117(100%) 6E-52 
orf16 putative transcriptional regulator Ps. aeruginosa PA38182  HG530068.1 1508/1512(99%) 0 
orf17 putative ClpA/B-type protease Ps. aeruginosa M18 CP002496.1 2130/2133(99%) 0 
orf18 putative ClpA/B-type protease Ps. aeruginosa PA38182  HG530068.1  314/315(99%) 3E-156 
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orf19 hypothetical protein Ps. aeruginosa PAO1-VE13  CP006832.1 1006/1008(99%) 0 
orf20 hypothetical protein Ps. aeruginosa DK2 CP003149.1 1785/1788(99%) 0 
orf21 Uncharacterized protein Ps. aeruginosa SCV20265 CP006931.1 408/408(100%) 0 
orf22 type VI secretion system Ps. aeruginosa LES431 CP006937.1 1475/1476(99%) 0 
orf23 hypothetical protein Ps. aeruginosa YL84 CP007147.1 507/507(100%) 0 
orf24 type VI secretion system ImpA Ps. aeruginosa LES431   CP006937.1 1178/1179(99%) 0 
orf25 glutathione S-transferase Ps. aeruginosa YL84 CP007147.1  603/603(100%) 0 
orf26 
Transcriptional regulators containing a DNA-
binding HTH domain and an aminotransferase 
domain (MocR family)  
Ps. aeruginosa PA1R 
 
CP004055.1 764/765(99%) 0 
Pseudomonas aeruginosa isolate JIP117 fosmid JIP117C34A contig 1 (size 17787-bp) 
orf1 Leucine export protein LeuE  Ps. aeruginosa LESlike4 CP006985.1 611/612(99%) 0 
orf2 carbamoyl phosphate synthase small subunit Ps. aeruginosa YL84 CP007147.1   1132/1137(99%) 0 
orf3 dihydrodipicolinate reductase Ps. aeruginosa PAO1-VE13  CP006832.1  786/789(99%) 0 
orf4 molecular chaperone DnaJ Ps. aeruginosa RP73 CP006245.1 1133/1134(99%) 0 
orf5 chaperone protein DnaK Ps. aeruginosa c7447m CP006728.1  1877/1878(99%) 0 
orf6 heat shock protein GrpE Ps. aeruginosa MTB-1 CP006853.1 560/561(99%) 0 
orf7 Recombinase Ps. aeruginosa YL84  CP007147.1 1042/1043(99%) 0 
orf8 DNA repair protein RecN Ps. aeruginosa PA1R CP004055.1 801/804(99%) 0 
orf9 Fur family transcriptional regulator Ps. aeruginosa YL84 CP007147.1 366/366(100%) 0 
orf10 outer membrane lipoprotein OmlA Ps. aeruginosa PA38182 HG530068.1 531/531(100%) 0 
orf11 putative lipid transport protein Ps. aeruginosa PA38182 HG530068.1   306/306(100%) 5E-158 
orf12 ribosome association toxin RatA Ps. aeruginosa LESlike4  CP006985.1   435/435(100%) 0 
orf13 SsrA-binding protein Ps. aeruginosa YL84 CP007147.1   480/480(100%) 0 
orf14 
Lactate-responsive regulator LldR in 
Enterobacteria 
Ps. aeruginosa PA1R CP004055.1 276/276(100%) 2E-141 
orf15 diguanylate cyclase domain protein Ps. aeruginosa PAO1-VE13  CP006832.1 1875/1877(99%) 0 
orf16 beta-D-glucoside glucohydrolase Ps. aeruginosa DK2 CP003149.1 1877/1877(100%) 0 
orf17 type III secretion system protein Ps. aeruginosa LESlike4  CP006985.1   645/645(100%) 0 
orf18 type III export protein PscK Ps. aeruginosa LESlike4  CP006985.1  548/549(99%) 0 
Pseudomonas aeruginosa isolate JIP117 fosmid JIP117C34A contig 2 (size 11646-bp) 
orf1 RNA-binding protein Ps. aeruginosa LESlike4  CP006985.1 432/432(100%) 0 
orf2 preprotein translocase G Ps. aeruginosa LESlike4  CP006985.1 348/348(100%) 0 
orf3 exoenzyme S secretion (psc) locus pscF Ps. aeruginosa PAU56077 258/258(100%) 2E-131 
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orf4 exoenzyme S secretion (psc) locus pscE Ps. aeruginosa PA38182  HG530068.1 201/201(100%) 8E-100 
orf5 
Type III secretion inner membrane protein (YscD, 
flagellar export components) 
Ps. aeruginosa PA1R 
 
CP004055.1   1299/1299(100%) 0 
orf6 exoenzyme S secretion (psc) locus pscC Ps. aeruginosa PAU56077 1803/1803(100%) 0 
orf7 type III export apparatus protein Ps. aeruginosa LESlike4 CP006985.1  201/204(99% 2E-96 
orf8 exoenzyme S secretion (psc) locus exsD Ps. aeruginosa PAU56077 792/792(100%) 0 
orf9 AraC family transcriptional regulator Ps. aeruginosa MTB-1  CP006853.1  837/837(100%) 0 
orf10 exoenzyme S secretion (psc) locus exsE Ps. aeruginosa YL84 CP007147.1 246/246(100%) 1E-124 
orf11 glycosyl transferase Ps. aeruginosa LESlike4  CP006985.1 438/438(100%) 0 
orf12 pepD gene Ps. aeruginosa c7447m CP006728.1  888/888(100%) 0 
orf13 Type III secretion host injection protein (YopB)  Ps. aeruginosa PA1R CP004055.1 1131/1131(100%) 0 
orf14 pcrH genes Ps. aeruginosa AF010149.1 507/507(100%) 0 
orf15 pcrV gene Ps. aeruginosa AF010149.1 591/591(100%) 0 
Pseudomonas alcaligenes isolate JM2 fosmid JM2C44G contig 18 (size 7704-bp) 
orf1 putative aspartate-semialdehyde dehydrogenase 
Ps. resinovorans NBRC 106553 
DNA 
AP013068.1 767/1024(75%) 0 
orf2 Hypothetical protein 
Ps. resinovorans NBRC 106553 
DNA 
AP013068.1 2181/2991(73%) 0 
orf3 tRNA pseudouridine synthase A Ps. fulva 12-X CP002727.1 679/820(83%) 0 
orf4 N-(5′-phosphoribosyl)anthranilate isomerase Ps. aeruginosa RP73  CP006245.1   466/611(76%) 5E-119 
orf5 sensor histidine kinase Ps. poae RE*1-1-14 CP004045.1  33/41(80%) 9.8 
orf6 
acetyl-CoA carboxylase carboxyltransferase beta 
subunit folylpolyglutamate synthetase 
Ps. resinovorans NBRC 106553 
DNA 
AP013068.1 777/887(88%) 0 
Pseudomonas alcaligenes isolate JM2 fosmid JM2C44G contig 19 (size 9337-bp) 
orf1 ABC transporter permease Ps. aeruginosa YL84  CP007147.1 840/1175(71%) 4E-150 
orf2 
macrolide export ATP-binding/permease protein 
MacB 
Ps. protegens CHA0 CP003190.1 529/674(78%) 1E-153 
orf3 TPR domain protein Ps. protegens CHA0 CP003190.1 45/56(80%) 0.021 
orf4 ubiquinone biosynthesis protein UbiB Ps. sp. TKP CP006852.1 171/246(70%) 4E-18 
orf5 Hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  263/316(83%) 1E-85 
orf6 Hypothetical protein Ps. sp. TKP CP006852.1 216/326(66%) 3E-11 
orf7 molybdenum-pterin-binding protein MopA Ps. protegens CHA0 CP003190.1 332/431(77%) 2E-84 
orf8 Mo regulation, Mo processing homeostasis Azotobacter vinelandii CA CP005094.1 574/779(74%) 9E-124 
Appendices 
272 
 
orf9 Hypothetical protein Ps. protegens CHA0 CP003190.1 526/738(71%) 5E-95 
orf10 
Shikimate dehydrogenase substrate binding 
domain protein 
Ps. fulva 12-X CP002727.1 592/776(76%)  1E-154 
Pseudomonas alcaligenes isolate JM2 fosmid JM2C44G contig 20 (size 33528-bp) 
orf1 UTP--glucose-1-phosphate uridylyltransferase Ps. resinovorans NBRC 106553  AP013068.1  720/774(93%) 0 
orf2 Hypothetical protein  Ps. resinovorans NBRC 106553  AP013068.1  354/419(84%) 9E-127 
orf3  glutathione reductase Ps. resinovorans NBRC 106553  AP013068.1  1170/1352(87%) 0 
orf4 hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  519/624(83%) 0 
orf5 
putative hydroxymethylpyrimidine transporter 
CytX 
Ps. putida DOT-T1E CP003734.1 48/60(80%) 5E-4 
orf6 hypothetical protein; putative signal peptide Ps. entomophila str. L48  CT573326.1 222/305(73%) 4E-34 
orf7 putative hydrolase Ps. resinovorans NBRC 106553  AP013068.1  658/800(82%) 0 
orf8 hypothetical protein 
Thermobispora bispora DSM 
43833  
CP001874.1 50/67(75%) 0.27 
orf9 6-phosphogluconate dehydratase Ps. resinovorans NBRC 106553  AP013068.1  1164/1360(86%) 0 
orf10 phosphogluconate dehydratase Azotobacter vinelandii  CP005095.1 406/496(82%) 8E-135 
orf11 Glucokinase Ps. stutzeri RCH2 CP003071.1 716/954(75%) 2E-172 
orf12 Two-component response regulator GltR 
Ps. stutzeri ATCC 17588 = LMG 
11199  
CP002881.1 610/725(84%) 0 
orf13 
integral membrane sensor signal transduction 
histidine kinase 
Ps. mendocina ymp CP000680.1 1188/1406(84%) 0 
orf14 ABC transporter ATP-binding protein Ps. sp. TKP CP006852.1  33/37(89%) 0.044 
orf15 transcriptional regulator, AraC family Burkholderia sp. 383 CP000152.1 180/246(73%) 7E-25 
orf16 glucose-binding protein Ps. mendocina ymp CP000680.1 1033/1254(82%) 0 
orf17 glucose ABC transporter membrane protein Ps. mendocina ymp CP000680.1 813/907(90%) 0 
orf18 glucose ABC transporter membrane protein Ps. mendocina ymp CP000680.1 738/819(90%) 0 
orf19 
sn-glycerol-3-phosphate import ATP-binding 
protein UgpC 
Ps. protegens CHA0 CP003190.1 723/813(89%) 0 
orf20 ABC transporter, ATP-binding component 
Ps. brassicacearum subsp. 
brassicacearum NFM421 
CP002585.1  242/322(75%) 7E-51 
orf21 porin, LamB type Aldose 1-epimerase Ps. mendocina ymp CP000680.1 972/1149(85%) 0 
orf22 Aldose 1-epimerase Ps. mendocina ymp CP000680.1 572/783(73%) 2E-113 
orf23 RpiR family transcriptional regulator HexR Ps. resinovorans NBRC 106553  AP013068.1  791/870(91%) 0 
orf24 glucose-6-phosphate 1-dehydrogenas Ps. resinovorans NBRC 106553  AP013068.1  1224/1436(85%) 0 
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orf25 
glucose-6-phosphate 1-dehydrogenase 
6-phosphogluconolactonase 
Ps. resinovorans NBRC 106553  AP013068.1 516/651(79%) 7E-156 
orf26 DNA 6-phosphogluconolactonase Ps. resinovorans NBRC 106553  AP013068.1  94/116(81%) 1E-21 
orf27 
2-dehydro-3-deoxy-phosphogluconate/4-hydroxy-
2-oxoglutarate aldolase 
Ps. resinovorans NBRC 106553  AP013068.1  538/654(82%) 9E-180 
orf28 glyceraldehyde-3-phosphate dehydrogenase Ps. denitrificans ATCC 13867 CP004143.1 1386/1600(87%) 0 
orf29 fructose transport system repressor FruR Ps. resinovorans NBRC 106553  
AP013068.1  
 
753/963(78%) 0 
orf30 
fructose-specific phosphotransferase system 
enzyme IIA/HPr/I component 
Ps. resinovorans NBRC 106553  
AP013068.1  
 
1412/1886(75%) 0 
orf31 
fructose-specific phosphotransferase system 
enzyme IIA/HP component 1-
phosphofructokinase 
Ps. resinovorans NBRC 106553  
AP013068.1  
 
730/960(76%) 0 
orf32 
fructose-specific phosphotransferase system 
enzyme IIBC component 
Ps. resinovorans NBRC 106553  
AP013068.1  
 
495/635(78%) 1E-139 
Pseudomonas alcaligenes isolate JM6 fosmid JM6C39D contig 1 (size 38602-bp) 
orf1 Hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  230/254(91%) 1E-88 
orf2 
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino) 
methylideneamino] imidazole-4-carboxamide 
isomerase 
Ps. resinovorans NBRC 106553  AP013068.1  684/719(95%) 0 
orf3 
imidazole glycerol phosphate synthase subunit 
HisF 
Ps. resinovorans NBRC 106553  AP013068.1  698/771(91%) 0 
orf4 putative ABC transporter substrate-binding protein Ps. resinovorans NBRC 106553 AP013068.1  592/721(82%) 8E-170 
orf5 putative ABC transporter substrate-binding protein Ps. resinovorans NBRC 106553  AP013068.1  670/755(89%) 0 
orf6 hypothetical protein Ps. aeruginosa RP73 CP006245.1 786/1122(70%) 7E-29 
orf7 hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  572/681(84%) 0 
orf8 putative S41 family peptidase Ps. resinovorans NBRC 106553  AP013068.1  1162/1335(87%) 0 
orf9 peptidase M23 family protein Ps. resinovorans NBRC 106553  
AP013068.1  
 
1038/1273(82%) 0 
orf10 
2,3-bisphosphoglycerate-independent-
phosphoglycerate mutase 
Ps. resinovorans NBRC 106553  
AP013068.1  
 
1403/1539(91%) 0 
orf11 hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  341/415(82%) 2E-94 
orf12 glutaredoxin 3 Ps. fulva 12-X CP002727.1 210/249(84%) 1E-59 
orf13 protein-export protein SecB Ps. resinovorans NBRC 106553  AP013068.1  398/439(91%) 2E-163 
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orf14 |tRNA (cytidine(34)-2'-O)-methyltransferase Ps. resinovorans NBRC 106553  AP013068.1  408/463(88%) 8E-153 
orf15 conserved hypothetical protein Ps. putida GB-1 CP000926.1|  219/313(70%) 1E-28 
orf16 
two-component histidine kinase NtrB 
two-component response regulator NtrC 
Ps. resinovorans NBRC 106553  AP013068.1  1316/1437(92%) 0 
orf17 
two-component histidine kinase NtrB 
two-component response regulator NtrC 
Ps. resinovorans NBRC 106553  AP013068.1  982/1086(90%) 0 
orf18 hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  467/580(81%) 4E-146 
orf19 hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  400/545(73%) 3E-77 
orf20 glutamine synthetase Ps. denitrificans ATCC 13867 CP004143.1 1312/1410(93%) 0 
orf21 Glutamine synthase Ps. denitrificans ATCC 13867 CP004143.1 1312/1410(93%) 0 
orf22 tRNA sulfurtransferase Ps. resinovorans NBRC 106553  AP013068.1  1292/1461(88%) 0 
orf23 GTP-binding protein TypA Ps. resinovorans NBRC 106553   AP013068.1  1735/1818(95%) 0 
orf24 histidinol-phosphate phosphatase, putative Sphingomonas wittichii RW1 CP000699.1 141/182(77%) 8E-16 
orf25 membrane protein regulates uhpT expression 
Serratia marcescens subsp. 
marcescens Db11 
HG326223.1  895/1215(74%) 4E-115 
orf26 Uncharacterized protein family UPF0126 Ps. fulva 12-X  CP002727.1 143/197(73%) 0 
orf27 methyl-accepting chemotaxis protein Ps. mendocina NK-01 CP002620.1  1377/1643(84%) 0 
orf28 hypothetical protein Kitasatospora setae KM-6054 AP010968.1 145/195(74%) 1E-9 
orf29 nitroreductase family protein 4 Achromobacter xylosoxidans A8 CP002287.1 498/625(80%) 3E-119 
orf30 
Bacterial regulatory helix-turn-helix protein, LysR 
family 
Achromobacter xylosoxidans A8 CP002287.1 679/874(78%) 9E-141 
orf31 Elastase LasB Ps. aeruginosa PA7 CP000744.1 769/971(79%) 0 
orf32 Cell division protein Ps. brassicacearum strain DF41 CP007410.1 317/436(73%) 1E-56 
orf33 hypothetical protein Ps. resinovorans NBRC 106553 AP013068.1  1389/1695(82%) 0 
orf34 hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  722/876(82%) 0 
orf35 hypothetical protein Ps. resinovorans NBRC 106553  AP013068.1  336/389(86%) 1E-115 
Stenotrophomonas maltophilia isolate LS5 fosmid LS5C2E contig 1(size 14241-bp) 
orf1 putative malate:quinone oxidoreductase St. maltophilia K279a AM743169.1 548/549(99%) 0 
orf2 
putative TonB-dependent receptor for Fe(III)-
coprogen, Fe(III)-ferrioxamine B and Fe(III)-
rhodotrulic acid 
St. maltophilia K279a AM743169.1 1869/1879(99%) 0 
orf3 putative malonate decarboxylase alpha-subunit St. maltophilia K279a AM743169.1 1624/1644(99%) 0 
orf4 Malonate decarboxylase delta subunit St. maltophilia D457 HE798556.1 318/321(99%) 3E-161 
orf5 Malonate decarboxylase beta subunit St. maltophilia D457 HE798556.1 857/873(98%) 0 
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orf6 putative malonate decarboxylase gamma-subunit St. maltophilia K279a AM743169.1 711/711(100%) 0 
orf7 putative coenzyme-A synthase St. maltophilia K279a AM743169.1 988/1014(97%) 0 
orf8 
putative malonyl CoA-acyl carrier protein 
transacylase 
St. maltophilia K279a AM743169.1 881/922(96%) 0 
orf9 
putative transmembrane dicarboxylate carrier 
protein 
St. maltophilia K279a AM743169.1 1351/1368(99%) 0 
Stenotrophomonas maltophilia isolate LS5 fosmid LS5C2E contig 1(size 14241-bp) 
orf1 
putative transmembrane GGDEF domain 
signalling protein 
St. maltophilia K279a AM743169.1 190/191(99%) 1E-92 
orf2 
putative transmembrane GGDEF domain 
signalling protein 
St. maltophilia K279a AM743169.1 124/126(98%) 5E-55 
orf3 
putative transmembrane GGDEF domain 
signalling protein 
St. maltophilia K279a AM743169.1 960/966(99%) 0 
orf4 
putative transmembrane GGDEF signalling 
regulatory protein 
St. maltophilia K279a AM743169.1 1504/1506(99%) 0 
orf5 
putative transmembrane GGDEF signalling 
regulatory protein 
St. maltophilia K279a AM743169.1 258/258(100%) 2E-131 
orf6 putative thioesterase St. maltophilia K279a AM743169.1 507/507(100%) 0 
orf7 putative transmembrane protein St. maltophilia K279a AM743169.1 435/435(100%) 0 
orf8 conserved hypothetical protein St. maltophilia K279a AM743169.1 432/432(100%) 0 
orf9 conserved hypothetical protein St. maltophilia K279a AM743169.1 1381/1395(99%) 0 
orf10 transcriptional regulator, ArsR family St. maltophilia D457 HE798556.1 307/310(99%) 3E-155 
orf11 conserved hypothetical exported protein St. maltophilia K279a AM743169.1 576/582(99%) 0 
orf12 putative transmembrane protein St. maltophilia K279a AM743169.1 466/468(99%) 0 
orf13 putative DNA-binding protein St. maltophilia K279a AM743169.1 224/225(99%) 2E-111 
orf14 
putative transmembrane transporter domain 
protein 
St. maltophilia K279a AM743169.1 1520/1539(99%) 0 
orf15 putative transmembrane phosphoesterase St. maltophilia K279a AM743169.1 1108/1128(98%) 0 
orf16 putative transmembrane protein St. maltophilia K279a AM743169.1 635/639(99%) 0 
orf17 conserved hypothetical protein St. maltophilia K279a AM743169.1 705/736(96%) 0 
orf18 conserved hypothetical protein St. maltophilia K279a AM743169.1 827/846(98%) 0 
orf19 conserved hypothetical protein St. maltophilia K279a AM743169.1 471/477(99%) 0 
orf20 putative transmembrane DoxX family protein St. maltophilia K279a AM743169.1 623/646(96%) 0 
orf21 Probable signal peptide protein St. maltophilia D457 HE798556.1 775/792(98%) 0 
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orf22 putative exported thioredoxin St. maltophilia K279a AM743169.1 520/546(95%) 0 
orf23 
putative two-component response regulator 
transcriptional regulatory protein 
St. maltophilia K279a AM743169.1 739/741(99%) 0 
orf24 
putative transmembrane sensor histidine kinase 
transcriptional regulatory protein 
St. maltophilia K279a AM743169.1 1298/1314(99%) 0 
orf25 putative exported protein St. maltophilia K279a AM743169.1 978/1014(96%) 0 
orf26 putative Major Facilitator Superfamily transporter St. maltophilia K279a AM743169.1 1230/1260(98%) 0 
orf27 
putative inosine-uridine preferring nucleoside 
hydrolase 
St. maltophilia K279a AM743169.1 508/513(99%) 0 
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A1.5.8 Assembled contigs aligned against Pseudomonas genomes 
To validate contig assembly and predicted orf identities for all five fosmid clones, contigs were 
aligned against genome sequences of Ps. aeruginosa PAO1 (NC_002516), Ps. resinovorans 
(NC_021499), and Ps. mendocina ymp (NC_009439). Alignments were generated using the Geneious 
Software package and up to 5 iterations were performed per alignment.  
 
For fosmid clone JIP117F34A, contigs 12-17 were aligned against the completed Ps. aeruginosa 
PAO1 genome. The contigs align with extensive synteny at 2 loci, separated by 3-Mb to the reference 
genome. Similarly, SSI284C9H contigs align with greater than 90% mean identity to one loci within 
PAO1 genome with a 4-kb deletion between the contigs within this loci in the original Ps. aeruginosa 
SSI2.84 isolate.  
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Figure A18: Genome mapping of JM2 and JM6 contigs against Ps. resinovorans NBC (NC_021499) 
A) JIP117 fosmid contigs 12-17 aligned against Ps. aeruginosa PAO1 genome (NC_002516). 
Contigs 14, 15 and 16 aligned between the 1 852 294-1 865 423bp region. Contigs 12, 13 and 17 
align between 5 343 156-5 361 217bp. Orange stretches indicated predicted orfs in contigs. Blue 
arrows indicate position of putative transposase in PAO1 genome. 
B) SSI284 fosmid contigs 7 and 8 aligned against Ps. aeruginosa PAO1 (NC_002516). A 4-kb 
deletion separates the contigs   
C) LS5C2E contigs align with greater than 90% mean identity to one loci within St. malthophilia 
K279a reference genome. All four contigs align between 1 248 699- 1 282 959bp with a 1.5-kb 
deletion between contigs 10 and 8.  
D) JM6 fosmid contigs 2, 3 and 4 aligned against reference genome. Contig 2 aligns with 1 loci at 
moderate synteny of 63%. 
E) JM2 fosmid contigs 18, 19 and 20 aligned against reference genome. Contig 18 is has aligned to 
1 loci with moderate synteny of 63%. 
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APPENDIX A2: Exploring IS1111-attC translocation potential 
 
Appendix A2.1 Screening Pst587 natural transformants for IS1111-attC translocation 
using plasmid flanking primers, NVC15 and NVC16 
Initial attempts to detect IS1111-attC translocation involved the use of crude total plate DNA 
as the PCR template and the flanking NVC15 and NVC16 primer pair (Figure A19). 
However, this method was not sensitive enough to detect IS translocation. Instead, individual 
transformants were screened for translocation (Figures A20 & A21). Screening individual 
transformants by these means identified IS1111-attC postive translocation into pPsattC1 trap 
only. Note that no positive controls were available for any of these PCR screens. Expected 
sizes were 1.8 and 1.7 kb for pPsattC and paadB-attC translocation respectively. 
 
 
Figure A19: Crude total plate harvest and plasmid flanking primers were not sensitive enough for the 
detection of an attC-trap invasion.  
Empty pPsattC traps and paadB-attC traps generate PCR products of  550-bp and 420-bp 
respectively. PCR product was generated using NVC15 and NVC 16 primers and total plate boil lysed 
DNA. In all screens, 20 ng, 200 ng and 2000 ng of boil lysed DNA was used as PCR template. 
Purified pattC traps (pPsattC1, pPsattC2, paadb-attC1 and paadB-atttc2) were used as a control. 
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Figure A20: Identifying IS1111-attC translocation positive Pst587 transformants by use of pattC 
flanking primers. Lane 51 and 52: pPs-attC1 constructs only. Expected product size is ~1.8-kb. Boil 
lysed DNA was used as PCR template with primers NVC15 and NVC16. Transformants 4, 6 and 8 are 
positive for intact translocation. Lanes 1-50: correspond to 50 Pst581 transformants screened. 
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Figure A21: Screening a) pPsattC1 b) pPSattC2 c) paadB-attC1 d) paadB-attC2 transformants for 
intact ISPst6 translocation. All showed a PCR signal for empty attC site.  
Only lane 20 of panel (a) showed a product of 1.8-kB, indicating insertion of an ISPst6 element into 
the Pseudomonas attC site. This transformant was annotated as Natural Transformant 20 (NT20) 
pPsattC1-IS and has a mixed plasmid population composed of pPsattC1 and pPsattC1-IS. 
  
A) 
 
 
 
 
B) 
 
 
 
C) 
 
 
 
D) 
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A2.2 Trap-IS junction PCR did not detect IS1111-attC translocation positive Pst587 transformants (pPsattC2 and paadB_attC2 traps). 
An alternative screening method, other than using pattC flanking primers NVC 15 and NVC16, is the use of one flanking primer with an ISPst6 
specific primer (ST123). NVC15 and ST123, were used to detect IS1111-attC translocation positive Pst587 transformed with pPsattC2 (←) and 
paadB_attC2 (←). In each case, 50 transformants were screened with this primer combination. However, no positive transformants were 
detected.  Note, there is no available positive control for this PCR. In silico prediction of the expected product sizes are 384-bp and 332-bp for 
pPsattC2 and paadB_attC2 respectively.   
 
    
Figure A22: Trap-IS junction PCR did not detect IS1111-attC translocation positive Pst587 transformed with a) pPsattC2 and b) paadB_attC2 traps. Lanes 
1-50: correspond to 50 Pst587 transformants. Lanes 51 and 52: pattC trap plasmid DNA. Lanes 53 and 54: NTC not template control. Boil lysed DNA was 
used as PCR template with primers NVC15 and NVC16. 
A) 
B) 
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A2.3 Mixed plasmid population, paadB_attC1 and paadB_attC1-IS is present in Pst587 
NT1 
Junction screening Pst587 transformants with paad_attC1 was expected to produce a single 
PCR product of ~280-bp. Instead, the product was over 300-bp. An additional band of ~500-
bp was observed, however this band was also present in the negative control. The plasmid 
was recovered from Pst587 NT1 and was rescreened for both the plasmid-IS junction and 
flanking product. The expected product size of ~298-bp corresponding to the plasmid-IS 
junction was observed when purified Pst587 NT1 plasmid preparation was used as template 
DNA. In comparison the positive control pPsattC1-IS produced a product whose size was 
greater by ~100-bp than expected. Furthermore, screening the NT1 plasmid preparation using 
plasmid flanking primer (NVC15/NVC16) gave a PCR product of ~400-bp, corresponging to 
empty attCaadB flanking size. 
                              
 
 
 
 
 
 
 
 
 
 
 
Figure A23: Junction and flanking PCR NT1 plasmid DNA suggests the presence of a mixed plasmid 
population.  
A) Junction PCR for ISPst6 element within paadB-attC1 trap. Primers NVC16 and ST123. Lane 1: 
paadB_attC1-IS plasmid  DNA from NT1, lane 2: pPsattC1-IS control DNA Lane 3: NTC (no 
template DNA). Note lanes 1 is expected to be ~100-bp smaller to pPsattC1-IS. B) Flanking PCR 
using NVC15 and NVC16 presence of empty aadB-attC1 site. Lane 1: paadB_attC1-IS plasmid DNA 
from NT1, lane 2: paadB_attC1 control,  Lane 3: NTC (no template DNA). Empty attC site is ~400-
bp. 
A) B) 
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A2.4 Pst405 and PstQ transformants maintain intact pPsattC1_IS constructs. 
Flanking primers (NVC15/NVC16) were used to screen for a loss of IS1111-attC elements 
from the introduced construct. If IS1111-attC translocation was by a cut-&-paste 
mechansism, then restoration of an empty Pseudomonas-type attC site was expected. The 
PCR product size would have dropped from ~1.8-kb to ~400-bp. In all transformants 
screened, restoration was not observed. 
 
 
Figure A24: A) Pst405 transformants and B) PstQ transformants maintain intact pPsattC1-IS 
constructs.  
Lanes 1-50: correspond to 50 transformants screened. Boil lysed DNA was used as PCR template. 
Lane 51: NT20 mixed plasmid preparation used as a control where a transformant may contain a 
mixed plasmid preparation of pPsattC1-IS and pPsattC1. Lane 52: pattC constructs only. Lane 53 
pBBR1MCS2 vector and Lane 54: no template control. 
 
A) 
 
 
 
 
 
 
 
 
 
 
 
B) 
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A2.5 Detection of ISPst6 minicircles in PstQ and Pst641 transformants 
To screen for the formation of ISPst6 minicircles in PstQ and Pst641 electrocompetent 
transformants, individual transformants were picked, DNA was prepared by boil lysis prior to 
PCR. ISPst6 specific minicircle primers ST89 and ST123 were used. These outwards facing 
(reverse) primers anneal at either end of the IS element. A product of ~280-bp is only 
possible if the IS has formed a minicircle.   
 
 
 
 
 
Figure A25:  
a) PstQ transformants 2, 8, 49 and 50 potentially have ISPst6 minicircles. 
 Lanes 1-50: correspond to 50 PstQ transformants screened. Lane 51: Pst587 gDNA positive 
for ISPst6 minicircles at 258-bp. Lane 52:  PstQ gDNA negative for ISPst6 minicircle. Lane 
53: no template control.  
b) Pst641 transformants 5, 9 and 11 potentially have ISPst6 minicircles. 
 Lanes 1-12: correspond to 12 Pst641 transformants screened.  Lane 13: Pst587 gDNA 
positive control for ISPst6 minicircles. Lane 14: no template control. 
A) PstQ   
B) Pst641   
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A2.5.1 Recovered ISPst6 minicircle junction sequences from PstQ and Pst641 transformants 
ISPst6 minicircle junction DNA was recovered from PstQ ET2 and Pst641 ET9. In both sequences, three nucleotide base differences were present when 
compared to the wild-type Pst587 sequence (Figure A26). At the alignment position 95 a G replaced an A, at position 109 a C replaced a T and at position 
123 a G replaced an A. 
 
Figure A26: Alignment of PstQET2, Pst641ET9 and Pst587 ISPst6 minicircle junctions. 
Primer sequences ST89 and ST123 are annotated in green. Non-coding regions (NCR) are annotated in hot pink, the inverted repeats (IRR and IRL) are in 
light blue and the 10-bp junction that forms upon circularization is shown in yellow. 
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APPENDIX A3: MBP Control 
 
Appendix A3.1 Expression of MBP as a control 
 
 
Figure A27: SDS-PAGE analysis of purified MBP protein. MBP was expressed in E.coli Rosetta2.  
Lane 1: Uninduced Rosetta2 cells. Lane 2: Cell lysate was separated by centrifugation to give soluble 
fraction. Lanes 3-4: Flow through amylose resin, which was washed in excess column buffer Lane 5. 
Lanes 6-9: MBP was eluted with 50mM maltose. Expected protein size is ~42 kDa. 
 
  
 
 
 
